*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER B 51 SER.? 1000.00 A 123 HIS E 97 HIS.? 1000.00 A 172 ASP B 48 ASP^? 1000.00 coo 45.74 29.80 42.79 47.58 31.06 41.64 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 44.17 25.61 37.60 45.21 25.56 35.81 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 39.85 24.35 34.94 41.12 25.58 33.83 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER D 51 SER.? 1000.00 A 123 HIS C 97 HIS.? 1000.00 A 172 ASP D 48 ASP^? 1000.00 coo 45.74 29.80 42.79 47.58 31.06 41.64 -33.08 -53.53 -7.15 -34.77 -54.71 -5.86 coo 44.17 25.61 37.60 45.21 25.56 35.81 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 39.85 24.35 34.94 41.12 25.58 33.83 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o00 naa= 3 ULMN 4 1a0j_c08 TRYPSIN user 1 4 # 1 A 57 HIS E 97 HIS.? 1000.00 A 102 ASP B 48 ASP^? 1000.00 A 195 SER B 51 SER.? 1000.00 A 196 GLY B 30 GLY^? 1000.00 coo 25.57 41.22 61.68 24.18 39.98 62.50 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 22.33 45.48 59.73 23.35 43.67 60.06 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 20.90 36.72 61.65 22.18 37.53 63.52 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 20.40 37.63 58.06 19.79 37.28 58.50 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 1a0j_c08 source 1a0j TRYPSIN : 1 hits 1a0j_c08 naa= 4 ULMN 4 1a0j_c09 TRYPSIN user 1 4 # 1 B 57 HIS E 97 HIS.? 1000.00 B 102 ASP B 48 ASP^? 1000.00 B 195 SER B 51 SER.? 1000.00 B 196 GLY B 30 GLY^? 1000.00 coo 44.08 45.58 52.81 45.86 46.55 52.85 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 43.04 44.75 47.18 43.31 45.51 49.13 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 48.11 50.52 52.24 48.62 48.46 53.13 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 45.44 52.17 50.15 46.23 52.37 50.05 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 1a0j_c09 source 1a0j TRYPSIN : 1 hits 1a0j_c09 naa= 4 ULMN 4 1a0j_c10 TRYPSIN user 1 4 # 1 C 57 HIS E 97 HIS.? 1000.00 C 102 ASP B 48 ASP^? 1000.00 C 195 SER B 51 SER.? 1000.00 C 196 GLY B 30 GLY^? 1000.00 coo 34.37 41.18 73.21 34.04 43.09 73.87 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 34.89 38.34 78.12 35.11 39.59 76.42 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 36.16 46.87 75.66 34.01 46.43 74.59 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 39.34 45.13 76.73 39.04 45.77 77.16 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 1a0j_c10 source 1a0j TRYPSIN : 1 hits 1a0j_c10 naa= 4 ULMN 4 1a0j_c11 TRYPSIN user 1 4 # 1 D 57 HIS E 97 HIS.? 1000.00 D 102 ASP B 48 ASP^? 1000.00 D 195 SER B 51 SER.? 1000.00 D 196 GLY B 30 GLY^? 1000.00 coo 8.19 15.01 95.72 7.78 16.53 97.01 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 13.53 16.28 93.98 11.45 16.21 94.40 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 6.63 21.03 97.42 6.71 19.20 98.95 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 7.63 22.04 93.90 7.66 22.58 94.52 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 1a0j_c11 source 1a0j TRYPSIN : 1 hits 1a0j_c11 naa= 4 ULMN 4 1a6d_c00 THERMOSOME user 1 4 # 1 A 63 ASP A 48 ASP^? 1000.00 A 96 THR A 46 THR^? 1000.00 A 97 THR A 34 THR^? 1000.00 A 390 ASP E 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -42.33 -15.12 -56.08 -43.18 -13.58 -57.35 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 4 1a6d_c00 THERMOSOME user 2 4 # 2 A 63 ASP A 48 ASP^? 1000.00 A 96 THR A 46 THR^? 1000.00 A 97 THR A 45 THR^? 1000.00 A 390 ASP E 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -45.89 -12.76 -52.82 -46.50 -13.35 -50.80 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 4 1a6d_c00 THERMOSOME user 3 4 # 3 A 63 ASP B 48 ASP^? 1000.00 A 96 THR B 46 THR^? 1000.00 A 97 THR B 34 THR^? 1000.00 A 390 ASP G 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -15.59 -35.86 -44.93 -16.46 -33.88 -45.17 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -19.36 -36.24 -46.83 -19.64 -34.64 -45.39 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 4 1a6d_c00 THERMOSOME user 4 4 # 4 A 63 ASP B 48 ASP^? 1000.00 A 96 THR B 46 THR^? 1000.00 A 97 THR B 45 THR^? 1000.00 A 390 ASP G 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -15.59 -35.86 -44.93 -16.46 -33.88 -45.17 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -16.90 -38.16 -42.20 -16.20 -40.16 -42.73 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 4 1a6d_c00 THERMOSOME user 5 4 # 5 A 63 ASP C 48 ASP^? 1000.00 A 96 THR C 46 THR^? 1000.00 A 97 THR C 34 THR^? 1000.00 A 390 ASP F 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -54.65 -37.38 -25.18 -56.17 -36.99 -26.65 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -52.37 -37.85 -28.96 -54.37 -38.44 -29.47 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 4 1a6d_c00 THERMOSOME user 6 4 # 6 A 63 ASP C 48 ASP^? 1000.00 A 96 THR C 46 THR^? 1000.00 A 97 THR C 45 THR^? 1000.00 A 390 ASP F 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -54.65 -37.38 -25.18 -56.17 -36.99 -26.65 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -53.59 -40.92 -24.31 -52.41 -41.01 -22.49 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 4 1a6d_c00 THERMOSOME user 7 4 # 7 A 63 ASP D 48 ASP^? 1000.00 A 96 THR D 46 THR^? 1000.00 A 97 THR D 34 THR^? 1000.00 A 390 ASP H 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -27.50 -50.23 -21.22 -29.54 -49.49 -21.28 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -27.89 -46.26 -19.44 -29.31 -46.15 -21.09 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1a6d_c00 THERMOSOME user 8 4 # 8 A 63 ASP D 48 ASP^? 1000.00 A 96 THR D 46 THR^? 1000.00 A 97 THR D 45 THR^? 1000.00 A 390 ASP H 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -27.50 -50.23 -21.22 -29.54 -49.49 -21.28 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -24.99 -48.61 -23.54 -22.98 -49.39 -23.53 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1a6d_c00 THERMOSOME user 9 4 # 9 A 63 ASP E 48 ASP^? 1000.00 A 96 THR E 45 THR^? 1000.00 A 97 THR E 34 THR^? 1000.00 A 390 ASP A 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -29.94 -11.10 -40.28 -29.56 -9.06 -39.62 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 4 1a6d_c00 THERMOSOME user 10 4 # 10 A 63 ASP E 48 ASP^? 1000.00 A 96 THR E 46 THR^? 1000.00 A 97 THR E 34 THR^? 1000.00 A 390 ASP A 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -30.70 -8.84 -43.79 -31.20 -7.44 -42.21 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -29.94 -11.10 -40.28 -29.56 -9.06 -39.62 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 4 1a6d_c00 THERMOSOME user 11 4 # 11 A 63 ASP E 48 ASP^? 1000.00 A 96 THR E 46 THR^? 1000.00 A 97 THR E 45 THR^? 1000.00 A 390 ASP A 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -30.70 -8.84 -43.79 -31.20 -7.44 -42.21 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 4 1a6d_c00 THERMOSOME user 12 4 # 12 A 63 ASP F 48 ASP^? 1000.00 A 96 THR F 46 THR^? 1000.00 A 97 THR F 34 THR^? 1000.00 A 390 ASP C 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -53.66 -24.14 -16.36 -54.70 -24.62 -14.51 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -50.35 -23.30 -13.81 -52.09 -22.66 -12.66 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 ULMN 4 1a6d_c00 THERMOSOME user 13 4 # 13 A 63 ASP F 48 ASP^? 1000.00 A 96 THR F 46 THR^? 1000.00 A 97 THR F 45 THR^? 1000.00 A 390 ASP C 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -53.66 -24.14 -16.36 -54.70 -24.62 -14.51 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -53.13 -20.55 -17.44 -52.54 -20.20 -19.48 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 ULMN 4 1a6d_c00 THERMOSOME user 14 4 # 14 A 63 ASP G 48 ASP^? 1000.00 A 96 THR G 45 THR^? 1000.00 A 97 THR G 34 THR^? 1000.00 A 390 ASP B 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -1.50 -34.99 -56.46 -3.32 -34.36 -57.43 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -0.50 -39.88 -54.46 1.25 -38.89 -53.69 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 4 1a6d_c00 THERMOSOME user 15 4 # 15 A 63 ASP G 48 ASP^? 1000.00 A 96 THR G 46 THR^? 1000.00 A 97 THR G 34 THR^? 1000.00 A 390 ASP B 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -1.95 -36.32 -52.94 -0.35 -36.61 -51.51 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -0.50 -39.88 -54.46 1.25 -38.89 -53.69 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 4 1a6d_c00 THERMOSOME user 16 4 # 16 A 63 ASP G 48 ASP^? 1000.00 A 96 THR G 46 THR^? 1000.00 A 97 THR G 45 THR^? 1000.00 A 390 ASP B 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -1.95 -36.32 -52.94 -0.35 -36.61 -51.51 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -1.50 -34.99 -56.46 -3.32 -34.36 -57.43 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 4 1a6d_c00 THERMOSOME user 17 4 # 17 A 63 ASP H 48 ASP^? 1000.00 A 96 THR H 46 THR^? 1000.00 A 97 THR H 34 THR^? 1000.00 A 390 ASP D 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -27.27 -63.43 -12.62 -26.65 -64.97 -14.02 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -23.65 -64.63 -10.64 -24.28 -66.51 -11.50 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 4 1a6d_c00 THERMOSOME user 18 4 # 18 A 63 ASP H 48 ASP^? 1000.00 A 96 THR H 46 THR^? 1000.00 A 97 THR H 45 THR^? 1000.00 A 390 ASP D 48 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 -27.27 -63.43 -12.62 -26.65 -64.97 -14.02 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 -28.98 -64.21 -9.31 -29.95 -62.48 -8.44 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 1a6d_c00 source 1a6d THERMOSOME : 18 hits 1a6d_c00 naa= 4 ULMN 4 1a6d_c01 THERMOSOME user 1 4 # 1 B 62 ASP A 48 ASP^? 1000.00 B 95 THR A 34 THR^? 1000.00 B 96 THR A 45 THR^? 1000.00 B 391 ASP E 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -42.33 -15.12 -56.08 -43.18 -13.58 -57.35 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -45.89 -12.76 -52.82 -46.50 -13.35 -50.80 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 4 1a6d_c01 THERMOSOME user 2 4 # 2 B 62 ASP A 48 ASP^? 1000.00 B 95 THR A 45 THR^? 1000.00 B 96 THR A 34 THR^? 1000.00 B 391 ASP E 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -45.89 -12.76 -52.82 -46.50 -13.35 -50.80 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -42.33 -15.12 -56.08 -43.18 -13.58 -57.35 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 4 1a6d_c01 THERMOSOME user 3 4 # 3 B 62 ASP B 48 ASP^? 1000.00 B 95 THR B 45 THR^? 1000.00 B 96 THR B 34 THR^? 1000.00 B 391 ASP G 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -16.90 -38.16 -42.20 -16.20 -40.16 -42.73 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -19.36 -36.24 -46.83 -19.64 -34.64 -45.39 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 4 1a6d_c01 THERMOSOME user 4 4 # 4 B 62 ASP B 48 ASP^? 1000.00 B 95 THR B 46 THR^? 1000.00 B 96 THR B 34 THR^? 1000.00 B 391 ASP G 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -15.59 -35.86 -44.93 -16.46 -33.88 -45.17 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -19.36 -36.24 -46.83 -19.64 -34.64 -45.39 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 4 1a6d_c01 THERMOSOME user 5 4 # 5 B 62 ASP B 48 ASP^? 1000.00 B 95 THR B 46 THR^? 1000.00 B 96 THR B 45 THR^? 1000.00 B 391 ASP G 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -15.59 -35.86 -44.93 -16.46 -33.88 -45.17 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -16.90 -38.16 -42.20 -16.20 -40.16 -42.73 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 4 1a6d_c01 THERMOSOME user 6 4 # 6 B 62 ASP C 48 ASP^? 1000.00 B 95 THR C 45 THR^? 1000.00 B 96 THR C 34 THR^? 1000.00 B 391 ASP F 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -53.59 -40.92 -24.31 -52.41 -41.01 -22.49 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -52.37 -37.85 -28.96 -54.37 -38.44 -29.47 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 4 1a6d_c01 THERMOSOME user 7 4 # 7 B 62 ASP C 48 ASP^? 1000.00 B 95 THR C 45 THR^? 1000.00 B 96 THR C 46 THR^? 1000.00 B 391 ASP F 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -53.59 -40.92 -24.31 -52.41 -41.01 -22.49 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -54.65 -37.38 -25.18 -56.17 -36.99 -26.65 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 4 1a6d_c01 THERMOSOME user 8 4 # 8 B 62 ASP D 48 ASP^? 1000.00 B 95 THR D 45 THR^? 1000.00 B 96 THR D 34 THR^? 1000.00 B 391 ASP H 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -24.99 -48.61 -23.54 -22.98 -49.39 -23.53 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -27.89 -46.26 -19.44 -29.31 -46.15 -21.09 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1a6d_c01 THERMOSOME user 9 4 # 9 B 62 ASP D 48 ASP^? 1000.00 B 95 THR D 46 THR^? 1000.00 B 96 THR D 34 THR^? 1000.00 B 391 ASP H 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -27.50 -50.23 -21.22 -29.54 -49.49 -21.28 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -27.89 -46.26 -19.44 -29.31 -46.15 -21.09 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1a6d_c01 THERMOSOME user 10 4 # 10 B 62 ASP E 48 ASP^? 1000.00 B 95 THR E 34 THR^? 1000.00 B 96 THR E 45 THR^? 1000.00 B 391 ASP A 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -29.94 -11.10 -40.28 -29.56 -9.06 -39.62 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 4 1a6d_c01 THERMOSOME user 11 4 # 11 B 62 ASP E 48 ASP^? 1000.00 B 95 THR E 45 THR^? 1000.00 B 96 THR E 34 THR^? 1000.00 B 391 ASP A 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -29.94 -11.10 -40.28 -29.56 -9.06 -39.62 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 4 1a6d_c01 THERMOSOME user 12 4 # 12 B 62 ASP F 48 ASP^? 1000.00 B 95 THR F 34 THR^? 1000.00 B 96 THR F 45 THR^? 1000.00 B 391 ASP C 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -50.35 -23.30 -13.81 -52.09 -22.66 -12.66 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -53.13 -20.55 -17.44 -52.54 -20.20 -19.48 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 ULMN 4 1a6d_c01 THERMOSOME user 13 4 # 13 B 62 ASP F 48 ASP^? 1000.00 B 95 THR F 45 THR^? 1000.00 B 96 THR F 34 THR^? 1000.00 B 391 ASP C 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -53.13 -20.55 -17.44 -52.54 -20.20 -19.48 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -50.35 -23.30 -13.81 -52.09 -22.66 -12.66 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 ULMN 4 1a6d_c01 THERMOSOME user 14 4 # 14 B 62 ASP G 48 ASP^? 1000.00 B 95 THR G 45 THR^? 1000.00 B 96 THR G 34 THR^? 1000.00 B 391 ASP B 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -1.50 -34.99 -56.46 -3.32 -34.36 -57.43 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -0.50 -39.88 -54.46 1.25 -38.89 -53.69 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 4 1a6d_c01 THERMOSOME user 15 4 # 15 B 62 ASP G 48 ASP^? 1000.00 B 95 THR G 45 THR^? 1000.00 B 96 THR G 46 THR^? 1000.00 B 391 ASP B 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -1.50 -34.99 -56.46 -3.32 -34.36 -57.43 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -1.95 -36.32 -52.94 -0.35 -36.61 -51.51 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 4 1a6d_c01 THERMOSOME user 16 4 # 16 B 62 ASP H 48 ASP^? 1000.00 B 95 THR H 45 THR^? 1000.00 B 96 THR H 34 THR^? 1000.00 B 391 ASP D 48 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 -28.98 -64.21 -9.31 -29.95 -62.48 -8.44 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 -23.65 -64.63 -10.64 -24.28 -66.51 -11.50 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 1a6d_c01 source 1a6d THERMOSOME : 16 hits 1a6d_c01 naa= 4 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 1 4 # 1 A 140 ALA D 73 ALA^? 1000.00 A 141 PRO D 4 PRO.? 1000.00 A 228 ASP H 48 ASP^? 1000.00 A 257 HIS C 94 HIS.? 1000.00 coo -3.17 33.71 41.15 -2.19 32.81 40.39 -36.99 -48.67 -12.69 -37.55 -48.29 -11.33 coo -4.29 30.56 43.91 -3.25 32.54 44.01 -34.18 -45.60 -10.06 -35.28 -44.24 -8.70 coo 2.03 38.95 28.44 3.60 38.60 29.83 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 6.85 37.62 29.99 7.50 38.47 31.78 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 2 4 # 2 A 140 ALA D 73 ALA^? 1000.00 A 141 PRO D 4 PRO.? 1000.00 A 228 ASP H 48 ASP^? 1000.00 A 257 HIS C 95 HIS.? 1000.00 coo -3.17 33.71 41.15 -2.19 32.81 40.39 -36.99 -48.67 -12.69 -37.55 -48.29 -11.33 coo -4.29 30.56 43.91 -3.25 32.54 44.01 -34.18 -45.60 -10.06 -35.28 -44.24 -8.70 coo 2.03 38.95 28.44 3.60 38.60 29.83 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 6.85 37.62 29.99 7.50 38.47 31.78 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 3 4 # 3 A 140 ALA D 73 ALA^? 1000.00 A 141 PRO D 24 PRO.? 1000.00 A 228 ASP H 48 ASP^? 1000.00 A 257 HIS C 94 HIS.? 1000.00 coo -3.17 33.71 41.15 -2.19 32.81 40.39 -36.99 -48.67 -12.69 -37.55 -48.29 -11.33 coo -4.29 30.56 43.91 -3.25 32.54 44.01 -36.92 -47.80 -7.54 -36.58 -47.25 -5.40 coo 2.03 38.95 28.44 3.60 38.60 29.83 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 6.85 37.62 29.99 7.50 38.47 31.78 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 ULMN 4 1a7u_c04 CHLOROPEROXIDASE T user 4 4 # 4 A 140 ALA D 73 ALA^? 1000.00 A 141 PRO D 24 PRO.? 1000.00 A 228 ASP H 48 ASP^? 1000.00 A 257 HIS C 95 HIS.? 1000.00 coo -3.17 33.71 41.15 -2.19 32.81 40.39 -36.99 -48.67 -12.69 -37.55 -48.29 -11.33 coo -4.29 30.56 43.91 -3.25 32.54 44.01 -36.92 -47.80 -7.54 -36.58 -47.25 -5.40 coo 2.03 38.95 28.44 3.60 38.60 29.83 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 6.85 37.62 29.99 7.50 38.47 31.78 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 1a7u_c04 source 1a7u CHLOROPEROXIDASE T : 4 hits 1a7u_c04 naa= 4 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 C 88 ASP B 40 ASP.? 1000.00 C 89 ASP B 43 ASP.? 1000.00 C 92 ASP D 43 ASP.? 1000.00 C 115 LYS D 38 LYS.? 1000.00 coo 35.82 109.51 58.11 36.79 111.39 58.16 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 34.50 112.32 53.52 36.24 113.36 54.10 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 44.76 111.03 53.07 46.05 111.62 51.50 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 43.88 105.59 49.49 44.98 111.77 48.53 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 4 1a95_c00 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 C 88 ASP B 43 ASP.? 1000.00 C 89 ASP B 40 ASP.? 1000.00 C 92 ASP D 43 ASP.? 1000.00 C 115 LYS D 38 LYS.? 1000.00 coo 35.82 109.51 58.11 36.79 111.39 58.16 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 34.50 112.32 53.52 36.24 113.36 54.10 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 44.76 111.03 53.07 46.05 111.62 51.50 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 43.88 105.59 49.49 44.98 111.77 48.53 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 1a95_c00 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 2 hits 1a95_c00 naa= 4 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 A 88 ASP B 40 ASP.? 1000.00 A 89 ASP B 43 ASP.? 1000.00 A 92 ASP D 43 ASP.? 1000.00 A 115 LYS D 38 LYS.? 1000.00 coo 28.94 110.40 17.72 27.05 109.42 17.78 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 27.21 110.68 22.97 26.09 108.99 22.41 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 28.82 100.59 20.87 28.57 98.90 22.12 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 34.37 100.82 23.64 28.36 99.87 25.42 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 4 1a95_c01 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 A 88 ASP B 43 ASP.? 1000.00 A 89 ASP B 40 ASP.? 1000.00 A 92 ASP D 43 ASP.? 1000.00 A 115 LYS D 38 LYS.? 1000.00 coo 28.94 110.40 17.72 27.05 109.42 17.78 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 27.21 110.68 22.97 26.09 108.99 22.41 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 28.82 100.59 20.87 28.57 98.90 22.12 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 34.37 100.82 23.64 28.36 99.87 25.42 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 1a95_c01 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 2 hits 1a95_c01 naa= 4 ULMN 4 1a95_c02 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 B 88 ASP B 43 ASP.? 1000.00 B 89 ASP B 40 ASP.? 1000.00 B 92 ASP D 43 ASP.? 1000.00 B 115 LYS D 38 LYS.? 1000.00 coo 15.87 130.02 20.98 17.78 130.94 20.91 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 18.52 128.66 25.62 19.66 130.36 25.09 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 17.38 138.95 26.03 17.97 140.13 27.68 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 11.86 138.01 29.49 18.01 139.06 30.49 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 1a95_c02 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 1 hits 1a95_c02 naa= 4 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 1 4 # 1 D 88 ASP B 40 ASP.? 1000.00 D 89 ASP B 43 ASP.? 1000.00 D 92 ASP D 43 ASP.? 1000.00 D 115 LYS D 38 LYS.? 1000.00 coo 16.10 122.43 61.36 15.17 120.52 61.32 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 16.52 120.83 56.08 14.84 119.68 56.64 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 6.41 122.44 58.21 4.75 122.21 56.90 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 6.66 128.09 55.52 5.74 122.11 53.55 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 4 1a95_c03 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSuser 2 4 # 2 D 88 ASP B 43 ASP.? 1000.00 D 89 ASP B 40 ASP.? 1000.00 D 92 ASP D 43 ASP.? 1000.00 D 115 LYS D 38 LYS.? 1000.00 coo 16.10 122.43 61.36 15.17 120.52 61.32 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 16.52 120.83 56.08 14.84 119.68 56.64 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 6.41 122.44 58.21 4.75 122.21 56.90 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 6.66 128.09 55.52 5.74 122.11 53.55 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 1a95_c03 source 1a95 XANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE : 2 hits 1a95_c03 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP B 40 ASP.? 1000.00 M 206 SER B 51 SER.? 1000.00 M 210 ARG B 74 ARG^? 1000.00 M 214 ASN B 75 ASN^? 1000.00 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -13.12 -21.77 -56.53 -13.64 -22.77 -58.34 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP H 48 ASP^? 1000.00 M 206 SER B 42 SER.? 1000.00 M 210 ARG B 37 ARG^? 1000.00 M 214 ASN B 39 ASN.? 1000.00 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -25.67 -45.26 -38.37 -22.78 -45.37 -37.35 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 2 hits 1c17_c11 naa= 4 ULMN 4 1ca0_c02 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 1 4 # 1 B 57 HIS E 97 HIS.? 1000.00 B 102 ASP B 48 ASP^? 1000.00 C 195 SER B 51 SER.? 1000.00 C 196 GLY B 30 GLY^? 1000.00 coo 9.31 59.87 4.78 10.85 60.06 6.19 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 5.59 57.53 8.57 7.14 58.09 7.29 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 14.55 58.92 8.37 13.10 60.57 7.33 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 13.67 55.27 8.79 14.08 55.70 9.37 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 1ca0_c02 source 1ca0 PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLO: 1 hits 1ca0_c02 naa= 4 ULMN 4 1ca0_c03 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 1 4 # 1 G 57 HIS E 97 HIS.? 1000.00 G 102 ASP B 48 ASP^? 1000.00 H 195 SER B 51 SER.? 1000.00 H 196 GLY B 30 GLY^? 1000.00 coo 55.62 80.38 34.57 53.54 80.49 34.33 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 55.92 77.51 29.55 55.59 78.35 31.47 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 49.36 79.22 35.31 50.95 80.97 34.93 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 49.96 75.54 34.73 49.24 75.92 34.45 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 1ca0_c03 source 1ca0 PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLO: 1 hits 1ca0_c03 naa= 4 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 1 4 # 1 A1020 THR A 88 THR^? 1000.00 A1034 TYR A 67 TYR^? 1000.00 A1100 THR A 13 THR.? 1000.00 B3294 GLU A 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -49.69 -29.03 -55.58 -51.35 -29.56 -56.84 coo 35.38 132.08 89.27 36.78 129.74 88.76 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo 43.56 124.16 89.51 42.17 124.73 91.05 -47.58 -31.45 -46.99 -46.54 -30.67 -45.25 coo 33.89 125.64 85.55 35.54 126.95 85.33 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 2 4 # 2 A1020 THR A 89 THR.? 1000.00 A1034 TYR A 67 TYR^? 1000.00 A1100 THR A 13 THR.? 1000.00 B3294 GLU A 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -50.23 -29.32 -51.83 -50.84 -27.38 -51.08 coo 35.38 132.08 89.27 36.78 129.74 88.76 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo 43.56 124.16 89.51 42.17 124.73 91.05 -47.58 -31.45 -46.99 -46.54 -30.67 -45.25 coo 33.89 125.64 85.55 35.54 126.95 85.33 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 3 4 # 3 A1020 THR C 88 THR^? 1000.00 A1034 TYR C 67 TYR^? 1000.00 A1100 THR C 13 THR.? 1000.00 B3294 GLU C 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 coo 35.38 132.08 89.27 36.78 129.74 88.76 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 43.56 124.16 89.51 42.17 124.73 91.05 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 coo 33.89 125.64 85.55 35.54 126.95 85.33 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 4 4 # 4 A1020 THR C 89 THR.? 1000.00 A1034 TYR C 67 TYR^? 1000.00 A1100 THR C 13 THR.? 1000.00 B3294 GLU C 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 coo 35.38 132.08 89.27 36.78 129.74 88.76 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 43.56 124.16 89.51 42.17 124.73 91.05 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 coo 33.89 125.64 85.55 35.54 126.95 85.33 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 5 4 # 5 A1020 THR D 88 THR^? 1000.00 A1034 TYR D 67 TYR^? 1000.00 A1100 THR D 13 THR.? 1000.00 B3294 GLU D 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -17.07 -35.15 -17.54 -16.96 -33.51 -18.95 coo 35.38 132.08 89.27 36.78 129.74 88.76 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo 43.56 124.16 89.51 42.17 124.73 91.05 -10.53 -40.25 -13.37 -10.17 -42.31 -12.84 coo 33.89 125.64 85.55 35.54 126.95 85.33 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 6 4 # 6 A1020 THR D 89 THR.? 1000.00 A1034 TYR D 67 TYR^? 1000.00 A1100 THR D 13 THR.? 1000.00 B3294 GLU D 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -13.87 -37.20 -17.43 -14.13 -38.77 -18.92 coo 35.38 132.08 89.27 36.78 129.74 88.76 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo 43.56 124.16 89.51 42.17 124.73 91.05 -10.53 -40.25 -13.37 -10.17 -42.31 -12.84 coo 33.89 125.64 85.55 35.54 126.95 85.33 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 7 4 # 7 A1020 THR E 15 THR.? 1000.00 A1034 TYR B 79 TYR^? 1000.00 A1100 THR E 89 THR.? 1000.00 B3294 GLU E 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo 35.38 132.08 89.27 36.78 129.74 88.76 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 coo 43.56 124.16 89.51 42.17 124.73 91.05 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 coo 33.89 125.64 85.55 35.54 126.95 85.33 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 8 4 # 8 A1020 THR E 88 THR^? 1000.00 A1034 TYR E 67 TYR^? 1000.00 A1100 THR E 13 THR.? 1000.00 B3294 GLU E 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 coo 35.38 132.08 89.27 36.78 129.74 88.76 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo 43.56 124.16 89.51 42.17 124.73 91.05 -22.32 -28.98 -42.19 -23.52 -29.23 -44.03 coo 33.89 125.64 85.55 35.54 126.95 85.33 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 9 4 # 9 A1020 THR E 89 THR.? 1000.00 A1034 TYR E 67 TYR^? 1000.00 A1100 THR E 13 THR.? 1000.00 B3294 GLU E 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 coo 35.38 132.08 89.27 36.78 129.74 88.76 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo 43.56 124.16 89.51 42.17 124.73 91.05 -22.32 -28.98 -42.19 -23.52 -29.23 -44.03 coo 33.89 125.64 85.55 35.54 126.95 85.33 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 10 4 # 10 A1020 THR F 88 THR^? 1000.00 A1034 TYR F 67 TYR^? 1000.00 A1100 THR F 13 THR.? 1000.00 B3294 GLU F 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -37.77 -14.05 -15.00 -37.42 -12.10 -14.15 coo 35.38 132.08 89.27 36.78 129.74 88.76 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 43.56 124.16 89.51 42.17 124.73 91.05 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 coo 33.89 125.64 85.55 35.54 126.95 85.33 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 11 4 # 11 A1020 THR F 89 THR.? 1000.00 A1034 TYR F 67 TYR^? 1000.00 A1100 THR F 13 THR.? 1000.00 B3294 GLU F 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -37.46 -13.84 -18.76 -39.46 -13.48 -19.54 coo 35.38 132.08 89.27 36.78 129.74 88.76 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 43.56 124.16 89.51 42.17 124.73 91.05 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 coo 33.89 125.64 85.55 35.54 126.95 85.33 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 12 4 # 12 A1020 THR G 88 THR^? 1000.00 A1034 TYR G 67 TYR^? 1000.00 A1100 THR G 13 THR.? 1000.00 B3294 GLU G 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -0.28 -46.35 -69.13 1.51 -46.38 -70.37 coo 35.38 132.08 89.27 36.78 129.74 88.76 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo 43.56 124.16 89.51 42.17 124.73 91.05 -8.92 -45.57 -71.07 -10.80 -44.92 -70.18 coo 33.89 125.64 85.55 35.54 126.95 85.33 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 13 4 # 13 A1020 THR H 88 THR^? 1000.00 A1034 TYR H 67 TYR^? 1000.00 A1100 THR H 13 THR.? 1000.00 B3294 GLU H 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -19.24 -64.03 4.54 -19.35 -65.74 5.89 coo 35.38 132.08 89.27 36.78 129.74 88.76 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo 43.56 124.16 89.51 42.17 124.73 91.05 -20.65 -55.18 6.19 -21.38 -53.37 5.29 coo 33.89 125.64 85.55 35.54 126.95 85.33 -29.93 -63.04 6.06 -30.63 -65.03 6.10 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 14 4 # 14 A1020 THR H 89 THR.? 1000.00 A1034 TYR H 67 TYR^? 1000.00 A1100 THR H 13 THR.? 1000.00 B3294 GLU H 62 GLU.? 1000.00 coo 40.94 131.25 89.60 39.24 130.12 90.27 -21.17 -60.97 5.70 -23.15 -61.14 4.87 coo 35.38 132.08 89.27 36.78 129.74 88.76 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo 43.56 124.16 89.51 42.17 124.73 91.05 -20.65 -55.18 6.19 -21.38 -53.37 5.29 coo 33.89 125.64 85.55 35.54 126.95 85.33 -29.93 -63.04 6.06 -30.63 -65.03 6.10 1djo_c00 source 1djo GLUTAMINASE-ASPARAGINASE : 14 hits 1djo_c00 naa= 4 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 1 4 # 1 A1294 GLU A 62 GLU.? 1000.00 B3020 THR A 88 THR^? 1000.00 B3034 TYR A 67 TYR^? 1000.00 B3100 THR A 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 35.69 87.89 89.88 37.41 89.09 90.33 -49.69 -29.03 -55.58 -51.35 -29.56 -56.84 coo 40.98 87.08 88.86 39.63 89.46 88.41 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo 33.09 94.86 90.18 34.63 94.22 91.55 -47.58 -31.45 -46.99 -46.54 -30.67 -45.25 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 2 4 # 2 A1294 GLU A 62 GLU.? 1000.00 B3020 THR A 89 THR.? 1000.00 B3034 TYR A 67 TYR^? 1000.00 B3100 THR A 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 35.69 87.89 89.88 37.41 89.09 90.33 -50.23 -29.32 -51.83 -50.84 -27.38 -51.08 coo 40.98 87.08 88.86 39.63 89.46 88.41 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo 33.09 94.86 90.18 34.63 94.22 91.55 -47.58 -31.45 -46.99 -46.54 -30.67 -45.25 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 3 4 # 3 A1294 GLU A 62 GLU.? 1000.00 B3020 THR A 89 THR.? 1000.00 B3034 TYR A 67 TYR^? 1000.00 B3100 THR A 16 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 35.69 87.89 89.88 37.41 89.09 90.33 -50.23 -29.32 -51.83 -50.84 -27.38 -51.08 coo 40.98 87.08 88.86 39.63 89.46 88.41 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo 33.09 94.86 90.18 34.63 94.22 91.55 -46.17 -26.76 -46.24 -44.99 -27.18 -44.49 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 4 4 # 4 A1294 GLU C 62 GLU.? 1000.00 B3020 THR C 15 THR.? 1000.00 B3034 TYR D 79 TYR^? 1000.00 B3100 THR C 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 35.69 87.89 89.88 37.41 89.09 90.33 -38.42 -45.23 -22.32 -37.90 -45.95 -20.35 coo 40.98 87.08 88.86 39.63 89.46 88.41 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 33.09 94.86 90.18 34.63 94.22 91.55 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 5 4 # 5 A1294 GLU C 62 GLU.? 1000.00 B3020 THR C 15 THR.? 1000.00 B3034 TYR D 79 TYR^? 1000.00 B3100 THR C 89 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 35.69 87.89 89.88 37.41 89.09 90.33 -38.42 -45.23 -22.32 -37.90 -45.95 -20.35 coo 40.98 87.08 88.86 39.63 89.46 88.41 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 33.09 94.86 90.18 34.63 94.22 91.55 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 6 4 # 6 A1294 GLU C 62 GLU.? 1000.00 B3020 THR C 88 THR^? 1000.00 B3034 TYR C 67 TYR^? 1000.00 B3100 THR C 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 35.69 87.89 89.88 37.41 89.09 90.33 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 coo 40.98 87.08 88.86 39.63 89.46 88.41 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 33.09 94.86 90.18 34.63 94.22 91.55 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 7 4 # 7 A1294 GLU C 62 GLU.? 1000.00 B3020 THR C 89 THR.? 1000.00 B3034 TYR C 67 TYR^? 1000.00 B3100 THR C 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 35.69 87.89 89.88 37.41 89.09 90.33 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 coo 40.98 87.08 88.86 39.63 89.46 88.41 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 33.09 94.86 90.18 34.63 94.22 91.55 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 8 4 # 8 A1294 GLU D 62 GLU.? 1000.00 B3020 THR D 88 THR^? 1000.00 B3034 TYR D 67 TYR^? 1000.00 B3100 THR D 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 coo 35.69 87.89 89.88 37.41 89.09 90.33 -17.07 -35.15 -17.54 -16.96 -33.51 -18.95 coo 40.98 87.08 88.86 39.63 89.46 88.41 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo 33.09 94.86 90.18 34.63 94.22 91.55 -10.53 -40.25 -13.37 -10.17 -42.31 -12.84 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 9 4 # 9 A1294 GLU D 62 GLU.? 1000.00 B3020 THR D 89 THR.? 1000.00 B3034 TYR D 67 TYR^? 1000.00 B3100 THR D 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 coo 35.69 87.89 89.88 37.41 89.09 90.33 -13.87 -37.20 -17.43 -14.13 -38.77 -18.92 coo 40.98 87.08 88.86 39.63 89.46 88.41 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo 33.09 94.86 90.18 34.63 94.22 91.55 -10.53 -40.25 -13.37 -10.17 -42.31 -12.84 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 10 4 # 10 A1294 GLU D 62 GLU.? 1000.00 B3020 THR D 89 THR.? 1000.00 B3034 TYR D 67 TYR^? 1000.00 B3100 THR D 16 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 coo 35.69 87.89 89.88 37.41 89.09 90.33 -13.87 -37.20 -17.43 -14.13 -38.77 -18.92 coo 40.98 87.08 88.86 39.63 89.46 88.41 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo 33.09 94.86 90.18 34.63 94.22 91.55 -13.26 -44.36 -15.10 -11.61 -45.23 -13.98 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 11 4 # 11 A1294 GLU E 62 GLU.? 1000.00 B3020 THR E 15 THR.? 1000.00 B3034 TYR B 79 TYR^? 1000.00 B3100 THR E 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 35.69 87.89 89.88 37.41 89.09 90.33 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo 40.98 87.08 88.86 39.63 89.46 88.41 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 coo 33.09 94.86 90.18 34.63 94.22 91.55 -22.32 -28.98 -42.19 -23.52 -29.23 -44.03 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 12 4 # 12 A1294 GLU E 62 GLU.? 1000.00 B3020 THR E 15 THR.? 1000.00 B3034 TYR B 79 TYR^? 1000.00 B3100 THR E 89 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 35.69 87.89 89.88 37.41 89.09 90.33 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo 40.98 87.08 88.86 39.63 89.46 88.41 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 coo 33.09 94.86 90.18 34.63 94.22 91.55 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 13 4 # 13 A1294 GLU E 62 GLU.? 1000.00 B3020 THR E 88 THR^? 1000.00 B3034 TYR E 67 TYR^? 1000.00 B3100 THR E 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 35.69 87.89 89.88 37.41 89.09 90.33 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 coo 40.98 87.08 88.86 39.63 89.46 88.41 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo 33.09 94.86 90.18 34.63 94.22 91.55 -22.32 -28.98 -42.19 -23.52 -29.23 -44.03 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 14 4 # 14 A1294 GLU E 62 GLU.? 1000.00 B3020 THR E 89 THR.? 1000.00 B3034 TYR E 67 TYR^? 1000.00 B3100 THR E 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 35.69 87.89 89.88 37.41 89.09 90.33 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 coo 40.98 87.08 88.86 39.63 89.46 88.41 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo 33.09 94.86 90.18 34.63 94.22 91.55 -22.32 -28.98 -42.19 -23.52 -29.23 -44.03 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 15 4 # 15 A1294 GLU F 62 GLU.? 1000.00 B3020 THR F 88 THR^? 1000.00 B3034 TYR F 67 TYR^? 1000.00 B3100 THR F 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 35.69 87.89 89.88 37.41 89.09 90.33 -37.77 -14.05 -15.00 -37.42 -12.10 -14.15 coo 40.98 87.08 88.86 39.63 89.46 88.41 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 33.09 94.86 90.18 34.63 94.22 91.55 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 16 4 # 16 A1294 GLU F 62 GLU.? 1000.00 B3020 THR F 89 THR.? 1000.00 B3034 TYR F 67 TYR^? 1000.00 B3100 THR F 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 35.69 87.89 89.88 37.41 89.09 90.33 -37.46 -13.84 -18.76 -39.46 -13.48 -19.54 coo 40.98 87.08 88.86 39.63 89.46 88.41 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 33.09 94.86 90.18 34.63 94.22 91.55 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 17 4 # 17 A1294 GLU G 62 GLU.? 1000.00 B3020 THR G 88 THR^? 1000.00 B3034 TYR G 67 TYR^? 1000.00 B3100 THR G 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 35.69 87.89 89.88 37.41 89.09 90.33 -0.28 -46.35 -69.13 1.51 -46.38 -70.37 coo 40.98 87.08 88.86 39.63 89.46 88.41 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo 33.09 94.86 90.18 34.63 94.22 91.55 -8.92 -45.57 -71.07 -10.80 -44.92 -70.18 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 18 4 # 18 A1294 GLU G 62 GLU.? 1000.00 B3020 THR G 89 THR.? 1000.00 B3034 TYR G 67 TYR^? 1000.00 B3100 THR G 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 35.69 87.89 89.88 37.41 89.09 90.33 -3.47 -44.79 -70.49 -3.37 -42.68 -70.06 coo 40.98 87.08 88.86 39.63 89.46 88.41 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo 33.09 94.86 90.18 34.63 94.22 91.55 -8.92 -45.57 -71.07 -10.80 -44.92 -70.18 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 19 4 # 19 A1294 GLU H 62 GLU.? 1000.00 B3020 THR H 88 THR^? 1000.00 B3034 TYR H 67 TYR^? 1000.00 B3100 THR H 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -29.93 -63.04 6.06 -30.63 -65.03 6.10 coo 35.69 87.89 89.88 37.41 89.09 90.33 -19.24 -64.03 4.54 -19.35 -65.74 5.89 coo 40.98 87.08 88.86 39.63 89.46 88.41 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo 33.09 94.86 90.18 34.63 94.22 91.55 -20.65 -55.18 6.19 -21.38 -53.37 5.29 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 20 4 # 20 A1294 GLU H 62 GLU.? 1000.00 B3020 THR H 89 THR.? 1000.00 B3034 TYR H 67 TYR^? 1000.00 B3100 THR H 13 THR.? 1000.00 coo 42.18 93.40 84.96 40.44 92.19 85.03 -29.93 -63.04 6.06 -30.63 -65.03 6.10 coo 35.69 87.89 89.88 37.41 89.09 90.33 -21.17 -60.97 5.70 -23.15 -61.14 4.87 coo 40.98 87.08 88.86 39.63 89.46 88.41 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo 33.09 94.86 90.18 34.63 94.22 91.55 -20.65 -55.18 6.19 -21.38 -53.37 5.29 1djo_c01 source 1djo GLUTAMINASE-ASPARAGINASE : 20 hits 1djo_c01 naa= 4 ULMN 4 1dnk_c00 DNA (5'-D(*GP*GP*TP*AP*TP*AP*C)-3') user 1 4 # 1 A 78 GLU D 29 GLU.? 1000.00 A 134 HIS C 97 HIS.? 1000.00 A 212 ASP H 48 ASP^? 1000.00 A 252 HIS C 95 HIS.? 1000.00 coo -14.14 41.26 -17.08 -15.94 40.74 -16.28 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 coo -19.39 38.52 -15.93 -19.35 39.89 -14.38 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -23.92 32.04 -10.64 -22.67 33.68 -10.21 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -20.50 36.14 -8.06 -21.57 37.72 -8.96 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 1dnk_c00 source 1dnk DNA (5'-D(*GP*GP*TP*AP*TP*AP*C)-3') : 1 hits 1dnk_c00 naa= 4 ULMN 4 1e6e_c00 ADRENODOXIN user 1 4 # 1 A 55 HIS C 94 HIS.? 1000.00 A 159 ASP D 48 ASP^? 1000.00 A 376 ILE H 53 ILE^? 1000.00 A 377 THR D 57 THR^? 1000.00 coo 17.95 58.52 112.81 17.29 59.41 111.03 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 11.32 57.46 110.35 12.85 58.48 111.39 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 15.00 65.23 121.40 15.42 63.95 122.00 -19.51 -52.57 -15.70 -20.80 -52.19 -15.11 coo 15.65 69.77 121.40 17.38 70.64 120.41 -17.76 -48.52 -11.62 -16.05 -48.76 -10.33 ULMN 4 1e6e_c00 ADRENODOXIN user 2 4 # 2 A 55 HIS C 94 HIS.? 1000.00 A 159 ASP D 48 ASP^? 1000.00 A 376 ILE H 53 ILE^? 1000.00 A 377 THR H 54 THR^? 1000.00 coo 17.95 58.52 112.81 17.29 59.41 111.03 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 11.32 57.46 110.35 12.85 58.48 111.39 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 15.00 65.23 121.40 15.42 63.95 122.00 -19.51 -52.57 -15.70 -20.80 -52.19 -15.11 coo 15.65 69.77 121.40 17.38 70.64 120.41 -15.69 -53.56 -13.29 -13.97 -52.36 -13.82 ULMN 4 1e6e_c00 ADRENODOXIN user 3 4 # 3 A 55 HIS E 94 HIS.? 1000.00 A 159 ASP B 48 ASP^? 1000.00 A 376 ILE G 53 ILE^? 1000.00 A 377 THR B 57 THR^? 1000.00 coo 17.95 58.52 112.81 17.29 59.41 111.03 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 11.32 57.46 110.35 12.85 58.48 111.39 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 15.00 65.23 121.40 15.42 63.95 122.00 -12.22 -44.44 -49.29 -12.65 -43.20 -49.80 coo 15.65 69.77 121.40 17.38 70.64 120.41 -15.96 -46.87 -53.11 -15.82 -48.81 -54.08 ULMN 4 1e6e_c00 ADRENODOXIN user 4 4 # 4 A 55 HIS E 94 HIS.? 1000.00 A 159 ASP B 48 ASP^? 1000.00 A 376 ILE G 53 ILE^? 1000.00 A 377 THR G 54 THR^? 1000.00 coo 17.95 58.52 112.81 17.29 59.41 111.03 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 11.32 57.46 110.35 12.85 58.48 111.39 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 15.00 65.23 121.40 15.42 63.95 122.00 -12.22 -44.44 -49.29 -12.65 -43.20 -49.80 coo 15.65 69.77 121.40 17.38 70.64 120.41 -10.90 -48.54 -51.13 -12.05 -50.22 -50.40 1e6e_c00 source 1e6e ADRENODOXIN : 4 hits 1e6e_c00 naa= 4 ULMN 4 1e6e_c01 ADRENODOXIN user 1 4 # 1 C 55 HIS C 94 HIS.? 1000.00 C 159 ASP D 48 ASP^? 1000.00 C 376 ILE H 53 ILE^? 1000.00 C 377 THR D 57 THR^? 1000.00 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -19.51 -52.57 -15.70 -20.80 -52.19 -15.11 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -17.76 -48.52 -11.62 -16.05 -48.76 -10.33 ULMN 4 1e6e_c01 ADRENODOXIN user 2 4 # 2 C 55 HIS C 94 HIS.? 1000.00 C 159 ASP D 48 ASP^? 1000.00 C 376 ILE H 53 ILE^? 1000.00 C 377 THR H 54 THR^? 1000.00 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -19.51 -52.57 -15.70 -20.80 -52.19 -15.11 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -15.69 -53.56 -13.29 -13.97 -52.36 -13.82 ULMN 4 1e6e_c01 ADRENODOXIN user 3 4 # 3 C 55 HIS E 94 HIS.? 1000.00 C 159 ASP B 48 ASP^? 1000.00 C 376 ILE G 53 ILE^? 1000.00 C 377 THR B 57 THR^? 1000.00 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -12.22 -44.44 -49.29 -12.65 -43.20 -49.80 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -15.96 -46.87 -53.11 -15.82 -48.81 -54.08 ULMN 4 1e6e_c01 ADRENODOXIN user 4 4 # 4 C 55 HIS E 94 HIS.? 1000.00 C 159 ASP B 48 ASP^? 1000.00 C 376 ILE G 53 ILE^? 1000.00 C 377 THR G 54 THR^? 1000.00 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -12.22 -44.44 -49.29 -12.65 -43.20 -49.80 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -10.90 -48.54 -51.13 -12.05 -50.22 -50.40 1e6e_c01 source 1e6e ADRENODOXIN : 4 hits 1e6e_c01 naa= 4 ULMN 4 1e7l_c00 RECOMBINATION ENDONUCLEASE VII user 1 4 # 1 A 41 HIS C 96 HIS.? 1000.00 A 43 HIS C 97 HIS.? 1000.00 A 65 GLU D 29 GLU.? 1000.00 B 105 HIS C 95 HIS.? 1000.00 coo -8.56 17.41 8.71 -9.21 15.58 9.51 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo -7.86 15.79 13.55 -6.41 15.13 12.19 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 0.61 18.90 14.14 -0.63 19.28 12.44 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 coo -9.53 15.99 5.74 -8.28 14.32 5.53 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 1e7l_c00 source 1e7l RECOMBINATION ENDONUCLEASE VII : 1 hits 1e7l_c00 naa= 4 ULMN 4 1e7l_c02 RECOMBINATION ENDONUCLEASE VII user 1 4 # 1 A 41 HIS C 96 HIS.? 1000.00 A 43 HIS C 97 HIS.? 1000.00 A 65 GLU D 29 GLU.? 1000.00 B 105 HIS C 95 HIS.? 1000.00 coo -8.56 17.41 8.71 -9.21 15.58 9.51 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo -7.86 15.79 13.55 -6.41 15.13 12.19 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 0.61 18.90 14.14 -0.63 19.28 12.44 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 coo -9.53 15.99 5.74 -8.28 14.32 5.53 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 1e7l_c02 source 1e7l RECOMBINATION ENDONUCLEASE VII : 1 hits 1e7l_c02 naa= 4 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 1 4 # 1 B 48 THR C 59 THR.? 1000.00 B 106 TYR D 79 TYR^? 1000.00 B 113 ASN C 64 ASN.? 1000.00 B 190 THR C 88 THR^? 1000.00 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 -41.85 -40.94 -20.16 -41.56 -39.78 -18.35 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 2 4 # 2 B 48 THR E 59 THR.? 1000.00 B 106 TYR B 79 TYR^? 1000.00 B 113 ASN E 64 ASN.? 1000.00 B 190 THR E 88 THR^? 1000.00 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 -25.29 -22.15 -48.17 -26.48 -22.83 -49.84 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 1eyp_c01 source 1eyp CHALCONE-FLAVONONE ISOMERASE 1 : 2 hits 1eyp_c01 naa= 4 ULMN 4 1j00_c00 THIOESTERASE I user 1 4 # 1 A 44 GLY D 76 GLY.? 1000.00 A 73 ASN D 75 ASN^? 1000.00 A 154 ASP D 48 ASP^? 1000.00 A 157 HIS C 96 HIS.? 1000.00 coo 5.31 35.31 46.19 5.56 34.58 46.17 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 coo 1.82 33.37 49.33 3.83 34.09 49.37 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 coo 8.45 43.15 56.37 9.67 41.50 55.89 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.95 38.09 54.06 8.12 38.46 53.08 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 1j00_c00 source 1j00 THIOESTERASE I : 1 hits 1j00_c00 naa= 4 ULMN 4 1j00_c01 THIOESTERASE I user 1 4 # 1 A 44 GLY D 76 GLY.? 1000.00 A 73 ASN D 75 ASN^? 1000.00 A 154 ASP D 48 ASP^? 1000.00 A 157 HIS C 96 HIS.? 1000.00 coo 5.31 35.31 46.19 5.56 34.58 46.17 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 coo 1.82 33.37 49.33 3.83 34.09 49.37 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 coo 8.45 43.15 56.37 9.67 41.50 55.89 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.95 38.09 54.06 8.12 38.46 53.08 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 1j00_c01 source 1j00 THIOESTERASE I : 1 hits 1j00_c01 naa= 4 ULMN 4 1n8o_c01 CHYMOTRYPSIN A, B CHAIN user 1 4 # 1 B 57 HIS E 97 HIS.? 1000.00 B 102 ASP B 48 ASP^? 1000.00 C 195 SER B 51 SER.? 1000.00 C 196 GLY B 30 GLY^? 1000.00 coo 31.98 -6.99 19.44 30.75 -5.55 18.68 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 36.93 -4.10 19.45 35.15 -5.13 19.05 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 28.33 -3.35 15.58 28.24 -4.45 17.63 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 31.25 -3.44 13.14 30.79 -2.74 13.19 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 1n8o_c01 source 1n8o CHYMOTRYPSIN A, B CHAIN : 1 hits 1n8o_c01 naa= 4 ULMN 4 1oba_c00 ENDOLYSIN user 1 4 # 1 A 10 ASP B 43 ASP.? 1000.00 A 92 ASP D 43 ASP.? 1000.00 A 94 GLU D 44 GLU.? 1000.00 A 182 ASP B 40 ASP.? 1000.00 coo 16.84 44.60 22.54 17.52 46.59 22.35 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 15.90 47.65 31.20 16.27 49.40 30.09 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 16.57 52.97 31.35 16.60 52.99 29.25 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 17.78 48.19 20.08 17.00 49.80 21.19 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 1oba_c00 source 1oba ENDOLYSIN : 1 hits 1oba_c00 naa= 4 ULMN 4 1q3q_c00 THERMOSOME ALPHA SUBUNIT user 1 4 # 1 A 64 ASP A 48 ASP^? 1000.00 A 97 THR A 46 THR^? 1000.00 A 98 THR A 34 THR^? 1000.00 A 393 ASP E 48 ASP^? 1000.00 coo 59.86 10.34 27.30 60.35 12.00 28.50 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 58.74 18.44 26.67 59.40 16.69 27.77 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 coo 57.84 17.57 23.09 57.09 15.82 22.10 -42.33 -15.12 -56.08 -43.18 -13.58 -57.35 coo 54.80 12.16 32.55 56.65 12.25 31.53 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 1q3q_c00 source 1q3q THERMOSOME ALPHA SUBUNIT : 1 hits 1q3q_c00 naa= 4 ULMN 4 1q3q_c01 THERMOSOME ALPHA SUBUNIT user 1 4 # 1 B 64 ASP A 48 ASP^? 1000.00 B 97 THR A 46 THR^? 1000.00 B 98 THR A 34 THR^? 1000.00 B 393 ASP E 48 ASP^? 1000.00 coo 65.73 -24.45 27.34 64.91 -22.86 28.45 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 59.15 -19.67 26.64 60.83 -20.49 27.71 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 coo 59.06 -20.82 23.02 59.87 -22.53 21.97 -42.33 -15.12 -56.08 -43.18 -13.58 -57.35 coo 60.77 -26.95 32.48 62.05 -25.69 31.35 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 1q3q_c01 source 1q3q THERMOSOME ALPHA SUBUNIT : 1 hits 1q3q_c01 naa= 4 ULMN 4 1q3q_c02 THERMOSOME ALPHA SUBUNIT user 1 4 # 1 C 64 ASP A 48 ASP^? 1000.00 C 97 THR A 46 THR^? 1000.00 C 98 THR A 34 THR^? 1000.00 C 393 ASP E 48 ASP^? 1000.00 coo 78.19 37.47 -17.60 76.77 36.40 -18.75 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 70.28 35.53 -16.93 72.19 35.63 -17.95 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 coo 70.77 36.63 -13.33 72.12 37.96 -12.27 -42.33 -15.12 -56.08 -43.18 -13.58 -57.35 coo 74.68 41.54 -22.78 75.15 39.79 -21.68 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 1q3q_c02 source 1q3q THERMOSOME ALPHA SUBUNIT : 1 hits 1q3q_c02 naa= 4 ULMN 4 1q3q_c03 THERMOSOME ALPHA SUBUNIT user 1 4 # 1 D 64 ASP A 48 ASP^? 1000.00 D 97 THR A 46 THR^? 1000.00 D 98 THR A 34 THR^? 1000.00 D 393 ASP E 48 ASP^? 1000.00 coo 59.28 7.65 -17.60 59.05 5.92 -18.77 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 55.19 0.63 -16.84 56.48 2.01 -17.90 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 coo 54.63 1.67 -13.23 54.72 3.56 -12.17 -42.33 -15.12 -56.08 -43.18 -13.58 -57.35 coo 53.92 8.02 -22.70 55.50 7.17 -21.57 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 1q3q_c03 source 1q3q THERMOSOME ALPHA SUBUNIT : 1 hits 1q3q_c03 naa= 4 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 1 4 # 1 A 41 HIS C 95 HIS.? 1000.00 A 43 ASP D 48 ASP^? 1000.00 A 74 HIS C 96 HIS.? 1000.00 A 185 ASP H 48 ASP^? 1000.00 coo 27.18 71.98 22.91 26.19 71.28 21.20 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 31.38 70.47 18.87 29.95 71.93 19.26 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 26.06 68.61 17.65 25.72 69.17 15.65 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 24.70 75.42 18.17 26.81 75.34 18.23 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 2 4 # 2 A 41 HIS E 94 HIS.? 1000.00 A 43 ASP G 48 ASP^? 1000.00 A 74 HIS E 95 HIS.? 1000.00 A 185 ASP B 48 ASP^? 1000.00 coo 27.18 71.98 22.91 26.19 71.28 21.20 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 31.38 70.47 18.87 29.95 71.93 19.26 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 26.06 68.61 17.65 25.72 69.17 15.65 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 24.70 75.42 18.17 26.81 75.34 18.23 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 3 4 # 3 A 41 HIS E 95 HIS.? 1000.00 A 43 ASP B 48 ASP^? 1000.00 A 74 HIS E 96 HIS.? 1000.00 A 185 ASP G 48 ASP^? 1000.00 coo 27.18 71.98 22.91 26.19 71.28 21.20 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 31.38 70.47 18.87 29.95 71.93 19.26 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 26.06 68.61 17.65 25.72 69.17 15.65 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 24.70 75.42 18.17 26.81 75.34 18.23 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 4 1rpx_c03 RIBULOSE-PHOSPHATE 3-EPIMERASE user 4 4 # 4 A 41 HIS E 95 HIS.? 1000.00 A 43 ASP G 48 ASP^? 1000.00 A 74 HIS E 94 HIS.? 1000.00 A 185 ASP B 48 ASP^? 1000.00 coo 27.18 71.98 22.91 26.19 71.28 21.20 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 31.38 70.47 18.87 29.95 71.93 19.26 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 26.06 68.61 17.65 25.72 69.17 15.65 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 24.70 75.42 18.17 26.81 75.34 18.23 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 1rpx_c03 source 1rpx RIBULOSE-PHOSPHATE 3-EPIMERASE : 4 hits 1rpx_c03 naa= 4 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 1 4 # 1 B 41 HIS C 94 HIS.? 1000.00 B 43 ASP D 48 ASP^? 1000.00 B 74 HIS C 95 HIS.? 1000.00 B 185 ASP H 48 ASP^? 1000.00 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 2 4 # 2 B 41 HIS C 94 HIS.? 1000.00 B 43 ASP H 48 ASP^? 1000.00 B 74 HIS C 95 HIS.? 1000.00 B 185 ASP D 48 ASP^? 1000.00 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 3 4 # 3 B 41 HIS C 95 HIS.? 1000.00 B 43 ASP D 48 ASP^? 1000.00 B 74 HIS C 94 HIS.? 1000.00 B 185 ASP H 48 ASP^? 1000.00 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 4 4 # 4 B 41 HIS C 95 HIS.? 1000.00 B 43 ASP D 48 ASP^? 1000.00 B 74 HIS C 96 HIS.? 1000.00 B 185 ASP H 48 ASP^? 1000.00 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 5 4 # 5 B 41 HIS C 95 HIS.? 1000.00 B 43 ASP H 48 ASP^? 1000.00 B 74 HIS C 94 HIS.? 1000.00 B 185 ASP D 48 ASP^? 1000.00 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 6 4 # 6 B 41 HIS E 94 HIS.? 1000.00 B 43 ASP G 48 ASP^? 1000.00 B 74 HIS E 95 HIS.? 1000.00 B 185 ASP B 48 ASP^? 1000.00 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 7 4 # 7 B 41 HIS E 95 HIS.? 1000.00 B 43 ASP B 48 ASP^? 1000.00 B 74 HIS E 96 HIS.? 1000.00 B 185 ASP G 48 ASP^? 1000.00 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 4 1rpx_c04 RIBULOSE-PHOSPHATE 3-EPIMERASE user 8 4 # 8 B 41 HIS E 95 HIS.? 1000.00 B 43 ASP G 48 ASP^? 1000.00 B 74 HIS E 94 HIS.? 1000.00 B 185 ASP B 48 ASP^? 1000.00 coo 24.50 75.09 -19.51 23.89 74.34 -17.66 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 26.91 69.57 -18.85 25.09 70.47 -19.25 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 24.59 71.76 -14.04 23.29 70.30 -13.26 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 19.05 72.11 -18.25 20.45 70.96 -19.39 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 1rpx_c04 source 1rpx RIBULOSE-PHOSPHATE 3-EPIMERASE : 8 hits 1rpx_c04 naa= 4 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 1 4 # 1 C 41 HIS C 94 HIS.? 1000.00 C 43 ASP D 48 ASP^? 1000.00 C 74 HIS C 95 HIS.? 1000.00 C 185 ASP H 48 ASP^? 1000.00 coo 7.25 41.55 0.57 8.02 43.50 0.47 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 12.91 41.40 2.63 11.01 42.07 3.21 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 11.42 46.38 0.05 11.97 47.90 1.39 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 6.41 46.06 4.90 7.75 44.49 5.43 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 2 4 # 2 C 41 HIS C 94 HIS.? 1000.00 C 43 ASP H 48 ASP^? 1000.00 C 74 HIS C 95 HIS.? 1000.00 C 185 ASP D 48 ASP^? 1000.00 coo 7.25 41.55 0.57 8.02 43.50 0.47 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 12.91 41.40 2.63 11.01 42.07 3.21 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 11.42 46.38 0.05 11.97 47.90 1.39 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 6.41 46.06 4.90 7.75 44.49 5.43 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 3 4 # 3 C 41 HIS C 95 HIS.? 1000.00 C 43 ASP D 48 ASP^? 1000.00 C 74 HIS C 94 HIS.? 1000.00 C 185 ASP H 48 ASP^? 1000.00 coo 7.25 41.55 0.57 8.02 43.50 0.47 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 12.91 41.40 2.63 11.01 42.07 3.21 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 11.42 46.38 0.05 11.97 47.90 1.39 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 6.41 46.06 4.90 7.75 44.49 5.43 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 4 4 # 4 C 41 HIS C 95 HIS.? 1000.00 C 43 ASP D 48 ASP^? 1000.00 C 74 HIS C 96 HIS.? 1000.00 C 185 ASP H 48 ASP^? 1000.00 coo 7.25 41.55 0.57 8.02 43.50 0.47 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 12.91 41.40 2.63 11.01 42.07 3.21 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 11.42 46.38 0.05 11.97 47.90 1.39 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 6.41 46.06 4.90 7.75 44.49 5.43 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 5 4 # 5 C 41 HIS C 95 HIS.? 1000.00 C 43 ASP H 48 ASP^? 1000.00 C 74 HIS C 94 HIS.? 1000.00 C 185 ASP D 48 ASP^? 1000.00 coo 7.25 41.55 0.57 8.02 43.50 0.47 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 12.91 41.40 2.63 11.01 42.07 3.21 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 11.42 46.38 0.05 11.97 47.90 1.39 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 6.41 46.06 4.90 7.75 44.49 5.43 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 6 4 # 6 C 41 HIS E 94 HIS.? 1000.00 C 43 ASP G 48 ASP^? 1000.00 C 74 HIS E 95 HIS.? 1000.00 C 185 ASP B 48 ASP^? 1000.00 coo 7.25 41.55 0.57 8.02 43.50 0.47 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 12.91 41.40 2.63 11.01 42.07 3.21 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 11.42 46.38 0.05 11.97 47.90 1.39 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 6.41 46.06 4.90 7.75 44.49 5.43 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 7 4 # 7 C 41 HIS E 95 HIS.? 1000.00 C 43 ASP B 48 ASP^? 1000.00 C 74 HIS E 96 HIS.? 1000.00 C 185 ASP G 48 ASP^? 1000.00 coo 7.25 41.55 0.57 8.02 43.50 0.47 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 12.91 41.40 2.63 11.01 42.07 3.21 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 11.42 46.38 0.05 11.97 47.90 1.39 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 6.41 46.06 4.90 7.75 44.49 5.43 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 4 1rpx_c05 RIBULOSE-PHOSPHATE 3-EPIMERASE user 8 4 # 8 C 41 HIS E 95 HIS.? 1000.00 C 43 ASP G 48 ASP^? 1000.00 C 74 HIS E 94 HIS.? 1000.00 C 185 ASP B 48 ASP^? 1000.00 coo 7.25 41.55 0.57 8.02 43.50 0.47 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 12.91 41.40 2.63 11.01 42.07 3.21 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 11.42 46.38 0.05 11.97 47.90 1.39 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 6.41 46.06 4.90 7.75 44.49 5.43 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 1rpx_c05 source 1rpx RIBULOSE-PHOSPHATE 3-EPIMERASE : 8 hits 1rpx_c05 naa= 4 ULMN 4 1rtf_c04 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 4 # 1 B 57 HIS E 97 HIS.? 1000.00 B 102 ASP B 48 ASP^? 1000.00 B 195 SER B 51 SER.? 1000.00 B 196 GLY B 30 GLY^? 1000.00 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 0.64 25.09 37.94 0.51 25.31 37.16 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 1rtf_c04 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 1 hits 1rtf_c04 naa= 4 ULMN 4 1x9h_c01 GLUCOSE-6-PHOSPHATE ISOMERASE user 1 4 # 1 B 135 ARG B 70 ARG^? 1000.00 B 203 GLU B 68 GLU^? 1000.00 B 219 HIS C 94 HIS.? 1000.00 B 298 LYS B 8 LYS^? 1000.00 coo 18.36 26.71 24.52 15.92 26.01 22.78 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 19.67 22.60 23.25 18.70 23.07 25.03 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 46.63 12.38 30.98 47.80 13.39 32.39 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 10.17 13.56 26.79 12.26 19.06 29.15 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 4 1x9h_c01 GLUCOSE-6-PHOSPHATE ISOMERASE user 2 4 # 2 B 135 ARG D 70 ARG^? 1000.00 B 203 GLU D 68 GLU^? 1000.00 B 219 HIS E 94 HIS.? 1000.00 B 298 LYS D 8 LYS^? 1000.00 coo 18.36 26.71 24.52 15.92 26.01 22.78 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo 19.67 22.60 23.25 18.70 23.07 25.03 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 coo 46.63 12.38 30.98 47.80 13.39 32.39 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 10.17 13.56 26.79 12.26 19.06 29.15 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 1x9h_c01 source 1x9h GLUCOSE-6-PHOSPHATE ISOMERASE : 2 hits 1x9h_c01 naa= 4 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 1 4 # 1 A 283 GLU C 62 GLU.? 1000.00 C 12 THR C 15 THR.? 1000.00 C 25 TYR D 79 TYR^? 1000.00 C 89 THR C 13 THR.? 1000.00 coo 60.56 18.92 0.90 61.14 20.52 2.16 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 55.95 25.18 2.21 55.69 23.16 3.11 -38.42 -45.23 -22.32 -37.90 -45.95 -20.35 coo 55.67 19.31 -0.41 56.70 20.51 1.90 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 59.81 26.53 8.25 58.00 25.30 8.32 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 ULMN 4 3eca_c04 ASPARAGINASE TYPE II user 2 4 # 2 A 283 GLU C 62 GLU.? 1000.00 C 12 THR C 15 THR.? 1000.00 C 25 TYR D 79 TYR^? 1000.00 C 89 THR C 89 THR.? 1000.00 coo 60.56 18.92 0.90 61.14 20.52 2.16 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 55.95 25.18 2.21 55.69 23.16 3.11 -38.42 -45.23 -22.32 -37.90 -45.95 -20.35 coo 55.67 19.31 -0.41 56.70 20.51 1.90 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 59.81 26.53 8.25 58.00 25.30 8.32 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 3eca_c04 source 3eca ASPARAGINASE TYPE II : 2 hits 3eca_c04 naa= 4 ULMN 4 3eca_c06 ASPARAGINASE TYPE II user 1 4 # 1 A 12 THR C 15 THR.? 1000.00 A 25 TYR D 79 TYR^? 1000.00 A 89 THR C 13 THR.? 1000.00 C 283 GLU C 62 GLU.? 1000.00 coo 76.53 15.20 38.92 75.75 17.07 38.27 -38.42 -45.23 -22.32 -37.90 -45.95 -20.35 coo 78.55 20.90 39.91 77.09 20.09 37.68 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 72.66 13.38 32.85 71.79 14.81 34.24 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 coo 79.85 20.73 35.44 79.36 18.97 34.45 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 ULMN 4 3eca_c06 ASPARAGINASE TYPE II user 2 4 # 2 A 12 THR C 15 THR.? 1000.00 A 25 TYR D 79 TYR^? 1000.00 A 89 THR C 89 THR.? 1000.00 C 283 GLU C 62 GLU.? 1000.00 coo 76.53 15.20 38.92 75.75 17.07 38.27 -38.42 -45.23 -22.32 -37.90 -45.95 -20.35 coo 78.55 20.90 39.91 77.09 20.09 37.68 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 72.66 13.38 32.85 71.79 14.81 34.24 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 coo 79.85 20.73 35.44 79.36 18.97 34.45 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 3eca_c06 source 3eca ASPARAGINASE TYPE II : 2 hits 3eca_c06 naa= 4 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS C 97 HIS.? 1000.00 A 102 ASP D 48 ASP^? 1000.00 A 195 SER D 51 SER.? 1000.00 coo 25.57 41.22 61.68 24.18 39.98 62.50 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 22.33 45.48 59.73 23.35 43.67 60.06 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 20.90 36.72 61.65 22.18 37.53 63.52 -33.08 -53.53 -7.15 -34.77 -54.71 -5.86 ULMN 3 1a0j_c00 TRYPSIN user 2 3 # 2 A 57 HIS E 97 HIS.? 1000.00 A 102 ASP B 48 ASP^? 1000.00 A 195 SER B 51 SER.? 1000.00 coo 25.57 41.22 61.68 24.18 39.98 62.50 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 22.33 45.48 59.73 23.35 43.67 60.06 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 20.90 36.72 61.65 22.18 37.53 63.52 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 1a0j_c00 source 1a0j TRYPSIN : 2 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS E 97 HIS.? 1000.00 B 102 ASP B 48 ASP^? 1000.00 B 195 SER B 51 SER.? 1000.00 coo 44.08 45.58 52.81 45.86 46.55 52.85 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 43.04 44.75 47.18 43.31 45.51 49.13 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 48.11 50.52 52.24 48.62 48.46 53.13 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 1a0j_c01 source 1a0j TRYPSIN : 1 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS C 97 HIS.? 1000.00 C 102 ASP D 48 ASP^? 1000.00 C 195 SER D 51 SER.? 1000.00 coo 34.37 41.18 73.21 34.04 43.09 73.87 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 34.89 38.34 78.12 35.11 39.59 76.42 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 36.16 46.87 75.66 34.01 46.43 74.59 -33.08 -53.53 -7.15 -34.77 -54.71 -5.86 ULMN 3 1a0j_c02 TRYPSIN user 2 3 # 2 C 57 HIS E 97 HIS.? 1000.00 C 102 ASP B 48 ASP^? 1000.00 C 195 SER B 51 SER.? 1000.00 coo 34.37 41.18 73.21 34.04 43.09 73.87 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 34.89 38.34 78.12 35.11 39.59 76.42 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 36.16 46.87 75.66 34.01 46.43 74.59 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 1a0j_c02 source 1a0j TRYPSIN : 2 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS E 97 HIS.? 1000.00 D 102 ASP B 48 ASP^? 1000.00 D 195 SER B 51 SER.? 1000.00 coo 8.19 15.01 95.72 7.78 16.53 97.01 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 13.53 16.28 93.98 11.45 16.21 94.40 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 6.63 21.03 97.42 6.71 19.20 98.95 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 1a0j_c03 source 1a0j TRYPSIN : 1 hits 1a0j_c03 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS C 96 HIS.? 1000.00 A 102 ASP D 48 ASP^? 1000.00 A 193 GLY D 76 GLY.? 1000.00 coo 25.57 41.22 61.68 24.18 39.98 62.50 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 22.33 45.48 59.73 23.35 43.67 60.06 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 22.57 32.23 64.13 21.98 32.82 64.22 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS C 97 HIS.? 1000.00 A 102 ASP D 48 ASP^? 1000.00 A 193 GLY D 76 GLY.? 1000.00 coo 25.57 41.22 61.68 24.18 39.98 62.50 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 22.33 45.48 59.73 23.35 43.67 60.06 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 22.57 32.23 64.13 21.98 32.82 64.22 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 1a0j_c12 source 1a0j TRYPSIN : 2 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS C 94 HIS.? 1000.00 B 102 ASP H 48 ASP^? 1000.00 B 193 GLY H 76 GLY.? 1000.00 coo 44.08 45.58 52.81 45.86 46.55 52.85 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 43.04 44.75 47.18 43.31 45.51 49.13 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 50.46 51.91 56.90 50.65 51.62 56.14 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS C 96 HIS.? 1000.00 B 102 ASP D 48 ASP^? 1000.00 B 193 GLY D 76 GLY.? 1000.00 coo 44.08 45.58 52.81 45.86 46.55 52.85 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 43.04 44.75 47.18 43.31 45.51 49.13 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 50.46 51.91 56.90 50.65 51.62 56.14 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1a0j_c13 TRYPSIN user 3 3 # 3 B 57 HIS C 97 HIS.? 1000.00 B 102 ASP D 48 ASP^? 1000.00 B 193 GLY D 76 GLY.? 1000.00 coo 44.08 45.58 52.81 45.86 46.55 52.85 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 43.04 44.75 47.18 43.31 45.51 49.13 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 50.46 51.91 56.90 50.65 51.62 56.14 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 1a0j_c13 source 1a0j TRYPSIN : 3 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS C 94 HIS.? 1000.00 C 102 ASP H 48 ASP^? 1000.00 C 193 GLY H 76 GLY.? 1000.00 coo 34.37 41.18 73.21 34.04 43.09 73.87 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 34.89 38.34 78.12 35.11 39.59 76.42 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 35.43 51.03 72.12 35.20 50.72 72.87 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS C 96 HIS.? 1000.00 C 102 ASP D 48 ASP^? 1000.00 C 193 GLY D 76 GLY.? 1000.00 coo 34.37 41.18 73.21 34.04 43.09 73.87 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 34.89 38.34 78.12 35.11 39.59 76.42 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 35.43 51.03 72.12 35.20 50.72 72.87 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1a0j_c14 TRYPSIN user 3 3 # 3 C 57 HIS C 97 HIS.? 1000.00 C 102 ASP D 48 ASP^? 1000.00 C 193 GLY D 76 GLY.? 1000.00 coo 34.37 41.18 73.21 34.04 43.09 73.87 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 34.89 38.34 78.12 35.11 39.59 76.42 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 35.43 51.03 72.12 35.20 50.72 72.87 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 1a0j_c14 source 1a0j TRYPSIN : 3 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS C 94 HIS.? 1000.00 D 102 ASP H 48 ASP^? 1000.00 D 193 GLY H 76 GLY.? 1000.00 coo 8.19 15.01 95.72 7.78 16.53 97.01 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 13.53 16.28 93.98 11.45 16.21 94.40 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 1.80 21.25 100.04 2.61 21.42 100.18 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS C 96 HIS.? 1000.00 D 102 ASP D 48 ASP^? 1000.00 D 193 GLY D 76 GLY.? 1000.00 coo 8.19 15.01 95.72 7.78 16.53 97.01 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 13.53 16.28 93.98 11.45 16.21 94.40 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 1.80 21.25 100.04 2.61 21.42 100.18 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1a0j_c15 TRYPSIN user 3 3 # 3 D 57 HIS C 97 HIS.? 1000.00 D 102 ASP D 48 ASP^? 1000.00 D 193 GLY D 76 GLY.? 1000.00 coo 8.19 15.01 95.72 7.78 16.53 97.01 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 13.53 16.28 93.98 11.45 16.21 94.40 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 1.80 21.25 100.04 2.61 21.42 100.18 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 1a0j_c15 source 1a0j TRYPSIN : 3 hits 1a0j_c15 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU C 62 GLU.? 1000.00 A 60 ASP C 43 ASP.? 1000.00 A 175 TYR D 79 TYR^? 1000.00 coo 46.10 28.27 19.27 45.48 26.99 20.84 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 56.42 28.06 12.93 55.01 27.92 14.50 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 45.02 22.04 15.38 46.16 24.00 13.76 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 1 hits 1a50_c03 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER B 51 SER.? 1000.00 A 228 ASP B 48 ASP^? 1000.00 A 257 HIS E 97 HIS.? 1000.00 coo 9.47 41.64 34.15 9.10 39.28 33.93 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 2.03 38.95 28.44 3.60 38.60 29.83 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 6.85 37.62 29.99 7.50 38.47 31.78 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 1 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER B 51 SER.? 1000.00 B 228 ASP B 48 ASP^? 1000.00 B 257 HIS E 97 HIS.? 1000.00 coo 28.35 71.07 3.94 30.08 69.46 4.49 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 32.76 68.02 0.70 31.21 68.44 2.05 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 1 hits 1a7u_c03 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER B 51 SER.? 1000.00 224 ASP B 48 ASP^? 1000.00 253 HIS E 97 HIS.? 1000.00 coo 16.00 80.13 58.60 16.16 82.12 59.96 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 8.47 84.84 62.27 10.52 84.40 62.08 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 13.14 83.03 63.68 14.37 82.62 62.02 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 2 3 # 2 94 SER D 51 SER.? 1000.00 224 ASP D 48 ASP^? 1000.00 253 HIS C 97 HIS.? 1000.00 coo 16.00 80.13 58.60 16.16 82.12 59.96 -33.08 -53.53 -7.15 -34.77 -54.71 -5.86 coo 8.47 84.84 62.27 10.52 84.40 62.08 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 13.14 83.03 63.68 14.37 82.62 62.02 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 2 hits 1a8s_c00 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG G 74 ARG^? 1000.00 78 HIS E 94 HIS.? 1000.00 122 TYR E 67 TYR^? 1000.00 coo 48.32 72.26 30.89 48.69 69.28 31.53 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 53.63 68.24 34.99 53.08 69.10 33.16 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 75.01 61.87 32.93 75.34 59.26 31.96 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG G 74 ARG^? 1000.00 78 HIS E 95 HIS.? 1000.00 122 TYR E 67 TYR^? 1000.00 coo 48.32 72.26 30.89 48.69 69.28 31.53 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 53.63 68.24 34.99 53.08 69.10 33.16 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 75.01 61.87 32.93 75.34 59.26 31.96 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG H 74 ARG^? 1000.00 78 HIS C 94 HIS.? 1000.00 122 TYR C 67 TYR^? 1000.00 coo 48.32 72.26 30.89 48.69 69.28 31.53 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 53.63 68.24 34.99 53.08 69.10 33.16 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 75.01 61.87 32.93 75.34 59.26 31.96 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1ab4_c00 GYRASE A user 4 3 # 4 32 ARG H 74 ARG^? 1000.00 78 HIS C 95 HIS.? 1000.00 122 TYR C 67 TYR^? 1000.00 coo 48.32 72.26 30.89 48.69 69.28 31.53 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 53.63 68.24 34.99 53.08 69.10 33.16 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 75.01 61.87 32.93 75.34 59.26 31.96 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 1ab4_c00 source 1ab4 GYRASE A : 4 hits 1ab4_c00 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS C 94 HIS.? 1000.00 A 262 HIS C 95 HIS.? 1000.00 A 312 ASP D 48 ASP^? 1000.00 coo 29.33 36.13 69.70 30.07 34.20 70.11 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 38.54 36.60 66.38 37.88 34.77 67.15 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 30.62 37.23 61.07 30.08 35.73 62.49 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS C 95 HIS.? 1000.00 A 262 HIS C 94 HIS.? 1000.00 A 312 ASP D 48 ASP^? 1000.00 coo 29.33 36.13 69.70 30.07 34.20 70.11 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 38.54 36.60 66.38 37.88 34.77 67.15 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 30.62 37.23 61.07 30.08 35.73 62.49 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 3 3 # 3 A 223 HIS C 96 HIS.? 1000.00 A 262 HIS C 98 HIS.? 1000.00 A 312 ASP H 48 ASP^? 1000.00 coo 29.33 36.13 69.70 30.07 34.20 70.11 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 38.54 36.60 66.38 37.88 34.77 67.15 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 30.62 37.23 61.07 30.08 35.73 62.49 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 4 3 # 4 A 223 HIS C 98 HIS.? 1000.00 A 262 HIS C 96 HIS.? 1000.00 A 312 ASP H 48 ASP^? 1000.00 coo 29.33 36.13 69.70 30.07 34.20 70.11 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 38.54 36.60 66.38 37.88 34.77 67.15 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 30.62 37.23 61.07 30.08 35.73 62.49 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 5 3 # 5 A 223 HIS E 94 HIS.? 1000.00 A 262 HIS E 95 HIS.? 1000.00 A 312 ASP B 48 ASP^? 1000.00 coo 29.33 36.13 69.70 30.07 34.20 70.11 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 38.54 36.60 66.38 37.88 34.77 67.15 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 30.62 37.23 61.07 30.08 35.73 62.49 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 6 3 # 6 A 223 HIS E 95 HIS.? 1000.00 A 262 HIS E 94 HIS.? 1000.00 A 312 ASP B 48 ASP^? 1000.00 coo 29.33 36.13 69.70 30.07 34.20 70.11 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 38.54 36.60 66.38 37.88 34.77 67.15 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 30.62 37.23 61.07 30.08 35.73 62.49 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 7 3 # 7 A 223 HIS E 95 HIS.? 1000.00 A 262 HIS E 98 HIS.? 1000.00 A 312 ASP B 48 ASP^? 1000.00 coo 29.33 36.13 69.70 30.07 34.20 70.11 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 38.54 36.60 66.38 37.88 34.77 67.15 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 30.62 37.23 61.07 30.08 35.73 62.49 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 8 3 # 8 A 223 HIS E 96 HIS.? 1000.00 A 262 HIS E 98 HIS.? 1000.00 A 312 ASP G 48 ASP^? 1000.00 coo 29.33 36.13 69.70 30.07 34.20 70.11 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 38.54 36.60 66.38 37.88 34.77 67.15 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 30.62 37.23 61.07 30.08 35.73 62.49 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 8 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS C 94 HIS.? 1000.00 B 262 HIS C 95 HIS.? 1000.00 B 312 ASP D 48 ASP^? 1000.00 coo 23.86 29.50 91.20 24.12 31.58 91.00 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 29.35 31.42 99.15 28.72 33.09 98.04 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 20.42 28.25 99.26 20.25 29.62 97.63 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS C 95 HIS.? 1000.00 B 262 HIS C 94 HIS.? 1000.00 B 312 ASP D 48 ASP^? 1000.00 coo 23.86 29.50 91.20 24.12 31.58 91.00 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 29.35 31.42 99.15 28.72 33.09 98.04 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 20.42 28.25 99.26 20.25 29.62 97.63 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 3 3 # 3 B 223 HIS C 96 HIS.? 1000.00 B 262 HIS C 98 HIS.? 1000.00 B 312 ASP H 48 ASP^? 1000.00 coo 23.86 29.50 91.20 24.12 31.58 91.00 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 29.35 31.42 99.15 28.72 33.09 98.04 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 20.42 28.25 99.26 20.25 29.62 97.63 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 4 3 # 4 B 223 HIS C 98 HIS.? 1000.00 B 262 HIS C 96 HIS.? 1000.00 B 312 ASP H 48 ASP^? 1000.00 coo 23.86 29.50 91.20 24.12 31.58 91.00 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 29.35 31.42 99.15 28.72 33.09 98.04 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 20.42 28.25 99.26 20.25 29.62 97.63 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 5 3 # 5 B 223 HIS E 94 HIS.? 1000.00 B 262 HIS E 95 HIS.? 1000.00 B 312 ASP B 48 ASP^? 1000.00 coo 23.86 29.50 91.20 24.12 31.58 91.00 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 29.35 31.42 99.15 28.72 33.09 98.04 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 20.42 28.25 99.26 20.25 29.62 97.63 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 6 3 # 6 B 223 HIS E 95 HIS.? 1000.00 B 262 HIS E 94 HIS.? 1000.00 B 312 ASP B 48 ASP^? 1000.00 coo 23.86 29.50 91.20 24.12 31.58 91.00 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 29.35 31.42 99.15 28.72 33.09 98.04 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 20.42 28.25 99.26 20.25 29.62 97.63 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 7 3 # 7 B 223 HIS E 95 HIS.? 1000.00 B 262 HIS E 98 HIS.? 1000.00 B 312 ASP B 48 ASP^? 1000.00 coo 23.86 29.50 91.20 24.12 31.58 91.00 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 29.35 31.42 99.15 28.72 33.09 98.04 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 20.42 28.25 99.26 20.25 29.62 97.63 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 8 3 # 8 B 223 HIS E 96 HIS.? 1000.00 B 262 HIS E 98 HIS.? 1000.00 B 312 ASP G 48 ASP^? 1000.00 coo 23.86 29.50 91.20 24.12 31.58 91.00 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 29.35 31.42 99.15 28.72 33.09 98.04 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 20.42 28.25 99.26 20.25 29.62 97.63 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 8 hits 1aj8_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS C 95 HIS.? 1000.00 320 HIS C 98 HIS.? 1000.00 375 ASP D 48 ASP^? 1000.00 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS C 96 HIS.? 1000.00 320 HIS C 98 HIS.? 1000.00 375 ASP H 48 ASP^? 1000.00 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1al6_c00 CITRATE SYNTHASE user 3 3 # 3 274 HIS C 98 HIS.? 1000.00 320 HIS C 96 HIS.? 1000.00 375 ASP H 48 ASP^? 1000.00 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1al6_c00 CITRATE SYNTHASE user 4 3 # 4 274 HIS E 95 HIS.? 1000.00 320 HIS E 94 HIS.? 1000.00 375 ASP B 48 ASP^? 1000.00 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1al6_c00 CITRATE SYNTHASE user 5 3 # 5 274 HIS E 95 HIS.? 1000.00 320 HIS E 98 HIS.? 1000.00 375 ASP B 48 ASP^? 1000.00 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1al6_c00 CITRATE SYNTHASE user 6 3 # 6 274 HIS E 96 HIS.? 1000.00 320 HIS E 98 HIS.? 1000.00 375 ASP G 48 ASP^? 1000.00 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1al6_c00 CITRATE SYNTHASE user 7 3 # 7 274 HIS E 98 HIS.? 1000.00 320 HIS E 96 HIS.? 1000.00 375 ASP G 48 ASP^? 1000.00 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 1al6_c00 source 1al6 CITRATE SYNTHASE : 7 hits 1al6_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP B 43 ASP.? 1000.00 35 SER B 42 SER.? 1000.00 215 ASP D 43 ASP.? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP D 40 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 40 ASP.? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1am5_c04 PEPSIN user 3 3 # 3 32 ASP D 40 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 43 ASP.? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1am5_c04 PEPSIN user 4 3 # 4 32 ASP D 43 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 43 ASP.? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1am5_c04 source 1am5 PEPSIN : 4 hits 1am5_c04 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP B 40 ASP.? 1000.00 227 GLU E 93 GLU.? 1000.00 289 ASP D 43 ASP.? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 3.96 55.76 41.24 4.83 57.69 41.17 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP B 43 ASP.? 1000.00 E 36 SER B 42 SER.? 1000.00 E 213 ASP D 43 ASP.? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 28.33 15.15 21.27 28.70 13.12 19.97 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 20.15 16.04 19.79 21.65 14.49 19.86 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP D 40 ASP.? 1000.00 E 36 SER D 42 SER.? 1000.00 E 213 ASP B 40 ASP.? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 28.33 15.15 21.27 28.70 13.12 19.97 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 20.15 16.04 19.79 21.65 14.49 19.86 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 3 # 3 E 33 ASP D 40 ASP.? 1000.00 E 36 SER D 42 SER.? 1000.00 E 213 ASP B 43 ASP.? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 28.33 15.15 21.27 28.70 13.12 19.97 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 20.15 16.04 19.79 21.65 14.49 19.86 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 4 3 # 4 E 33 ASP D 43 ASP.? 1000.00 E 36 SER D 42 SER.? 1000.00 E 213 ASP B 43 ASP.? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 28.33 15.15 21.27 28.70 13.12 19.97 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 20.15 16.04 19.79 21.65 14.49 19.86 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 4 hits 1apt_c04 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER B 80 SER.? 1000.00 A 292 ASP A 48 ASP^? 1000.00 A 322 HIS E 96 HIS.? 1000.00 coo 36.34 32.23 39.60 36.43 34.62 39.93 -21.51 -24.30 -54.11 -21.06 -26.53 -54.83 coo 19.73 19.18 41.39 21.50 18.65 40.34 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 41.69 45.14 46.60 41.78 47.19 46.18 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER B 80 SER.? 1000.00 A 292 ASP A 48 ASP^? 1000.00 A 322 HIS E 97 HIS.? 1000.00 coo 36.34 32.23 39.60 36.43 34.62 39.93 -21.51 -24.30 -54.11 -21.06 -26.53 -54.83 coo 19.73 19.18 41.39 21.50 18.65 40.34 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 41.69 45.14 46.60 41.78 47.19 46.18 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER C 84 SER^? 1000.00 A 292 ASP B 40 ASP.? 1000.00 A 322 HIS A 94 HIS.? 1000.00 coo 36.34 32.23 39.60 36.43 34.62 39.93 -48.21 -36.91 -37.27 -49.64 -38.47 -38.48 coo 19.73 19.18 41.39 21.50 18.65 40.34 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 41.69 45.14 46.60 41.78 47.19 46.18 -61.56 -37.44 -41.77 -61.34 -38.91 -40.29 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER D 80 SER.? 1000.00 A 292 ASP F 48 ASP^? 1000.00 A 322 HIS C 96 HIS.? 1000.00 coo 36.34 32.23 39.60 36.43 34.62 39.93 -40.65 -44.96 -14.21 -38.59 -44.99 -12.95 coo 19.73 19.18 41.39 21.50 18.65 40.34 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 41.69 45.14 46.60 41.78 47.19 46.18 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER D 80 SER.? 1000.00 A 292 ASP F 48 ASP^? 1000.00 A 322 HIS C 97 HIS.? 1000.00 coo 36.34 32.23 39.60 36.43 34.62 39.93 -40.65 -44.96 -14.21 -38.59 -44.99 -12.95 coo 19.73 19.18 41.39 21.50 18.65 40.34 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 41.69 45.14 46.60 41.78 47.19 46.18 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER E 91 SER.? 1000.00 A 292 ASP D 43 ASP.? 1000.00 A 322 HIS E 97 HIS.? 1000.00 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.63 -28.61 -39.94 -13.90 -29.30 -37.73 coo 19.73 19.18 41.39 21.50 18.65 40.34 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 41.69 45.14 46.60 41.78 47.19 46.18 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 6 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER B 80 SER.? 1000.00 B 292 ASP A 48 ASP^? 1000.00 B 322 HIS E 96 HIS.? 1000.00 coo 35.42 71.28 22.94 36.24 69.06 22.37 -21.51 -24.30 -54.11 -21.06 -26.53 -54.83 coo 24.74 78.07 5.59 24.32 79.03 7.46 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 48.81 64.16 26.34 49.30 62.16 26.73 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 80 SER.? 1000.00 B 292 ASP A 48 ASP^? 1000.00 B 322 HIS E 97 HIS.? 1000.00 coo 35.42 71.28 22.94 36.24 69.06 22.37 -21.51 -24.30 -54.11 -21.06 -26.53 -54.83 coo 24.74 78.07 5.59 24.32 79.03 7.46 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 48.81 64.16 26.34 49.30 62.16 26.73 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER C 84 SER^? 1000.00 B 292 ASP B 40 ASP.? 1000.00 B 322 HIS A 94 HIS.? 1000.00 coo 35.42 71.28 22.94 36.24 69.06 22.37 -48.21 -36.91 -37.27 -49.64 -38.47 -38.48 coo 24.74 78.07 5.59 24.32 79.03 7.46 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 48.81 64.16 26.34 49.30 62.16 26.73 -61.56 -37.44 -41.77 -61.34 -38.91 -40.29 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER D 80 SER.? 1000.00 B 292 ASP C 48 ASP^? 1000.00 B 322 HIS C 96 HIS.? 1000.00 coo 35.42 71.28 22.94 36.24 69.06 22.37 -40.65 -44.96 -14.21 -38.59 -44.99 -12.95 coo 24.74 78.07 5.59 24.32 79.03 7.46 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 coo 48.81 64.16 26.34 49.30 62.16 26.73 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER D 80 SER.? 1000.00 B 292 ASP F 48 ASP^? 1000.00 B 322 HIS C 96 HIS.? 1000.00 coo 35.42 71.28 22.94 36.24 69.06 22.37 -40.65 -44.96 -14.21 -38.59 -44.99 -12.95 coo 24.74 78.07 5.59 24.32 79.03 7.46 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 48.81 64.16 26.34 49.30 62.16 26.73 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER D 80 SER.? 1000.00 B 292 ASP F 48 ASP^? 1000.00 B 322 HIS C 97 HIS.? 1000.00 coo 35.42 71.28 22.94 36.24 69.06 22.37 -40.65 -44.96 -14.21 -38.59 -44.99 -12.95 coo 24.74 78.07 5.59 24.32 79.03 7.46 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 48.81 64.16 26.34 49.30 62.16 26.73 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 6 hits 1aql_c03 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP B 40 ASP.? 1000.00 A 35 SER B 42 SER.? 1000.00 A 217 ASP D 43 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP B 43 ASP.? 1000.00 A 35 SER B 42 SER.? 1000.00 A 217 ASP D 43 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP D 40 ASP.? 1000.00 A 35 SER D 42 SER.? 1000.00 A 217 ASP B 40 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP D 40 ASP.? 1000.00 A 35 SER D 42 SER.? 1000.00 A 217 ASP B 43 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1avf_c04 GASTRICSIN user 5 3 # 5 A 32 ASP D 43 ASP.? 1000.00 A 35 SER D 42 SER.? 1000.00 A 217 ASP B 40 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1avf_c04 GASTRICSIN user 6 3 # 6 A 32 ASP D 43 ASP.? 1000.00 A 35 SER D 42 SER.? 1000.00 A 217 ASP B 43 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1avf_c04 source 1avf GASTRICSIN : 6 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP B 40 ASP.? 1000.00 J 35 SER B 42 SER.? 1000.00 J 217 ASP D 43 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP B 43 ASP.? 1000.00 J 35 SER B 42 SER.? 1000.00 J 217 ASP D 43 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1avf_c05 GASTRICSIN user 3 3 # 3 J 32 ASP D 40 ASP.? 1000.00 J 35 SER D 42 SER.? 1000.00 J 217 ASP B 40 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1avf_c05 GASTRICSIN user 4 3 # 4 J 32 ASP D 40 ASP.? 1000.00 J 35 SER D 42 SER.? 1000.00 J 217 ASP B 43 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1avf_c05 GASTRICSIN user 5 3 # 5 J 32 ASP D 43 ASP.? 1000.00 J 35 SER D 42 SER.? 1000.00 J 217 ASP B 40 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1avf_c05 GASTRICSIN user 6 3 # 6 J 32 ASP D 43 ASP.? 1000.00 J 35 SER D 42 SER.? 1000.00 J 217 ASP B 43 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1avf_c05 source 1avf GASTRICSIN : 6 hits 1avf_c05 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 43 ASP.? 1000.00 A 182 GLU A 62 GLU.? 1000.00 A 286 ASN A 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -52.49 -15.23 -55.19 -52.13 -15.99 -53.25 coo 18.06 44.02 105.38 18.08 45.37 107.03 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 25.47 38.28 112.06 27.26 39.30 111.54 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP B 40 ASP.? 1000.00 A 182 GLU B 44 GLU.? 1000.00 A 286 ASN B 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 18.06 44.02 105.38 18.08 45.37 107.03 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 25.47 38.28 112.06 27.26 39.30 111.54 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP B 40 ASP.? 1000.00 A 182 GLU B 62 GLU.? 1000.00 A 286 ASN B 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 18.06 44.02 105.38 18.08 45.37 107.03 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 25.47 38.28 112.06 27.26 39.30 111.54 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP B 40 ASP.? 1000.00 A 182 GLU B 68 GLU^? 1000.00 A 286 ASN B 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 18.06 44.02 105.38 18.08 45.37 107.03 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 25.47 38.28 112.06 27.26 39.30 111.54 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 A 109 ASP C 40 ASP.? 1000.00 A 182 GLU C 44 GLU.? 1000.00 A 286 ASN C 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 18.06 44.02 105.38 18.08 45.37 107.03 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 25.47 38.28 112.06 27.26 39.30 111.54 -49.60 -52.13 -34.79 -48.70 -51.69 -36.70 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 A 109 ASP C 40 ASP.? 1000.00 A 182 GLU C 68 GLU^? 1000.00 A 286 ASN C 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 18.06 44.02 105.38 18.08 45.37 107.03 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 coo 25.47 38.28 112.06 27.26 39.30 111.54 -49.60 -52.13 -34.79 -48.70 -51.69 -36.70 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 A 109 ASP D 40 ASP.? 1000.00 A 182 GLU D 44 GLU.? 1000.00 A 286 ASN D 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 18.06 44.02 105.38 18.08 45.37 107.03 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 25.47 38.28 112.06 27.26 39.30 111.54 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 8 3 # 8 A 109 ASP D 43 ASP.? 1000.00 A 182 GLU D 62 GLU.? 1000.00 A 286 ASN D 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 18.06 44.02 105.38 18.08 45.37 107.03 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 coo 25.47 38.28 112.06 27.26 39.30 111.54 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 9 3 # 9 A 109 ASP F 40 ASP.? 1000.00 A 182 GLU F 44 GLU.? 1000.00 A 286 ASN F 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 18.06 44.02 105.38 18.08 45.37 107.03 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 25.47 38.28 112.06 27.26 39.30 111.54 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 10 3 # 10 A 109 ASP F 40 ASP.? 1000.00 A 182 GLU F 62 GLU.? 1000.00 A 286 ASN F 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 18.06 44.02 105.38 18.08 45.37 107.03 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 25.47 38.28 112.06 27.26 39.30 111.54 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 11 3 # 11 A 109 ASP F 40 ASP.? 1000.00 A 182 GLU F 68 GLU^? 1000.00 A 286 ASN F 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 18.06 44.02 105.38 18.08 45.37 107.03 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 coo 25.47 38.28 112.06 27.26 39.30 111.54 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 12 3 # 12 A 109 ASP F 43 ASP.? 1000.00 A 182 GLU F 62 GLU.? 1000.00 A 286 ASN F 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 18.06 44.02 105.38 18.08 45.37 107.03 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 25.47 38.28 112.06 27.26 39.30 111.54 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 13 3 # 13 A 109 ASP F 43 ASP.? 1000.00 A 182 GLU F 68 GLU^? 1000.00 A 286 ASN F 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 18.06 44.02 105.38 18.08 45.37 107.03 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 coo 25.47 38.28 112.06 27.26 39.30 111.54 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 14 3 # 14 A 109 ASP G 40 ASP.? 1000.00 A 182 GLU G 44 GLU.? 1000.00 A 286 ASN G 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 18.06 44.02 105.38 18.08 45.37 107.03 3.40 -36.79 -57.23 5.30 -37.24 -56.45 coo 25.47 38.28 112.06 27.26 39.30 111.54 8.96 -39.36 -66.77 9.19 -41.39 -67.43 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 15 3 # 15 A 109 ASP G 40 ASP.? 1000.00 A 182 GLU G 62 GLU.? 1000.00 A 286 ASN G 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 18.06 44.02 105.38 18.08 45.37 107.03 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 25.47 38.28 112.06 27.26 39.30 111.54 8.96 -39.36 -66.77 9.19 -41.39 -67.43 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 16 3 # 16 A 109 ASP G 40 ASP.? 1000.00 A 182 GLU G 68 GLU^? 1000.00 A 286 ASN G 39 ASN.? 1000.00 coo 26.03 44.66 108.90 25.67 42.61 108.82 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 18.06 44.02 105.38 18.08 45.37 107.03 4.41 -43.97 -59.17 6.44 -44.61 -59.08 coo 25.47 38.28 112.06 27.26 39.30 111.54 8.96 -39.36 -66.77 9.19 -41.39 -67.43 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 16 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 43 ASP.? 1000.00 B 182 GLU A 62 GLU.? 1000.00 B 286 ASN A 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 -52.49 -15.23 -55.19 -52.13 -15.99 -53.25 coo 8.74 63.05 136.42 9.87 62.19 134.79 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 8.26 72.60 129.22 10.14 73.45 129.80 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP A 43 ASP.? 1000.00 B 182 GLU A 68 GLU^? 1000.00 B 286 ASN A 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 -52.49 -15.23 -55.19 -52.13 -15.99 -53.25 coo 8.74 63.05 136.42 9.87 62.19 134.79 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 coo 8.26 72.60 129.22 10.14 73.45 129.80 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP B 40 ASP.? 1000.00 B 182 GLU B 44 GLU.? 1000.00 B 286 ASN B 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 8.74 63.05 136.42 9.87 62.19 134.79 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 8.26 72.60 129.22 10.14 73.45 129.80 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP B 40 ASP.? 1000.00 B 182 GLU B 62 GLU.? 1000.00 B 286 ASN B 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 8.74 63.05 136.42 9.87 62.19 134.79 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 8.26 72.60 129.22 10.14 73.45 129.80 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 B 109 ASP B 40 ASP.? 1000.00 B 182 GLU B 68 GLU^? 1000.00 B 286 ASN B 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 8.74 63.05 136.42 9.87 62.19 134.79 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 8.26 72.60 129.22 10.14 73.45 129.80 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 B 109 ASP C 40 ASP.? 1000.00 B 182 GLU C 44 GLU.? 1000.00 B 286 ASN C 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 8.74 63.05 136.42 9.87 62.19 134.79 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 8.26 72.60 129.22 10.14 73.45 129.80 -49.60 -52.13 -34.79 -48.70 -51.69 -36.70 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 B 109 ASP D 40 ASP.? 1000.00 B 182 GLU D 44 GLU.? 1000.00 B 286 ASN D 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 8.74 63.05 136.42 9.87 62.19 134.79 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 8.26 72.60 129.22 10.14 73.45 129.80 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 8 3 # 8 B 109 ASP D 43 ASP.? 1000.00 B 182 GLU D 62 GLU.? 1000.00 B 286 ASN D 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 8.74 63.05 136.42 9.87 62.19 134.79 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 coo 8.26 72.60 129.22 10.14 73.45 129.80 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 9 3 # 9 B 109 ASP F 43 ASP.? 1000.00 B 182 GLU F 62 GLU.? 1000.00 B 286 ASN F 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 8.74 63.05 136.42 9.87 62.19 134.79 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 8.26 72.60 129.22 10.14 73.45 129.80 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 10 3 # 10 B 109 ASP F 43 ASP.? 1000.00 B 182 GLU F 68 GLU^? 1000.00 B 286 ASN F 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 8.74 63.05 136.42 9.87 62.19 134.79 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 coo 8.26 72.60 129.22 10.14 73.45 129.80 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 11 3 # 11 B 109 ASP G 40 ASP.? 1000.00 B 182 GLU G 44 GLU.? 1000.00 B 286 ASN G 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 8.74 63.05 136.42 9.87 62.19 134.79 3.40 -36.79 -57.23 5.30 -37.24 -56.45 coo 8.26 72.60 129.22 10.14 73.45 129.80 8.96 -39.36 -66.77 9.19 -41.39 -67.43 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 12 3 # 12 B 109 ASP G 40 ASP.? 1000.00 B 182 GLU G 62 GLU.? 1000.00 B 286 ASN G 39 ASN.? 1000.00 coo 13.82 69.26 132.27 11.87 70.14 132.51 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 8.74 63.05 136.42 9.87 62.19 134.79 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 8.26 72.60 129.22 10.14 73.45 129.80 8.96 -39.36 -66.77 9.19 -41.39 -67.43 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 12 hits 1b57_c01 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 68 GLU^? 1000.00 B 88 ASP D 48 ASP^? 1000.00 B 89 HIS C 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 coo 58.74 13.49 55.78 58.72 14.38 57.67 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 60.89 12.20 60.42 60.43 13.81 61.68 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU E 29 GLU.? 1000.00 B 88 ASP D 48 ASP^? 1000.00 B 89 HIS C 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -47.46 -5.14 -41.90 -47.28 -3.05 -42.08 coo 58.74 13.49 55.78 58.72 14.38 57.67 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 60.89 12.20 60.42 60.43 13.81 61.68 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU F 29 GLU.? 1000.00 B 88 ASP B 48 ASP^? 1000.00 B 89 HIS E 96 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -55.76 -40.65 -11.19 -57.86 -40.71 -11.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 60.89 12.20 60.42 60.43 13.81 61.68 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU F 44 GLU.? 1000.00 B 88 ASP B 48 ASP^? 1000.00 B 89 HIS E 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 58.74 13.49 55.78 58.72 14.38 57.67 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 60.89 12.20 60.42 60.43 13.81 61.68 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 5 3 # 5 A 133 GLU G 68 GLU^? 1000.00 B 88 ASP D 48 ASP^? 1000.00 B 89 HIS C 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 4.41 -43.97 -59.17 6.44 -44.61 -59.08 coo 58.74 13.49 55.78 58.72 14.38 57.67 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 60.89 12.20 60.42 60.43 13.81 61.68 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 6 3 # 6 A 133 GLU H 44 GLU.? 1000.00 B 88 ASP B 48 ASP^? 1000.00 B 89 HIS E 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 coo 58.74 13.49 55.78 58.72 14.38 57.67 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 60.89 12.20 60.42 60.43 13.81 61.68 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 7 3 # 7 A 133 GLU H 68 GLU^? 1000.00 B 88 ASP B 48 ASP^? 1000.00 B 89 HIS E 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 coo 58.74 13.49 55.78 58.72 14.38 57.67 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 60.89 12.20 60.42 60.43 13.81 61.68 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 7 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU A 68 GLU^? 1000.00 B 88 ASP D 48 ASP^? 1000.00 B 89 HIS C 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 coo 58.74 13.49 55.78 58.72 14.38 57.67 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 60.89 12.20 60.42 60.43 13.81 61.68 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU E 29 GLU.? 1000.00 B 88 ASP D 48 ASP^? 1000.00 B 89 HIS C 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -47.46 -5.14 -41.90 -47.28 -3.05 -42.08 coo 58.74 13.49 55.78 58.72 14.38 57.67 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 60.89 12.20 60.42 60.43 13.81 61.68 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 3 3 # 3 A 133 GLU F 29 GLU.? 1000.00 B 88 ASP B 48 ASP^? 1000.00 B 89 HIS E 96 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -55.76 -40.65 -11.19 -57.86 -40.71 -11.33 coo 58.74 13.49 55.78 58.72 14.38 57.67 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 60.89 12.20 60.42 60.43 13.81 61.68 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 4 3 # 4 A 133 GLU F 44 GLU.? 1000.00 B 88 ASP B 48 ASP^? 1000.00 B 89 HIS E 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 58.74 13.49 55.78 58.72 14.38 57.67 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 60.89 12.20 60.42 60.43 13.81 61.68 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 5 3 # 5 A 133 GLU G 68 GLU^? 1000.00 B 88 ASP D 48 ASP^? 1000.00 B 89 HIS C 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 4.41 -43.97 -59.17 6.44 -44.61 -59.08 coo 58.74 13.49 55.78 58.72 14.38 57.67 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 60.89 12.20 60.42 60.43 13.81 61.68 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 6 3 # 6 A 133 GLU H 44 GLU.? 1000.00 B 88 ASP B 48 ASP^? 1000.00 B 89 HIS E 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 coo 58.74 13.49 55.78 58.72 14.38 57.67 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 60.89 12.20 60.42 60.43 13.81 61.68 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 7 3 # 7 A 133 GLU H 68 GLU^? 1000.00 B 88 ASP B 48 ASP^? 1000.00 B 89 HIS E 97 HIS.? 1000.00 coo 44.53 38.98 5.35 43.53 40.60 6.22 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 coo 58.74 13.49 55.78 58.72 14.38 57.67 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 60.89 12.20 60.42 60.43 13.81 61.68 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 7 hits 1b66_c02 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS C 94 HIS.? 1000.00 A 91 ARG H 74 ARG^? 1000.00 A 129 SER H 51 SER.? 1000.00 coo 24.39 47.01 49.70 26.42 47.04 49.21 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 25.98 44.20 42.23 28.53 42.98 43.43 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 30.00 49.76 45.68 28.73 48.72 47.47 -17.19 -55.50 -20.23 -16.47 -55.34 -22.54 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 1 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS C 94 HIS.? 1000.00 B 91 ARG H 74 ARG^? 1000.00 B 129 SER H 51 SER.? 1000.00 coo 18.19 17.03 40.71 18.55 17.18 38.64 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 25.60 21.10 38.54 23.57 20.93 36.25 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 21.33 14.29 34.62 19.25 14.88 35.71 -17.19 -55.50 -20.23 -16.47 -55.34 -22.54 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 B 18 HIS C 97 HIS.? 1000.00 B 91 ARG D 74 ARG^? 1000.00 B 129 SER D 51 SER.? 1000.00 coo 18.19 17.03 40.71 18.55 17.18 38.64 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 25.60 21.10 38.54 23.57 20.93 36.25 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 21.33 14.29 34.62 19.25 14.88 35.71 -33.08 -53.53 -7.15 -34.77 -54.71 -5.86 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 3 3 # 3 B 18 HIS E 94 HIS.? 1000.00 B 91 ARG G 74 ARG^? 1000.00 B 129 SER G 51 SER.? 1000.00 coo 18.19 17.03 40.71 18.55 17.18 38.64 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 25.60 21.10 38.54 23.57 20.93 36.25 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 21.33 14.29 34.62 19.25 14.88 35.71 -9.46 -46.18 -44.33 -9.56 -46.75 -41.96 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 4 3 # 4 B 18 HIS E 97 HIS.? 1000.00 B 91 ARG B 74 ARG^? 1000.00 B 129 SER B 51 SER.? 1000.00 coo 18.19 17.03 40.71 18.55 17.18 38.64 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 25.60 21.10 38.54 23.57 20.93 36.25 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 21.33 14.29 34.62 19.25 14.88 35.71 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 4 hits 1b6t_c01 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP B 43 ASP.? 1000.00 35 SER B 42 SER.? 1000.00 215 ASP D 43 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 66.00 46.17 80.29 64.31 47.92 79.91 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 63.61 40.10 74.06 64.05 42.07 74.70 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP D 40 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 43 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 66.00 46.17 80.29 64.31 47.92 79.91 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 63.61 40.10 74.06 64.05 42.07 74.70 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1bbs_c06 RENIN user 3 3 # 3 32 ASP D 43 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 43 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 66.00 46.17 80.29 64.31 47.92 79.91 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 63.61 40.10 74.06 64.05 42.07 74.70 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1bbs_c06 source 1bbs RENIN : 3 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP B 43 ASP.? 1000.00 35 SER B 42 SER.? 1000.00 215 ASP D 43 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 66.00 46.17 80.29 64.31 47.92 79.91 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 63.61 40.10 74.06 64.05 42.07 74.70 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP D 40 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 43 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 66.00 46.17 80.29 64.31 47.92 79.91 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 63.61 40.10 74.06 64.05 42.07 74.70 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1bbs_c07 RENIN user 3 3 # 3 32 ASP D 43 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 43 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 66.00 46.17 80.29 64.31 47.92 79.91 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 63.61 40.10 74.06 64.05 42.07 74.70 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1bbs_c07 source 1bbs RENIN : 3 hits 1bbs_c07 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 70 ARG^? 1000.00 A 141 THR A 85 THR^? 1000.00 A 235 ASP A 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 coo 6.80 92.87 28.33 4.91 92.74 27.40 -42.19 -24.60 -61.59 -41.24 -25.78 -60.06 coo 12.98 90.36 47.57 11.26 89.62 46.62 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 70 ARG^? 1000.00 A 141 THR A 86 THR^? 1000.00 A 235 ASP A 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 coo 6.80 92.87 28.33 4.91 92.74 27.40 -45.50 -25.51 -60.06 -46.77 -25.59 -61.84 coo 12.98 90.36 47.57 11.26 89.62 46.62 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG B 70 ARG^? 1000.00 A 141 THR B 85 THR^? 1000.00 A 235 ASP B 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 6.80 92.87 28.33 4.91 92.74 27.40 -28.41 -38.58 -52.26 -27.40 -40.12 -53.39 coo 12.98 90.36 47.57 11.26 89.62 46.62 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 70 ARG^? 1000.00 A 141 THR B 86 THR^? 1000.00 A 235 ASP B 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 6.80 92.87 28.33 4.91 92.74 27.40 -29.28 -41.29 -49.77 -31.08 -40.36 -48.98 coo 12.98 90.36 47.57 11.26 89.62 46.62 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG B 70 ARG^? 1000.00 A 141 THR E 15 THR.? 1000.00 A 235 ASP B 40 ASP.? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 6.80 92.87 28.33 4.91 92.74 27.40 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo 12.98 90.36 47.57 11.26 89.62 46.62 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG B 70 ARG^? 1000.00 A 141 THR E 15 THR.? 1000.00 A 235 ASP B 43 ASP.? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 6.80 92.87 28.33 4.91 92.74 27.40 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo 12.98 90.36 47.57 11.26 89.62 46.62 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 A 137 ARG B 70 ARG^? 1000.00 A 141 THR E 16 THR.? 1000.00 A 235 ASP B 43 ASP.? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 6.80 92.87 28.33 4.91 92.74 27.40 -24.49 -24.91 -44.90 -24.95 -26.52 -46.29 coo 12.98 90.36 47.57 11.26 89.62 46.62 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 A 137 ARG B 74 ARG^? 1000.00 A 141 THR E 15 THR.? 1000.00 A 235 ASP G 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 6.80 92.87 28.33 4.91 92.74 27.40 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo 12.98 90.36 47.57 11.26 89.62 46.62 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 A 137 ARG C 70 ARG^? 1000.00 A 141 THR C 85 THR^? 1000.00 A 235 ASP C 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo 6.80 92.87 28.33 4.91 92.74 27.40 -45.23 -39.21 -37.26 -43.32 -38.52 -36.49 coo 12.98 90.36 47.57 11.26 89.62 46.62 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 A 137 ARG D 70 ARG^? 1000.00 A 141 THR D 85 THR^? 1000.00 A 235 ASP D 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo 6.80 92.87 28.33 4.91 92.74 27.40 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo 12.98 90.36 47.57 11.26 89.62 46.62 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 A 137 ARG E 70 ARG^? 1000.00 A 141 THR E 85 THR^? 1000.00 A 235 ASP E 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 coo 6.80 92.87 28.33 4.91 92.74 27.40 -28.41 -17.47 -31.71 -28.97 -19.43 -32.44 coo 12.98 90.36 47.57 11.26 89.62 46.62 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 A 137 ARG F 70 ARG^? 1000.00 A 141 THR F 85 THR^? 1000.00 A 235 ASP F 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo 6.80 92.87 28.33 4.91 92.74 27.40 -41.10 -21.73 -8.64 -39.57 -22.99 -9.47 coo 12.98 90.36 47.57 11.26 89.62 46.62 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 A 137 ARG F 70 ARG^? 1000.00 A 141 THR F 86 THR^? 1000.00 A 235 ASP F 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo 6.80 92.87 28.33 4.91 92.74 27.40 -40.71 -18.28 -10.10 -40.84 -17.16 -8.25 coo 12.98 90.36 47.57 11.26 89.62 46.62 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 A 137 ARG G 70 ARG^? 1000.00 A 141 THR G 85 THR^? 1000.00 A 235 ASP G 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo 6.80 92.87 28.33 4.91 92.74 27.40 2.06 -49.47 -59.26 0.14 -50.15 -59.99 coo 12.98 90.36 47.57 11.26 89.62 46.62 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 A 137 ARG G 70 ARG^? 1000.00 A 141 THR G 86 THR^? 1000.00 A 235 ASP G 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo 6.80 92.87 28.33 4.91 92.74 27.40 2.42 -48.12 -62.78 4.54 -47.79 -63.09 coo 12.98 90.36 47.57 11.26 89.62 46.62 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 A 137 ARG H 70 ARG^? 1000.00 A 141 THR H 85 THR^? 1000.00 A 235 ASP H 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo 6.80 92.87 28.33 4.91 92.74 27.40 -14.64 -66.33 -4.70 -14.38 -64.30 -4.02 coo 12.98 90.36 47.57 11.26 89.62 46.62 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 A 137 ARG H 70 ARG^? 1000.00 A 141 THR H 86 THR^? 1000.00 A 235 ASP H 48 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo 6.80 92.87 28.33 4.91 92.74 27.40 -16.49 -66.84 -1.43 -17.05 -68.81 -0.71 coo 12.98 90.36 47.57 11.26 89.62 46.62 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 17 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 70 ARG^? 1000.00 D 141 THR A 85 THR^? 1000.00 D 235 ASP A 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -42.19 -24.60 -61.59 -41.24 -25.78 -60.06 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 70 ARG^? 1000.00 D 141 THR A 86 THR^? 1000.00 D 235 ASP A 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -45.50 -25.51 -60.06 -46.77 -25.59 -61.84 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG B 70 ARG^? 1000.00 D 141 THR B 85 THR^? 1000.00 D 235 ASP B 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -28.41 -38.58 -52.26 -27.40 -40.12 -53.39 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 70 ARG^? 1000.00 D 141 THR B 86 THR^? 1000.00 D 235 ASP B 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -29.28 -41.29 -49.77 -31.08 -40.36 -48.98 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG B 74 ARG^? 1000.00 D 141 THR E 15 THR.? 1000.00 D 235 ASP G 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG C 70 ARG^? 1000.00 D 141 THR C 85 THR^? 1000.00 D 235 ASP C 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -45.23 -39.21 -37.26 -43.32 -38.52 -36.49 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG D 37 ARG^? 1000.00 D 141 THR D 88 THR^? 1000.00 D 235 ASP B 40 ASP.? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -18.79 -39.36 -27.13 -18.50 -42.28 -28.04 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -17.07 -35.15 -17.54 -16.96 -33.51 -18.95 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 D 137 ARG D 70 ARG^? 1000.00 D 141 THR C 59 THR.? 1000.00 D 235 ASP D 40 ASP.? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -41.85 -40.94 -20.16 -41.56 -39.78 -18.35 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 D 137 ARG D 70 ARG^? 1000.00 D 141 THR C 59 THR.? 1000.00 D 235 ASP D 43 ASP.? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -41.85 -40.94 -20.16 -41.56 -39.78 -18.35 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 D 137 ARG D 70 ARG^? 1000.00 D 141 THR D 85 THR^? 1000.00 D 235 ASP D 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 D 137 ARG D 70 ARG^? 1000.00 D 141 THR D 86 THR^? 1000.00 D 235 ASP D 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -24.01 -35.70 -16.08 -25.04 -34.15 -17.17 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 D 137 ARG D 74 ARG^? 1000.00 D 141 THR C 15 THR.? 1000.00 D 235 ASP H 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -38.42 -45.23 -22.32 -37.90 -45.95 -20.35 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 D 137 ARG E 70 ARG^? 1000.00 D 141 THR E 85 THR^? 1000.00 D 235 ASP E 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -28.41 -17.47 -31.71 -28.97 -19.43 -32.44 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 D 137 ARG E 70 ARG^? 1000.00 D 141 THR E 86 THR^? 1000.00 D 235 ASP E 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -24.93 -18.44 -32.83 -23.81 -17.47 -31.27 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 D 137 ARG F 70 ARG^? 1000.00 D 141 THR F 85 THR^? 1000.00 D 235 ASP F 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -41.10 -21.73 -8.64 -39.57 -22.99 -9.47 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 D 137 ARG F 70 ARG^? 1000.00 D 141 THR F 86 THR^? 1000.00 D 235 ASP F 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -40.71 -18.28 -10.10 -40.84 -17.16 -8.25 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 D 137 ARG G 70 ARG^? 1000.00 D 141 THR G 85 THR^? 1000.00 D 235 ASP G 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo -9.24 93.49 108.77 -7.37 94.21 109.61 2.06 -49.47 -59.26 0.14 -50.15 -59.99 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 D 137 ARG G 70 ARG^? 1000.00 D 141 THR G 86 THR^? 1000.00 D 235 ASP G 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo -9.24 93.49 108.77 -7.37 94.21 109.61 2.42 -48.12 -62.78 4.54 -47.79 -63.09 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 D 137 ARG H 70 ARG^? 1000.00 D 141 THR H 85 THR^? 1000.00 D 235 ASP H 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -14.64 -66.33 -4.70 -14.38 -64.30 -4.02 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 D 137 ARG H 70 ARG^? 1000.00 D 141 THR H 86 THR^? 1000.00 D 235 ASP H 48 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -16.49 -66.84 -1.43 -17.05 -68.81 -0.71 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 20 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 70 ARG^? 1000.00 C 141 THR A 85 THR^? 1000.00 C 235 ASP A 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -42.19 -24.60 -61.59 -41.24 -25.78 -60.06 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 70 ARG^? 1000.00 C 141 THR A 86 THR^? 1000.00 C 235 ASP A 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -45.50 -25.51 -60.06 -46.77 -25.59 -61.84 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG B 70 ARG^? 1000.00 C 141 THR B 85 THR^? 1000.00 C 235 ASP B 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -28.41 -38.58 -52.26 -27.40 -40.12 -53.39 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG B 70 ARG^? 1000.00 C 141 THR B 86 THR^? 1000.00 C 235 ASP B 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -29.28 -41.29 -49.77 -31.08 -40.36 -48.98 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG B 70 ARG^? 1000.00 C 141 THR E 15 THR.? 1000.00 C 235 ASP B 40 ASP.? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG B 70 ARG^? 1000.00 C 141 THR E 15 THR.? 1000.00 C 235 ASP B 43 ASP.? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 C 137 ARG B 70 ARG^? 1000.00 C 141 THR E 16 THR.? 1000.00 C 235 ASP B 43 ASP.? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -24.49 -24.91 -44.90 -24.95 -26.52 -46.29 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 C 137 ARG B 74 ARG^? 1000.00 C 141 THR E 15 THR.? 1000.00 C 235 ASP G 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 C 137 ARG C 70 ARG^? 1000.00 C 141 THR C 85 THR^? 1000.00 C 235 ASP C 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -45.23 -39.21 -37.26 -43.32 -38.52 -36.49 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 C 137 ARG D 37 ARG^? 1000.00 C 141 THR D 88 THR^? 1000.00 C 235 ASP B 40 ASP.? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -18.79 -39.36 -27.13 -18.50 -42.28 -28.04 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -17.07 -35.15 -17.54 -16.96 -33.51 -18.95 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 C 137 ARG D 70 ARG^? 1000.00 C 141 THR C 59 THR.? 1000.00 C 235 ASP D 40 ASP.? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -41.85 -40.94 -20.16 -41.56 -39.78 -18.35 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 C 137 ARG D 70 ARG^? 1000.00 C 141 THR C 59 THR.? 1000.00 C 235 ASP D 43 ASP.? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -41.85 -40.94 -20.16 -41.56 -39.78 -18.35 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 C 137 ARG D 70 ARG^? 1000.00 C 141 THR D 85 THR^? 1000.00 C 235 ASP D 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 C 137 ARG D 70 ARG^? 1000.00 C 141 THR D 86 THR^? 1000.00 C 235 ASP D 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -24.01 -35.70 -16.08 -25.04 -34.15 -17.17 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 C 137 ARG D 74 ARG^? 1000.00 C 141 THR C 15 THR.? 1000.00 C 235 ASP H 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -38.42 -45.23 -22.32 -37.90 -45.95 -20.35 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 C 137 ARG E 70 ARG^? 1000.00 C 141 THR E 85 THR^? 1000.00 C 235 ASP E 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -28.41 -17.47 -31.71 -28.97 -19.43 -32.44 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 C 137 ARG E 70 ARG^? 1000.00 C 141 THR E 86 THR^? 1000.00 C 235 ASP E 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -24.93 -18.44 -32.83 -23.81 -17.47 -31.27 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 C 137 ARG F 70 ARG^? 1000.00 C 141 THR F 85 THR^? 1000.00 C 235 ASP F 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -41.10 -21.73 -8.64 -39.57 -22.99 -9.47 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 19 3 # 19 C 137 ARG F 70 ARG^? 1000.00 C 141 THR F 86 THR^? 1000.00 C 235 ASP F 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -40.71 -18.28 -10.10 -40.84 -17.16 -8.25 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 20 3 # 20 C 137 ARG G 70 ARG^? 1000.00 C 141 THR G 85 THR^? 1000.00 C 235 ASP G 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo -6.81 68.31 28.28 -4.82 68.47 27.57 2.06 -49.47 -59.26 0.14 -50.15 -59.99 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 21 3 # 21 C 137 ARG G 70 ARG^? 1000.00 C 141 THR G 86 THR^? 1000.00 C 235 ASP G 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo -6.81 68.31 28.28 -4.82 68.47 27.57 2.42 -48.12 -62.78 4.54 -47.79 -63.09 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 22 3 # 22 C 137 ARG H 70 ARG^? 1000.00 C 141 THR H 85 THR^? 1000.00 C 235 ASP H 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -14.64 -66.33 -4.70 -14.38 -64.30 -4.02 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 23 3 # 23 C 137 ARG H 70 ARG^? 1000.00 C 141 THR H 86 THR^? 1000.00 C 235 ASP H 48 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -16.49 -66.84 -1.43 -17.05 -68.81 -0.71 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 23 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 70 ARG^? 1000.00 B 141 THR A 85 THR^? 1000.00 B 235 ASP A 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 coo 8.28 67.78 108.81 6.22 67.65 109.43 -42.19 -24.60 -61.59 -41.24 -25.78 -60.06 coo 14.55 73.52 89.47 12.81 73.95 90.56 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 70 ARG^? 1000.00 B 141 THR A 86 THR^? 1000.00 B 235 ASP A 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 coo 8.28 67.78 108.81 6.22 67.65 109.43 -45.50 -25.51 -60.06 -46.77 -25.59 -61.84 coo 14.55 73.52 89.47 12.81 73.95 90.56 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG B 70 ARG^? 1000.00 B 141 THR B 85 THR^? 1000.00 B 235 ASP B 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 8.28 67.78 108.81 6.22 67.65 109.43 -28.41 -38.58 -52.26 -27.40 -40.12 -53.39 coo 14.55 73.52 89.47 12.81 73.95 90.56 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG B 70 ARG^? 1000.00 B 141 THR B 86 THR^? 1000.00 B 235 ASP B 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 8.28 67.78 108.81 6.22 67.65 109.43 -29.28 -41.29 -49.77 -31.08 -40.36 -48.98 coo 14.55 73.52 89.47 12.81 73.95 90.56 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG B 74 ARG^? 1000.00 B 141 THR E 15 THR.? 1000.00 B 235 ASP G 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 8.28 67.78 108.81 6.22 67.65 109.43 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo 14.55 73.52 89.47 12.81 73.95 90.56 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG C 70 ARG^? 1000.00 B 141 THR C 85 THR^? 1000.00 B 235 ASP C 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo 8.28 67.78 108.81 6.22 67.65 109.43 -45.23 -39.21 -37.26 -43.32 -38.52 -36.49 coo 14.55 73.52 89.47 12.81 73.95 90.56 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 B 137 ARG D 70 ARG^? 1000.00 B 141 THR C 59 THR.? 1000.00 B 235 ASP D 40 ASP.? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo 8.28 67.78 108.81 6.22 67.65 109.43 -41.85 -40.94 -20.16 -41.56 -39.78 -18.35 coo 14.55 73.52 89.47 12.81 73.95 90.56 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 8 3 # 8 B 137 ARG D 70 ARG^? 1000.00 B 141 THR D 85 THR^? 1000.00 B 235 ASP D 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo 8.28 67.78 108.81 6.22 67.65 109.43 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo 14.55 73.52 89.47 12.81 73.95 90.56 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 9 3 # 9 B 137 ARG D 70 ARG^? 1000.00 B 141 THR D 86 THR^? 1000.00 B 235 ASP D 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo 8.28 67.78 108.81 6.22 67.65 109.43 -24.01 -35.70 -16.08 -25.04 -34.15 -17.17 coo 14.55 73.52 89.47 12.81 73.95 90.56 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 10 3 # 10 B 137 ARG D 74 ARG^? 1000.00 B 141 THR C 15 THR.? 1000.00 B 235 ASP H 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 8.28 67.78 108.81 6.22 67.65 109.43 -38.42 -45.23 -22.32 -37.90 -45.95 -20.35 coo 14.55 73.52 89.47 12.81 73.95 90.56 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 11 3 # 11 B 137 ARG E 70 ARG^? 1000.00 B 141 THR E 85 THR^? 1000.00 B 235 ASP E 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 coo 8.28 67.78 108.81 6.22 67.65 109.43 -28.41 -17.47 -31.71 -28.97 -19.43 -32.44 coo 14.55 73.52 89.47 12.81 73.95 90.56 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 12 3 # 12 B 137 ARG E 70 ARG^? 1000.00 B 141 THR E 86 THR^? 1000.00 B 235 ASP E 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 coo 8.28 67.78 108.81 6.22 67.65 109.43 -24.93 -18.44 -32.83 -23.81 -17.47 -31.27 coo 14.55 73.52 89.47 12.81 73.95 90.56 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 13 3 # 13 B 137 ARG F 70 ARG^? 1000.00 B 141 THR F 85 THR^? 1000.00 B 235 ASP F 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo 8.28 67.78 108.81 6.22 67.65 109.43 -41.10 -21.73 -8.64 -39.57 -22.99 -9.47 coo 14.55 73.52 89.47 12.81 73.95 90.56 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 14 3 # 14 B 137 ARG F 70 ARG^? 1000.00 B 141 THR F 86 THR^? 1000.00 B 235 ASP F 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo 8.28 67.78 108.81 6.22 67.65 109.43 -40.71 -18.28 -10.10 -40.84 -17.16 -8.25 coo 14.55 73.52 89.47 12.81 73.95 90.56 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 15 3 # 15 B 137 ARG G 70 ARG^? 1000.00 B 141 THR G 85 THR^? 1000.00 B 235 ASP G 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo 8.28 67.78 108.81 6.22 67.65 109.43 2.06 -49.47 -59.26 0.14 -50.15 -59.99 coo 14.55 73.52 89.47 12.81 73.95 90.56 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 16 3 # 16 B 137 ARG G 70 ARG^? 1000.00 B 141 THR G 86 THR^? 1000.00 B 235 ASP G 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo 8.28 67.78 108.81 6.22 67.65 109.43 2.42 -48.12 -62.78 4.54 -47.79 -63.09 coo 14.55 73.52 89.47 12.81 73.95 90.56 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 17 3 # 17 B 137 ARG H 70 ARG^? 1000.00 B 141 THR H 85 THR^? 1000.00 B 235 ASP H 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo 8.28 67.78 108.81 6.22 67.65 109.43 -14.64 -66.33 -4.70 -14.38 -64.30 -4.02 coo 14.55 73.52 89.47 12.81 73.95 90.56 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 18 3 # 18 B 137 ARG H 70 ARG^? 1000.00 B 141 THR H 86 THR^? 1000.00 B 235 ASP H 48 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo 8.28 67.78 108.81 6.22 67.65 109.43 -16.49 -66.84 -1.43 -17.05 -68.81 -0.71 coo 14.55 73.52 89.47 12.81 73.95 90.56 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 18 hits 1bd3_c03 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU B 44 GLU.? 1000.00 A 503 TYR B 67 TYR^? 1000.00 A 537 GLU B 68 GLU^? 1000.00 coo 24.06 146.21 11.09 22.89 146.18 9.36 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 15.91 140.69 8.32 15.71 143.39 9.13 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 coo 16.65 144.44 13.24 18.34 145.22 12.33 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU C 44 GLU.? 1000.00 A 503 TYR C 67 TYR^? 1000.00 A 537 GLU C 68 GLU^? 1000.00 coo 24.06 146.21 11.09 22.89 146.18 9.36 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 15.91 140.69 8.32 15.71 143.39 9.13 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 16.65 144.44 13.24 18.34 145.22 12.33 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU F 44 GLU.? 1000.00 A 503 TYR F 67 TYR^? 1000.00 A 537 GLU F 68 GLU^? 1000.00 coo 24.06 146.21 11.09 22.89 146.18 9.36 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 15.91 140.69 8.32 15.71 143.39 9.13 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 16.65 144.44 13.24 18.34 145.22 12.33 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU G 44 GLU.? 1000.00 A 503 TYR G 67 TYR^? 1000.00 A 537 GLU G 68 GLU^? 1000.00 coo 24.06 146.21 11.09 22.89 146.18 9.36 3.40 -36.79 -57.23 5.30 -37.24 -56.45 coo 15.91 140.69 8.32 15.71 143.39 9.13 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo 16.65 144.44 13.24 18.34 145.22 12.33 4.41 -43.97 -59.17 6.44 -44.61 -59.08 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 4 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU C 44 GLU.? 1000.00 A 504 TYR C 67 TYR^? 1000.00 A 540 GLU C 68 GLU^? 1000.00 coo 81.34 87.29 87.22 82.36 86.09 88.61 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 80.85 81.34 94.77 81.70 80.16 92.41 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 79.94 80.46 88.84 81.11 81.36 87.27 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 44 GLU.? 1000.00 B 504 TYR A 67 TYR^? 1000.00 B 540 GLU A 68 GLU^? 1000.00 coo 86.52 35.28 112.74 87.08 36.38 110.99 -47.53 -13.80 -58.12 -49.26 -14.21 -59.28 coo 84.93 40.21 105.31 85.72 41.45 107.72 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo 83.38 41.19 112.55 85.47 40.59 112.72 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU B 44 GLU.? 1000.00 B 504 TYR B 67 TYR^? 1000.00 B 540 GLU B 68 GLU^? 1000.00 coo 86.52 35.28 112.74 87.08 36.38 110.99 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 84.93 40.21 105.31 85.72 41.45 107.72 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 coo 83.38 41.19 112.55 85.47 40.59 112.72 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU C 44 GLU.? 1000.00 B 504 TYR C 67 TYR^? 1000.00 B 540 GLU C 68 GLU^? 1000.00 coo 86.52 35.28 112.74 87.08 36.38 110.99 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 84.93 40.21 105.31 85.72 41.45 107.72 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 83.38 41.19 112.55 85.47 40.59 112.72 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU D 44 GLU.? 1000.00 B 504 TYR D 67 TYR^? 1000.00 B 540 GLU D 68 GLU^? 1000.00 coo 86.52 35.28 112.74 87.08 36.38 110.99 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 84.93 40.21 105.31 85.72 41.45 107.72 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo 83.38 41.19 112.55 85.47 40.59 112.72 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 5 3 # 5 B 451 GLU E 44 GLU.? 1000.00 B 504 TYR E 67 TYR^? 1000.00 B 540 GLU E 68 GLU^? 1000.00 coo 86.52 35.28 112.74 87.08 36.38 110.99 -24.48 -8.54 -40.01 -24.93 -7.20 -38.47 coo 84.93 40.21 105.31 85.72 41.45 107.72 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo 83.38 41.19 112.55 85.47 40.59 112.72 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 6 3 # 6 B 451 GLU F 44 GLU.? 1000.00 B 504 TYR F 67 TYR^? 1000.00 B 540 GLU F 68 GLU^? 1000.00 coo 86.52 35.28 112.74 87.08 36.38 110.99 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 84.93 40.21 105.31 85.72 41.45 107.72 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 83.38 41.19 112.55 85.47 40.59 112.72 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 7 3 # 7 B 451 GLU G 44 GLU.? 1000.00 B 504 TYR G 67 TYR^? 1000.00 B 540 GLU G 68 GLU^? 1000.00 coo 86.52 35.28 112.74 87.08 36.38 110.99 3.40 -36.79 -57.23 5.30 -37.24 -56.45 coo 84.93 40.21 105.31 85.72 41.45 107.72 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo 83.38 41.19 112.55 85.47 40.59 112.72 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 8 3 # 8 B 451 GLU H 44 GLU.? 1000.00 B 504 TYR H 67 TYR^? 1000.00 B 540 GLU H 68 GLU^? 1000.00 coo 86.52 35.28 112.74 87.08 36.38 110.99 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 coo 84.93 40.21 105.31 85.72 41.45 107.72 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo 83.38 41.19 112.55 85.47 40.59 112.72 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 8 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG E 37 ARG^? 1000.00 A 451 GLU E 68 GLU^? 1000.00 A 540 GLU E 44 GLU.? 1000.00 coo 79.04 80.20 80.81 79.58 81.40 83.63 -16.50 -14.01 -41.09 -16.70 -12.05 -43.45 coo 81.34 87.29 87.22 82.36 86.09 88.61 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 coo 79.94 80.46 88.84 81.11 81.36 87.27 -24.48 -8.54 -40.01 -24.93 -7.20 -38.47 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG F 37 ARG^? 1000.00 A 451 GLU F 68 GLU^? 1000.00 A 540 GLU F 44 GLU.? 1000.00 coo 79.04 80.20 80.81 79.58 81.40 83.63 -48.09 -10.25 -16.84 -50.78 -9.38 -18.06 coo 81.34 87.29 87.22 82.36 86.09 88.61 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 coo 79.94 80.46 88.84 81.11 81.36 87.27 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG G 37 ARG^? 1000.00 A 451 GLU G 68 GLU^? 1000.00 A 540 GLU G 44 GLU.? 1000.00 coo 79.04 80.20 80.81 79.58 81.40 83.63 2.57 -36.22 -67.13 1.93 -33.23 -67.01 coo 81.34 87.29 87.22 82.36 86.09 88.61 4.41 -43.97 -59.17 6.44 -44.61 -59.08 coo 79.94 80.46 88.84 81.11 81.36 87.27 3.40 -36.79 -57.23 5.30 -37.24 -56.45 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG H 37 ARG^? 1000.00 A 451 GLU H 68 GLU^? 1000.00 A 540 GLU H 44 GLU.? 1000.00 coo 79.04 80.20 80.81 79.58 81.40 83.63 -28.82 -68.15 1.75 -31.05 -66.20 1.05 coo 81.34 87.29 87.22 82.36 86.09 88.61 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 coo 79.94 80.46 88.84 81.11 81.36 87.27 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG F 70 ARG^? 1000.00 B 451 GLU F 44 GLU.? 1000.00 B 540 GLU F 68 GLU^? 1000.00 coo 82.21 41.07 119.14 83.95 40.66 116.59 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo 86.52 35.28 112.74 87.08 36.38 110.99 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 83.38 41.19 112.55 85.47 40.59 112.72 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 1 hits 1bhg_c05 naa= 3 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 1 3 # 1 A 53 SER A 42 SER.? 1000.00 A 54 PRO A 41 PRO.? 1000.00 A 96 ASP A 40 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -53.21 -11.52 -58.21 -55.59 -11.71 -57.82 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -53.87 -14.40 -62.93 -52.98 -14.30 -60.89 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -55.02 -16.32 -57.84 -55.96 -14.51 -57.37 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 2 3 # 2 A 53 SER A 42 SER.? 1000.00 A 54 PRO A 41 PRO.? 1000.00 A 96 ASP A 43 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -53.21 -11.52 -58.21 -55.59 -11.71 -57.82 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -53.87 -14.40 -62.93 -52.98 -14.30 -60.89 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -52.49 -15.23 -55.19 -52.13 -15.99 -53.25 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 3 3 # 3 A 53 SER B 42 SER.? 1000.00 A 54 PRO B 41 PRO.? 1000.00 A 96 ASP B 40 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -26.75 -35.29 -35.80 -25.15 -36.60 -36.65 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 4 3 # 4 A 53 SER B 42 SER.? 1000.00 A 54 PRO B 41 PRO.? 1000.00 A 96 ASP B 43 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -26.75 -35.29 -35.80 -25.15 -36.60 -36.65 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 5 3 # 5 A 53 SER B 42 SER.? 1000.00 A 54 PRO B 41 PRO.? 1000.00 A 96 ASP D 40 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -26.75 -35.29 -35.80 -25.15 -36.60 -36.65 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 6 3 # 6 A 53 SER C 42 SER.? 1000.00 A 54 PRO C 41 PRO.? 1000.00 A 96 ASP C 43 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -56.87 -48.92 -27.51 -55.71 -50.87 -26.62 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -56.54 -49.99 -32.94 -55.36 -49.10 -31.28 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 7 3 # 7 A 53 SER D 42 SER.? 1000.00 A 54 PRO D 41 PRO.? 1000.00 A 96 ASP D 40 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -28.82 -39.34 -29.55 -27.25 -40.88 -29.23 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 8 3 # 8 A 53 SER D 42 SER.? 1000.00 A 54 PRO D 41 PRO.? 1000.00 A 96 ASP D 43 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -28.82 -39.34 -29.55 -27.25 -40.88 -29.23 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 9 3 # 9 A 53 SER E 42 SER.? 1000.00 A 54 PRO E 41 PRO.? 1000.00 A 96 ASP E 40 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -19.71 -5.41 -41.38 -17.64 -4.19 -40.99 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -19.71 -6.00 -35.73 -19.96 -6.87 -37.76 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -17.17 -9.50 -39.47 -16.76 -7.92 -40.81 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 10 3 # 10 A 53 SER E 42 SER.? 1000.00 A 54 PRO E 41 PRO.? 1000.00 A 96 ASP E 43 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -19.71 -5.41 -41.38 -17.64 -4.19 -40.99 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -19.71 -6.00 -35.73 -19.96 -6.87 -37.76 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 11 3 # 11 A 53 SER F 42 SER.? 1000.00 A 54 PRO F 41 PRO.? 1000.00 A 96 ASP F 40 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -55.66 -12.57 -13.02 -55.09 -10.66 -14.44 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -52.79 -12.09 -8.05 -52.91 -12.60 -10.21 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 12 3 # 12 A 53 SER F 42 SER.? 1000.00 A 54 PRO F 41 PRO.? 1000.00 A 96 ASP F 43 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -55.66 -12.57 -13.02 -55.09 -10.66 -14.44 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -52.79 -12.09 -8.05 -52.91 -12.60 -10.21 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 13 3 # 13 A 53 SER G 42 SER.? 1000.00 A 54 PRO G 41 PRO.? 1000.00 A 96 ASP G 40 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 6.29 -31.30 -60.40 6.11 -30.89 -62.79 coo -12.82 46.62 43.11 -11.69 44.75 42.79 10.43 -34.69 -60.59 8.20 -34.75 -60.52 coo -5.86 47.39 44.34 -4.55 46.60 42.83 6.57 -35.54 -64.10 6.50 -33.43 -64.08 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 14 3 # 14 A 53 SER G 42 SER.? 1000.00 A 54 PRO G 41 PRO.? 1000.00 A 96 ASP G 43 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 6.29 -31.30 -60.40 6.11 -30.89 -62.79 coo -12.82 46.62 43.11 -11.69 44.75 42.79 10.43 -34.69 -60.59 8.20 -34.75 -60.52 coo -5.86 47.39 44.34 -4.55 46.60 42.83 2.83 -33.73 -62.69 0.93 -34.64 -62.87 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 15 3 # 15 A 53 SER H 42 SER.? 1000.00 A 54 PRO H 41 PRO.? 1000.00 A 96 ASP H 40 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -32.17 -71.96 -5.72 -32.97 -73.73 -4.26 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -27.86 -75.63 -6.01 -28.56 -73.53 -5.76 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -28.41 -71.72 -1.86 -30.52 -71.82 -1.58 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 16 3 # 16 A 53 SER H 42 SER.? 1000.00 A 54 PRO H 41 PRO.? 1000.00 A 96 ASP H 43 ASP.? 1000.00 coo -9.03 45.15 44.45 -7.51 43.26 44.28 -32.17 -71.96 -5.72 -32.97 -73.73 -4.26 coo -12.82 46.62 43.11 -11.69 44.75 42.79 -27.86 -75.63 -6.01 -28.56 -73.53 -5.76 coo -5.86 47.39 44.34 -4.55 46.60 42.83 -30.59 -68.33 -3.12 -29.92 -66.39 -2.72 1boo_c00 source 1boo N-4 CYTOSINE-SPECIFIC METHYLTRANSFERASE PVU II: 16 hits 1boo_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY D 76 GLY.? 1000.00 48 HIS C 96 HIS.? 1000.00 99 ASP D 48 ASP^? 1000.00 coo 12.38 5.55 24.25 13.27 5.59 24.39 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 coo 18.80 12.68 24.53 17.69 13.54 26.08 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 17.07 18.51 26.62 16.67 17.07 28.09 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY D 76 GLY.? 1000.00 48 HIS C 97 HIS.? 1000.00 99 ASP D 48 ASP^? 1000.00 coo 12.38 5.55 24.25 13.27 5.59 24.39 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 coo 18.80 12.68 24.53 17.69 13.54 26.08 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 17.07 18.51 26.62 16.67 17.07 28.09 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 2 hits 1bp2_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG G 70 ARG^? 1000.00 A 128 GLU G 44 GLU.? 1000.00 A 225 GLU G 68 GLU^? 1000.00 coo 38.56 19.11 14.83 37.12 21.00 16.76 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo 36.48 24.43 22.02 36.86 26.34 21.13 3.40 -36.79 -57.23 5.30 -37.24 -56.45 coo 40.16 23.71 17.01 38.52 24.96 17.40 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG H 70 ARG^? 1000.00 A 128 GLU H 44 GLU.? 1000.00 A 225 GLU H 68 GLU^? 1000.00 coo 38.56 19.11 14.83 37.12 21.00 16.76 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo 36.48 24.43 22.02 36.86 26.34 21.13 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 coo 40.16 23.71 17.01 38.52 24.96 17.40 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 1bqc_c01 source 1bqc BETA-MANNANASE : 2 hits 1bqc_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 2 GLN.? 1000.00 A 91 LEU A 1 LEU.? 1000.00 A 133 GLU A 29 GLU.? 1000.00 coo 43.58 43.67 66.73 42.32 42.78 68.15 -25.90 -14.03 -63.96 -24.99 -12.36 -64.97 coo 38.58 45.09 70.44 38.28 45.21 72.59 -29.32 -10.68 -66.11 -28.49 -10.21 -64.16 coo 44.05 36.87 70.65 43.15 38.64 69.97 -26.00 -6.81 -57.60 -25.88 -4.71 -57.52 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 78 GLN^? 1000.00 A 91 LEU A 1 LEU.? 1000.00 A 133 GLU A 29 GLU.? 1000.00 coo 43.58 43.67 66.73 42.32 42.78 68.15 -28.84 -5.45 -66.49 -29.86 -4.60 -68.15 coo 38.58 45.09 70.44 38.28 45.21 72.59 -29.32 -10.68 -66.11 -28.49 -10.21 -64.16 coo 44.05 36.87 70.65 43.15 38.64 69.97 -26.00 -6.81 -57.60 -25.88 -4.71 -57.52 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN C 2 GLN.? 1000.00 A 91 LEU C 1 LEU.? 1000.00 A 133 GLU A 62 GLU.? 1000.00 coo 43.58 43.67 66.73 42.32 42.78 68.15 -53.89 -22.56 -41.69 -52.94 -23.66 -43.24 coo 38.58 45.09 70.44 38.28 45.21 72.59 -58.75 -25.15 -38.19 -58.15 -23.97 -36.48 coo 44.05 36.87 70.65 43.15 38.64 69.97 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN C 2 GLN.? 1000.00 A 91 LEU C 26 LEU.? 1000.00 A 133 GLU A 62 GLU.? 1000.00 coo 43.58 43.67 66.73 42.32 42.78 68.15 -53.89 -22.56 -41.69 -52.94 -23.66 -43.24 coo 38.58 45.09 70.44 38.28 45.21 72.59 -54.63 -18.37 -37.63 -55.01 -19.96 -39.06 coo 44.05 36.87 70.65 43.15 38.64 69.97 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN E 2 GLN.? 1000.00 A 91 LEU E 1 LEU.? 1000.00 A 133 GLU F 62 GLU.? 1000.00 coo 43.58 43.67 66.73 42.32 42.78 68.15 -45.61 -10.31 -28.01 -44.41 -10.92 -26.33 coo 38.58 45.09 70.44 38.28 45.21 72.59 -43.57 -5.47 -31.90 -44.70 -5.99 -33.63 coo 44.05 36.87 70.65 43.15 38.64 69.97 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN E 2 GLN.? 1000.00 A 91 LEU E 26 LEU.? 1000.00 A 133 GLU F 62 GLU.? 1000.00 coo 43.58 43.67 66.73 42.32 42.78 68.15 -45.61 -10.31 -28.01 -44.41 -10.92 -26.33 coo 38.58 45.09 70.44 38.28 45.21 72.59 -49.82 -10.18 -32.75 -50.77 -9.65 -30.88 coo 44.05 36.87 70.65 43.15 38.64 69.97 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN F 78 GLN.? 1000.00 A 91 LEU F 1 LEU.? 1000.00 A 133 GLU F 29 GLU.? 1000.00 coo 43.58 43.67 66.73 42.32 42.78 68.15 -58.13 -37.25 -2.37 -58.72 -35.97 -0.77 coo 38.58 45.09 70.44 38.28 45.21 72.59 -51.69 -36.86 -1.73 -51.75 -37.06 -3.88 coo 44.05 36.87 70.65 43.15 38.64 69.97 -55.76 -40.65 -11.19 -57.86 -40.71 -11.33 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 7 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 2 GLN.? 1000.00 B 591 LEU A 1 LEU.? 1000.00 B 633 GLU A 29 GLU.? 1000.00 coo 88.06 44.34 57.19 89.06 45.53 55.74 -25.90 -14.03 -63.96 -24.99 -12.36 -64.97 coo 86.70 48.66 52.61 87.15 48.69 50.51 -29.32 -10.68 -66.11 -28.49 -10.21 -64.16 coo 95.42 44.52 54.43 93.46 45.31 54.70 -26.00 -6.81 -57.60 -25.88 -4.71 -57.52 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 78 GLN^? 1000.00 B 591 LEU A 1 LEU.? 1000.00 B 633 GLU A 29 GLU.? 1000.00 coo 88.06 44.34 57.19 89.06 45.53 55.74 -28.84 -5.45 -66.49 -29.86 -4.60 -68.15 coo 86.70 48.66 52.61 87.15 48.69 50.51 -29.32 -10.68 -66.11 -28.49 -10.21 -64.16 coo 95.42 44.52 54.43 93.46 45.31 54.70 -26.00 -6.81 -57.60 -25.88 -4.71 -57.52 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN C 2 GLN.? 1000.00 B 591 LEU C 1 LEU.? 1000.00 B 633 GLU A 62 GLU.? 1000.00 coo 88.06 44.34 57.19 89.06 45.53 55.74 -53.89 -22.56 -41.69 -52.94 -23.66 -43.24 coo 86.70 48.66 52.61 87.15 48.69 50.51 -58.75 -25.15 -38.19 -58.15 -23.97 -36.48 coo 95.42 44.52 54.43 93.46 45.31 54.70 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN C 2 GLN.? 1000.00 B 591 LEU C 26 LEU.? 1000.00 B 633 GLU A 62 GLU.? 1000.00 coo 88.06 44.34 57.19 89.06 45.53 55.74 -53.89 -22.56 -41.69 -52.94 -23.66 -43.24 coo 86.70 48.66 52.61 87.15 48.69 50.51 -54.63 -18.37 -37.63 -55.01 -19.96 -39.06 coo 95.42 44.52 54.43 93.46 45.31 54.70 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN E 2 GLN.? 1000.00 B 591 LEU E 1 LEU.? 1000.00 B 633 GLU F 62 GLU.? 1000.00 coo 88.06 44.34 57.19 89.06 45.53 55.74 -45.61 -10.31 -28.01 -44.41 -10.92 -26.33 coo 86.70 48.66 52.61 87.15 48.69 50.51 -43.57 -5.47 -31.90 -44.70 -5.99 -33.63 coo 95.42 44.52 54.43 93.46 45.31 54.70 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN E 2 GLN.? 1000.00 B 591 LEU E 26 LEU.? 1000.00 B 633 GLU F 62 GLU.? 1000.00 coo 88.06 44.34 57.19 89.06 45.53 55.74 -45.61 -10.31 -28.01 -44.41 -10.92 -26.33 coo 86.70 48.66 52.61 87.15 48.69 50.51 -49.82 -10.18 -32.75 -50.77 -9.65 -30.88 coo 95.42 44.52 54.43 93.46 45.31 54.70 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 7 3 # 7 B 550 GLN F 78 GLN.? 1000.00 B 591 LEU F 1 LEU.? 1000.00 B 633 GLU F 29 GLU.? 1000.00 coo 88.06 44.34 57.19 89.06 45.53 55.74 -58.13 -37.25 -2.37 -58.72 -35.97 -0.77 coo 86.70 48.66 52.61 87.15 48.69 50.51 -51.69 -36.86 -1.73 -51.75 -37.06 -3.88 coo 95.42 44.52 54.43 93.46 45.31 54.70 -55.76 -40.65 -11.19 -57.86 -40.71 -11.33 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 7 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 2 GLN.? 1000.00 C1091 LEU A 1 LEU.? 1000.00 C1133 GLU A 29 GLU.? 1000.00 coo 68.29 34.44 43.03 66.67 34.74 44.37 -25.90 -14.03 -63.96 -24.99 -12.36 -64.97 coo 65.83 38.95 47.05 65.46 38.90 49.20 -29.32 -10.68 -66.11 -28.49 -10.21 -64.16 coo 63.14 29.39 46.25 63.84 31.31 45.74 -26.00 -6.81 -57.60 -25.88 -4.71 -57.52 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 78 GLN^? 1000.00 C1091 LEU A 1 LEU.? 1000.00 C1133 GLU A 29 GLU.? 1000.00 coo 68.29 34.44 43.03 66.67 34.74 44.37 -28.84 -5.45 -66.49 -29.86 -4.60 -68.15 coo 65.83 38.95 47.05 65.46 38.90 49.20 -29.32 -10.68 -66.11 -28.49 -10.21 -64.16 coo 63.14 29.39 46.25 63.84 31.31 45.74 -26.00 -6.81 -57.60 -25.88 -4.71 -57.52 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN C 2 GLN.? 1000.00 C1091 LEU C 1 LEU.? 1000.00 C1133 GLU A 62 GLU.? 1000.00 coo 68.29 34.44 43.03 66.67 34.74 44.37 -53.89 -22.56 -41.69 -52.94 -23.66 -43.24 coo 65.83 38.95 47.05 65.46 38.90 49.20 -58.75 -25.15 -38.19 -58.15 -23.97 -36.48 coo 63.14 29.39 46.25 63.84 31.31 45.74 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN C 2 GLN.? 1000.00 C1091 LEU C 26 LEU.? 1000.00 C1133 GLU A 62 GLU.? 1000.00 coo 68.29 34.44 43.03 66.67 34.74 44.37 -53.89 -22.56 -41.69 -52.94 -23.66 -43.24 coo 65.83 38.95 47.05 65.46 38.90 49.20 -54.63 -18.37 -37.63 -55.01 -19.96 -39.06 coo 63.14 29.39 46.25 63.84 31.31 45.74 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN E 2 GLN.? 1000.00 C1091 LEU E 1 LEU.? 1000.00 C1133 GLU F 62 GLU.? 1000.00 coo 68.29 34.44 43.03 66.67 34.74 44.37 -45.61 -10.31 -28.01 -44.41 -10.92 -26.33 coo 65.83 38.95 47.05 65.46 38.90 49.20 -43.57 -5.47 -31.90 -44.70 -5.99 -33.63 coo 63.14 29.39 46.25 63.84 31.31 45.74 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN E 2 GLN.? 1000.00 C1091 LEU E 26 LEU.? 1000.00 C1133 GLU F 62 GLU.? 1000.00 coo 68.29 34.44 43.03 66.67 34.74 44.37 -45.61 -10.31 -28.01 -44.41 -10.92 -26.33 coo 65.83 38.95 47.05 65.46 38.90 49.20 -49.82 -10.18 -32.75 -50.77 -9.65 -30.88 coo 63.14 29.39 46.25 63.84 31.31 45.74 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN F 78 GLN.? 1000.00 C1091 LEU F 1 LEU.? 1000.00 C1133 GLU F 29 GLU.? 1000.00 coo 68.29 34.44 43.03 66.67 34.74 44.37 -58.13 -37.25 -2.37 -58.72 -35.97 -0.77 coo 65.83 38.95 47.05 65.46 38.90 49.20 -51.69 -36.86 -1.73 -51.75 -37.06 -3.88 coo 63.14 29.39 46.25 63.84 31.31 45.74 -55.76 -40.65 -11.19 -57.86 -40.71 -11.33 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 7 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 2 GLN.? 1000.00 A 91 LEU A 1 LEU.? 1000.00 A 133 GLU A 29 GLU.? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 -25.90 -14.03 -63.96 -24.99 -12.36 -64.97 coo 35.40 53.22 73.30 35.37 54.87 74.74 -29.32 -10.68 -66.11 -28.49 -10.21 -64.16 coo 45.08 56.04 70.60 43.15 55.19 70.77 -26.00 -6.81 -57.60 -25.88 -4.71 -57.52 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 78 GLN^? 1000.00 A 91 LEU A 1 LEU.? 1000.00 A 133 GLU A 29 GLU.? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 -28.84 -5.45 -66.49 -29.86 -4.60 -68.15 coo 35.40 53.22 73.30 35.37 54.87 74.74 -29.32 -10.68 -66.11 -28.49 -10.21 -64.16 coo 45.08 56.04 70.60 43.15 55.19 70.77 -26.00 -6.81 -57.60 -25.88 -4.71 -57.52 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN C 2 GLN.? 1000.00 A 91 LEU C 1 LEU.? 1000.00 A 133 GLU A 62 GLU.? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 -53.89 -22.56 -41.69 -52.94 -23.66 -43.24 coo 35.40 53.22 73.30 35.37 54.87 74.74 -58.75 -25.15 -38.19 -58.15 -23.97 -36.48 coo 45.08 56.04 70.60 43.15 55.19 70.77 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN C 2 GLN.? 1000.00 A 91 LEU C 26 LEU.? 1000.00 A 133 GLU A 62 GLU.? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 -53.89 -22.56 -41.69 -52.94 -23.66 -43.24 coo 35.40 53.22 73.30 35.37 54.87 74.74 -54.63 -18.37 -37.63 -55.01 -19.96 -39.06 coo 45.08 56.04 70.60 43.15 55.19 70.77 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN D 78 GLN^? 1000.00 A 91 LEU D 1 LEU.? 1000.00 A 133 GLU C 62 GLU.? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 -46.76 -50.20 -15.48 -47.64 -48.54 -16.49 coo 35.40 53.22 73.30 35.37 54.87 74.74 -43.48 -47.31 -12.39 -42.58 -48.99 -11.33 coo 45.08 56.04 70.60 43.15 55.19 70.77 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN D 78 GLN^? 1000.00 A 91 LEU D 1 LEU.? 1000.00 A 133 GLU D 29 GLU.? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 -46.76 -50.20 -15.48 -47.64 -48.54 -16.49 coo 35.40 53.22 73.30 35.37 54.87 74.74 -43.48 -47.31 -12.39 -42.58 -48.99 -11.33 coo 45.08 56.04 70.60 43.15 55.19 70.77 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN E 2 GLN.? 1000.00 A 91 LEU E 1 LEU.? 1000.00 A 133 GLU F 62 GLU.? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 -45.61 -10.31 -28.01 -44.41 -10.92 -26.33 coo 35.40 53.22 73.30 35.37 54.87 74.74 -43.57 -5.47 -31.90 -44.70 -5.99 -33.63 coo 45.08 56.04 70.60 43.15 55.19 70.77 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN E 2 GLN.? 1000.00 A 91 LEU E 26 LEU.? 1000.00 A 133 GLU F 62 GLU.? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 -45.61 -10.31 -28.01 -44.41 -10.92 -26.33 coo 35.40 53.22 73.30 35.37 54.87 74.74 -49.82 -10.18 -32.75 -50.77 -9.65 -30.88 coo 45.08 56.04 70.60 43.15 55.19 70.77 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN F 78 GLN.? 1000.00 A 91 LEU F 1 LEU.? 1000.00 A 133 GLU F 29 GLU.? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 -58.13 -37.25 -2.37 -58.72 -35.97 -0.77 coo 35.40 53.22 73.30 35.37 54.87 74.74 -51.69 -36.86 -1.73 -51.75 -37.06 -3.88 coo 45.08 56.04 70.60 43.15 55.19 70.77 -55.76 -40.65 -11.19 -57.86 -40.71 -11.33 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN G 78 GLN^? 1000.00 A 91 LEU G 1 LEU.? 1000.00 A 133 GLU G 29 GLU.? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 4.40 -43.80 -36.26 6.44 -43.22 -36.02 coo 35.40 53.22 73.30 35.37 54.87 74.74 2.75 -48.46 -39.32 0.89 -47.49 -39.87 coo 45.08 56.04 70.60 43.15 55.19 70.77 -5.31 -41.94 -36.91 -3.79 -40.93 -35.87 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 10 hits 1bsj_c00 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN B 75 ASN^? 1000.00 192 ASP B 48 ASP^? 1000.00 195 HIS E 96 HIS.? 1000.00 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -13.12 -21.77 -56.53 -13.64 -22.77 -58.34 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN B 75 ASN^? 1000.00 192 ASP B 48 ASP^? 1000.00 195 HIS E 97 HIS.? 1000.00 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -13.12 -21.77 -56.53 -13.64 -22.77 -58.34 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 3 3 # 3 104 ASN C 64 ASN.? 1000.00 192 ASP D 48 ASP^? 1000.00 195 HIS C 95 HIS.? 1000.00 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 4 3 # 4 104 ASN C 64 ASN.? 1000.00 192 ASP D 48 ASP^? 1000.00 195 HIS C 96 HIS.? 1000.00 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 5 3 # 5 104 ASN D 75 ASN^? 1000.00 192 ASP D 48 ASP^? 1000.00 195 HIS C 96 HIS.? 1000.00 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 6 3 # 6 104 ASN D 75 ASN^? 1000.00 192 ASP D 48 ASP^? 1000.00 195 HIS C 97 HIS.? 1000.00 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 7 3 # 7 104 ASN E 64 ASN.? 1000.00 192 ASP B 48 ASP^? 1000.00 195 HIS E 96 HIS.? 1000.00 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 8 3 # 8 104 ASN H 75 ASN.? 1000.00 192 ASP H 48 ASP^? 1000.00 195 HIS C 94 HIS.? 1000.00 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -16.78 -63.47 -26.75 -16.16 -62.12 -28.26 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 8 hits 1bwp_c01 naa= 3 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 1 3 # 1 A 110 SER B 51 SER.? 1000.00 A 235 ASP B 48 ASP^? 1000.00 A 263 HIS E 97 HIS.? 1000.00 coo 30.32 56.27 16.76 31.62 57.99 17.94 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 31.33 62.80 9.68 31.68 62.04 11.62 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 30.23 62.32 14.77 30.86 60.47 15.53 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1c4x_c00 source 1c4x 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDR: 1 hits 1c4x_c00 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU C 93 GLU.? 1000.00 A 65 ARG H 74 ARG^? 1000.00 A 85 HIS C 95 HIS.? 1000.00 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 1c54_c00 source 1c54 RIBONUCLEASE SA : 1 hits 1c54_c00 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP B 48 ASP^? 1000.00 A 16 HIS E 95 HIS.? 1000.00 A 67 GLY B 30 GLY^? 1000.00 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP D 48 ASP^? 1000.00 A 16 HIS C 95 HIS.? 1000.00 A 67 GLY D 30 GLY^? 1000.00 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -35.39 -54.56 -12.18 -35.92 -53.95 -12.08 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP G 48 ASP^? 1000.00 A 16 HIS E 95 HIS.? 1000.00 A 67 GLY G 30 GLY^? 1000.00 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP H 48 ASP^? 1000.00 A 16 HIS C 95 HIS.? 1000.00 A 67 GLY H 30 GLY^? 1000.00 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 4 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP D 48 ASP^? 1000.00 C 16 HIS C 95 HIS.? 1000.00 C 67 GLY D 30 GLY^? 1000.00 coo 10.04 44.27 88.44 9.47 42.32 89.03 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 6.38 39.80 88.71 6.88 38.89 86.87 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 17.63 42.50 89.25 18.11 42.29 88.64 -35.39 -54.56 -12.18 -35.92 -53.95 -12.08 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP G 48 ASP^? 1000.00 C 16 HIS E 95 HIS.? 1000.00 C 67 GLY G 30 GLY^? 1000.00 coo 10.04 44.27 88.44 9.47 42.32 89.03 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 6.38 39.80 88.71 6.88 38.89 86.87 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 17.63 42.50 89.25 18.11 42.29 88.64 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP H 48 ASP^? 1000.00 C 16 HIS C 95 HIS.? 1000.00 C 67 GLY H 30 GLY^? 1000.00 coo 10.04 44.27 88.44 9.47 42.32 89.03 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 6.38 39.80 88.71 6.88 38.89 86.87 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 17.63 42.50 89.25 18.11 42.29 88.64 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 3 hits 1cb7_c07 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP B 40 ASP.? 1000.00 37 SER B 42 SER.? 1000.00 216 ASP D 43 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 12.23 24.31 30.40 14.55 23.96 31.03 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 13.93 25.52 22.10 14.75 24.44 23.75 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP B 43 ASP.? 1000.00 37 SER B 42 SER.? 1000.00 216 ASP D 43 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 12.23 24.31 30.40 14.55 23.96 31.03 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 13.93 25.52 22.10 14.75 24.44 23.75 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 3 # 3 34 ASP D 40 ASP.? 1000.00 37 SER D 42 SER.? 1000.00 216 ASP B 40 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 12.23 24.31 30.40 14.55 23.96 31.03 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 13.93 25.52 22.10 14.75 24.44 23.75 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 4 3 # 4 34 ASP D 40 ASP.? 1000.00 37 SER D 42 SER.? 1000.00 216 ASP B 43 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 12.23 24.31 30.40 14.55 23.96 31.03 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 13.93 25.52 22.10 14.75 24.44 23.75 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 5 3 # 5 34 ASP D 43 ASP.? 1000.00 37 SER D 42 SER.? 1000.00 216 ASP B 40 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 12.23 24.31 30.40 14.55 23.96 31.03 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 13.93 25.52 22.10 14.75 24.44 23.75 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 6 3 # 6 34 ASP D 43 ASP.? 1000.00 37 SER D 42 SER.? 1000.00 216 ASP B 43 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 12.23 24.31 30.40 14.55 23.96 31.03 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 13.93 25.52 22.10 14.75 24.44 23.75 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 6 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU B 44 GLU.? 1000.00 A 89 GLU E 93 GLU.? 1000.00 A 120 SER E 91 SER.? 1000.00 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -14.63 -28.61 -39.94 -13.90 -29.30 -37.73 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU D 44 GLU.? 1000.00 A 89 GLU C 93 GLU.? 1000.00 A 120 SER C 91 SER.? 1000.00 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -33.93 -51.43 -27.03 -33.28 -52.39 -29.17 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU E 93 GLU.? 1000.00 A 89 GLU B 44 GLU.? 1000.00 A 120 SER B 42 SER.? 1000.00 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 1cns_c00 source 1cns CHITINASE : 3 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU B 62 GLU.? 1000.00 B 89 GLU C 93 GLU.? 1000.00 B 120 SER D 42 SER.? 1000.00 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU C 93 GLU.? 1000.00 B 89 GLU B 62 GLU.? 1000.00 B 120 SER D 42 SER.? 1000.00 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 1cns_c01 source 1cns CHITINASE : 2 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR D 67 TYR^? 1000.00 B 173 ASP D 40 ASP.? 1000.00 D 48 ARG D 70 ARG^? 1000.00 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1cs1_c03 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP B 43 ASP.? 1000.00 A 56 ILE B 69 ILE^? 1000.00 A 82 TYR B 67 TYR^? 1000.00 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -23.40 -39.35 -50.26 -22.44 -40.27 -50.87 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP G 43 ASP.? 1000.00 A 56 ILE G 69 ILE^? 1000.00 A 82 TYR G 67 TYR^? 1000.00 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -1.06 -45.12 -58.16 -2.53 -45.07 -58.31 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP H 40 ASP.? 1000.00 A 56 ILE H 69 ILE^? 1000.00 A 82 TYR H 67 TYR^? 1000.00 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -28.41 -71.72 -1.86 -30.52 -71.82 -1.58 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -19.16 -63.62 -6.47 -19.40 -62.14 -6.43 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP H 43 ASP.? 1000.00 A 56 ILE H 69 ILE^? 1000.00 A 82 TYR H 67 TYR^? 1000.00 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -30.59 -68.33 -3.12 -29.92 -66.39 -2.72 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -19.16 -63.62 -6.47 -19.40 -62.14 -6.43 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 4 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP B 43 ASP.? 1000.00 B 56 ILE B 69 ILE^? 1000.00 B 82 TYR B 67 TYR^? 1000.00 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -23.40 -39.35 -50.26 -22.44 -40.27 -50.87 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP C 43 ASP.? 1000.00 B 56 ILE C 69 ILE^? 1000.00 B 82 TYR C 67 TYR^? 1000.00 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -46.86 -38.22 -31.79 -45.94 -37.73 -30.80 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP D 43 ASP.? 1000.00 B 56 ILE D 69 ILE^? 1000.00 B 82 TYR D 67 TYR^? 1000.00 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -25.69 -41.77 -15.60 -24.87 -42.54 -14.77 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP G 43 ASP.? 1000.00 B 56 ILE G 69 ILE^? 1000.00 B 82 TYR G 67 TYR^? 1000.00 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -1.06 -45.12 -58.16 -2.53 -45.07 -58.31 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP H 40 ASP.? 1000.00 B 56 ILE H 69 ILE^? 1000.00 B 82 TYR H 67 TYR^? 1000.00 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -28.41 -71.72 -1.86 -30.52 -71.82 -1.58 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -19.16 -63.62 -6.47 -19.40 -62.14 -6.43 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP H 43 ASP.? 1000.00 B 56 ILE H 69 ILE^? 1000.00 B 82 TYR H 67 TYR^? 1000.00 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -30.59 -68.33 -3.12 -29.92 -66.39 -2.72 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -19.16 -63.62 -6.47 -19.40 -62.14 -6.43 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 6 hits 1d6o_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 86 THR^? 1000.00 A 156 TYR A 67 TYR^? 1000.00 A 160 LYS A 38 LYS.? 1000.00 coo 10.50 56.87 17.73 11.24 57.93 19.43 -45.50 -25.51 -60.06 -46.77 -25.59 -61.84 coo 11.64 63.07 23.95 11.76 62.47 21.20 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo 5.78 61.30 21.65 8.04 62.89 17.54 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 86 THR^? 1000.00 A 156 TYR B 67 TYR^? 1000.00 A 160 LYS B 38 LYS.? 1000.00 coo 10.50 56.87 17.73 11.24 57.93 19.43 -29.28 -41.29 -49.77 -31.08 -40.36 -48.98 coo 11.64 63.07 23.95 11.76 62.47 21.20 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 coo 5.78 61.30 21.65 8.04 62.89 17.54 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 3 3 # 3 A 132 THR C 86 THR^? 1000.00 A 156 TYR C 67 TYR^? 1000.00 A 160 LYS C 38 LYS.? 1000.00 coo 10.50 56.87 17.73 11.24 57.93 19.43 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 11.64 63.07 23.95 11.76 62.47 21.20 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 5.78 61.30 21.65 8.04 62.89 17.54 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 4 3 # 4 A 132 THR D 86 THR^? 1000.00 A 156 TYR D 67 TYR^? 1000.00 A 160 LYS D 38 LYS.? 1000.00 coo 10.50 56.87 17.73 11.24 57.93 19.43 -24.01 -35.70 -16.08 -25.04 -34.15 -17.17 coo 11.64 63.07 23.95 11.76 62.47 21.20 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo 5.78 61.30 21.65 8.04 62.89 17.54 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 5 3 # 5 A 132 THR E 86 THR^? 1000.00 A 156 TYR E 67 TYR^? 1000.00 A 160 LYS E 38 LYS.? 1000.00 coo 10.50 56.87 17.73 11.24 57.93 19.43 -24.93 -18.44 -32.83 -23.81 -17.47 -31.27 coo 11.64 63.07 23.95 11.76 62.47 21.20 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo 5.78 61.30 21.65 8.04 62.89 17.54 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 6 3 # 6 A 132 THR F 86 THR^? 1000.00 A 156 TYR F 67 TYR^? 1000.00 A 160 LYS F 38 LYS.? 1000.00 coo 10.50 56.87 17.73 11.24 57.93 19.43 -40.71 -18.28 -10.10 -40.84 -17.16 -8.25 coo 11.64 63.07 23.95 11.76 62.47 21.20 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 5.78 61.30 21.65 8.04 62.89 17.54 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 7 3 # 7 A 132 THR G 86 THR^? 1000.00 A 156 TYR G 67 TYR^? 1000.00 A 160 LYS G 38 LYS.? 1000.00 coo 10.50 56.87 17.73 11.24 57.93 19.43 2.42 -48.12 -62.78 4.54 -47.79 -63.09 coo 11.64 63.07 23.95 11.76 62.47 21.20 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo 5.78 61.30 21.65 8.04 62.89 17.54 6.01 -41.17 -63.42 7.43 -47.25 -63.10 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 8 3 # 8 A 132 THR H 86 THR^? 1000.00 A 156 TYR H 67 TYR^? 1000.00 A 160 LYS H 38 LYS.? 1000.00 coo 10.50 56.87 17.73 11.24 57.93 19.43 -16.49 -66.84 -1.43 -17.05 -68.81 -0.71 coo 11.64 63.07 23.95 11.76 62.47 21.20 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo 5.78 61.30 21.65 8.04 62.89 17.54 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 8 hits 1db3_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS C 97 HIS.? 1000.00 A 63 HIS C 98 HIS.? 1000.00 A 89 ASP D 48 ASP^? 1000.00 coo 49.66 36.74 42.37 48.88 35.30 43.64 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 49.93 35.76 35.94 51.58 36.96 35.47 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 46.15 35.33 47.12 47.46 33.99 46.29 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1dco_c00 DCOH user 2 3 # 2 A 62 HIS E 97 HIS.? 1000.00 A 63 HIS E 98 HIS.? 1000.00 A 89 ASP B 48 ASP^? 1000.00 coo 49.66 36.74 42.37 48.88 35.30 43.64 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 49.93 35.76 35.94 51.58 36.96 35.47 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 46.15 35.33 47.12 47.46 33.99 46.29 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 1dco_c00 source 1dco DCOH : 2 hits 1dco_c00 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS C 94 HIS.? 1000.00 A 646 ASP D 48 ASP^? 1000.00 A 739 GLY C 90 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 11.37 50.89 2.29 11.05 51.63 2.25 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS C 94 HIS.? 1000.00 A 646 ASP H 48 ASP^? 1000.00 A 739 GLY D 30 GLY^? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 11.37 50.89 2.29 11.05 51.63 2.25 -35.39 -54.56 -12.18 -35.92 -53.95 -12.08 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS C 94 HIS.? 1000.00 A 646 ASP H 48 ASP^? 1000.00 A 739 GLY H 76 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 11.37 50.89 2.29 11.05 51.63 2.25 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS C 95 HIS.? 1000.00 A 646 ASP D 48 ASP^? 1000.00 A 739 GLY D 76 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 11.37 50.89 2.29 11.05 51.63 2.25 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS C 95 HIS.? 1000.00 A 646 ASP D 48 ASP^? 1000.00 A 739 GLY H 30 GLY^? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 11.37 50.89 2.29 11.05 51.63 2.25 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS C 95 HIS.? 1000.00 A 646 ASP H 48 ASP^? 1000.00 A 739 GLY D 30 GLY^? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 11.37 50.89 2.29 11.05 51.63 2.25 -35.39 -54.56 -12.18 -35.92 -53.95 -12.08 ULMN 3 1ddj_c12 PLASMINOGEN user 7 3 # 7 A 603 HIS C 95 HIS.? 1000.00 A 646 ASP H 48 ASP^? 1000.00 A 739 GLY H 76 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 11.37 50.89 2.29 11.05 51.63 2.25 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 ULMN 3 1ddj_c12 PLASMINOGEN user 8 3 # 8 A 603 HIS C 96 HIS.? 1000.00 A 646 ASP D 48 ASP^? 1000.00 A 739 GLY C 90 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 11.37 50.89 2.29 11.05 51.63 2.25 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1ddj_c12 PLASMINOGEN user 9 3 # 9 A 603 HIS C 96 HIS.? 1000.00 A 646 ASP D 48 ASP^? 1000.00 A 739 GLY H 30 GLY^? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 11.37 50.89 2.29 11.05 51.63 2.25 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 ULMN 3 1ddj_c12 PLASMINOGEN user 10 3 # 10 A 603 HIS C 97 HIS.? 1000.00 A 646 ASP D 48 ASP^? 1000.00 A 739 GLY D 76 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 11.37 50.89 2.29 11.05 51.63 2.25 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1ddj_c12 PLASMINOGEN user 11 3 # 11 A 603 HIS E 94 HIS.? 1000.00 A 646 ASP B 48 ASP^? 1000.00 A 739 GLY E 90 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 11.37 50.89 2.29 11.05 51.63 2.25 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c12 PLASMINOGEN user 12 3 # 12 A 603 HIS E 94 HIS.? 1000.00 A 646 ASP G 48 ASP^? 1000.00 A 739 GLY G 76 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 11.37 50.89 2.29 11.05 51.63 2.25 -0.35 -40.77 -35.64 -0.27 -40.87 -36.52 ULMN 3 1ddj_c12 PLASMINOGEN user 13 3 # 13 A 603 HIS E 95 HIS.? 1000.00 A 646 ASP B 48 ASP^? 1000.00 A 739 GLY E 90 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 11.37 50.89 2.29 11.05 51.63 2.25 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c12 PLASMINOGEN user 14 3 # 14 A 603 HIS E 95 HIS.? 1000.00 A 646 ASP B 48 ASP^? 1000.00 A 739 GLY G 30 GLY^? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 11.37 50.89 2.29 11.05 51.63 2.25 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 ULMN 3 1ddj_c12 PLASMINOGEN user 15 3 # 15 A 603 HIS E 95 HIS.? 1000.00 A 646 ASP G 48 ASP^? 1000.00 A 739 GLY B 30 GLY^? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 11.37 50.89 2.29 11.05 51.63 2.25 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 ULMN 3 1ddj_c12 PLASMINOGEN user 16 3 # 16 A 603 HIS E 95 HIS.? 1000.00 A 646 ASP G 48 ASP^? 1000.00 A 739 GLY G 76 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 11.37 50.89 2.29 11.05 51.63 2.25 -0.35 -40.77 -35.64 -0.27 -40.87 -36.52 ULMN 3 1ddj_c12 PLASMINOGEN user 17 3 # 17 A 603 HIS E 96 HIS.? 1000.00 A 646 ASP B 48 ASP^? 1000.00 A 739 GLY E 90 GLY.? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 11.37 50.89 2.29 11.05 51.63 2.25 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c12 PLASMINOGEN user 18 3 # 18 A 603 HIS E 96 HIS.? 1000.00 A 646 ASP B 48 ASP^? 1000.00 A 739 GLY G 30 GLY^? 1000.00 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 11.37 50.89 2.29 11.05 51.63 2.25 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 1ddj_c12 source 1ddj PLASMINOGEN : 18 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS C 94 HIS.? 1000.00 B 646 ASP D 48 ASP^? 1000.00 B 739 GLY C 90 GLY.? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS C 94 HIS.? 1000.00 B 646 ASP D 48 ASP^? 1000.00 B 739 GLY D 36 GLY^? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS C 95 HIS.? 1000.00 B 646 ASP D 48 ASP^? 1000.00 B 739 GLY D 76 GLY.? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS C 95 HIS.? 1000.00 B 646 ASP D 48 ASP^? 1000.00 B 739 GLY H 30 GLY^? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 ULMN 3 1ddj_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS C 96 HIS.? 1000.00 B 646 ASP D 48 ASP^? 1000.00 B 739 GLY C 90 GLY.? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1ddj_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS C 96 HIS.? 1000.00 B 646 ASP D 48 ASP^? 1000.00 B 739 GLY H 30 GLY^? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 ULMN 3 1ddj_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS C 97 HIS.? 1000.00 B 646 ASP D 48 ASP^? 1000.00 B 739 GLY D 76 GLY.? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1ddj_c13 PLASMINOGEN user 8 3 # 8 B 603 HIS E 94 HIS.? 1000.00 B 646 ASP B 48 ASP^? 1000.00 B 739 GLY B 36 GLY^? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 ULMN 3 1ddj_c13 PLASMINOGEN user 9 3 # 9 B 603 HIS E 94 HIS.? 1000.00 B 646 ASP B 48 ASP^? 1000.00 B 739 GLY E 90 GLY.? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c13 PLASMINOGEN user 10 3 # 10 B 603 HIS E 94 HIS.? 1000.00 B 646 ASP G 48 ASP^? 1000.00 B 739 GLY B 30 GLY^? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 ULMN 3 1ddj_c13 PLASMINOGEN user 11 3 # 11 B 603 HIS E 94 HIS.? 1000.00 B 646 ASP G 48 ASP^? 1000.00 B 739 GLY G 76 GLY.? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -0.35 -40.77 -35.64 -0.27 -40.87 -36.52 ULMN 3 1ddj_c13 PLASMINOGEN user 12 3 # 12 B 603 HIS E 95 HIS.? 1000.00 B 646 ASP B 48 ASP^? 1000.00 B 739 GLY E 90 GLY.? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c13 PLASMINOGEN user 13 3 # 13 B 603 HIS E 95 HIS.? 1000.00 B 646 ASP B 48 ASP^? 1000.00 B 739 GLY G 30 GLY^? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 ULMN 3 1ddj_c13 PLASMINOGEN user 14 3 # 14 B 603 HIS E 95 HIS.? 1000.00 B 646 ASP G 48 ASP^? 1000.00 B 739 GLY B 30 GLY^? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 ULMN 3 1ddj_c13 PLASMINOGEN user 15 3 # 15 B 603 HIS E 95 HIS.? 1000.00 B 646 ASP G 48 ASP^? 1000.00 B 739 GLY G 76 GLY.? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -0.35 -40.77 -35.64 -0.27 -40.87 -36.52 ULMN 3 1ddj_c13 PLASMINOGEN user 16 3 # 16 B 603 HIS E 96 HIS.? 1000.00 B 646 ASP B 48 ASP^? 1000.00 B 739 GLY E 90 GLY.? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c13 PLASMINOGEN user 17 3 # 17 B 603 HIS E 96 HIS.? 1000.00 B 646 ASP B 48 ASP^? 1000.00 B 739 GLY G 30 GLY^? 1000.00 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 1ddj_c13 source 1ddj PLASMINOGEN : 17 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS C 94 HIS.? 1000.00 C 646 ASP D 48 ASP^? 1000.00 C 739 GLY C 90 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 16.06 55.72 54.73 15.97 56.49 56.70 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.38 49.29 65.28 9.01 50.03 65.31 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS C 94 HIS.? 1000.00 C 646 ASP H 48 ASP^? 1000.00 C 739 GLY D 30 GLY^? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 16.06 55.72 54.73 15.97 56.49 56.70 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -35.39 -54.56 -12.18 -35.92 -53.95 -12.08 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS C 94 HIS.? 1000.00 C 646 ASP H 48 ASP^? 1000.00 C 739 GLY H 76 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 16.06 55.72 54.73 15.97 56.49 56.70 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS C 95 HIS.? 1000.00 C 646 ASP D 48 ASP^? 1000.00 C 739 GLY C 90 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 16.06 55.72 54.73 15.97 56.49 56.70 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.38 49.29 65.28 9.01 50.03 65.31 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS C 95 HIS.? 1000.00 C 646 ASP D 48 ASP^? 1000.00 C 739 GLY D 76 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 16.06 55.72 54.73 15.97 56.49 56.70 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.38 49.29 65.28 9.01 50.03 65.31 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS C 95 HIS.? 1000.00 C 646 ASP D 48 ASP^? 1000.00 C 739 GLY H 30 GLY^? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 16.06 55.72 54.73 15.97 56.49 56.70 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.38 49.29 65.28 9.01 50.03 65.31 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 ULMN 3 1ddj_c14 PLASMINOGEN user 7 3 # 7 C 603 HIS C 95 HIS.? 1000.00 C 646 ASP H 48 ASP^? 1000.00 C 739 GLY D 30 GLY^? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 16.06 55.72 54.73 15.97 56.49 56.70 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -35.39 -54.56 -12.18 -35.92 -53.95 -12.08 ULMN 3 1ddj_c14 PLASMINOGEN user 8 3 # 8 C 603 HIS C 95 HIS.? 1000.00 C 646 ASP H 48 ASP^? 1000.00 C 739 GLY H 76 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 16.06 55.72 54.73 15.97 56.49 56.70 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 ULMN 3 1ddj_c14 PLASMINOGEN user 9 3 # 9 C 603 HIS C 96 HIS.? 1000.00 C 646 ASP D 48 ASP^? 1000.00 C 739 GLY C 90 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 16.06 55.72 54.73 15.97 56.49 56.70 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.38 49.29 65.28 9.01 50.03 65.31 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1ddj_c14 PLASMINOGEN user 10 3 # 10 C 603 HIS C 96 HIS.? 1000.00 C 646 ASP D 48 ASP^? 1000.00 C 739 GLY H 30 GLY^? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 16.06 55.72 54.73 15.97 56.49 56.70 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.38 49.29 65.28 9.01 50.03 65.31 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 ULMN 3 1ddj_c14 PLASMINOGEN user 11 3 # 11 C 603 HIS C 97 HIS.? 1000.00 C 646 ASP D 48 ASP^? 1000.00 C 739 GLY D 76 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 16.06 55.72 54.73 15.97 56.49 56.70 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 9.38 49.29 65.28 9.01 50.03 65.31 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1ddj_c14 PLASMINOGEN user 12 3 # 12 C 603 HIS E 94 HIS.? 1000.00 C 646 ASP B 48 ASP^? 1000.00 C 739 GLY E 90 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 16.06 55.72 54.73 15.97 56.49 56.70 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 9.38 49.29 65.28 9.01 50.03 65.31 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c14 PLASMINOGEN user 13 3 # 13 C 603 HIS E 94 HIS.? 1000.00 C 646 ASP G 48 ASP^? 1000.00 C 739 GLY B 30 GLY^? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 ULMN 3 1ddj_c14 PLASMINOGEN user 14 3 # 14 C 603 HIS E 94 HIS.? 1000.00 C 646 ASP G 48 ASP^? 1000.00 C 739 GLY G 76 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -0.35 -40.77 -35.64 -0.27 -40.87 -36.52 ULMN 3 1ddj_c14 PLASMINOGEN user 15 3 # 15 C 603 HIS E 95 HIS.? 1000.00 C 646 ASP B 48 ASP^? 1000.00 C 739 GLY E 90 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 16.06 55.72 54.73 15.97 56.49 56.70 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 9.38 49.29 65.28 9.01 50.03 65.31 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c14 PLASMINOGEN user 16 3 # 16 C 603 HIS E 95 HIS.? 1000.00 C 646 ASP B 48 ASP^? 1000.00 C 739 GLY G 30 GLY^? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 16.06 55.72 54.73 15.97 56.49 56.70 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 9.38 49.29 65.28 9.01 50.03 65.31 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 ULMN 3 1ddj_c14 PLASMINOGEN user 17 3 # 17 C 603 HIS E 95 HIS.? 1000.00 C 646 ASP G 48 ASP^? 1000.00 C 739 GLY B 30 GLY^? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 ULMN 3 1ddj_c14 PLASMINOGEN user 18 3 # 18 C 603 HIS E 95 HIS.? 1000.00 C 646 ASP G 48 ASP^? 1000.00 C 739 GLY G 76 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 16.06 55.72 54.73 15.97 56.49 56.70 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -0.35 -40.77 -35.64 -0.27 -40.87 -36.52 ULMN 3 1ddj_c14 PLASMINOGEN user 19 3 # 19 C 603 HIS E 96 HIS.? 1000.00 C 646 ASP B 48 ASP^? 1000.00 C 739 GLY E 90 GLY.? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 16.06 55.72 54.73 15.97 56.49 56.70 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 9.38 49.29 65.28 9.01 50.03 65.31 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c14 PLASMINOGEN user 20 3 # 20 C 603 HIS E 96 HIS.? 1000.00 C 646 ASP B 48 ASP^? 1000.00 C 739 GLY G 30 GLY^? 1000.00 coo 15.33 59.81 59.60 13.98 60.99 60.69 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 16.06 55.72 54.73 15.97 56.49 56.70 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 9.38 49.29 65.28 9.01 50.03 65.31 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 1ddj_c14 source 1ddj PLASMINOGEN : 20 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS C 94 HIS.? 1000.00 D 646 ASP D 48 ASP^? 1000.00 D 739 GLY C 90 GLY.? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS C 94 HIS.? 1000.00 D 646 ASP D 48 ASP^? 1000.00 D 739 GLY D 36 GLY^? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS C 95 HIS.? 1000.00 D 646 ASP D 48 ASP^? 1000.00 D 739 GLY C 90 GLY.? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS C 95 HIS.? 1000.00 D 646 ASP D 48 ASP^? 1000.00 D 739 GLY D 76 GLY.? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1ddj_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS C 95 HIS.? 1000.00 D 646 ASP D 48 ASP^? 1000.00 D 739 GLY H 30 GLY^? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 ULMN 3 1ddj_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS C 96 HIS.? 1000.00 D 646 ASP D 48 ASP^? 1000.00 D 739 GLY C 90 GLY.? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1ddj_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS C 96 HIS.? 1000.00 D 646 ASP D 48 ASP^? 1000.00 D 739 GLY H 30 GLY^? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 ULMN 3 1ddj_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS C 97 HIS.? 1000.00 D 646 ASP D 48 ASP^? 1000.00 D 739 GLY H 30 GLY^? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 ULMN 3 1ddj_c15 PLASMINOGEN user 9 3 # 9 D 603 HIS E 94 HIS.? 1000.00 D 646 ASP B 48 ASP^? 1000.00 D 739 GLY B 36 GLY^? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 ULMN 3 1ddj_c15 PLASMINOGEN user 10 3 # 10 D 603 HIS E 94 HIS.? 1000.00 D 646 ASP B 48 ASP^? 1000.00 D 739 GLY E 90 GLY.? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c15 PLASMINOGEN user 11 3 # 11 D 603 HIS E 94 HIS.? 1000.00 D 646 ASP G 48 ASP^? 1000.00 D 739 GLY B 30 GLY^? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 ULMN 3 1ddj_c15 PLASMINOGEN user 12 3 # 12 D 603 HIS E 94 HIS.? 1000.00 D 646 ASP G 48 ASP^? 1000.00 D 739 GLY G 76 GLY.? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -0.35 -40.77 -35.64 -0.27 -40.87 -36.52 ULMN 3 1ddj_c15 PLASMINOGEN user 13 3 # 13 D 603 HIS E 95 HIS.? 1000.00 D 646 ASP B 48 ASP^? 1000.00 D 739 GLY E 90 GLY.? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c15 PLASMINOGEN user 14 3 # 14 D 603 HIS E 95 HIS.? 1000.00 D 646 ASP G 48 ASP^? 1000.00 D 739 GLY B 30 GLY^? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -11.79 -29.12 -55.60 -12.43 -28.79 -55.90 ULMN 3 1ddj_c15 PLASMINOGEN user 15 3 # 15 D 603 HIS E 95 HIS.? 1000.00 D 646 ASP G 48 ASP^? 1000.00 D 739 GLY G 76 GLY.? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -0.35 -40.77 -35.64 -0.27 -40.87 -36.52 ULMN 3 1ddj_c15 PLASMINOGEN user 16 3 # 16 D 603 HIS E 96 HIS.? 1000.00 D 646 ASP B 48 ASP^? 1000.00 D 739 GLY E 90 GLY.? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1ddj_c15 PLASMINOGEN user 17 3 # 17 D 603 HIS E 96 HIS.? 1000.00 D 646 ASP B 48 ASP^? 1000.00 D 739 GLY G 30 GLY^? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 ULMN 3 1ddj_c15 PLASMINOGEN user 18 3 # 18 D 603 HIS E 97 HIS.? 1000.00 D 646 ASP B 48 ASP^? 1000.00 D 739 GLY G 30 GLY^? 1000.00 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 1ddj_c15 source 1ddj PLASMINOGEN : 18 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 62 GLU.? 1000.00 A 226 THR E 20 THR^? 1000.00 A 229 LYS E 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 7.24 97.46 49.60 8.11 95.69 48.80 -36.03 -22.15 -38.71 -36.49 -24.28 -38.46 coo 10.53 97.56 43.71 9.33 93.71 47.17 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU A 93 GLU.? 1000.00 A 226 THR A 10 THR^? 1000.00 A 229 LYS A 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 coo 7.24 97.46 49.60 8.11 95.69 48.80 -39.93 -31.21 -51.78 -37.78 -31.39 -51.70 coo 10.53 97.56 43.71 9.33 93.71 47.17 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU A 93 GLU.? 1000.00 A 226 THR A 66 THR^? 1000.00 A 229 LYS A 38 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 coo 7.24 97.46 49.60 8.11 95.69 48.80 -51.73 -25.65 -57.14 -51.84 -26.51 -59.11 coo 10.53 97.56 43.71 9.33 93.71 47.17 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 57 GLU B 62 GLU.? 1000.00 A 226 THR C 65 THR.? 1000.00 A 229 LYS C 38 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 7.24 97.46 49.60 8.11 95.69 48.80 -41.67 -50.27 -29.26 -43.16 -50.66 -27.74 coo 10.53 97.56 43.71 9.33 93.71 47.17 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 57 GLU B 62 GLU.? 1000.00 A 226 THR C 66 THR^? 1000.00 A 229 LYS C 38 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 7.24 97.46 49.60 8.11 95.69 48.80 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 57 GLU B 62 GLU.? 1000.00 A 226 THR C 86 THR^? 1000.00 A 229 LYS C 38 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 7.24 97.46 49.60 8.11 95.69 48.80 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 10.53 97.56 43.71 9.33 93.71 47.17 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 57 GLU B 62 GLU.? 1000.00 A 226 THR G 20 THR^? 1000.00 A 229 LYS G 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 7.24 97.46 49.60 8.11 95.69 48.80 -8.47 -49.97 -55.83 -9.63 -51.40 -56.99 coo 10.53 97.56 43.71 9.33 93.71 47.17 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 57 GLU B 68 GLU^? 1000.00 A 226 THR C 86 THR^? 1000.00 A 229 LYS C 38 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 7.24 97.46 49.60 8.11 95.69 48.80 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 10.53 97.56 43.71 9.33 93.71 47.17 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 57 GLU B 68 GLU^? 1000.00 A 226 THR E 66 THR^? 1000.00 A 229 LYS E 38 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 7.24 97.46 49.60 8.11 95.69 48.80 -18.84 -18.95 -36.17 -18.49 -18.94 -34.03 coo 10.53 97.56 43.71 9.33 93.71 47.17 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 57 GLU C 68 GLU^? 1000.00 A 226 THR A 10 THR^? 1000.00 A 229 LYS A 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 coo 7.24 97.46 49.60 8.11 95.69 48.80 -39.93 -31.21 -51.78 -37.78 -31.39 -51.70 coo 10.53 97.56 43.71 9.33 93.71 47.17 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 57 GLU C 93 GLU.? 1000.00 A 226 THR D 85 THR^? 1000.00 A 229 LYS D 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 7.24 97.46 49.60 8.11 95.69 48.80 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo 10.53 97.56 43.71 9.33 93.71 47.17 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 57 GLU D 29 GLU.? 1000.00 A 226 THR C 66 THR^? 1000.00 A 229 LYS C 38 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 coo 7.24 97.46 49.60 8.11 95.69 48.80 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 57 GLU D 68 GLU^? 1000.00 A 226 THR C 65 THR.? 1000.00 A 229 LYS C 38 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 coo 7.24 97.46 49.60 8.11 95.69 48.80 -41.67 -50.27 -29.26 -43.16 -50.66 -27.74 coo 10.53 97.56 43.71 9.33 93.71 47.17 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 57 GLU D 68 GLU^? 1000.00 A 226 THR C 66 THR^? 1000.00 A 229 LYS C 38 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 coo 7.24 97.46 49.60 8.11 95.69 48.80 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 57 GLU E 62 GLU.? 1000.00 A 226 THR A 20 THR^? 1000.00 A 229 LYS A 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 7.24 97.46 49.60 8.11 95.69 48.80 -34.82 -25.15 -53.40 -33.69 -26.66 -52.30 coo 10.53 97.56 43.71 9.33 93.71 47.17 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 A 57 GLU E 68 GLU^? 1000.00 A 226 THR F 10 THR^? 1000.00 A 229 LYS F 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 coo 7.24 97.46 49.60 8.11 95.69 48.80 -34.22 -23.55 -18.35 -33.71 -25.63 -18.09 coo 10.53 97.56 43.71 9.33 93.71 47.17 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 A 57 GLU E 93 GLU.? 1000.00 A 226 THR G 20 THR^? 1000.00 A 229 LYS G 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 7.24 97.46 49.60 8.11 95.69 48.80 -8.47 -49.97 -55.83 -9.63 -51.40 -56.99 coo 10.53 97.56 43.71 9.33 93.71 47.17 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 A 57 GLU F 62 GLU.? 1000.00 A 226 THR C 20 THR^? 1000.00 A 229 LYS C 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 7.24 97.46 49.60 8.11 95.69 48.80 -41.88 -30.62 -30.53 -39.74 -30.38 -30.64 coo 10.53 97.56 43.71 9.33 93.71 47.17 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 A 57 GLU G 62 GLU.? 1000.00 A 226 THR B 20 THR^? 1000.00 A 229 LYS B 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 7.24 97.46 49.60 8.11 95.69 48.80 -20.08 -41.64 -58.57 -20.58 -43.29 -59.92 coo 10.53 97.56 43.71 9.33 93.71 47.17 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 A 57 GLU G 93 GLU.? 1000.00 A 226 THR G 10 THR^? 1000.00 A 229 LYS G 8 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -5.22 -46.46 -82.88 -6.14 -48.32 -83.21 coo 7.24 97.46 49.60 8.11 95.69 48.80 -8.21 -51.25 -63.80 -10.04 -52.16 -63.09 coo 10.53 97.56 43.71 9.33 93.71 47.17 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 A 57 GLU H 29 GLU.? 1000.00 A 226 THR B 65 THR.? 1000.00 A 229 LYS B 38 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 -19.75 -60.10 -27.61 -21.15 -61.23 -28.71 coo 7.24 97.46 49.60 8.11 95.69 48.80 -28.51 -49.05 -42.85 -27.19 -48.57 -41.20 coo 10.53 97.56 43.71 9.33 93.71 47.17 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 21 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 62 GLU.? 1000.00 B 226 THR E 20 THR^? 1000.00 B 229 LYS E 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 20.74 95.78 68.68 19.29 96.84 69.83 -36.03 -22.15 -38.71 -36.49 -24.28 -38.46 coo 22.32 101.61 71.64 17.89 98.63 71.55 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU A 93 GLU.? 1000.00 B 226 THR A 10 THR^? 1000.00 B 229 LYS A 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 coo 20.74 95.78 68.68 19.29 96.84 69.83 -39.93 -31.21 -51.78 -37.78 -31.39 -51.70 coo 22.32 101.61 71.64 17.89 98.63 71.55 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU A 93 GLU.? 1000.00 B 226 THR A 66 THR^? 1000.00 B 229 LYS A 38 LYS.? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 coo 20.74 95.78 68.68 19.29 96.84 69.83 -51.73 -25.65 -57.14 -51.84 -26.51 -59.11 coo 22.32 101.61 71.64 17.89 98.63 71.55 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 57 GLU B 62 GLU.? 1000.00 B 226 THR C 66 THR^? 1000.00 B 229 LYS C 38 LYS.? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 20.74 95.78 68.68 19.29 96.84 69.83 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 57 GLU B 62 GLU.? 1000.00 B 226 THR C 86 THR^? 1000.00 B 229 LYS C 38 LYS.? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 20.74 95.78 68.68 19.29 96.84 69.83 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 22.32 101.61 71.64 17.89 98.63 71.55 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 57 GLU B 62 GLU.? 1000.00 B 226 THR G 20 THR^? 1000.00 B 229 LYS G 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 20.74 95.78 68.68 19.29 96.84 69.83 -8.47 -49.97 -55.83 -9.63 -51.40 -56.99 coo 22.32 101.61 71.64 17.89 98.63 71.55 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 57 GLU B 68 GLU^? 1000.00 B 226 THR C 86 THR^? 1000.00 B 229 LYS C 38 LYS.? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 20.74 95.78 68.68 19.29 96.84 69.83 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 22.32 101.61 71.64 17.89 98.63 71.55 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 57 GLU B 68 GLU^? 1000.00 B 226 THR E 66 THR^? 1000.00 B 229 LYS E 38 LYS.? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 20.74 95.78 68.68 19.29 96.84 69.83 -18.84 -18.95 -36.17 -18.49 -18.94 -34.03 coo 22.32 101.61 71.64 17.89 98.63 71.55 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 57 GLU C 68 GLU^? 1000.00 B 226 THR A 10 THR^? 1000.00 B 229 LYS A 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 coo 20.74 95.78 68.68 19.29 96.84 69.83 -39.93 -31.21 -51.78 -37.78 -31.39 -51.70 coo 22.32 101.61 71.64 17.89 98.63 71.55 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 57 GLU C 93 GLU.? 1000.00 B 226 THR D 85 THR^? 1000.00 B 229 LYS D 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 20.74 95.78 68.68 19.29 96.84 69.83 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo 22.32 101.61 71.64 17.89 98.63 71.55 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 57 GLU D 29 GLU.? 1000.00 B 226 THR C 66 THR^? 1000.00 B 229 LYS C 38 LYS.? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 coo 20.74 95.78 68.68 19.29 96.84 69.83 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 57 GLU D 68 GLU^? 1000.00 B 226 THR C 66 THR^? 1000.00 B 229 LYS C 38 LYS.? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 coo 20.74 95.78 68.68 19.29 96.84 69.83 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 57 GLU E 62 GLU.? 1000.00 B 226 THR A 20 THR^? 1000.00 B 229 LYS A 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 20.74 95.78 68.68 19.29 96.84 69.83 -34.82 -25.15 -53.40 -33.69 -26.66 -52.30 coo 22.32 101.61 71.64 17.89 98.63 71.55 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 57 GLU E 68 GLU^? 1000.00 B 226 THR F 10 THR^? 1000.00 B 229 LYS F 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 coo 20.74 95.78 68.68 19.29 96.84 69.83 -34.22 -23.55 -18.35 -33.71 -25.63 -18.09 coo 22.32 101.61 71.64 17.89 98.63 71.55 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 57 GLU E 93 GLU.? 1000.00 B 226 THR G 20 THR^? 1000.00 B 229 LYS G 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 20.74 95.78 68.68 19.29 96.84 69.83 -8.47 -49.97 -55.83 -9.63 -51.40 -56.99 coo 22.32 101.61 71.64 17.89 98.63 71.55 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 B 57 GLU F 62 GLU.? 1000.00 B 226 THR C 20 THR^? 1000.00 B 229 LYS C 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 20.74 95.78 68.68 19.29 96.84 69.83 -41.88 -30.62 -30.53 -39.74 -30.38 -30.64 coo 22.32 101.61 71.64 17.89 98.63 71.55 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 B 57 GLU G 62 GLU.? 1000.00 B 226 THR B 20 THR^? 1000.00 B 229 LYS B 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 20.74 95.78 68.68 19.29 96.84 69.83 -20.08 -41.64 -58.57 -20.58 -43.29 -59.92 coo 22.32 101.61 71.64 17.89 98.63 71.55 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 B 57 GLU G 93 GLU.? 1000.00 B 226 THR G 10 THR^? 1000.00 B 229 LYS G 8 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 -5.22 -46.46 -82.88 -6.14 -48.32 -83.21 coo 20.74 95.78 68.68 19.29 96.84 69.83 -8.21 -51.25 -63.80 -10.04 -52.16 -63.09 coo 22.32 101.61 71.64 17.89 98.63 71.55 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 18 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 62 GLU.? 1000.00 C 226 THR E 20 THR^? 1000.00 C 229 LYS E 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 22.16 45.88 73.63 23.23 47.70 73.25 -36.03 -22.15 -38.71 -36.49 -24.28 -38.46 coo 28.90 45.91 73.55 25.22 49.72 72.97 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU A 93 GLU.? 1000.00 C 226 THR A 10 THR^? 1000.00 C 229 LYS A 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 coo 22.16 45.88 73.63 23.23 47.70 73.25 -39.93 -31.21 -51.78 -37.78 -31.39 -51.70 coo 28.90 45.91 73.55 25.22 49.72 72.97 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU A 93 GLU.? 1000.00 C 226 THR A 66 THR^? 1000.00 C 229 LYS A 38 LYS.? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 coo 22.16 45.88 73.63 23.23 47.70 73.25 -51.73 -25.65 -57.14 -51.84 -26.51 -59.11 coo 28.90 45.91 73.55 25.22 49.72 72.97 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 57 GLU B 62 GLU.? 1000.00 C 226 THR C 66 THR^? 1000.00 C 229 LYS C 38 LYS.? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 22.16 45.88 73.63 23.23 47.70 73.25 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 57 GLU B 62 GLU.? 1000.00 C 226 THR C 86 THR^? 1000.00 C 229 LYS C 38 LYS.? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 22.16 45.88 73.63 23.23 47.70 73.25 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 28.90 45.91 73.55 25.22 49.72 72.97 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 57 GLU B 62 GLU.? 1000.00 C 226 THR G 20 THR^? 1000.00 C 229 LYS G 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 22.16 45.88 73.63 23.23 47.70 73.25 -8.47 -49.97 -55.83 -9.63 -51.40 -56.99 coo 28.90 45.91 73.55 25.22 49.72 72.97 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 57 GLU B 68 GLU^? 1000.00 C 226 THR C 86 THR^? 1000.00 C 229 LYS C 38 LYS.? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 22.16 45.88 73.63 23.23 47.70 73.25 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 28.90 45.91 73.55 25.22 49.72 72.97 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 57 GLU B 68 GLU^? 1000.00 C 226 THR E 66 THR^? 1000.00 C 229 LYS E 38 LYS.? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 22.16 45.88 73.63 23.23 47.70 73.25 -18.84 -18.95 -36.17 -18.49 -18.94 -34.03 coo 28.90 45.91 73.55 25.22 49.72 72.97 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 57 GLU C 68 GLU^? 1000.00 C 226 THR A 10 THR^? 1000.00 C 229 LYS A 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 coo 22.16 45.88 73.63 23.23 47.70 73.25 -39.93 -31.21 -51.78 -37.78 -31.39 -51.70 coo 28.90 45.91 73.55 25.22 49.72 72.97 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 57 GLU C 93 GLU.? 1000.00 C 226 THR D 85 THR^? 1000.00 C 229 LYS D 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 22.16 45.88 73.63 23.23 47.70 73.25 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo 28.90 45.91 73.55 25.22 49.72 72.97 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 57 GLU D 29 GLU.? 1000.00 C 226 THR C 66 THR^? 1000.00 C 229 LYS C 38 LYS.? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 coo 22.16 45.88 73.63 23.23 47.70 73.25 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 57 GLU D 68 GLU^? 1000.00 C 226 THR C 66 THR^? 1000.00 C 229 LYS C 38 LYS.? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 coo 22.16 45.88 73.63 23.23 47.70 73.25 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 57 GLU E 62 GLU.? 1000.00 C 226 THR A 20 THR^? 1000.00 C 229 LYS A 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 22.16 45.88 73.63 23.23 47.70 73.25 -34.82 -25.15 -53.40 -33.69 -26.66 -52.30 coo 28.90 45.91 73.55 25.22 49.72 72.97 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 57 GLU E 68 GLU^? 1000.00 C 226 THR F 10 THR^? 1000.00 C 229 LYS F 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 coo 22.16 45.88 73.63 23.23 47.70 73.25 -34.22 -23.55 -18.35 -33.71 -25.63 -18.09 coo 28.90 45.91 73.55 25.22 49.72 72.97 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 57 GLU E 93 GLU.? 1000.00 C 226 THR G 20 THR^? 1000.00 C 229 LYS G 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 22.16 45.88 73.63 23.23 47.70 73.25 -8.47 -49.97 -55.83 -9.63 -51.40 -56.99 coo 28.90 45.91 73.55 25.22 49.72 72.97 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 C 57 GLU F 62 GLU.? 1000.00 C 226 THR C 20 THR^? 1000.00 C 229 LYS C 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 22.16 45.88 73.63 23.23 47.70 73.25 -41.88 -30.62 -30.53 -39.74 -30.38 -30.64 coo 28.90 45.91 73.55 25.22 49.72 72.97 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 C 57 GLU G 62 GLU.? 1000.00 C 226 THR B 20 THR^? 1000.00 C 229 LYS B 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 22.16 45.88 73.63 23.23 47.70 73.25 -20.08 -41.64 -58.57 -20.58 -43.29 -59.92 coo 28.90 45.91 73.55 25.22 49.72 72.97 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 C 57 GLU G 93 GLU.? 1000.00 C 226 THR G 10 THR^? 1000.00 C 229 LYS G 8 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 -5.22 -46.46 -82.88 -6.14 -48.32 -83.21 coo 22.16 45.88 73.63 23.23 47.70 73.25 -8.21 -51.25 -63.80 -10.04 -52.16 -63.09 coo 28.90 45.91 73.55 25.22 49.72 72.97 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 18 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 62 GLU.? 1000.00 D 226 THR E 20 THR^? 1000.00 D 229 LYS E 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 11.79 47.62 52.67 10.10 46.51 53.39 -36.03 -22.15 -38.71 -36.49 -24.28 -38.46 coo 10.05 41.79 49.80 7.94 44.71 53.76 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU A 93 GLU.? 1000.00 D 226 THR A 10 THR^? 1000.00 D 229 LYS A 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 coo 11.79 47.62 52.67 10.10 46.51 53.39 -39.93 -31.21 -51.78 -37.78 -31.39 -51.70 coo 10.05 41.79 49.80 7.94 44.71 53.76 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU A 93 GLU.? 1000.00 D 226 THR A 66 THR^? 1000.00 D 229 LYS A 38 LYS.? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 coo 11.79 47.62 52.67 10.10 46.51 53.39 -51.73 -25.65 -57.14 -51.84 -26.51 -59.11 coo 10.05 41.79 49.80 7.94 44.71 53.76 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 57 GLU B 62 GLU.? 1000.00 D 226 THR C 66 THR^? 1000.00 D 229 LYS C 38 LYS.? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 11.79 47.62 52.67 10.10 46.51 53.39 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 57 GLU B 62 GLU.? 1000.00 D 226 THR C 86 THR^? 1000.00 D 229 LYS C 38 LYS.? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 11.79 47.62 52.67 10.10 46.51 53.39 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 10.05 41.79 49.80 7.94 44.71 53.76 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 57 GLU B 62 GLU.? 1000.00 D 226 THR G 20 THR^? 1000.00 D 229 LYS G 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 11.79 47.62 52.67 10.10 46.51 53.39 -8.47 -49.97 -55.83 -9.63 -51.40 -56.99 coo 10.05 41.79 49.80 7.94 44.71 53.76 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 57 GLU B 68 GLU^? 1000.00 D 226 THR C 86 THR^? 1000.00 D 229 LYS C 38 LYS.? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 11.79 47.62 52.67 10.10 46.51 53.39 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 10.05 41.79 49.80 7.94 44.71 53.76 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 57 GLU B 68 GLU^? 1000.00 D 226 THR E 66 THR^? 1000.00 D 229 LYS E 38 LYS.? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 11.79 47.62 52.67 10.10 46.51 53.39 -18.84 -18.95 -36.17 -18.49 -18.94 -34.03 coo 10.05 41.79 49.80 7.94 44.71 53.76 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 57 GLU C 68 GLU^? 1000.00 D 226 THR A 10 THR^? 1000.00 D 229 LYS A 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 coo 11.79 47.62 52.67 10.10 46.51 53.39 -39.93 -31.21 -51.78 -37.78 -31.39 -51.70 coo 10.05 41.79 49.80 7.94 44.71 53.76 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 57 GLU C 93 GLU.? 1000.00 D 226 THR D 85 THR^? 1000.00 D 229 LYS D 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 11.79 47.62 52.67 10.10 46.51 53.39 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo 10.05 41.79 49.80 7.94 44.71 53.76 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 57 GLU D 29 GLU.? 1000.00 D 226 THR C 66 THR^? 1000.00 D 229 LYS C 38 LYS.? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 coo 11.79 47.62 52.67 10.10 46.51 53.39 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 57 GLU D 68 GLU^? 1000.00 D 226 THR C 66 THR^? 1000.00 D 229 LYS C 38 LYS.? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 coo 11.79 47.62 52.67 10.10 46.51 53.39 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 57 GLU E 62 GLU.? 1000.00 D 226 THR A 20 THR^? 1000.00 D 229 LYS A 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 11.79 47.62 52.67 10.10 46.51 53.39 -34.82 -25.15 -53.40 -33.69 -26.66 -52.30 coo 10.05 41.79 49.80 7.94 44.71 53.76 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 57 GLU E 68 GLU^? 1000.00 D 226 THR F 10 THR^? 1000.00 D 229 LYS F 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 coo 11.79 47.62 52.67 10.10 46.51 53.39 -34.22 -23.55 -18.35 -33.71 -25.63 -18.09 coo 10.05 41.79 49.80 7.94 44.71 53.76 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 57 GLU E 93 GLU.? 1000.00 D 226 THR G 20 THR^? 1000.00 D 229 LYS G 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 11.79 47.62 52.67 10.10 46.51 53.39 -8.47 -49.97 -55.83 -9.63 -51.40 -56.99 coo 10.05 41.79 49.80 7.94 44.71 53.76 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 D 57 GLU F 62 GLU.? 1000.00 D 226 THR C 20 THR^? 1000.00 D 229 LYS C 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 11.79 47.62 52.67 10.10 46.51 53.39 -41.88 -30.62 -30.53 -39.74 -30.38 -30.64 coo 10.05 41.79 49.80 7.94 44.71 53.76 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 D 57 GLU G 62 GLU.? 1000.00 D 226 THR B 20 THR^? 1000.00 D 229 LYS B 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 11.79 47.62 52.67 10.10 46.51 53.39 -20.08 -41.64 -58.57 -20.58 -43.29 -59.92 coo 10.05 41.79 49.80 7.94 44.71 53.76 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 D 57 GLU G 93 GLU.? 1000.00 D 226 THR G 10 THR^? 1000.00 D 229 LYS G 8 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 -5.22 -46.46 -82.88 -6.14 -48.32 -83.21 coo 11.79 47.62 52.67 10.10 46.51 53.39 -8.21 -51.25 -63.80 -10.04 -52.16 -63.09 coo 10.05 41.79 49.80 7.94 44.71 53.76 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 18 hits 1dfo_c07 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 16 THR.? 1000.00 A 45 THR A 13 THR.? 1000.00 A 161 LYS A 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -46.17 -26.76 -46.24 -44.99 -27.18 -44.49 coo 27.73 89.90 76.08 29.24 91.46 75.95 -47.58 -31.45 -46.99 -46.54 -30.67 -45.25 coo 33.83 91.15 88.62 31.07 91.06 83.02 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 34 THR^? 1000.00 A 45 THR A 46 THR^? 1000.00 A 161 LYS A 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -42.33 -15.12 -56.08 -43.18 -13.58 -57.35 coo 27.73 89.90 76.08 29.24 91.46 75.95 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 coo 33.83 91.15 88.62 31.07 91.06 83.02 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR A 45 THR^? 1000.00 A 45 THR A 46 THR^? 1000.00 A 161 LYS A 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -45.89 -12.76 -52.82 -46.50 -13.35 -50.80 coo 27.73 89.90 76.08 29.24 91.46 75.95 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 coo 33.83 91.15 88.62 31.07 91.06 83.02 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR A 88 THR^? 1000.00 A 45 THR A 66 THR^? 1000.00 A 161 LYS A 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -49.69 -29.03 -55.58 -51.35 -29.56 -56.84 coo 27.73 89.90 76.08 29.24 91.46 75.95 -51.73 -25.65 -57.14 -51.84 -26.51 -59.11 coo 33.83 91.15 88.62 31.07 91.06 83.02 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR A 88 THR^? 1000.00 A 45 THR A 89 THR.? 1000.00 A 161 LYS A 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -49.69 -29.03 -55.58 -51.35 -29.56 -56.84 coo 27.73 89.90 76.08 29.24 91.46 75.95 -50.23 -29.32 -51.83 -50.84 -27.38 -51.08 coo 33.83 91.15 88.62 31.07 91.06 83.02 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR A 89 THR.? 1000.00 A 45 THR A 88 THR^? 1000.00 A 161 LYS A 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -50.23 -29.32 -51.83 -50.84 -27.38 -51.08 coo 27.73 89.90 76.08 29.24 91.46 75.95 -49.69 -29.03 -55.58 -51.35 -29.56 -56.84 coo 33.83 91.15 88.62 31.07 91.06 83.02 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 A 44 THR B 16 THR.? 1000.00 A 45 THR B 13 THR.? 1000.00 A 161 LYS B 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -20.03 -51.44 -49.33 -18.81 -53.02 -50.16 coo 27.73 89.90 76.08 29.24 91.46 75.95 -23.90 -54.74 -50.91 -21.76 -54.96 -51.26 coo 33.83 91.15 88.62 31.07 91.06 83.02 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 A 44 THR B 34 THR^? 1000.00 A 45 THR B 46 THR^? 1000.00 A 161 LYS B 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -19.36 -36.24 -46.83 -19.64 -34.64 -45.39 coo 27.73 89.90 76.08 29.24 91.46 75.95 -15.59 -35.86 -44.93 -16.46 -33.88 -45.17 coo 33.83 91.15 88.62 31.07 91.06 83.02 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 A 44 THR B 45 THR^? 1000.00 A 45 THR B 46 THR^? 1000.00 A 161 LYS B 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -16.90 -38.16 -42.20 -16.20 -40.16 -42.73 coo 27.73 89.90 76.08 29.24 91.46 75.95 -15.59 -35.86 -44.93 -16.46 -33.88 -45.17 coo 33.83 91.15 88.62 31.07 91.06 83.02 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 A 44 THR B 54 THR^? 1000.00 A 45 THR G 57 THR^? 1000.00 A 161 LYS B 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -15.28 -38.81 -60.02 -15.02 -38.82 -62.16 coo 27.73 89.90 76.08 29.24 91.46 75.95 -11.73 -43.22 -60.42 -13.41 -43.82 -61.59 coo 33.83 91.15 88.62 31.07 91.06 83.02 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 11 3 # 11 A 44 THR B 88 THR^? 1000.00 A 45 THR B 66 THR^? 1000.00 A 161 LYS B 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -29.52 -48.22 -47.90 -31.42 -48.56 -46.89 coo 27.73 89.90 76.08 29.24 91.46 75.95 -29.43 -45.79 -44.56 -31.38 -45.09 -45.08 coo 33.83 91.15 88.62 31.07 91.06 83.02 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 12 3 # 12 A 44 THR B 88 THR^? 1000.00 A 45 THR B 89 THR.? 1000.00 A 161 LYS B 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -29.52 -48.22 -47.90 -31.42 -48.56 -46.89 coo 27.73 89.90 76.08 29.24 91.46 75.95 -27.18 -51.21 -47.58 -25.70 -50.66 -46.11 coo 33.83 91.15 88.62 31.07 91.06 83.02 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 13 3 # 13 A 44 THR B 89 THR.? 1000.00 A 45 THR B 88 THR^? 1000.00 A 161 LYS B 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -27.18 -51.21 -47.58 -25.70 -50.66 -46.11 coo 27.73 89.90 76.08 29.24 91.46 75.95 -29.52 -48.22 -47.90 -31.42 -48.56 -46.89 coo 33.83 91.15 88.62 31.07 91.06 83.02 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 14 3 # 14 A 44 THR C 13 THR.? 1000.00 A 45 THR C 16 THR.? 1000.00 A 161 LYS D 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 coo 27.73 89.90 76.08 29.24 91.46 75.95 -38.73 -41.54 -23.23 -37.24 -40.73 -21.87 coo 33.83 91.15 88.62 31.07 91.06 83.02 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 15 3 # 15 A 44 THR C 16 THR.? 1000.00 A 45 THR C 13 THR.? 1000.00 A 161 LYS C 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -38.73 -41.54 -23.23 -37.24 -40.73 -21.87 coo 27.73 89.90 76.08 29.24 91.46 75.95 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 coo 33.83 91.15 88.62 31.07 91.06 83.02 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 16 3 # 16 A 44 THR C 20 THR^? 1000.00 A 45 THR C 54 THR^? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -41.88 -30.62 -30.53 -39.74 -30.38 -30.64 coo 27.73 89.90 76.08 29.24 91.46 75.95 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 17 3 # 17 A 44 THR C 34 THR^? 1000.00 A 45 THR C 45 THR^? 1000.00 A 161 LYS C 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -52.37 -37.85 -28.96 -54.37 -38.44 -29.47 coo 27.73 89.90 76.08 29.24 91.46 75.95 -53.59 -40.92 -24.31 -52.41 -41.01 -22.49 coo 33.83 91.15 88.62 31.07 91.06 83.02 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 18 3 # 18 A 44 THR C 34 THR^? 1000.00 A 45 THR C 46 THR^? 1000.00 A 161 LYS C 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -52.37 -37.85 -28.96 -54.37 -38.44 -29.47 coo 27.73 89.90 76.08 29.24 91.46 75.95 -54.65 -37.38 -25.18 -56.17 -36.99 -26.65 coo 33.83 91.15 88.62 31.07 91.06 83.02 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 19 3 # 19 A 44 THR C 45 THR^? 1000.00 A 45 THR C 46 THR^? 1000.00 A 161 LYS C 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -53.59 -40.92 -24.31 -52.41 -41.01 -22.49 coo 27.73 89.90 76.08 29.24 91.46 75.95 -54.65 -37.38 -25.18 -56.17 -36.99 -26.65 coo 33.83 91.15 88.62 31.07 91.06 83.02 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 20 3 # 20 A 44 THR C 46 THR^? 1000.00 A 45 THR C 45 THR^? 1000.00 A 161 LYS C 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -54.65 -37.38 -25.18 -56.17 -36.99 -26.65 coo 27.73 89.90 76.08 29.24 91.46 75.95 -53.59 -40.92 -24.31 -52.41 -41.01 -22.49 coo 33.83 91.15 88.62 31.07 91.06 83.02 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 21 3 # 21 A 44 THR C 54 THR^? 1000.00 A 45 THR F 57 THR^? 1000.00 A 161 LYS C 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo 27.73 89.90 76.08 29.24 91.46 75.95 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo 33.83 91.15 88.62 31.07 91.06 83.02 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 22 3 # 22 A 44 THR C 54 THR^? 1000.00 A 45 THR F 57 THR^? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo 27.73 89.90 76.08 29.24 91.46 75.95 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 23 3 # 23 A 44 THR C 88 THR^? 1000.00 A 45 THR C 66 THR^? 1000.00 A 161 LYS C 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 coo 27.73 89.90 76.08 29.24 91.46 75.95 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 33.83 91.15 88.62 31.07 91.06 83.02 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 24 3 # 24 A 44 THR C 88 THR^? 1000.00 A 45 THR C 89 THR.? 1000.00 A 161 LYS C 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 coo 27.73 89.90 76.08 29.24 91.46 75.95 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 coo 33.83 91.15 88.62 31.07 91.06 83.02 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 25 3 # 25 A 44 THR C 89 THR.? 1000.00 A 45 THR C 88 THR^? 1000.00 A 161 LYS C 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 coo 27.73 89.90 76.08 29.24 91.46 75.95 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 coo 33.83 91.15 88.62 31.07 91.06 83.02 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 26 3 # 26 A 44 THR D 16 THR.? 1000.00 A 45 THR D 13 THR.? 1000.00 A 161 LYS D 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -13.26 -44.36 -15.10 -11.61 -45.23 -13.98 coo 27.73 89.90 76.08 29.24 91.46 75.95 -10.53 -40.25 -13.37 -10.17 -42.31 -12.84 coo 33.83 91.15 88.62 31.07 91.06 83.02 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 27 3 # 27 A 44 THR D 34 THR^? 1000.00 A 45 THR D 46 THR^? 1000.00 A 161 LYS D 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -27.89 -46.26 -19.44 -29.31 -46.15 -21.09 coo 27.73 89.90 76.08 29.24 91.46 75.95 -27.50 -50.23 -21.22 -29.54 -49.49 -21.28 coo 33.83 91.15 88.62 31.07 91.06 83.02 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 28 3 # 28 A 44 THR D 45 THR^? 1000.00 A 45 THR D 46 THR^? 1000.00 A 161 LYS D 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -24.99 -48.61 -23.54 -22.98 -49.39 -23.53 coo 27.73 89.90 76.08 29.24 91.46 75.95 -27.50 -50.23 -21.22 -29.54 -49.49 -21.28 coo 33.83 91.15 88.62 31.07 91.06 83.02 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 29 3 # 29 A 44 THR D 54 THR^? 1000.00 A 45 THR H 57 THR^? 1000.00 A 161 LYS D 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -26.58 -49.74 -5.75 -26.83 -49.90 -3.63 coo 27.73 89.90 76.08 29.24 91.46 75.95 -22.01 -53.02 -4.72 -21.58 -51.28 -3.54 coo 33.83 91.15 88.62 31.07 91.06 83.02 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 30 3 # 30 A 44 THR D 85 THR^? 1000.00 A 45 THR D 86 THR^? 1000.00 A 161 LYS F 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo 27.73 89.90 76.08 29.24 91.46 75.95 -24.01 -35.70 -16.08 -25.04 -34.15 -17.17 coo 33.83 91.15 88.62 31.07 91.06 83.02 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 31 3 # 31 A 44 THR D 88 THR^? 1000.00 A 45 THR D 66 THR^? 1000.00 A 161 LYS D 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -17.07 -35.15 -17.54 -16.96 -33.51 -18.95 coo 27.73 89.90 76.08 29.24 91.46 75.95 -19.29 -35.44 -21.10 -20.09 -33.46 -20.75 coo 33.83 91.15 88.62 31.07 91.06 83.02 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 32 3 # 32 A 44 THR D 88 THR^? 1000.00 A 45 THR D 89 THR.? 1000.00 A 161 LYS D 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -17.07 -35.15 -17.54 -16.96 -33.51 -18.95 coo 27.73 89.90 76.08 29.24 91.46 75.95 -13.87 -37.20 -17.43 -14.13 -38.77 -18.92 coo 33.83 91.15 88.62 31.07 91.06 83.02 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 33 3 # 33 A 44 THR D 89 THR.? 1000.00 A 45 THR D 88 THR^? 1000.00 A 161 LYS D 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -13.87 -37.20 -17.43 -14.13 -38.77 -18.92 coo 27.73 89.90 76.08 29.24 91.46 75.95 -17.07 -35.15 -17.54 -16.96 -33.51 -18.95 coo 33.83 91.15 88.62 31.07 91.06 83.02 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 34 3 # 34 A 44 THR E 16 THR.? 1000.00 A 45 THR E 13 THR.? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -24.49 -24.91 -44.90 -24.95 -26.52 -46.29 coo 27.73 89.90 76.08 29.24 91.46 75.95 -22.32 -28.98 -42.19 -23.52 -29.23 -44.03 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 35 3 # 35 A 44 THR E 20 THR^? 1000.00 A 45 THR E 54 THR^? 1000.00 A 161 LYS C 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -36.03 -22.15 -38.71 -36.49 -24.28 -38.46 coo 27.73 89.90 76.08 29.24 91.46 75.95 -40.50 -20.24 -41.39 -42.17 -21.46 -40.79 coo 33.83 91.15 88.62 31.07 91.06 83.02 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 36 3 # 36 A 44 THR E 34 THR^? 1000.00 A 45 THR E 45 THR^? 1000.00 A 161 LYS E 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -29.94 -11.10 -40.28 -29.56 -9.06 -39.62 coo 27.73 89.90 76.08 29.24 91.46 75.95 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 coo 33.83 91.15 88.62 31.07 91.06 83.02 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 37 3 # 37 A 44 THR E 34 THR^? 1000.00 A 45 THR E 46 THR^? 1000.00 A 161 LYS E 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -29.94 -11.10 -40.28 -29.56 -9.06 -39.62 coo 27.73 89.90 76.08 29.24 91.46 75.95 -30.70 -8.84 -43.79 -31.20 -7.44 -42.21 coo 33.83 91.15 88.62 31.07 91.06 83.02 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 38 3 # 38 A 44 THR E 45 THR^? 1000.00 A 45 THR E 46 THR^? 1000.00 A 161 LYS E 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 coo 27.73 89.90 76.08 29.24 91.46 75.95 -30.70 -8.84 -43.79 -31.20 -7.44 -42.21 coo 33.83 91.15 88.62 31.07 91.06 83.02 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 39 3 # 39 A 44 THR E 46 THR^? 1000.00 A 45 THR E 45 THR^? 1000.00 A 161 LYS E 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -30.70 -8.84 -43.79 -31.20 -7.44 -42.21 coo 27.73 89.90 76.08 29.24 91.46 75.95 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 coo 33.83 91.15 88.62 31.07 91.06 83.02 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 40 3 # 40 A 44 THR E 88 THR^? 1000.00 A 45 THR E 66 THR^? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 coo 27.73 89.90 76.08 29.24 91.46 75.95 -18.84 -18.95 -36.17 -18.49 -18.94 -34.03 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 41 3 # 41 A 44 THR E 88 THR^? 1000.00 A 45 THR E 89 THR.? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 coo 27.73 89.90 76.08 29.24 91.46 75.95 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 42 3 # 42 A 44 THR E 89 THR.? 1000.00 A 45 THR E 88 THR^? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 coo 27.73 89.90 76.08 29.24 91.46 75.95 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 43 3 # 43 A 44 THR F 13 THR.? 1000.00 A 45 THR F 15 THR.? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 coo 27.73 89.90 76.08 29.24 91.46 75.95 -40.21 -15.05 -24.42 -40.56 -14.25 -26.40 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 44 3 # 44 A 44 THR F 13 THR.? 1000.00 A 45 THR F 16 THR.? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 coo 27.73 89.90 76.08 29.24 91.46 75.95 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 45 3 # 45 A 44 THR F 16 THR.? 1000.00 A 45 THR F 13 THR.? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo 27.73 89.90 76.08 29.24 91.46 75.95 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 46 3 # 46 A 44 THR F 16 THR.? 1000.00 A 45 THR F 13 THR.? 1000.00 A 161 LYS F 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo 27.73 89.90 76.08 29.24 91.46 75.95 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 coo 33.83 91.15 88.62 31.07 91.06 83.02 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 47 3 # 47 A 44 THR F 16 THR.? 1000.00 A 45 THR F 15 THR.? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo 27.73 89.90 76.08 29.24 91.46 75.95 -40.21 -15.05 -24.42 -40.56 -14.25 -26.40 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 48 3 # 48 A 44 THR F 16 THR.? 1000.00 A 45 THR F 59 THR.? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo 27.73 89.90 76.08 29.24 91.46 75.95 -43.89 -19.57 -25.18 -44.09 -20.84 -26.90 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 49 3 # 49 A 44 THR F 34 THR^? 1000.00 A 45 THR F 46 THR^? 1000.00 A 161 LYS F 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -50.35 -23.30 -13.81 -52.09 -22.66 -12.66 coo 27.73 89.90 76.08 29.24 91.46 75.95 -53.66 -24.14 -16.36 -54.70 -24.62 -14.51 coo 33.83 91.15 88.62 31.07 91.06 83.02 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 50 3 # 50 A 44 THR F 45 THR^? 1000.00 A 45 THR F 46 THR^? 1000.00 A 161 LYS F 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -53.13 -20.55 -17.44 -52.54 -20.20 -19.48 coo 27.73 89.90 76.08 29.24 91.46 75.95 -53.66 -24.14 -16.36 -54.70 -24.62 -14.51 coo 33.83 91.15 88.62 31.07 91.06 83.02 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 51 3 # 51 A 44 THR F 54 THR^? 1000.00 A 45 THR C 57 THR^? 1000.00 A 161 LYS F 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -42.11 -34.37 -17.32 -40.78 -36.07 -17.42 coo 27.73 89.90 76.08 29.24 91.46 75.95 -41.24 -34.76 -22.98 -39.22 -34.48 -22.21 coo 33.83 91.15 88.62 31.07 91.06 83.02 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 52 3 # 52 A 44 THR F 57 THR^? 1000.00 A 45 THR C 54 THR^? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo 27.73 89.90 76.08 29.24 91.46 75.95 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 53 3 # 53 A 44 THR F 59 THR.? 1000.00 A 45 THR F 16 THR.? 1000.00 A 161 LYS E 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -43.89 -19.57 -25.18 -44.09 -20.84 -26.90 coo 27.73 89.90 76.08 29.24 91.46 75.95 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo 33.83 91.15 88.62 31.07 91.06 83.02 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 54 3 # 54 A 44 THR F 88 THR^? 1000.00 A 45 THR F 66 THR^? 1000.00 A 161 LYS F 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -37.77 -14.05 -15.00 -37.42 -12.10 -14.15 coo 27.73 89.90 76.08 29.24 91.46 75.95 -41.46 -12.42 -13.58 -40.70 -12.09 -11.59 coo 33.83 91.15 88.62 31.07 91.06 83.02 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 55 3 # 55 A 44 THR F 88 THR^? 1000.00 A 45 THR F 89 THR.? 1000.00 A 161 LYS F 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -37.77 -14.05 -15.00 -37.42 -12.10 -14.15 coo 27.73 89.90 76.08 29.24 91.46 75.95 -37.46 -13.84 -18.76 -39.46 -13.48 -19.54 coo 33.83 91.15 88.62 31.07 91.06 83.02 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 56 3 # 56 A 44 THR F 89 THR.? 1000.00 A 45 THR F 88 THR^? 1000.00 A 161 LYS F 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -37.46 -13.84 -18.76 -39.46 -13.48 -19.54 coo 27.73 89.90 76.08 29.24 91.46 75.95 -37.77 -14.05 -15.00 -37.42 -12.10 -14.15 coo 33.83 91.15 88.62 31.07 91.06 83.02 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 57 3 # 57 A 44 THR G 16 THR.? 1000.00 A 45 THR G 13 THR.? 1000.00 A 161 LYS G 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -9.31 -42.23 -66.96 -11.43 -42.13 -67.48 coo 27.73 89.90 76.08 29.24 91.46 75.95 -8.92 -45.57 -71.07 -10.80 -44.92 -70.18 coo 33.83 91.15 88.62 31.07 91.06 83.02 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 58 3 # 58 A 44 THR G 34 THR^? 1000.00 A 45 THR G 46 THR^? 1000.00 A 161 LYS G 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -0.50 -39.88 -54.46 1.25 -38.89 -53.69 coo 27.73 89.90 76.08 29.24 91.46 75.95 -1.95 -36.32 -52.94 -0.35 -36.61 -51.51 coo 33.83 91.15 88.62 31.07 91.06 83.02 6.01 -41.17 -63.42 7.43 -47.25 -63.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 59 3 # 59 A 44 THR G 45 THR^? 1000.00 A 45 THR G 46 THR^? 1000.00 A 161 LYS G 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -1.50 -34.99 -56.46 -3.32 -34.36 -57.43 coo 27.73 89.90 76.08 29.24 91.46 75.95 -1.95 -36.32 -52.94 -0.35 -36.61 -51.51 coo 33.83 91.15 88.62 31.07 91.06 83.02 6.01 -41.17 -63.42 7.43 -47.25 -63.10 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 60 3 # 60 A 44 THR G 88 THR^? 1000.00 A 45 THR G 66 THR^? 1000.00 A 161 LYS G 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -0.28 -46.35 -69.13 1.51 -46.38 -70.37 coo 27.73 89.90 76.08 29.24 91.46 75.95 2.66 -43.43 -68.00 4.28 -44.88 -68.13 coo 33.83 91.15 88.62 31.07 91.06 83.02 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 61 3 # 61 A 44 THR G 88 THR^? 1000.00 A 45 THR G 89 THR.? 1000.00 A 161 LYS G 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -0.28 -46.35 -69.13 1.51 -46.38 -70.37 coo 27.73 89.90 76.08 29.24 91.46 75.95 -3.47 -44.79 -70.49 -3.37 -42.68 -70.06 coo 33.83 91.15 88.62 31.07 91.06 83.02 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 62 3 # 62 A 44 THR G 89 THR.? 1000.00 A 45 THR G 13 THR.? 1000.00 A 161 LYS G 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -3.47 -44.79 -70.49 -3.37 -42.68 -70.06 coo 27.73 89.90 76.08 29.24 91.46 75.95 -8.92 -45.57 -71.07 -10.80 -44.92 -70.18 coo 33.83 91.15 88.62 31.07 91.06 83.02 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 63 3 # 63 A 44 THR G 89 THR.? 1000.00 A 45 THR G 88 THR^? 1000.00 A 161 LYS G 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -3.47 -44.79 -70.49 -3.37 -42.68 -70.06 coo 27.73 89.90 76.08 29.24 91.46 75.95 -0.28 -46.35 -69.13 1.51 -46.38 -70.37 coo 33.83 91.15 88.62 31.07 91.06 83.02 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 64 3 # 64 A 44 THR H 16 THR.? 1000.00 A 45 THR H 13 THR.? 1000.00 A 161 LYS H 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -23.37 -55.18 1.78 -23.47 -53.10 2.34 coo 27.73 89.90 76.08 29.24 91.46 75.95 -20.65 -55.18 6.19 -21.38 -53.37 5.29 coo 33.83 91.15 88.62 31.07 91.06 83.02 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 65 3 # 65 A 44 THR H 34 THR^? 1000.00 A 45 THR H 46 THR^? 1000.00 A 161 LYS H 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -23.65 -64.63 -10.64 -24.28 -66.51 -11.50 coo 27.73 89.90 76.08 29.24 91.46 75.95 -27.27 -63.43 -12.62 -26.65 -64.97 -14.02 coo 33.83 91.15 88.62 31.07 91.06 83.02 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 66 3 # 66 A 44 THR H 45 THR^? 1000.00 A 45 THR H 46 THR^? 1000.00 A 161 LYS H 38 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -28.98 -64.21 -9.31 -29.95 -62.48 -8.44 coo 27.73 89.90 76.08 29.24 91.46 75.95 -27.27 -63.43 -12.62 -26.65 -64.97 -14.02 coo 33.83 91.15 88.62 31.07 91.06 83.02 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 67 3 # 67 A 44 THR H 54 THR^? 1000.00 A 45 THR D 57 THR^? 1000.00 A 161 LYS H 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -15.69 -53.56 -13.29 -13.97 -52.36 -13.82 coo 27.73 89.90 76.08 29.24 91.46 75.95 -17.76 -48.52 -11.62 -16.05 -48.76 -10.33 coo 33.83 91.15 88.62 31.07 91.06 83.02 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 68 3 # 68 A 44 THR H 88 THR^? 1000.00 A 45 THR H 66 THR^? 1000.00 A 161 LYS H 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -19.24 -64.03 4.54 -19.35 -65.74 5.89 coo 27.73 89.90 76.08 29.24 91.46 75.95 -21.74 -67.10 3.11 -20.33 -68.69 3.44 coo 33.83 91.15 88.62 31.07 91.06 83.02 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 69 3 # 69 A 44 THR H 88 THR^? 1000.00 A 45 THR H 89 THR.? 1000.00 A 161 LYS H 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -19.24 -64.03 4.54 -19.35 -65.74 5.89 coo 27.73 89.90 76.08 29.24 91.46 75.95 -21.17 -60.97 5.70 -23.15 -61.14 4.87 coo 33.83 91.15 88.62 31.07 91.06 83.02 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 70 3 # 70 A 44 THR H 89 THR.? 1000.00 A 45 THR H 88 THR^? 1000.00 A 161 LYS H 8 LYS^? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 -21.17 -60.97 5.70 -23.15 -61.14 4.87 coo 27.73 89.90 76.08 29.24 91.46 75.95 -19.24 -64.03 4.54 -19.35 -65.74 5.89 coo 33.83 91.15 88.62 31.07 91.06 83.02 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 70 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 16 THR.? 1000.00 B 45 THR A 13 THR.? 1000.00 B 161 LYS A 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -46.17 -26.76 -46.24 -44.99 -27.18 -44.49 coo 5.75 129.25 91.25 4.29 128.16 90.07 -47.58 -31.45 -46.99 -46.54 -30.67 -45.25 coo -0.17 119.75 99.65 2.51 123.83 95.70 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 34 THR^? 1000.00 B 45 THR A 46 THR^? 1000.00 B 161 LYS A 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -42.33 -15.12 -56.08 -43.18 -13.58 -57.35 coo 5.75 129.25 91.25 4.29 128.16 90.07 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 coo -0.17 119.75 99.65 2.51 123.83 95.70 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR A 45 THR^? 1000.00 B 45 THR A 46 THR^? 1000.00 B 161 LYS A 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -45.89 -12.76 -52.82 -46.50 -13.35 -50.80 coo 5.75 129.25 91.25 4.29 128.16 90.07 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 coo -0.17 119.75 99.65 2.51 123.83 95.70 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR A 88 THR^? 1000.00 B 45 THR A 66 THR^? 1000.00 B 161 LYS A 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -49.69 -29.03 -55.58 -51.35 -29.56 -56.84 coo 5.75 129.25 91.25 4.29 128.16 90.07 -51.73 -25.65 -57.14 -51.84 -26.51 -59.11 coo -0.17 119.75 99.65 2.51 123.83 95.70 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR A 88 THR^? 1000.00 B 45 THR A 89 THR.? 1000.00 B 161 LYS A 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -49.69 -29.03 -55.58 -51.35 -29.56 -56.84 coo 5.75 129.25 91.25 4.29 128.16 90.07 -50.23 -29.32 -51.83 -50.84 -27.38 -51.08 coo -0.17 119.75 99.65 2.51 123.83 95.70 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR A 89 THR.? 1000.00 B 45 THR A 88 THR^? 1000.00 B 161 LYS A 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -50.23 -29.32 -51.83 -50.84 -27.38 -51.08 coo 5.75 129.25 91.25 4.29 128.16 90.07 -49.69 -29.03 -55.58 -51.35 -29.56 -56.84 coo -0.17 119.75 99.65 2.51 123.83 95.70 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 B 44 THR B 16 THR.? 1000.00 B 45 THR B 13 THR.? 1000.00 B 161 LYS B 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -20.03 -51.44 -49.33 -18.81 -53.02 -50.16 coo 5.75 129.25 91.25 4.29 128.16 90.07 -23.90 -54.74 -50.91 -21.76 -54.96 -51.26 coo -0.17 119.75 99.65 2.51 123.83 95.70 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 B 44 THR B 34 THR^? 1000.00 B 45 THR B 46 THR^? 1000.00 B 161 LYS B 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -19.36 -36.24 -46.83 -19.64 -34.64 -45.39 coo 5.75 129.25 91.25 4.29 128.16 90.07 -15.59 -35.86 -44.93 -16.46 -33.88 -45.17 coo -0.17 119.75 99.65 2.51 123.83 95.70 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 B 44 THR B 45 THR^? 1000.00 B 45 THR B 46 THR^? 1000.00 B 161 LYS B 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -16.90 -38.16 -42.20 -16.20 -40.16 -42.73 coo 5.75 129.25 91.25 4.29 128.16 90.07 -15.59 -35.86 -44.93 -16.46 -33.88 -45.17 coo -0.17 119.75 99.65 2.51 123.83 95.70 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 B 44 THR B 54 THR^? 1000.00 B 45 THR G 57 THR^? 1000.00 B 161 LYS B 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -15.28 -38.81 -60.02 -15.02 -38.82 -62.16 coo 5.75 129.25 91.25 4.29 128.16 90.07 -11.73 -43.22 -60.42 -13.41 -43.82 -61.59 coo -0.17 119.75 99.65 2.51 123.83 95.70 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 11 3 # 11 B 44 THR B 88 THR^? 1000.00 B 45 THR B 66 THR^? 1000.00 B 161 LYS B 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -29.52 -48.22 -47.90 -31.42 -48.56 -46.89 coo 5.75 129.25 91.25 4.29 128.16 90.07 -29.43 -45.79 -44.56 -31.38 -45.09 -45.08 coo -0.17 119.75 99.65 2.51 123.83 95.70 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 12 3 # 12 B 44 THR B 88 THR^? 1000.00 B 45 THR B 89 THR.? 1000.00 B 161 LYS B 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -29.52 -48.22 -47.90 -31.42 -48.56 -46.89 coo 5.75 129.25 91.25 4.29 128.16 90.07 -27.18 -51.21 -47.58 -25.70 -50.66 -46.11 coo -0.17 119.75 99.65 2.51 123.83 95.70 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 13 3 # 13 B 44 THR B 89 THR.? 1000.00 B 45 THR B 88 THR^? 1000.00 B 161 LYS B 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -27.18 -51.21 -47.58 -25.70 -50.66 -46.11 coo 5.75 129.25 91.25 4.29 128.16 90.07 -29.52 -48.22 -47.90 -31.42 -48.56 -46.89 coo -0.17 119.75 99.65 2.51 123.83 95.70 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 14 3 # 14 B 44 THR C 13 THR.? 1000.00 B 45 THR C 16 THR.? 1000.00 B 161 LYS D 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 coo 5.75 129.25 91.25 4.29 128.16 90.07 -38.73 -41.54 -23.23 -37.24 -40.73 -21.87 coo -0.17 119.75 99.65 2.51 123.83 95.70 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 15 3 # 15 B 44 THR C 16 THR.? 1000.00 B 45 THR C 13 THR.? 1000.00 B 161 LYS C 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -38.73 -41.54 -23.23 -37.24 -40.73 -21.87 coo 5.75 129.25 91.25 4.29 128.16 90.07 -34.25 -43.29 -25.30 -34.39 -41.97 -23.58 coo -0.17 119.75 99.65 2.51 123.83 95.70 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 16 3 # 16 B 44 THR C 20 THR^? 1000.00 B 45 THR C 54 THR^? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -41.88 -30.62 -30.53 -39.74 -30.38 -30.64 coo 5.75 129.25 91.25 4.29 128.16 90.07 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 17 3 # 17 B 44 THR C 34 THR^? 1000.00 B 45 THR C 45 THR^? 1000.00 B 161 LYS C 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -52.37 -37.85 -28.96 -54.37 -38.44 -29.47 coo 5.75 129.25 91.25 4.29 128.16 90.07 -53.59 -40.92 -24.31 -52.41 -41.01 -22.49 coo -0.17 119.75 99.65 2.51 123.83 95.70 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 18 3 # 18 B 44 THR C 34 THR^? 1000.00 B 45 THR C 46 THR^? 1000.00 B 161 LYS C 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -52.37 -37.85 -28.96 -54.37 -38.44 -29.47 coo 5.75 129.25 91.25 4.29 128.16 90.07 -54.65 -37.38 -25.18 -56.17 -36.99 -26.65 coo -0.17 119.75 99.65 2.51 123.83 95.70 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 19 3 # 19 B 44 THR C 45 THR^? 1000.00 B 45 THR C 46 THR^? 1000.00 B 161 LYS C 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -53.59 -40.92 -24.31 -52.41 -41.01 -22.49 coo 5.75 129.25 91.25 4.29 128.16 90.07 -54.65 -37.38 -25.18 -56.17 -36.99 -26.65 coo -0.17 119.75 99.65 2.51 123.83 95.70 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 20 3 # 20 B 44 THR C 46 THR^? 1000.00 B 45 THR C 45 THR^? 1000.00 B 161 LYS C 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -54.65 -37.38 -25.18 -56.17 -36.99 -26.65 coo 5.75 129.25 91.25 4.29 128.16 90.07 -53.59 -40.92 -24.31 -52.41 -41.01 -22.49 coo -0.17 119.75 99.65 2.51 123.83 95.70 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 21 3 # 21 B 44 THR C 54 THR^? 1000.00 B 45 THR F 57 THR^? 1000.00 B 161 LYS C 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo 5.75 129.25 91.25 4.29 128.16 90.07 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo -0.17 119.75 99.65 2.51 123.83 95.70 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 22 3 # 22 B 44 THR C 54 THR^? 1000.00 B 45 THR F 57 THR^? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo 5.75 129.25 91.25 4.29 128.16 90.07 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 23 3 # 23 B 44 THR C 88 THR^? 1000.00 B 45 THR C 66 THR^? 1000.00 B 161 LYS C 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 coo 5.75 129.25 91.25 4.29 128.16 90.07 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo -0.17 119.75 99.65 2.51 123.83 95.70 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 24 3 # 24 B 44 THR C 88 THR^? 1000.00 B 45 THR C 89 THR.? 1000.00 B 161 LYS C 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 coo 5.75 129.25 91.25 4.29 128.16 90.07 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 coo -0.17 119.75 99.65 2.51 123.83 95.70 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 25 3 # 25 B 44 THR C 89 THR.? 1000.00 B 45 THR C 88 THR^? 1000.00 B 161 LYS C 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 coo 5.75 129.25 91.25 4.29 128.16 90.07 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 coo -0.17 119.75 99.65 2.51 123.83 95.70 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 26 3 # 26 B 44 THR D 16 THR.? 1000.00 B 45 THR D 13 THR.? 1000.00 B 161 LYS D 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -13.26 -44.36 -15.10 -11.61 -45.23 -13.98 coo 5.75 129.25 91.25 4.29 128.16 90.07 -10.53 -40.25 -13.37 -10.17 -42.31 -12.84 coo -0.17 119.75 99.65 2.51 123.83 95.70 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 27 3 # 27 B 44 THR D 34 THR^? 1000.00 B 45 THR D 46 THR^? 1000.00 B 161 LYS D 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -27.89 -46.26 -19.44 -29.31 -46.15 -21.09 coo 5.75 129.25 91.25 4.29 128.16 90.07 -27.50 -50.23 -21.22 -29.54 -49.49 -21.28 coo -0.17 119.75 99.65 2.51 123.83 95.70 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 28 3 # 28 B 44 THR D 45 THR^? 1000.00 B 45 THR D 46 THR^? 1000.00 B 161 LYS D 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -24.99 -48.61 -23.54 -22.98 -49.39 -23.53 coo 5.75 129.25 91.25 4.29 128.16 90.07 -27.50 -50.23 -21.22 -29.54 -49.49 -21.28 coo -0.17 119.75 99.65 2.51 123.83 95.70 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 29 3 # 29 B 44 THR D 54 THR^? 1000.00 B 45 THR H 57 THR^? 1000.00 B 161 LYS D 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -26.58 -49.74 -5.75 -26.83 -49.90 -3.63 coo 5.75 129.25 91.25 4.29 128.16 90.07 -22.01 -53.02 -4.72 -21.58 -51.28 -3.54 coo -0.17 119.75 99.65 2.51 123.83 95.70 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 30 3 # 30 B 44 THR D 85 THR^? 1000.00 B 45 THR D 86 THR^? 1000.00 B 161 LYS F 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo 5.75 129.25 91.25 4.29 128.16 90.07 -24.01 -35.70 -16.08 -25.04 -34.15 -17.17 coo -0.17 119.75 99.65 2.51 123.83 95.70 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 31 3 # 31 B 44 THR D 88 THR^? 1000.00 B 45 THR D 66 THR^? 1000.00 B 161 LYS D 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -17.07 -35.15 -17.54 -16.96 -33.51 -18.95 coo 5.75 129.25 91.25 4.29 128.16 90.07 -19.29 -35.44 -21.10 -20.09 -33.46 -20.75 coo -0.17 119.75 99.65 2.51 123.83 95.70 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 32 3 # 32 B 44 THR D 88 THR^? 1000.00 B 45 THR D 89 THR.? 1000.00 B 161 LYS D 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -17.07 -35.15 -17.54 -16.96 -33.51 -18.95 coo 5.75 129.25 91.25 4.29 128.16 90.07 -13.87 -37.20 -17.43 -14.13 -38.77 -18.92 coo -0.17 119.75 99.65 2.51 123.83 95.70 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 33 3 # 33 B 44 THR D 89 THR.? 1000.00 B 45 THR D 88 THR^? 1000.00 B 161 LYS D 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -13.87 -37.20 -17.43 -14.13 -38.77 -18.92 coo 5.75 129.25 91.25 4.29 128.16 90.07 -17.07 -35.15 -17.54 -16.96 -33.51 -18.95 coo -0.17 119.75 99.65 2.51 123.83 95.70 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 34 3 # 34 B 44 THR E 16 THR.? 1000.00 B 45 THR E 13 THR.? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -24.49 -24.91 -44.90 -24.95 -26.52 -46.29 coo 5.75 129.25 91.25 4.29 128.16 90.07 -22.32 -28.98 -42.19 -23.52 -29.23 -44.03 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 35 3 # 35 B 44 THR E 20 THR^? 1000.00 B 45 THR E 54 THR^? 1000.00 B 161 LYS C 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -36.03 -22.15 -38.71 -36.49 -24.28 -38.46 coo 5.75 129.25 91.25 4.29 128.16 90.07 -40.50 -20.24 -41.39 -42.17 -21.46 -40.79 coo -0.17 119.75 99.65 2.51 123.83 95.70 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 36 3 # 36 B 44 THR E 34 THR^? 1000.00 B 45 THR E 45 THR^? 1000.00 B 161 LYS E 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -29.94 -11.10 -40.28 -29.56 -9.06 -39.62 coo 5.75 129.25 91.25 4.29 128.16 90.07 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 coo -0.17 119.75 99.65 2.51 123.83 95.70 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 37 3 # 37 B 44 THR E 34 THR^? 1000.00 B 45 THR E 46 THR^? 1000.00 B 161 LYS E 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -29.94 -11.10 -40.28 -29.56 -9.06 -39.62 coo 5.75 129.25 91.25 4.29 128.16 90.07 -30.70 -8.84 -43.79 -31.20 -7.44 -42.21 coo -0.17 119.75 99.65 2.51 123.83 95.70 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 38 3 # 38 B 44 THR E 45 THR^? 1000.00 B 45 THR E 46 THR^? 1000.00 B 161 LYS E 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 coo 5.75 129.25 91.25 4.29 128.16 90.07 -30.70 -8.84 -43.79 -31.20 -7.44 -42.21 coo -0.17 119.75 99.65 2.51 123.83 95.70 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 39 3 # 39 B 44 THR E 46 THR^? 1000.00 B 45 THR E 45 THR^? 1000.00 B 161 LYS E 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -30.70 -8.84 -43.79 -31.20 -7.44 -42.21 coo 5.75 129.25 91.25 4.29 128.16 90.07 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 coo -0.17 119.75 99.65 2.51 123.83 95.70 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 40 3 # 40 B 44 THR E 88 THR^? 1000.00 B 45 THR E 66 THR^? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 coo 5.75 129.25 91.25 4.29 128.16 90.07 -18.84 -18.95 -36.17 -18.49 -18.94 -34.03 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 41 3 # 41 B 44 THR E 88 THR^? 1000.00 B 45 THR E 89 THR.? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 coo 5.75 129.25 91.25 4.29 128.16 90.07 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 42 3 # 42 B 44 THR E 89 THR.? 1000.00 B 45 THR E 88 THR^? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 coo 5.75 129.25 91.25 4.29 128.16 90.07 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 43 3 # 43 B 44 THR F 13 THR.? 1000.00 B 45 THR F 15 THR.? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 coo 5.75 129.25 91.25 4.29 128.16 90.07 -40.21 -15.05 -24.42 -40.56 -14.25 -26.40 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 44 3 # 44 B 44 THR F 13 THR.? 1000.00 B 45 THR F 16 THR.? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 coo 5.75 129.25 91.25 4.29 128.16 90.07 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 45 3 # 45 B 44 THR F 16 THR.? 1000.00 B 45 THR F 13 THR.? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo 5.75 129.25 91.25 4.29 128.16 90.07 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 46 3 # 46 B 44 THR F 16 THR.? 1000.00 B 45 THR F 13 THR.? 1000.00 B 161 LYS F 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo 5.75 129.25 91.25 4.29 128.16 90.07 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 coo -0.17 119.75 99.65 2.51 123.83 95.70 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 47 3 # 47 B 44 THR F 16 THR.? 1000.00 B 45 THR F 15 THR.? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo 5.75 129.25 91.25 4.29 128.16 90.07 -40.21 -15.05 -24.42 -40.56 -14.25 -26.40 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 48 3 # 48 B 44 THR F 16 THR.? 1000.00 B 45 THR F 59 THR.? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo 5.75 129.25 91.25 4.29 128.16 90.07 -43.89 -19.57 -25.18 -44.09 -20.84 -26.90 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 49 3 # 49 B 44 THR F 34 THR^? 1000.00 B 45 THR F 46 THR^? 1000.00 B 161 LYS F 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -50.35 -23.30 -13.81 -52.09 -22.66 -12.66 coo 5.75 129.25 91.25 4.29 128.16 90.07 -53.66 -24.14 -16.36 -54.70 -24.62 -14.51 coo -0.17 119.75 99.65 2.51 123.83 95.70 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 50 3 # 50 B 44 THR F 45 THR^? 1000.00 B 45 THR F 46 THR^? 1000.00 B 161 LYS F 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -53.13 -20.55 -17.44 -52.54 -20.20 -19.48 coo 5.75 129.25 91.25 4.29 128.16 90.07 -53.66 -24.14 -16.36 -54.70 -24.62 -14.51 coo -0.17 119.75 99.65 2.51 123.83 95.70 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 51 3 # 51 B 44 THR F 54 THR^? 1000.00 B 45 THR C 57 THR^? 1000.00 B 161 LYS F 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -42.11 -34.37 -17.32 -40.78 -36.07 -17.42 coo 5.75 129.25 91.25 4.29 128.16 90.07 -41.24 -34.76 -22.98 -39.22 -34.48 -22.21 coo -0.17 119.75 99.65 2.51 123.83 95.70 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 52 3 # 52 B 44 THR F 57 THR^? 1000.00 B 45 THR C 54 THR^? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo 5.75 129.25 91.25 4.29 128.16 90.07 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 53 3 # 53 B 44 THR F 59 THR.? 1000.00 B 45 THR F 16 THR.? 1000.00 B 161 LYS E 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -43.89 -19.57 -25.18 -44.09 -20.84 -26.90 coo 5.75 129.25 91.25 4.29 128.16 90.07 -39.81 -18.79 -23.79 -39.06 -19.25 -25.76 coo -0.17 119.75 99.65 2.51 123.83 95.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 54 3 # 54 B 44 THR F 88 THR^? 1000.00 B 45 THR F 66 THR^? 1000.00 B 161 LYS F 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -37.77 -14.05 -15.00 -37.42 -12.10 -14.15 coo 5.75 129.25 91.25 4.29 128.16 90.07 -41.46 -12.42 -13.58 -40.70 -12.09 -11.59 coo -0.17 119.75 99.65 2.51 123.83 95.70 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 55 3 # 55 B 44 THR F 88 THR^? 1000.00 B 45 THR F 89 THR.? 1000.00 B 161 LYS F 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -37.77 -14.05 -15.00 -37.42 -12.10 -14.15 coo 5.75 129.25 91.25 4.29 128.16 90.07 -37.46 -13.84 -18.76 -39.46 -13.48 -19.54 coo -0.17 119.75 99.65 2.51 123.83 95.70 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 56 3 # 56 B 44 THR F 89 THR.? 1000.00 B 45 THR F 88 THR^? 1000.00 B 161 LYS F 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -37.46 -13.84 -18.76 -39.46 -13.48 -19.54 coo 5.75 129.25 91.25 4.29 128.16 90.07 -37.77 -14.05 -15.00 -37.42 -12.10 -14.15 coo -0.17 119.75 99.65 2.51 123.83 95.70 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 57 3 # 57 B 44 THR G 16 THR.? 1000.00 B 45 THR G 13 THR.? 1000.00 B 161 LYS G 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -9.31 -42.23 -66.96 -11.43 -42.13 -67.48 coo 5.75 129.25 91.25 4.29 128.16 90.07 -8.92 -45.57 -71.07 -10.80 -44.92 -70.18 coo -0.17 119.75 99.65 2.51 123.83 95.70 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 58 3 # 58 B 44 THR G 34 THR^? 1000.00 B 45 THR G 46 THR^? 1000.00 B 161 LYS G 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -0.50 -39.88 -54.46 1.25 -38.89 -53.69 coo 5.75 129.25 91.25 4.29 128.16 90.07 -1.95 -36.32 -52.94 -0.35 -36.61 -51.51 coo -0.17 119.75 99.65 2.51 123.83 95.70 6.01 -41.17 -63.42 7.43 -47.25 -63.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 59 3 # 59 B 44 THR G 45 THR^? 1000.00 B 45 THR G 46 THR^? 1000.00 B 161 LYS G 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -1.50 -34.99 -56.46 -3.32 -34.36 -57.43 coo 5.75 129.25 91.25 4.29 128.16 90.07 -1.95 -36.32 -52.94 -0.35 -36.61 -51.51 coo -0.17 119.75 99.65 2.51 123.83 95.70 6.01 -41.17 -63.42 7.43 -47.25 -63.10 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 60 3 # 60 B 44 THR G 88 THR^? 1000.00 B 45 THR G 66 THR^? 1000.00 B 161 LYS G 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -0.28 -46.35 -69.13 1.51 -46.38 -70.37 coo 5.75 129.25 91.25 4.29 128.16 90.07 2.66 -43.43 -68.00 4.28 -44.88 -68.13 coo -0.17 119.75 99.65 2.51 123.83 95.70 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 61 3 # 61 B 44 THR G 88 THR^? 1000.00 B 45 THR G 89 THR.? 1000.00 B 161 LYS G 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -0.28 -46.35 -69.13 1.51 -46.38 -70.37 coo 5.75 129.25 91.25 4.29 128.16 90.07 -3.47 -44.79 -70.49 -3.37 -42.68 -70.06 coo -0.17 119.75 99.65 2.51 123.83 95.70 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 62 3 # 62 B 44 THR G 89 THR.? 1000.00 B 45 THR G 13 THR.? 1000.00 B 161 LYS G 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -3.47 -44.79 -70.49 -3.37 -42.68 -70.06 coo 5.75 129.25 91.25 4.29 128.16 90.07 -8.92 -45.57 -71.07 -10.80 -44.92 -70.18 coo -0.17 119.75 99.65 2.51 123.83 95.70 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 63 3 # 63 B 44 THR G 89 THR.? 1000.00 B 45 THR G 88 THR^? 1000.00 B 161 LYS G 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -3.47 -44.79 -70.49 -3.37 -42.68 -70.06 coo 5.75 129.25 91.25 4.29 128.16 90.07 -0.28 -46.35 -69.13 1.51 -46.38 -70.37 coo -0.17 119.75 99.65 2.51 123.83 95.70 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 64 3 # 64 B 44 THR H 16 THR.? 1000.00 B 45 THR H 13 THR.? 1000.00 B 161 LYS H 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -23.37 -55.18 1.78 -23.47 -53.10 2.34 coo 5.75 129.25 91.25 4.29 128.16 90.07 -20.65 -55.18 6.19 -21.38 -53.37 5.29 coo -0.17 119.75 99.65 2.51 123.83 95.70 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 65 3 # 65 B 44 THR H 34 THR^? 1000.00 B 45 THR H 46 THR^? 1000.00 B 161 LYS H 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -23.65 -64.63 -10.64 -24.28 -66.51 -11.50 coo 5.75 129.25 91.25 4.29 128.16 90.07 -27.27 -63.43 -12.62 -26.65 -64.97 -14.02 coo -0.17 119.75 99.65 2.51 123.83 95.70 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 66 3 # 66 B 44 THR H 45 THR^? 1000.00 B 45 THR H 46 THR^? 1000.00 B 161 LYS H 38 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -28.98 -64.21 -9.31 -29.95 -62.48 -8.44 coo 5.75 129.25 91.25 4.29 128.16 90.07 -27.27 -63.43 -12.62 -26.65 -64.97 -14.02 coo -0.17 119.75 99.65 2.51 123.83 95.70 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 67 3 # 67 B 44 THR H 54 THR^? 1000.00 B 45 THR D 57 THR^? 1000.00 B 161 LYS H 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -15.69 -53.56 -13.29 -13.97 -52.36 -13.82 coo 5.75 129.25 91.25 4.29 128.16 90.07 -17.76 -48.52 -11.62 -16.05 -48.76 -10.33 coo -0.17 119.75 99.65 2.51 123.83 95.70 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 68 3 # 68 B 44 THR H 88 THR^? 1000.00 B 45 THR H 66 THR^? 1000.00 B 161 LYS H 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -19.24 -64.03 4.54 -19.35 -65.74 5.89 coo 5.75 129.25 91.25 4.29 128.16 90.07 -21.74 -67.10 3.11 -20.33 -68.69 3.44 coo -0.17 119.75 99.65 2.51 123.83 95.70 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 69 3 # 69 B 44 THR H 88 THR^? 1000.00 B 45 THR H 89 THR.? 1000.00 B 161 LYS H 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -19.24 -64.03 4.54 -19.35 -65.74 5.89 coo 5.75 129.25 91.25 4.29 128.16 90.07 -21.17 -60.97 5.70 -23.15 -61.14 4.87 coo -0.17 119.75 99.65 2.51 123.83 95.70 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 70 3 # 70 B 44 THR H 89 THR.? 1000.00 B 45 THR H 88 THR^? 1000.00 B 161 LYS H 8 LYS^? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 -21.17 -60.97 5.70 -23.15 -61.14 4.87 coo 5.75 129.25 91.25 4.29 128.16 90.07 -19.24 -64.03 4.54 -19.35 -65.74 5.89 coo -0.17 119.75 99.65 2.51 123.83 95.70 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 70 hits 1dhp_c03 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 67 TYR^? 1000.00 150 LYS A 38 LYS.? 1000.00 186 ASN A 11 ASN.? 1000.00 coo 32.88 50.55 24.33 31.89 51.78 26.65 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo 27.04 52.42 22.30 26.88 49.99 27.00 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 coo 36.98 50.30 37.29 35.85 50.29 35.50 -40.60 -31.75 -47.42 -38.71 -32.73 -47.31 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR B 67 TYR^? 1000.00 150 LYS B 38 LYS.? 1000.00 186 ASN B 11 ASN.? 1000.00 coo 32.88 50.55 24.33 31.89 51.78 26.65 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 coo 27.04 52.42 22.30 26.88 49.99 27.00 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 coo 36.98 50.30 37.29 35.85 50.29 35.50 -21.79 -51.90 -56.91 -21.57 -52.35 -58.98 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR C 67 TYR^? 1000.00 150 LYS C 38 LYS.? 1000.00 186 ASN C 11 ASN.? 1000.00 coo 32.88 50.55 24.33 31.89 51.78 26.65 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 27.04 52.42 22.30 26.88 49.99 27.00 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 coo 36.98 50.30 37.29 35.85 50.29 35.50 -33.93 -36.54 -26.69 -32.43 -35.02 -26.74 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR E 67 TYR^? 1000.00 150 LYS E 38 LYS.? 1000.00 186 ASN E 11 ASN.? 1000.00 coo 32.88 50.55 24.33 31.89 51.78 26.65 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo 27.04 52.42 22.30 26.88 49.99 27.00 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 coo 36.98 50.30 37.29 35.85 50.29 35.50 -29.20 -29.79 -41.39 -30.70 -31.31 -41.23 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR F 67 TYR^? 1000.00 150 LYS F 38 LYS.? 1000.00 186 ASN F 11 ASN.? 1000.00 coo 32.88 50.55 24.33 31.89 51.78 26.65 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 27.04 52.42 22.30 26.88 49.99 27.00 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 coo 36.98 50.30 37.29 35.85 50.29 35.50 -33.67 -23.03 -22.79 -32.30 -24.62 -23.11 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR G 67 TYR^? 1000.00 150 LYS G 38 LYS.? 1000.00 186 ASN G 11 ASN.? 1000.00 coo 32.88 50.55 24.33 31.89 51.78 26.65 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 6.01 -41.17 -63.42 7.43 -47.25 -63.10 coo 36.98 50.30 37.29 35.85 50.29 35.50 -11.72 -49.35 -65.84 -13.49 -50.35 -66.39 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR H 67 TYR^? 1000.00 150 LYS H 38 LYS.? 1000.00 186 ASN H 11 ASN.? 1000.00 coo 32.88 50.55 24.33 31.89 51.78 26.65 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo 27.04 52.42 22.30 26.88 49.99 27.00 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 coo 36.98 50.30 37.29 35.85 50.29 35.50 -16.58 -51.98 1.51 -14.95 -50.69 1.02 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 7 hits 1dhr_c00 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS C 95 HIS.? 1000.00 E 102 ASP D 48 ASP^? 1000.00 E 193 GLY H 30 GLY^? 1000.00 coo 11.39 26.86 25.95 9.85 26.64 27.36 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 10.90 32.83 25.96 10.83 30.68 25.98 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 4.57 20.60 30.29 4.74 21.36 30.66 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS C 96 HIS.? 1000.00 E 102 ASP D 48 ASP^? 1000.00 E 193 GLY D 76 GLY.? 1000.00 coo 11.39 26.86 25.95 9.85 26.64 27.36 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 10.90 32.83 25.96 10.83 30.68 25.98 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 4.57 20.60 30.29 4.74 21.36 30.66 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS C 97 HIS.? 1000.00 E 102 ASP D 48 ASP^? 1000.00 E 193 GLY D 76 GLY.? 1000.00 coo 11.39 26.86 25.95 9.85 26.64 27.36 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 10.90 32.83 25.96 10.83 30.68 25.98 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 4.57 20.60 30.29 4.74 21.36 30.66 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 4 3 # 4 E 57 HIS E 95 HIS.? 1000.00 E 102 ASP B 48 ASP^? 1000.00 E 193 GLY G 30 GLY^? 1000.00 coo 11.39 26.86 25.95 9.85 26.64 27.36 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 10.90 32.83 25.96 10.83 30.68 25.98 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 4.57 20.60 30.29 4.74 21.36 30.66 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 4 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 36 GLY^? 1000.00 B 144 GLU A 44 GLU.? 1000.00 B 164 GLU A 68 GLU^? 1000.00 coo 88.87 114.43 152.30 88.45 115.15 152.32 -48.92 -17.78 -55.02 -48.59 -18.42 -55.51 coo 85.20 111.99 152.05 86.60 110.89 150.91 -47.53 -13.80 -58.12 -49.26 -14.21 -59.28 coo 88.14 113.46 145.73 86.79 113.92 147.30 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY B 36 GLY^? 1000.00 B 144 GLU B 44 GLU.? 1000.00 B 164 GLU B 68 GLU^? 1000.00 coo 88.87 114.43 152.30 88.45 115.15 152.32 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 coo 85.20 111.99 152.05 86.60 110.89 150.91 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 88.14 113.46 145.73 86.79 113.92 147.30 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY C 36 GLY^? 1000.00 B 144 GLU C 44 GLU.? 1000.00 B 164 GLU C 68 GLU^? 1000.00 coo 88.87 114.43 152.30 88.45 115.15 152.32 -49.78 -44.46 -28.07 -49.37 -44.25 -28.79 coo 85.20 111.99 152.05 86.60 110.89 150.91 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 88.14 113.46 145.73 86.79 113.92 147.30 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 4 3 # 4 B 141 GLY D 36 GLY^? 1000.00 B 144 GLU D 44 GLU.? 1000.00 B 164 GLU D 68 GLU^? 1000.00 coo 88.87 114.43 152.30 88.45 115.15 152.32 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 coo 85.20 111.99 152.05 86.60 110.89 150.91 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 88.14 113.46 145.73 86.79 113.92 147.30 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 5 3 # 5 B 141 GLY E 36 GLY^? 1000.00 B 144 GLU E 44 GLU.? 1000.00 B 164 GLU E 68 GLU^? 1000.00 coo 88.87 114.43 152.30 88.45 115.15 152.32 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo 85.20 111.99 152.05 86.60 110.89 150.91 -24.48 -8.54 -40.01 -24.93 -7.20 -38.47 coo 88.14 113.46 145.73 86.79 113.92 147.30 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 6 3 # 6 B 141 GLY F 36 GLY^? 1000.00 B 144 GLU F 44 GLU.? 1000.00 B 164 GLU F 68 GLU^? 1000.00 coo 88.87 114.43 152.30 88.45 115.15 152.32 -48.82 -16.54 -15.32 -48.14 -16.69 -14.82 coo 85.20 111.99 152.05 86.60 110.89 150.91 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 88.14 113.46 145.73 86.79 113.92 147.30 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 7 3 # 7 B 141 GLY G 36 GLY^? 1000.00 B 144 GLU G 44 GLU.? 1000.00 B 164 GLU G 68 GLU^? 1000.00 coo 88.87 114.43 152.30 88.45 115.15 152.32 0.93 -38.28 -61.29 1.11 -39.11 -61.33 coo 85.20 111.99 152.05 86.60 110.89 150.91 3.40 -36.79 -57.23 5.30 -37.24 -56.45 coo 88.14 113.46 145.73 86.79 113.92 147.30 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 8 3 # 8 B 141 GLY H 36 GLY^? 1000.00 B 144 GLU H 44 GLU.? 1000.00 B 164 GLU H 68 GLU^? 1000.00 coo 88.87 114.43 152.30 88.45 115.15 152.32 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 coo 85.20 111.99 152.05 86.60 110.89 150.91 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 coo 88.14 113.46 145.73 86.79 113.92 147.30 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 36 GLY^? 1000.00 C 144 GLU A 44 GLU.? 1000.00 C 164 GLU A 68 GLU^? 1000.00 coo 56.28 104.55 135.84 56.09 105.34 136.05 -48.92 -17.78 -55.02 -48.59 -18.42 -55.51 coo 58.46 103.90 139.48 57.57 102.00 139.16 -47.53 -13.80 -58.12 -49.26 -14.21 -59.28 coo 51.71 102.03 140.09 53.02 103.62 140.54 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY B 36 GLY^? 1000.00 C 144 GLU B 44 GLU.? 1000.00 C 164 GLU B 68 GLU^? 1000.00 coo 56.28 104.55 135.84 56.09 105.34 136.05 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 coo 58.46 103.90 139.48 57.57 102.00 139.16 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 51.71 102.03 140.09 53.02 103.62 140.54 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY C 36 GLY^? 1000.00 C 144 GLU C 44 GLU.? 1000.00 C 164 GLU C 68 GLU^? 1000.00 coo 56.28 104.55 135.84 56.09 105.34 136.05 -49.78 -44.46 -28.07 -49.37 -44.25 -28.79 coo 58.46 103.90 139.48 57.57 102.00 139.16 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 51.71 102.03 140.09 53.02 103.62 140.54 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 4 3 # 4 C 141 GLY D 36 GLY^? 1000.00 C 144 GLU D 44 GLU.? 1000.00 C 164 GLU D 68 GLU^? 1000.00 coo 56.28 104.55 135.84 56.09 105.34 136.05 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 coo 58.46 103.90 139.48 57.57 102.00 139.16 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 51.71 102.03 140.09 53.02 103.62 140.54 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 5 3 # 5 C 141 GLY E 36 GLY^? 1000.00 C 144 GLU E 44 GLU.? 1000.00 C 164 GLU E 68 GLU^? 1000.00 coo 56.28 104.55 135.84 56.09 105.34 136.05 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo 58.46 103.90 139.48 57.57 102.00 139.16 -24.48 -8.54 -40.01 -24.93 -7.20 -38.47 coo 51.71 102.03 140.09 53.02 103.62 140.54 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 6 3 # 6 C 141 GLY F 36 GLY^? 1000.00 C 144 GLU F 44 GLU.? 1000.00 C 164 GLU F 68 GLU^? 1000.00 coo 56.28 104.55 135.84 56.09 105.34 136.05 -48.82 -16.54 -15.32 -48.14 -16.69 -14.82 coo 58.46 103.90 139.48 57.57 102.00 139.16 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 51.71 102.03 140.09 53.02 103.62 140.54 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 7 3 # 7 C 141 GLY G 36 GLY^? 1000.00 C 144 GLU G 44 GLU.? 1000.00 C 164 GLU G 68 GLU^? 1000.00 coo 56.28 104.55 135.84 56.09 105.34 136.05 0.93 -38.28 -61.29 1.11 -39.11 -61.33 coo 58.46 103.90 139.48 57.57 102.00 139.16 3.40 -36.79 -57.23 5.30 -37.24 -56.45 coo 51.71 102.03 140.09 53.02 103.62 140.54 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 8 3 # 8 C 141 GLY H 36 GLY^? 1000.00 C 144 GLU H 44 GLU.? 1000.00 C 164 GLU H 68 GLU^? 1000.00 coo 56.28 104.55 135.84 56.09 105.34 136.05 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 coo 58.46 103.90 139.48 57.57 102.00 139.16 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 coo 51.71 102.03 140.09 53.02 103.62 140.54 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 36 GLY^? 1000.00 D 144 GLU A 44 GLU.? 1000.00 D 164 GLU A 68 GLU^? 1000.00 coo 86.19 80.64 132.77 86.38 79.85 132.93 -48.92 -17.78 -55.02 -48.59 -18.42 -55.51 coo 84.75 81.24 136.88 85.62 83.14 136.43 -47.53 -13.80 -58.12 -49.26 -14.21 -59.28 coo 91.47 83.05 136.24 90.35 81.38 136.84 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY B 36 GLY^? 1000.00 D 144 GLU B 44 GLU.? 1000.00 D 164 GLU B 68 GLU^? 1000.00 coo 86.19 80.64 132.77 86.38 79.85 132.93 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 coo 84.75 81.24 136.88 85.62 83.14 136.43 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 91.47 83.05 136.24 90.35 81.38 136.84 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY C 36 GLY^? 1000.00 D 144 GLU C 44 GLU.? 1000.00 D 164 GLU C 68 GLU^? 1000.00 coo 86.19 80.64 132.77 86.38 79.85 132.93 -49.78 -44.46 -28.07 -49.37 -44.25 -28.79 coo 84.75 81.24 136.88 85.62 83.14 136.43 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 91.47 83.05 136.24 90.35 81.38 136.84 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 4 3 # 4 D 141 GLY D 36 GLY^? 1000.00 D 144 GLU D 44 GLU.? 1000.00 D 164 GLU D 68 GLU^? 1000.00 coo 86.19 80.64 132.77 86.38 79.85 132.93 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 coo 84.75 81.24 136.88 85.62 83.14 136.43 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 91.47 83.05 136.24 90.35 81.38 136.84 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 5 3 # 5 D 141 GLY E 36 GLY^? 1000.00 D 144 GLU E 44 GLU.? 1000.00 D 164 GLU E 68 GLU^? 1000.00 coo 86.19 80.64 132.77 86.38 79.85 132.93 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo 84.75 81.24 136.88 85.62 83.14 136.43 -24.48 -8.54 -40.01 -24.93 -7.20 -38.47 coo 91.47 83.05 136.24 90.35 81.38 136.84 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 6 3 # 6 D 141 GLY F 36 GLY^? 1000.00 D 144 GLU F 44 GLU.? 1000.00 D 164 GLU F 68 GLU^? 1000.00 coo 86.19 80.64 132.77 86.38 79.85 132.93 -48.82 -16.54 -15.32 -48.14 -16.69 -14.82 coo 84.75 81.24 136.88 85.62 83.14 136.43 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 91.47 83.05 136.24 90.35 81.38 136.84 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 7 3 # 7 D 141 GLY G 36 GLY^? 1000.00 D 144 GLU G 44 GLU.? 1000.00 D 164 GLU G 68 GLU^? 1000.00 coo 86.19 80.64 132.77 86.38 79.85 132.93 0.93 -38.28 -61.29 1.11 -39.11 -61.33 coo 84.75 81.24 136.88 85.62 83.14 136.43 3.40 -36.79 -57.23 5.30 -37.24 -56.45 coo 91.47 83.05 136.24 90.35 81.38 136.84 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 8 3 # 8 D 141 GLY H 36 GLY^? 1000.00 D 144 GLU H 44 GLU.? 1000.00 D 164 GLU H 68 GLU^? 1000.00 coo 86.19 80.64 132.77 86.38 79.85 132.93 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 coo 84.75 81.24 136.88 85.62 83.14 136.43 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 coo 91.47 83.05 136.24 90.35 81.38 136.84 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 36 GLY^? 1000.00 E 144 GLU A 44 GLU.? 1000.00 E 164 GLU A 68 GLU^? 1000.00 coo 90.07 81.07 170.50 90.23 80.26 170.38 -48.92 -17.78 -55.02 -48.59 -18.42 -55.51 coo 87.05 81.30 167.53 86.38 82.74 168.94 -47.53 -13.80 -58.12 -49.26 -14.21 -59.28 coo 84.40 80.02 173.80 85.08 79.06 172.03 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY B 36 GLY^? 1000.00 E 144 GLU B 44 GLU.? 1000.00 E 164 GLU B 68 GLU^? 1000.00 coo 90.07 81.07 170.50 90.23 80.26 170.38 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 coo 87.05 81.30 167.53 86.38 82.74 168.94 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 84.40 80.02 173.80 85.08 79.06 172.03 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY C 36 GLY^? 1000.00 E 144 GLU C 44 GLU.? 1000.00 E 164 GLU C 68 GLU^? 1000.00 coo 90.07 81.07 170.50 90.23 80.26 170.38 -49.78 -44.46 -28.07 -49.37 -44.25 -28.79 coo 87.05 81.30 167.53 86.38 82.74 168.94 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 84.40 80.02 173.80 85.08 79.06 172.03 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 4 3 # 4 E 141 GLY D 36 GLY^? 1000.00 E 144 GLU D 44 GLU.? 1000.00 E 164 GLU D 68 GLU^? 1000.00 coo 90.07 81.07 170.50 90.23 80.26 170.38 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 coo 87.05 81.30 167.53 86.38 82.74 168.94 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 84.40 80.02 173.80 85.08 79.06 172.03 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 5 3 # 5 E 141 GLY E 36 GLY^? 1000.00 E 144 GLU E 44 GLU.? 1000.00 E 164 GLU E 68 GLU^? 1000.00 coo 90.07 81.07 170.50 90.23 80.26 170.38 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo 87.05 81.30 167.53 86.38 82.74 168.94 -24.48 -8.54 -40.01 -24.93 -7.20 -38.47 coo 84.40 80.02 173.80 85.08 79.06 172.03 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 6 3 # 6 E 141 GLY F 36 GLY^? 1000.00 E 144 GLU F 44 GLU.? 1000.00 E 164 GLU F 68 GLU^? 1000.00 coo 90.07 81.07 170.50 90.23 80.26 170.38 -48.82 -16.54 -15.32 -48.14 -16.69 -14.82 coo 87.05 81.30 167.53 86.38 82.74 168.94 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 84.40 80.02 173.80 85.08 79.06 172.03 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 7 3 # 7 E 141 GLY G 36 GLY^? 1000.00 E 144 GLU G 44 GLU.? 1000.00 E 164 GLU G 68 GLU^? 1000.00 coo 90.07 81.07 170.50 90.23 80.26 170.38 0.93 -38.28 -61.29 1.11 -39.11 -61.33 coo 87.05 81.30 167.53 86.38 82.74 168.94 3.40 -36.79 -57.23 5.30 -37.24 -56.45 coo 84.40 80.02 173.80 85.08 79.06 172.03 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 8 3 # 8 E 141 GLY H 36 GLY^? 1000.00 E 144 GLU H 44 GLU.? 1000.00 E 164 GLU H 68 GLU^? 1000.00 coo 90.07 81.07 170.50 90.23 80.26 170.38 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 coo 87.05 81.30 167.53 86.38 82.74 168.94 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 coo 84.40 80.02 173.80 85.08 79.06 172.03 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 36 GLY^? 1000.00 F 144 GLU A 44 GLU.? 1000.00 F 164 GLU A 68 GLU^? 1000.00 coo 57.12 70.68 155.10 57.52 69.95 155.02 -48.92 -17.78 -55.02 -48.59 -18.42 -55.51 coo 60.62 73.13 154.21 59.05 74.26 153.35 -47.53 -13.80 -58.12 -49.26 -14.21 -59.28 coo 56.75 71.71 148.46 58.44 71.01 149.54 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY B 36 GLY^? 1000.00 F 144 GLU B 44 GLU.? 1000.00 F 164 GLU B 68 GLU^? 1000.00 coo 57.12 70.68 155.10 57.52 69.95 155.02 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 coo 60.62 73.13 154.21 59.05 74.26 153.35 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 56.75 71.71 148.46 58.44 71.01 149.54 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY C 36 GLY^? 1000.00 F 144 GLU C 44 GLU.? 1000.00 F 164 GLU C 68 GLU^? 1000.00 coo 57.12 70.68 155.10 57.52 69.95 155.02 -49.78 -44.46 -28.07 -49.37 -44.25 -28.79 coo 60.62 73.13 154.21 59.05 74.26 153.35 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 56.75 71.71 148.46 58.44 71.01 149.54 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 4 3 # 4 F 141 GLY D 36 GLY^? 1000.00 F 144 GLU D 44 GLU.? 1000.00 F 164 GLU D 68 GLU^? 1000.00 coo 57.12 70.68 155.10 57.52 69.95 155.02 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 coo 60.62 73.13 154.21 59.05 74.26 153.35 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 56.75 71.71 148.46 58.44 71.01 149.54 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 5 3 # 5 F 141 GLY E 36 GLY^? 1000.00 F 144 GLU E 44 GLU.? 1000.00 F 164 GLU E 68 GLU^? 1000.00 coo 57.12 70.68 155.10 57.52 69.95 155.02 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo 60.62 73.13 154.21 59.05 74.26 153.35 -24.48 -8.54 -40.01 -24.93 -7.20 -38.47 coo 56.75 71.71 148.46 58.44 71.01 149.54 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 6 3 # 6 F 141 GLY F 36 GLY^? 1000.00 F 144 GLU F 44 GLU.? 1000.00 F 164 GLU F 68 GLU^? 1000.00 coo 57.12 70.68 155.10 57.52 69.95 155.02 -48.82 -16.54 -15.32 -48.14 -16.69 -14.82 coo 60.62 73.13 154.21 59.05 74.26 153.35 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 56.75 71.71 148.46 58.44 71.01 149.54 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 7 3 # 7 F 141 GLY G 36 GLY^? 1000.00 F 144 GLU G 44 GLU.? 1000.00 F 164 GLU G 68 GLU^? 1000.00 coo 57.12 70.68 155.10 57.52 69.95 155.02 0.93 -38.28 -61.29 1.11 -39.11 -61.33 coo 60.62 73.13 154.21 59.05 74.26 153.35 3.40 -36.79 -57.23 5.30 -37.24 -56.45 coo 56.75 71.71 148.46 58.44 71.01 149.54 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 8 3 # 8 F 141 GLY H 36 GLY^? 1000.00 F 144 GLU H 44 GLU.? 1000.00 F 164 GLU H 68 GLU^? 1000.00 coo 57.12 70.68 155.10 57.52 69.95 155.02 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 coo 60.62 73.13 154.21 59.05 74.26 153.35 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 coo 56.75 71.71 148.46 58.44 71.01 149.54 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 8 hits 1dub_c17 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER B 51 SER.? 1000.00 A 208 ASP B 48 ASP^? 1000.00 A 236 HIS E 97 HIS.? 1000.00 coo 49.19 42.85 125.39 50.92 43.54 123.63 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 57.80 42.94 129.59 56.47 43.28 127.93 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 55.54 41.70 125.00 53.71 42.50 124.53 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER D 51 SER.? 1000.00 A 208 ASP D 48 ASP^? 1000.00 A 236 HIS C 97 HIS.? 1000.00 coo 49.19 42.85 125.39 50.92 43.54 123.63 -33.08 -53.53 -7.15 -34.77 -54.71 -5.86 coo 57.80 42.94 129.59 56.47 43.28 127.93 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 55.54 41.70 125.00 53.71 42.50 124.53 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 2 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER B 51 SER.? 1000.00 B 208 ASP B 48 ASP^? 1000.00 B 236 HIS E 97 HIS.? 1000.00 coo 55.25 19.46 97.60 53.04 19.32 98.76 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 57.34 11.46 102.30 56.11 13.10 101.70 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 55.03 16.17 103.08 54.39 17.23 101.45 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 1 hits 1dwo_c01 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS C 96 HIS.? 1000.00 B 43 HIS C 95 HIS.? 1000.00 B 65 GLU C 93 GLU.? 1000.00 coo 20.15 22.08 34.36 20.84 20.10 34.21 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 19.55 18.91 30.27 18.21 18.65 31.84 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 10.90 21.31 28.81 12.14 22.15 30.31 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS C 96 HIS.? 1000.00 B 43 HIS C 97 HIS.? 1000.00 B 65 GLU D 29 GLU.? 1000.00 coo 20.15 22.08 34.36 20.84 20.10 34.21 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 19.55 18.91 30.27 18.21 18.65 31.84 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 10.90 21.31 28.81 12.14 22.15 30.31 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS E 96 HIS.? 1000.00 B 43 HIS E 95 HIS.? 1000.00 B 65 GLU E 93 GLU.? 1000.00 coo 20.15 22.08 34.36 20.84 20.10 34.21 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 19.55 18.91 30.27 18.21 18.65 31.84 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 10.90 21.31 28.81 12.14 22.15 30.31 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS E 96 HIS.? 1000.00 B 43 HIS E 97 HIS.? 1000.00 B 65 GLU B 29 GLU.? 1000.00 coo 20.15 22.08 34.36 20.84 20.10 34.21 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 19.55 18.91 30.27 18.21 18.65 31.84 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 10.90 21.31 28.81 12.14 22.15 30.31 -9.38 -24.09 -58.12 -8.97 -22.30 -57.06 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 5 3 # 5 B 41 HIS E 97 HIS.? 1000.00 B 43 HIS E 98 HIS.? 1000.00 B 65 GLU G 44 GLU.? 1000.00 coo 20.15 22.08 34.36 20.84 20.10 34.21 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 19.55 18.91 30.27 18.21 18.65 31.84 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 10.90 21.31 28.81 12.14 22.15 30.31 3.40 -36.79 -57.23 5.30 -37.24 -56.45 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 6 3 # 6 B 41 HIS E 98 HIS.? 1000.00 B 43 HIS E 97 HIS.? 1000.00 B 65 GLU B 29 GLU.? 1000.00 coo 20.15 22.08 34.36 20.84 20.10 34.21 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 19.55 18.91 30.27 18.21 18.65 31.84 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 10.90 21.31 28.81 12.14 22.15 30.31 -9.38 -24.09 -58.12 -8.97 -22.30 -57.06 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 7 3 # 7 B 41 HIS G 96 HIS.? 1000.00 B 43 HIS G 95 HIS.? 1000.00 B 65 GLU G 93 GLU.? 1000.00 coo 20.15 22.08 34.36 20.84 20.10 34.21 -4.23 -34.33 -81.91 -3.90 -35.35 -80.10 coo 19.55 18.91 30.27 18.21 18.65 31.84 -3.23 -38.22 -87.57 -1.92 -39.63 -88.40 coo 10.90 21.31 28.81 12.14 22.15 30.31 -5.22 -46.46 -82.88 -6.14 -48.32 -83.21 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 7 hits 1e7l_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP B 43 ASP.? 1000.00 A 35 SER B 42 SER.? 1000.00 A 218 ASP D 43 ASP.? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 43.58 20.85 5.15 44.62 23.01 5.76 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 44.05 16.99 12.67 44.05 18.89 11.74 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP D 40 ASP.? 1000.00 A 35 SER D 42 SER.? 1000.00 A 218 ASP B 40 ASP.? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 43.58 20.85 5.15 44.62 23.01 5.76 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 44.05 16.99 12.67 44.05 18.89 11.74 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 3 3 # 3 A 32 ASP D 40 ASP.? 1000.00 A 35 SER D 42 SER.? 1000.00 A 218 ASP B 43 ASP.? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 43.58 20.85 5.15 44.62 23.01 5.76 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 44.05 16.99 12.67 44.05 18.89 11.74 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 4 3 # 4 A 32 ASP D 43 ASP.? 1000.00 A 35 SER D 42 SER.? 1000.00 A 218 ASP B 43 ASP.? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 43.58 20.85 5.15 44.62 23.01 5.76 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 44.05 16.99 12.67 44.05 18.89 11.74 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1eag_c04 source 1eag PEPTIDE INHIBITOR : 4 hits 1eag_c04 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP B 43 ASP.? 1000.00 P 35 SER B 42 SER.? 1000.00 P 215 ASP D 43 ASP.? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 7.57 37.60 10.00 8.86 37.02 12.03 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 4.04 29.97 8.82 4.78 31.15 10.46 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP D 40 ASP.? 1000.00 P 35 SER D 42 SER.? 1000.00 P 215 ASP B 40 ASP.? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 7.57 37.60 10.00 8.86 37.02 12.03 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 4.04 29.97 8.82 4.78 31.15 10.46 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 3 3 # 3 P 32 ASP D 40 ASP.? 1000.00 P 35 SER D 42 SER.? 1000.00 P 215 ASP B 43 ASP.? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 7.57 37.60 10.00 8.86 37.02 12.03 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 4.04 29.97 8.82 4.78 31.15 10.46 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 4 3 # 4 P 32 ASP D 43 ASP.? 1000.00 P 35 SER D 42 SER.? 1000.00 P 215 ASP B 43 ASP.? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 7.57 37.60 10.00 8.86 37.02 12.03 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 4.04 29.97 8.82 4.78 31.15 10.46 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 4 hits 1eed_c04 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP B 48 ASP^? 1000.00 B 246 ASP G 43 ASP.? 1000.00 B 275 HIS E 97 HIS.? 1000.00 coo 34.84 56.77 81.62 34.95 54.74 82.03 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 43.18 49.30 68.39 44.75 49.87 69.78 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 38.73 55.10 77.62 36.80 55.01 78.46 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP D 48 ASP^? 1000.00 B 246 ASP H 43 ASP.? 1000.00 B 275 HIS C 97 HIS.? 1000.00 coo 34.84 56.77 81.62 34.95 54.74 82.03 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 43.18 49.30 68.39 44.75 49.87 69.78 -30.59 -68.33 -3.12 -29.92 -66.39 -2.72 coo 38.73 55.10 77.62 36.80 55.01 78.46 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 2 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP B 48 ASP^? 1000.00 C 246 ASP G 43 ASP.? 1000.00 C 275 HIS E 97 HIS.? 1000.00 coo 1.90 35.26 72.76 3.20 35.74 71.18 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 12.03 20.33 71.56 10.48 19.25 70.56 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 3.92 29.96 71.75 4.22 31.96 72.31 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP D 48 ASP^? 1000.00 C 246 ASP D 43 ASP.? 1000.00 C 275 HIS C 94 HIS.? 1000.00 coo 1.90 35.26 72.76 3.20 35.74 71.18 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 12.03 20.33 71.56 10.48 19.25 70.56 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 3.92 29.96 71.75 4.22 31.96 72.31 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP D 48 ASP^? 1000.00 C 246 ASP H 43 ASP.? 1000.00 C 275 HIS C 97 HIS.? 1000.00 coo 1.90 35.26 72.76 3.20 35.74 71.18 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 12.03 20.33 71.56 10.48 19.25 70.56 -30.59 -68.33 -3.12 -29.92 -66.39 -2.72 coo 3.92 29.96 71.75 4.22 31.96 72.31 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP H 48 ASP^? 1000.00 C 246 ASP D 43 ASP.? 1000.00 C 275 HIS C 94 HIS.? 1000.00 coo 1.90 35.26 72.76 3.20 35.74 71.18 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 12.03 20.33 71.56 10.48 19.25 70.56 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 3.92 29.96 71.75 4.22 31.96 72.31 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 4 hits 1ehy_c02 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP B 48 ASP^? 1000.00 153 ARG B 74 ARG^? 1000.00 177 HIS E 97 HIS.? 1000.00 coo 6.83 2.75 19.17 7.40 0.75 19.11 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP D 48 ASP^? 1000.00 153 ARG D 74 ARG^? 1000.00 177 HIS C 97 HIS.? 1000.00 coo 6.83 2.75 19.17 7.40 0.75 19.11 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 3 3 # 3 150 ASP G 48 ASP^? 1000.00 153 ARG G 74 ARG^? 1000.00 177 HIS E 94 HIS.? 1000.00 coo 6.83 2.75 19.17 7.40 0.75 19.11 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 4 3 # 4 150 ASP G 48 ASP^? 1000.00 153 ARG G 74 ARG^? 1000.00 177 HIS E 95 HIS.? 1000.00 coo 6.83 2.75 19.17 7.40 0.75 19.11 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 5 3 # 5 150 ASP H 48 ASP^? 1000.00 153 ARG H 74 ARG^? 1000.00 177 HIS C 94 HIS.? 1000.00 coo 6.83 2.75 19.17 7.40 0.75 19.11 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 6 3 # 6 150 ASP H 48 ASP^? 1000.00 153 ARG H 74 ARG^? 1000.00 177 HIS C 95 HIS.? 1000.00 coo 6.83 2.75 19.17 7.40 0.75 19.11 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 6 hits 1emd_c01 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 34 THR^? 1000.00 A 159 LYS A 38 LYS.? 1000.00 A 193 GLU A 62 GLU.? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -42.33 -15.12 -56.08 -43.18 -13.58 -57.35 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 54 THR^? 1000.00 A 159 LYS A 8 LYS^? 1000.00 A 193 GLU A 68 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -30.80 -21.49 -51.59 -28.90 -22.44 -51.89 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 57 THR^? 1000.00 A 159 LYS A 8 LYS^? 1000.00 A 193 GLU A 68 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -39.95 -23.49 -46.38 -39.66 -25.04 -44.91 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 34 THR^? 1000.00 A 159 LYS B 38 LYS.? 1000.00 A 193 GLU B 62 GLU.? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -19.36 -36.24 -46.83 -19.64 -34.64 -45.39 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR B 57 THR^? 1000.00 A 159 LYS B 8 LYS^? 1000.00 A 193 GLU B 68 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -15.96 -46.87 -53.11 -15.82 -48.81 -54.08 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR C 34 THR^? 1000.00 A 159 LYS C 38 LYS.? 1000.00 A 193 GLU C 62 GLU.? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -52.37 -37.85 -28.96 -54.37 -38.44 -29.47 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR C 57 THR^? 1000.00 A 159 LYS C 8 LYS^? 1000.00 A 193 GLU C 68 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -41.24 -34.76 -22.98 -39.22 -34.48 -22.21 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR D 34 THR^? 1000.00 A 159 LYS D 38 LYS.? 1000.00 A 193 GLU D 62 GLU.? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -27.89 -46.26 -19.44 -29.31 -46.15 -21.09 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 38 THR D 57 THR^? 1000.00 A 159 LYS D 8 LYS^? 1000.00 A 193 GLU D 68 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -17.76 -48.52 -11.62 -16.05 -48.76 -10.33 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 38 THR D 86 THR^? 1000.00 A 159 LYS D 38 LYS.? 1000.00 A 193 GLU D 62 GLU.? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -24.01 -35.70 -16.08 -25.04 -34.15 -17.17 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 38 THR E 57 THR^? 1000.00 A 159 LYS E 8 LYS^? 1000.00 A 193 GLU E 68 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -31.19 -22.88 -45.65 -31.34 -24.89 -46.32 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 38 THR F 34 THR^? 1000.00 A 159 LYS F 38 LYS.? 1000.00 A 193 GLU F 62 GLU.? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -50.35 -23.30 -13.81 -52.09 -22.66 -12.66 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 13 3 # 13 A 38 THR G 34 THR^? 1000.00 A 159 LYS G 38 LYS.? 1000.00 A 193 GLU G 62 GLU.? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -0.50 -39.88 -54.46 1.25 -38.89 -53.69 coo 2.10 10.68 61.44 -2.14 13.16 60.61 6.01 -41.17 -63.42 7.43 -47.25 -63.10 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 14 3 # 14 A 38 THR G 54 THR^? 1000.00 A 159 LYS G 8 LYS^? 1000.00 A 193 GLU G 68 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -10.90 -48.54 -51.13 -12.05 -50.22 -50.40 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 coo -5.33 11.71 69.72 -4.62 11.92 67.73 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 15 3 # 15 A 38 THR G 57 THR^? 1000.00 A 159 LYS G 8 LYS^? 1000.00 A 193 GLU G 68 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -11.73 -43.22 -60.42 -13.41 -43.82 -61.59 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 coo -5.33 11.71 69.72 -4.62 11.92 67.73 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 16 3 # 16 A 38 THR H 45 THR^? 1000.00 A 159 LYS H 38 LYS.? 1000.00 A 193 GLU H 62 GLU.? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -28.98 -64.21 -9.31 -29.95 -62.48 -8.44 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -29.93 -63.04 6.06 -30.63 -65.03 6.10 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 17 3 # 17 A 38 THR H 57 THR^? 1000.00 A 159 LYS H 8 LYS^? 1000.00 A 193 GLU H 68 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -22.01 -53.02 -4.72 -21.58 -51.28 -3.54 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 17 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 40 ASP.? 1000.00 260 GLU A 62 GLU.? 1000.00 370 TYR A 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -55.02 -16.32 -57.84 -55.96 -14.51 -57.37 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP A 40 ASP.? 1000.00 260 GLU A 68 GLU^? 1000.00 370 TYR A 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -55.02 -16.32 -57.84 -55.96 -14.51 -57.37 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP B 40 ASP.? 1000.00 260 GLU B 62 GLU.? 1000.00 370 TYR B 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP B 40 ASP.? 1000.00 260 GLU B 68 GLU^? 1000.00 370 TYR B 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 ULMN 3 1euu_c00 SIALIDASE user 5 3 # 5 92 ASP C 40 ASP.? 1000.00 260 GLU C 62 GLU.? 1000.00 370 TYR C 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1euu_c00 SIALIDASE user 6 3 # 6 92 ASP C 40 ASP.? 1000.00 260 GLU C 68 GLU^? 1000.00 370 TYR C 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1euu_c00 SIALIDASE user 7 3 # 7 92 ASP D 40 ASP.? 1000.00 260 GLU D 62 GLU.? 1000.00 370 TYR D 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 ULMN 3 1euu_c00 SIALIDASE user 8 3 # 8 92 ASP D 40 ASP.? 1000.00 260 GLU D 68 GLU^? 1000.00 370 TYR D 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 ULMN 3 1euu_c00 SIALIDASE user 9 3 # 9 92 ASP E 40 ASP.? 1000.00 260 GLU E 62 GLU.? 1000.00 370 TYR E 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -17.17 -9.50 -39.47 -16.76 -7.92 -40.81 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 ULMN 3 1euu_c00 SIALIDASE user 10 3 # 10 92 ASP E 40 ASP.? 1000.00 260 GLU E 68 GLU^? 1000.00 370 TYR E 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -17.17 -9.50 -39.47 -16.76 -7.92 -40.81 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 ULMN 3 1euu_c00 SIALIDASE user 11 3 # 11 92 ASP F 40 ASP.? 1000.00 260 GLU F 62 GLU.? 1000.00 370 TYR F 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 ULMN 3 1euu_c00 SIALIDASE user 12 3 # 12 92 ASP F 40 ASP.? 1000.00 260 GLU F 68 GLU^? 1000.00 370 TYR F 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 ULMN 3 1euu_c00 SIALIDASE user 13 3 # 13 92 ASP G 40 ASP.? 1000.00 260 GLU G 62 GLU.? 1000.00 370 TYR G 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 ULMN 3 1euu_c00 SIALIDASE user 14 3 # 14 92 ASP G 40 ASP.? 1000.00 260 GLU G 68 GLU^? 1000.00 370 TYR G 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 4.41 -43.97 -59.17 6.44 -44.61 -59.08 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 ULMN 3 1euu_c00 SIALIDASE user 15 3 # 15 92 ASP H 40 ASP.? 1000.00 260 GLU H 62 GLU.? 1000.00 370 TYR H 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -28.41 -71.72 -1.86 -30.52 -71.82 -1.58 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -29.93 -63.04 6.06 -30.63 -65.03 6.10 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 ULMN 3 1euu_c00 SIALIDASE user 16 3 # 16 92 ASP H 40 ASP.? 1000.00 260 GLU H 68 GLU^? 1000.00 370 TYR H 67 TYR^? 1000.00 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -28.41 -71.72 -1.86 -30.52 -71.82 -1.58 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 1euu_c00 source 1euu SIALIDASE : 16 hits 1euu_c00 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 67 TYR^? 1000.00 A 142 LEU A 58 LEU^? 1000.00 A 165 LYS A 38 LYS.? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -43.96 -22.06 -48.62 -43.50 -20.81 -50.30 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR B 67 TYR^? 1000.00 A 142 LEU B 58 LEU^? 1000.00 A 165 LYS B 38 LYS.? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -18.32 -46.28 -49.00 -18.31 -44.15 -48.64 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR C 67 TYR^? 1000.00 A 142 LEU C 58 LEU^? 1000.00 A 165 LYS C 38 LYS.? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -43.57 -38.85 -23.82 -45.20 -38.02 -24.97 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR D 67 TYR^? 1000.00 A 142 LEU D 58 LEU^? 1000.00 A 165 LYS D 38 LYS.? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -18.15 -46.55 -15.90 -20.28 -46.70 -16.23 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR E 67 TYR^? 1000.00 A 142 LEU E 58 LEU^? 1000.00 A 165 LYS E 38 LYS.? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -27.39 -20.20 -44.52 -28.14 -18.41 -43.58 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR F 67 TYR^? 1000.00 A 142 LEU F 58 LEU^? 1000.00 A 165 LYS F 38 LYS.? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -43.70 -21.76 -21.17 -44.81 -22.53 -19.51 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR G 67 TYR^? 1000.00 A 142 LEU G 58 LEU^? 1000.00 A 165 LYS G 38 LYS.? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -7.72 -41.06 -61.74 -6.65 -41.19 -59.86 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 6.01 -41.17 -63.42 7.43 -47.25 -63.10 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 137 TYR H 67 TYR^? 1000.00 A 142 LEU H 58 LEU^? 1000.00 A 165 LYS H 38 LYS.? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -24.21 -57.05 -3.38 -23.75 -58.30 -5.08 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 8 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 67 TYR^? 1000.00 B 142 LEU A 58 LEU^? 1000.00 B 165 LYS A 38 LYS.? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -43.96 -22.06 -48.62 -43.50 -20.81 -50.30 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR B 67 TYR^? 1000.00 B 142 LEU B 58 LEU^? 1000.00 B 165 LYS B 38 LYS.? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -18.32 -46.28 -49.00 -18.31 -44.15 -48.64 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR C 67 TYR^? 1000.00 B 142 LEU C 58 LEU^? 1000.00 B 165 LYS C 38 LYS.? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -43.57 -38.85 -23.82 -45.20 -38.02 -24.97 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR D 67 TYR^? 1000.00 B 142 LEU D 58 LEU^? 1000.00 B 165 LYS D 38 LYS.? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -18.15 -46.55 -15.90 -20.28 -46.70 -16.23 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR E 67 TYR^? 1000.00 B 142 LEU E 58 LEU^? 1000.00 B 165 LYS E 38 LYS.? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -27.39 -20.20 -44.52 -28.14 -18.41 -43.58 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR F 67 TYR^? 1000.00 B 142 LEU F 58 LEU^? 1000.00 B 165 LYS F 38 LYS.? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -43.70 -21.76 -21.17 -44.81 -22.53 -19.51 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 137 TYR G 67 TYR^? 1000.00 B 142 LEU G 58 LEU^? 1000.00 B 165 LYS G 38 LYS.? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -7.72 -41.06 -61.74 -6.65 -41.19 -59.86 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 6.01 -41.17 -63.42 7.43 -47.25 -63.10 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 B 137 TYR H 67 TYR^? 1000.00 B 142 LEU H 58 LEU^? 1000.00 B 165 LYS H 38 LYS.? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -24.21 -57.05 -3.38 -23.75 -58.30 -5.08 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 8 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 67 TYR^? 1000.00 C 142 LEU A 58 LEU^? 1000.00 C 165 LYS A 38 LYS.? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -43.96 -22.06 -48.62 -43.50 -20.81 -50.30 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR B 67 TYR^? 1000.00 C 142 LEU B 58 LEU^? 1000.00 C 165 LYS B 38 LYS.? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -18.32 -46.28 -49.00 -18.31 -44.15 -48.64 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR C 67 TYR^? 1000.00 C 142 LEU C 58 LEU^? 1000.00 C 165 LYS C 38 LYS.? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -43.57 -38.85 -23.82 -45.20 -38.02 -24.97 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR D 67 TYR^? 1000.00 C 142 LEU D 58 LEU^? 1000.00 C 165 LYS D 38 LYS.? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -18.15 -46.55 -15.90 -20.28 -46.70 -16.23 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR E 67 TYR^? 1000.00 C 142 LEU E 58 LEU^? 1000.00 C 165 LYS E 38 LYS.? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -27.39 -20.20 -44.52 -28.14 -18.41 -43.58 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR F 67 TYR^? 1000.00 C 142 LEU F 58 LEU^? 1000.00 C 165 LYS F 38 LYS.? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -43.70 -21.76 -21.17 -44.81 -22.53 -19.51 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 137 TYR G 67 TYR^? 1000.00 C 142 LEU G 58 LEU^? 1000.00 C 165 LYS G 38 LYS.? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -7.72 -41.06 -61.74 -6.65 -41.19 -59.86 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 6.01 -41.17 -63.42 7.43 -47.25 -63.10 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 137 TYR H 67 TYR^? 1000.00 C 142 LEU H 58 LEU^? 1000.00 C 165 LYS H 38 LYS.? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -24.21 -57.05 -3.38 -23.75 -58.30 -5.08 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 8 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 67 TYR^? 1000.00 D 142 LEU A 58 LEU^? 1000.00 D 165 LYS A 38 LYS.? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -43.96 -22.06 -48.62 -43.50 -20.81 -50.30 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR B 67 TYR^? 1000.00 D 142 LEU B 58 LEU^? 1000.00 D 165 LYS B 38 LYS.? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -18.32 -46.28 -49.00 -18.31 -44.15 -48.64 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR C 67 TYR^? 1000.00 D 142 LEU C 58 LEU^? 1000.00 D 165 LYS C 38 LYS.? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -43.57 -38.85 -23.82 -45.20 -38.02 -24.97 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR D 67 TYR^? 1000.00 D 142 LEU D 58 LEU^? 1000.00 D 165 LYS D 38 LYS.? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -18.15 -46.55 -15.90 -20.28 -46.70 -16.23 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR E 67 TYR^? 1000.00 D 142 LEU E 58 LEU^? 1000.00 D 165 LYS E 38 LYS.? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -27.39 -20.20 -44.52 -28.14 -18.41 -43.58 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR F 67 TYR^? 1000.00 D 142 LEU F 58 LEU^? 1000.00 D 165 LYS F 38 LYS.? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -43.70 -21.76 -21.17 -44.81 -22.53 -19.51 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 137 TYR G 67 TYR^? 1000.00 D 142 LEU G 58 LEU^? 1000.00 D 165 LYS G 38 LYS.? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -7.72 -41.06 -61.74 -6.65 -41.19 -59.86 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 6.01 -41.17 -63.42 7.43 -47.25 -63.10 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 137 TYR H 67 TYR^? 1000.00 D 142 LEU H 58 LEU^? 1000.00 D 165 LYS H 38 LYS.? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -24.21 -57.05 -3.38 -23.75 -58.30 -5.08 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 8 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER B 84 SER^? 1000.00 A 48 THR B 85 THR^? 1000.00 A 165 LYS A 8 LYS^? 1000.00 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -27.31 -34.98 -51.96 -28.03 -35.42 -49.66 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -28.41 -38.58 -52.26 -27.40 -40.12 -53.39 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER C 55 SER^? 1000.00 A 48 THR C 20 THR^? 1000.00 A 165 LYS E 8 LYS^? 1000.00 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -41.88 -30.62 -30.53 -39.74 -30.38 -30.64 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER C 55 SER^? 1000.00 A 48 THR C 54 THR^? 1000.00 A 165 LYS E 8 LYS^? 1000.00 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER C 55 SER^? 1000.00 A 48 THR F 57 THR^? 1000.00 A 165 LYS E 8 LYS^? 1000.00 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 47 SER D 84 SER^? 1000.00 A 48 THR D 85 THR^? 1000.00 A 165 LYS F 8 LYS^? 1000.00 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -30.32 -38.70 -14.87 -30.83 -36.85 -16.33 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER B 84 SER^? 1000.00 B 48 THR B 85 THR^? 1000.00 B 165 LYS A 8 LYS^? 1000.00 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -27.31 -34.98 -51.96 -28.03 -35.42 -49.66 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -28.41 -38.58 -52.26 -27.40 -40.12 -53.39 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER C 55 SER^? 1000.00 B 48 THR C 20 THR^? 1000.00 B 165 LYS E 8 LYS^? 1000.00 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -41.88 -30.62 -30.53 -39.74 -30.38 -30.64 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER C 55 SER^? 1000.00 B 48 THR C 54 THR^? 1000.00 B 165 LYS E 8 LYS^? 1000.00 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 47 SER C 55 SER^? 1000.00 B 48 THR F 57 THR^? 1000.00 B 165 LYS E 8 LYS^? 1000.00 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 47 SER D 84 SER^? 1000.00 B 48 THR D 85 THR^? 1000.00 B 165 LYS F 8 LYS^? 1000.00 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -30.32 -38.70 -14.87 -30.83 -36.85 -16.33 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER B 84 SER^? 1000.00 C 48 THR B 85 THR^? 1000.00 C 165 LYS A 8 LYS^? 1000.00 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -27.31 -34.98 -51.96 -28.03 -35.42 -49.66 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -28.41 -38.58 -52.26 -27.40 -40.12 -53.39 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER C 55 SER^? 1000.00 C 48 THR C 20 THR^? 1000.00 C 165 LYS E 8 LYS^? 1000.00 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -41.88 -30.62 -30.53 -39.74 -30.38 -30.64 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER C 55 SER^? 1000.00 C 48 THR C 54 THR^? 1000.00 C 165 LYS E 8 LYS^? 1000.00 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER C 55 SER^? 1000.00 C 48 THR F 57 THR^? 1000.00 C 165 LYS E 8 LYS^? 1000.00 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 47 SER D 84 SER^? 1000.00 C 48 THR D 85 THR^? 1000.00 C 165 LYS F 8 LYS^? 1000.00 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -30.32 -38.70 -14.87 -30.83 -36.85 -16.33 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER B 84 SER^? 1000.00 D 48 THR B 85 THR^? 1000.00 D 165 LYS A 8 LYS^? 1000.00 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -27.31 -34.98 -51.96 -28.03 -35.42 -49.66 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -28.41 -38.58 -52.26 -27.40 -40.12 -53.39 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER C 55 SER^? 1000.00 D 48 THR C 20 THR^? 1000.00 D 165 LYS E 8 LYS^? 1000.00 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -41.88 -30.62 -30.53 -39.74 -30.38 -30.64 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 47 SER C 55 SER^? 1000.00 D 48 THR C 54 THR^? 1000.00 D 165 LYS E 8 LYS^? 1000.00 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 47 SER C 55 SER^? 1000.00 D 48 THR F 57 THR^? 1000.00 D 165 LYS E 8 LYS^? 1000.00 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -42.92 -29.14 -26.72 -40.65 -30.04 -26.72 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 47 SER D 84 SER^? 1000.00 D 48 THR D 85 THR^? 1000.00 D 165 LYS F 8 LYS^? 1000.00 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 -30.32 -38.70 -14.87 -30.83 -36.85 -16.33 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 -27.06 -36.94 -14.19 -25.63 -37.59 -12.70 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c07 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG F 70 ARG^? 1000.00 A 136 GLU F 44 GLU.? 1000.00 A 246 GLU F 68 GLU^? 1000.00 coo 13.48 30.30 107.06 11.75 30.99 109.44 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo 9.46 32.37 115.82 8.50 34.20 115.47 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 11.99 34.33 109.92 10.08 34.19 110.77 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 1 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG F 70 ARG^? 1000.00 A 136 GLU F 44 GLU.? 1000.00 A 246 GLU F 68 GLU^? 1000.00 coo 13.94 29.84 106.80 11.67 30.40 108.79 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo 9.52 31.97 115.23 8.45 33.74 114.72 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 11.92 33.82 109.35 10.10 33.50 110.39 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 1 hits 1fob_c00 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG G 74 ARG^? 1000.00 A 201 HIS E 97 HIS.? 1000.00 A 204 HIS E 96 HIS.? 1000.00 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG H 74 ARG^? 1000.00 A 201 HIS C 97 HIS.? 1000.00 A 204 HIS C 96 HIS.? 1000.00 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 2 hits 1g8f_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU B 29 GLU.? 1000.00 516 HIS E 96 HIS.? 1000.00 559 HIS E 97 HIS.? 1000.00 coo 49.01 14.50 52.53 46.99 14.61 52.78 -9.38 -24.09 -58.12 -8.97 -22.30 -57.06 coo 41.59 7.83 54.15 41.16 9.87 53.87 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 42.22 14.55 52.50 43.91 14.87 53.60 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU B 29 GLU.? 1000.00 516 HIS E 98 HIS.? 1000.00 559 HIS E 97 HIS.? 1000.00 coo 49.01 14.50 52.53 46.99 14.61 52.78 -9.38 -24.09 -58.12 -8.97 -22.30 -57.06 coo 41.59 7.83 54.15 41.16 9.87 53.87 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 42.22 14.55 52.50 43.91 14.87 53.60 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU C 93 GLU.? 1000.00 516 HIS C 95 HIS.? 1000.00 559 HIS C 94 HIS.? 1000.00 coo 49.01 14.50 52.53 46.99 14.61 52.78 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 41.59 7.83 54.15 41.16 9.87 53.87 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 42.22 14.55 52.50 43.91 14.87 53.60 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU D 29 GLU.? 1000.00 516 HIS C 96 HIS.? 1000.00 559 HIS C 97 HIS.? 1000.00 coo 49.01 14.50 52.53 46.99 14.61 52.78 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 coo 41.59 7.83 54.15 41.16 9.87 53.87 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 42.22 14.55 52.50 43.91 14.87 53.60 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 5 3 # 5 412 GLU E 93 GLU.? 1000.00 516 HIS E 95 HIS.? 1000.00 559 HIS E 94 HIS.? 1000.00 coo 49.01 14.50 52.53 46.99 14.61 52.78 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 41.59 7.83 54.15 41.16 9.87 53.87 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 42.22 14.55 52.50 43.91 14.87 53.60 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 6 3 # 6 412 GLU G 93 GLU.? 1000.00 516 HIS G 95 HIS.? 1000.00 559 HIS G 94 HIS.? 1000.00 coo 49.01 14.50 52.53 46.99 14.61 52.78 -5.22 -46.46 -82.88 -6.14 -48.32 -83.21 coo 41.59 7.83 54.15 41.16 9.87 53.87 -3.23 -38.22 -87.57 -1.92 -39.63 -88.40 coo 42.22 14.55 52.50 43.91 14.87 53.60 -8.64 -42.01 -86.48 -9.37 -43.48 -87.79 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 6 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU C 62 GLU.? 1000.00 A 47 ASP D 48 ASP^? 1000.00 A 161 TYR D 79 TYR^? 1000.00 coo 37.12 18.35 73.76 37.09 16.69 72.44 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 29.81 8.06 73.13 30.21 10.11 72.95 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 37.29 15.56 67.90 37.37 13.79 70.08 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU E 62 GLU.? 1000.00 A 47 ASP B 48 ASP^? 1000.00 A 161 TYR B 79 TYR^? 1000.00 coo 37.12 18.35 73.76 37.09 16.69 72.44 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 29.81 8.06 73.13 30.21 10.11 72.95 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 37.29 15.56 67.90 37.37 13.79 70.08 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 2 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU C 62 GLU.? 1000.00 B 47 ASP D 48 ASP^? 1000.00 B 161 TYR D 79 TYR^? 1000.00 coo 53.87 35.49 53.22 55.44 35.72 54.61 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 63.47 43.65 53.95 61.45 43.07 54.06 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 56.38 35.81 59.19 58.25 35.77 57.10 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU E 62 GLU.? 1000.00 B 47 ASP B 48 ASP^? 1000.00 B 161 TYR B 79 TYR^? 1000.00 coo 53.87 35.49 53.22 55.44 35.72 54.61 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 63.47 43.65 53.95 61.45 43.07 54.06 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 56.38 35.81 59.19 58.25 35.77 57.10 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 2 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP B 48 ASP^? 1000.00 A 64 HIS E 96 HIS.? 1000.00 A 155 ASN E 64 ASN.? 1000.00 coo 3.12 38.70 24.20 3.24 38.59 26.33 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 1.90 38.00 29.77 3.91 38.35 29.95 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 9.89 36.55 37.38 9.27 37.99 36.08 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP B 48 ASP^? 1000.00 A 64 HIS E 97 HIS.? 1000.00 A 155 ASN G 60 ASN.? 1000.00 coo 3.12 38.70 24.20 3.24 38.59 26.33 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 1.90 38.00 29.77 3.91 38.35 29.95 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 9.89 36.55 37.38 9.27 37.99 36.08 -7.92 -34.66 -65.50 -6.82 -32.91 -66.09 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP D 48 ASP^? 1000.00 A 64 HIS C 96 HIS.? 1000.00 A 155 ASN C 64 ASN.? 1000.00 coo 3.12 38.70 24.20 3.24 38.59 26.33 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 1.90 38.00 29.77 3.91 38.35 29.95 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 9.89 36.55 37.38 9.27 37.99 36.08 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP G 48 ASP^? 1000.00 A 64 HIS E 94 HIS.? 1000.00 A 155 ASN G 75 ASN^? 1000.00 coo 3.12 38.70 24.20 3.24 38.59 26.33 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 1.90 38.00 29.77 3.91 38.35 29.95 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 9.89 36.55 37.38 9.27 37.99 36.08 -1.10 -45.07 -37.41 -2.90 -46.10 -36.91 ULMN 3 1gns_c00 SUBTILISIN BPN' user 5 3 # 5 A 32 ASP G 48 ASP^? 1000.00 A 64 HIS E 95 HIS.? 1000.00 A 155 ASN E 64 ASN.? 1000.00 coo 3.12 38.70 24.20 3.24 38.59 26.33 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 1.90 38.00 29.77 3.91 38.35 29.95 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 9.89 36.55 37.38 9.27 37.99 36.08 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 ULMN 3 1gns_c00 SUBTILISIN BPN' user 6 3 # 6 A 32 ASP H 48 ASP^? 1000.00 A 64 HIS C 95 HIS.? 1000.00 A 155 ASN C 64 ASN.? 1000.00 coo 3.12 38.70 24.20 3.24 38.59 26.33 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 1.90 38.00 29.77 3.91 38.35 29.95 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 9.89 36.55 37.38 9.27 37.99 36.08 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 1gns_c00 source 1gns SUBTILISIN BPN' : 6 hits 1gns_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 40 ASP.? 1000.00 A 327 GLU B 62 GLU.? 1000.00 A 339 ARG B 37 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -55.02 -16.32 -57.84 -55.96 -14.51 -57.37 coo 75.11 41.01 160.30 76.65 40.06 161.41 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 82.23 40.35 159.87 85.09 40.67 161.01 -25.67 -45.26 -38.37 -22.78 -45.37 -37.35 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 43 ASP.? 1000.00 A 327 GLU D 44 GLU.? 1000.00 A 339 ARG D 70 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -52.49 -15.23 -55.19 -52.13 -15.99 -53.25 coo 75.11 41.01 160.30 76.65 40.06 161.41 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 82.23 40.35 159.87 85.09 40.67 161.01 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 43 ASP.? 1000.00 A 327 GLU D 68 GLU^? 1000.00 A 339 ARG D 70 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -52.49 -15.23 -55.19 -52.13 -15.99 -53.25 coo 75.11 41.01 160.30 76.65 40.06 161.41 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 coo 82.23 40.35 159.87 85.09 40.67 161.01 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 48 ASP^? 1000.00 A 327 GLU G 29 GLU.? 1000.00 A 339 ARG G 74 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo 75.11 41.01 160.30 76.65 40.06 161.41 -5.31 -41.94 -36.91 -3.79 -40.93 -35.87 coo 82.23 40.35 159.87 85.09 40.67 161.01 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP B 40 ASP.? 1000.00 A 327 GLU H 62 GLU.? 1000.00 A 339 ARG H 37 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 -29.93 -63.04 6.06 -30.63 -65.03 6.10 coo 82.23 40.35 159.87 85.09 40.67 161.01 -28.82 -68.15 1.75 -31.05 -66.20 1.05 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP B 43 ASP.? 1000.00 A 327 GLU F 44 GLU.? 1000.00 A 339 ARG F 70 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 coo 82.23 40.35 159.87 85.09 40.67 161.01 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP B 43 ASP.? 1000.00 A 327 GLU H 62 GLU.? 1000.00 A 339 ARG H 37 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 75.11 41.01 160.30 76.65 40.06 161.41 -29.93 -63.04 6.06 -30.63 -65.03 6.10 coo 82.23 40.35 159.87 85.09 40.67 161.01 -28.82 -68.15 1.75 -31.05 -66.20 1.05 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP B 48 ASP^? 1000.00 A 327 GLU C 44 GLU.? 1000.00 A 339 ARG C 70 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 75.11 41.01 160.30 76.65 40.06 161.41 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 82.23 40.35 159.87 85.09 40.67 161.01 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP C 40 ASP.? 1000.00 A 327 GLU A 44 GLU.? 1000.00 A 339 ARG A 70 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 75.11 41.01 160.30 76.65 40.06 161.41 -47.53 -13.80 -58.12 -49.26 -14.21 -59.28 coo 82.23 40.35 159.87 85.09 40.67 161.01 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 10 3 # 10 A 50 ASP C 40 ASP.? 1000.00 A 327 GLU E 29 GLU.? 1000.00 A 339 ARG E 74 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 75.11 41.01 160.30 76.65 40.06 161.41 -47.46 -5.14 -41.90 -47.28 -3.05 -42.08 coo 82.23 40.35 159.87 85.09 40.67 161.01 -40.74 -4.80 -41.62 -42.54 -4.95 -44.12 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 11 3 # 11 A 50 ASP C 43 ASP.? 1000.00 A 327 GLU E 44 GLU.? 1000.00 A 339 ARG E 70 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 75.11 41.01 160.30 76.65 40.06 161.41 -24.48 -8.54 -40.01 -24.93 -7.20 -38.47 coo 82.23 40.35 159.87 85.09 40.67 161.01 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 12 3 # 12 A 50 ASP C 48 ASP^? 1000.00 A 327 GLU E 62 GLU.? 1000.00 A 339 ARG E 37 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 82.23 40.35 159.87 85.09 40.67 161.01 -16.50 -14.01 -41.09 -16.70 -12.05 -43.45 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 13 3 # 13 A 50 ASP C 48 ASP^? 1000.00 A 327 GLU H 29 GLU.? 1000.00 A 339 ARG H 74 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 -19.75 -60.10 -27.61 -21.15 -61.23 -28.71 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 14 3 # 14 A 50 ASP D 43 ASP.? 1000.00 A 327 GLU A 29 GLU.? 1000.00 A 339 ARG A 74 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 75.11 41.01 160.30 76.65 40.06 161.41 -26.00 -6.81 -57.60 -25.88 -4.71 -57.52 coo 82.23 40.35 159.87 85.09 40.67 161.01 -32.79 -7.25 -57.44 -31.11 -6.28 -55.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 15 3 # 15 A 50 ASP D 43 ASP.? 1000.00 A 327 GLU A 44 GLU.? 1000.00 A 339 ARG A 70 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 75.11 41.01 160.30 76.65 40.06 161.41 -47.53 -13.80 -58.12 -49.26 -14.21 -59.28 coo 82.23 40.35 159.87 85.09 40.67 161.01 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 16 3 # 16 A 50 ASP D 43 ASP.? 1000.00 A 327 GLU G 62 GLU.? 1000.00 A 339 ARG G 37 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 75.11 41.01 160.30 76.65 40.06 161.41 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 82.23 40.35 159.87 85.09 40.67 161.01 2.57 -36.22 -67.13 1.93 -33.23 -67.01 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 17 3 # 17 A 50 ASP D 48 ASP^? 1000.00 A 327 GLU F 62 GLU.? 1000.00 A 339 ARG F 37 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 75.11 41.01 160.30 76.65 40.06 161.41 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 82.23 40.35 159.87 85.09 40.67 161.01 -48.09 -10.25 -16.84 -50.78 -9.38 -18.06 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 18 3 # 18 A 50 ASP E 43 ASP.? 1000.00 A 327 GLU C 44 GLU.? 1000.00 A 339 ARG C 70 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 coo 75.11 41.01 160.30 76.65 40.06 161.41 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 82.23 40.35 159.87 85.09 40.67 161.01 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 19 3 # 19 A 50 ASP E 48 ASP^? 1000.00 A 327 GLU C 62 GLU.? 1000.00 A 339 ARG C 37 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 coo 75.11 41.01 160.30 76.65 40.06 161.41 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 82.23 40.35 159.87 85.09 40.67 161.01 -47.98 -50.77 -27.47 -48.61 -50.31 -24.50 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 20 3 # 20 A 50 ASP E 48 ASP^? 1000.00 A 327 GLU G 29 GLU.? 1000.00 A 339 ARG G 74 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 coo 75.11 41.01 160.30 76.65 40.06 161.41 -5.31 -41.94 -36.91 -3.79 -40.93 -35.87 coo 82.23 40.35 159.87 85.09 40.67 161.01 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 21 3 # 21 A 50 ASP F 40 ASP.? 1000.00 A 327 GLU B 44 GLU.? 1000.00 A 339 ARG B 70 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 82.23 40.35 159.87 85.09 40.67 161.01 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 22 3 # 22 A 50 ASP F 40 ASP.? 1000.00 A 327 GLU D 29 GLU.? 1000.00 A 339 ARG D 74 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 coo 82.23 40.35 159.87 85.09 40.67 161.01 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 23 3 # 23 A 50 ASP F 40 ASP.? 1000.00 A 327 GLU D 62 GLU.? 1000.00 A 339 ARG D 37 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 75.11 41.01 160.30 76.65 40.06 161.41 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 coo 82.23 40.35 159.87 85.09 40.67 161.01 -18.79 -39.36 -27.13 -18.50 -42.28 -28.04 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 24 3 # 24 A 50 ASP F 43 ASP.? 1000.00 A 327 GLU A 29 GLU.? 1000.00 A 339 ARG A 74 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 75.11 41.01 160.30 76.65 40.06 161.41 -26.00 -6.81 -57.60 -25.88 -4.71 -57.52 coo 82.23 40.35 159.87 85.09 40.67 161.01 -32.79 -7.25 -57.44 -31.11 -6.28 -55.07 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 25 3 # 25 A 50 ASP F 48 ASP^? 1000.00 A 327 GLU E 62 GLU.? 1000.00 A 339 ARG E 37 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 82.23 40.35 159.87 85.09 40.67 161.01 -16.50 -14.01 -41.09 -16.70 -12.05 -43.45 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 26 3 # 26 A 50 ASP F 48 ASP^? 1000.00 A 327 GLU H 29 GLU.? 1000.00 A 339 ARG H 74 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 -19.75 -60.10 -27.61 -21.15 -61.23 -28.71 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 27 3 # 27 A 50 ASP F 48 ASP^? 1000.00 A 327 GLU H 62 GLU.? 1000.00 A 339 ARG H 37 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo 75.11 41.01 160.30 76.65 40.06 161.41 -29.93 -63.04 6.06 -30.63 -65.03 6.10 coo 82.23 40.35 159.87 85.09 40.67 161.01 -28.82 -68.15 1.75 -31.05 -66.20 1.05 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 28 3 # 28 A 50 ASP G 48 ASP^? 1000.00 A 327 GLU A 44 GLU.? 1000.00 A 339 ARG A 70 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 75.11 41.01 160.30 76.65 40.06 161.41 -47.53 -13.80 -58.12 -49.26 -14.21 -59.28 coo 82.23 40.35 159.87 85.09 40.67 161.01 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 28 hits 1hto_c00 naa= 3 ULMN 3 1i1e_c00 BOTULINUM NEUROTOXIN TYPE B user 1 3 # 1 A 267 GLU C 62 GLU.? 1000.00 A 369 ARG D 74 ARG^? 1000.00 A 372 TYR D 79 TYR^? 1000.00 coo 16.47 7.99 31.03 17.36 6.90 32.63 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 18.73 -1.52 28.96 15.88 -0.55 29.44 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 16.01 4.58 27.39 13.82 5.38 28.94 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 1i1e_c00 source 1i1e BOTULINUM NEUROTOXIN TYPE B : 1 hits 1i1e_c00 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER B 42 SER.? 1000.00 A 173 ARG B 70 ARG^? 1000.00 A 211 ASP D 40 ASP.? 1000.00 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 18.77 77.82 11.69 20.55 80.22 10.73 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER D 42 SER.? 1000.00 A 173 ARG D 70 ARG^? 1000.00 A 211 ASP B 40 ASP.? 1000.00 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 18.77 77.82 11.69 20.55 80.22 10.73 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER D 42 SER.? 1000.00 A 173 ARG D 70 ARG^? 1000.00 A 211 ASP B 43 ASP.? 1000.00 coo 22.72 76.24 0.23 24.60 76.86 -1.25 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 18.77 77.82 11.69 20.55 80.22 10.73 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1ig8_c00 source 1ig8 HEXOKINASE PII : 3 hits 1ig8_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU C 93 GLU.? 1000.00 A 61 GLU D 44 GLU.? 1000.00 A 162 HIS C 94 HIS.? 1000.00 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 1 hits 1j53_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG G 74 ARG^? 1000.00 A 201 HIS E 97 HIS.? 1000.00 A 204 HIS E 96 HIS.? 1000.00 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG H 74 ARG^? 1000.00 A 201 HIS C 97 HIS.? 1000.00 A 204 HIS C 96 HIS.? 1000.00 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 1j70_c00 source 1j70 ATP SULPHURYLASE : 2 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG G 74 ARG^? 1000.00 B 201 HIS E 97 HIS.? 1000.00 B 204 HIS E 96 HIS.? 1000.00 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG H 74 ARG^? 1000.00 B 201 HIS C 97 HIS.? 1000.00 B 204 HIS C 96 HIS.? 1000.00 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 1j70_c01 source 1j70 ATP SULPHURYLASE : 2 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG G 74 ARG^? 1000.00 C 201 HIS E 97 HIS.? 1000.00 C 204 HIS E 96 HIS.? 1000.00 coo 30.92 14.23 15.70 28.82 13.90 13.48 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 20.16 5.55 18.86 20.00 7.59 19.34 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 24.92 3.29 16.90 24.41 4.92 15.69 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG H 74 ARG^? 1000.00 C 201 HIS C 97 HIS.? 1000.00 C 204 HIS C 96 HIS.? 1000.00 coo 30.92 14.23 15.70 28.82 13.90 13.48 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 20.16 5.55 18.86 20.00 7.59 19.34 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 24.92 3.29 16.90 24.41 4.92 15.69 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 1j70_c02 source 1j70 ATP SULPHURYLASE : 2 hits 1j70_c02 naa= 3 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 1 3 # 1 A 202 SER B 51 SER.? 1000.00 A 308 ASP B 48 ASP^? 1000.00 A 338 HIS E 97 HIS.? 1000.00 coo 37.44 15.05 21.90 37.18 17.02 20.71 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 45.75 18.77 19.41 43.72 18.70 19.99 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 41.13 18.39 17.83 39.67 17.70 19.17 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1jkm_c00 source 1jkm BREFELDIN A ESTERASE : 1 hits 1jkm_c00 naa= 3 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 1 3 # 1 B 202 SER B 51 SER.? 1000.00 B 308 ASP B 48 ASP^? 1000.00 B 338 HIS E 97 HIS.? 1000.00 coo 67.81 2.11 21.29 69.09 3.00 23.04 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 64.20 9.21 26.15 65.67 7.96 25.24 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 66.92 5.20 26.82 67.69 4.22 25.14 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1jkm_c01 source 1jkm BREFELDIN A ESTERASE : 1 hits 1jkm_c01 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP B 40 ASP.? 1000.00 A 58 ASP B 43 ASP.? 1000.00 A 424 GLU B 62 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 58.59 41.80 18.81 58.94 43.89 18.94 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 52.85 46.34 13.34 54.09 44.97 14.42 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP B 43 ASP.? 1000.00 A 58 ASP B 40 ASP.? 1000.00 A 424 GLU B 62 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 58.59 41.80 18.81 58.94 43.89 18.94 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 52.85 46.34 13.34 54.09 44.97 14.42 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP B 48 ASP^? 1000.00 A 58 ASP G 48 ASP^? 1000.00 A 424 GLU E 93 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 58.59 41.80 18.81 58.94 43.89 18.94 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 52.85 46.34 13.34 54.09 44.97 14.42 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP C 40 ASP.? 1000.00 A 58 ASP C 43 ASP.? 1000.00 A 424 GLU C 62 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 58.59 41.80 18.81 58.94 43.89 18.94 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 52.85 46.34 13.34 54.09 44.97 14.42 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP C 43 ASP.? 1000.00 A 58 ASP C 40 ASP.? 1000.00 A 424 GLU C 68 GLU^? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 58.59 41.80 18.81 58.94 43.89 18.94 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 52.85 46.34 13.34 54.09 44.97 14.42 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP F 40 ASP.? 1000.00 A 58 ASP F 43 ASP.? 1000.00 A 424 GLU F 62 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 58.59 41.80 18.81 58.94 43.89 18.94 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 52.85 46.34 13.34 54.09 44.97 14.42 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 7 3 # 7 A 55 ASP F 40 ASP.? 1000.00 A 58 ASP F 43 ASP.? 1000.00 A 424 GLU F 68 GLU^? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 58.59 41.80 18.81 58.94 43.89 18.94 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 52.85 46.34 13.34 54.09 44.97 14.42 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 8 3 # 8 A 55 ASP F 43 ASP.? 1000.00 A 58 ASP F 40 ASP.? 1000.00 A 424 GLU F 62 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 58.59 41.80 18.81 58.94 43.89 18.94 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 52.85 46.34 13.34 54.09 44.97 14.42 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 9 3 # 9 A 55 ASP F 43 ASP.? 1000.00 A 58 ASP F 40 ASP.? 1000.00 A 424 GLU F 68 GLU^? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 58.59 41.80 18.81 58.94 43.89 18.94 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 52.85 46.34 13.34 54.09 44.97 14.42 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 10 3 # 10 A 55 ASP G 40 ASP.? 1000.00 A 58 ASP G 43 ASP.? 1000.00 A 424 GLU G 62 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 58.59 41.80 18.81 58.94 43.89 18.94 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 52.85 46.34 13.34 54.09 44.97 14.42 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 11 3 # 11 A 55 ASP G 40 ASP.? 1000.00 A 58 ASP G 43 ASP.? 1000.00 A 424 GLU G 68 GLU^? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 58.59 41.80 18.81 58.94 43.89 18.94 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 52.85 46.34 13.34 54.09 44.97 14.42 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 12 3 # 12 A 55 ASP G 43 ASP.? 1000.00 A 58 ASP G 40 ASP.? 1000.00 A 424 GLU G 62 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 58.59 41.80 18.81 58.94 43.89 18.94 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 52.85 46.34 13.34 54.09 44.97 14.42 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 13 3 # 13 A 55 ASP G 43 ASP.? 1000.00 A 58 ASP G 40 ASP.? 1000.00 A 424 GLU G 68 GLU^? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 58.59 41.80 18.81 58.94 43.89 18.94 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 52.85 46.34 13.34 54.09 44.97 14.42 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 14 3 # 14 A 55 ASP G 48 ASP^? 1000.00 A 58 ASP B 48 ASP^? 1000.00 A 424 GLU E 93 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 58.59 41.80 18.81 58.94 43.89 18.94 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 52.85 46.34 13.34 54.09 44.97 14.42 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 14 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP B 40 ASP.? 1000.00 B 58 ASP B 43 ASP.? 1000.00 B 424 GLU B 44 GLU.? 1000.00 coo 112.10 61.46 19.99 111.82 60.65 18.07 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 117.85 63.62 21.08 115.96 63.25 20.18 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 118.47 57.23 15.57 119.32 58.77 16.73 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP B 40 ASP.? 1000.00 B 58 ASP B 43 ASP.? 1000.00 B 424 GLU B 62 GLU.? 1000.00 coo 112.10 61.46 19.99 111.82 60.65 18.07 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 117.85 63.62 21.08 115.96 63.25 20.18 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 118.47 57.23 15.57 119.32 58.77 16.73 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP B 43 ASP.? 1000.00 B 58 ASP B 40 ASP.? 1000.00 B 424 GLU B 44 GLU.? 1000.00 coo 112.10 61.46 19.99 111.82 60.65 18.07 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 117.85 63.62 21.08 115.96 63.25 20.18 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 118.47 57.23 15.57 119.32 58.77 16.73 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP B 43 ASP.? 1000.00 B 58 ASP B 40 ASP.? 1000.00 B 424 GLU B 62 GLU.? 1000.00 coo 112.10 61.46 19.99 111.82 60.65 18.07 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 117.85 63.62 21.08 115.96 63.25 20.18 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 118.47 57.23 15.57 119.32 58.77 16.73 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP C 40 ASP.? 1000.00 B 58 ASP C 43 ASP.? 1000.00 B 424 GLU C 44 GLU.? 1000.00 coo 112.10 61.46 19.99 111.82 60.65 18.07 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 117.85 63.62 21.08 115.96 63.25 20.18 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 118.47 57.23 15.57 119.32 58.77 16.73 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 6 3 # 6 B 55 ASP F 40 ASP.? 1000.00 B 58 ASP F 43 ASP.? 1000.00 B 424 GLU F 62 GLU.? 1000.00 coo 112.10 61.46 19.99 111.82 60.65 18.07 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 117.85 63.62 21.08 115.96 63.25 20.18 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 118.47 57.23 15.57 119.32 58.77 16.73 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 7 3 # 7 B 55 ASP F 43 ASP.? 1000.00 B 58 ASP F 40 ASP.? 1000.00 B 424 GLU F 62 GLU.? 1000.00 coo 112.10 61.46 19.99 111.82 60.65 18.07 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 117.85 63.62 21.08 115.96 63.25 20.18 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 118.47 57.23 15.57 119.32 58.77 16.73 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 8 3 # 8 B 55 ASP F 43 ASP.? 1000.00 B 58 ASP F 40 ASP.? 1000.00 B 424 GLU F 68 GLU^? 1000.00 coo 112.10 61.46 19.99 111.82 60.65 18.07 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 117.85 63.62 21.08 115.96 63.25 20.18 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 118.47 57.23 15.57 119.32 58.77 16.73 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 9 3 # 9 B 55 ASP G 40 ASP.? 1000.00 B 58 ASP G 43 ASP.? 1000.00 B 424 GLU G 62 GLU.? 1000.00 coo 112.10 61.46 19.99 111.82 60.65 18.07 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 117.85 63.62 21.08 115.96 63.25 20.18 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 118.47 57.23 15.57 119.32 58.77 16.73 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 10 3 # 10 B 55 ASP G 43 ASP.? 1000.00 B 58 ASP G 40 ASP.? 1000.00 B 424 GLU G 62 GLU.? 1000.00 coo 112.10 61.46 19.99 111.82 60.65 18.07 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 117.85 63.62 21.08 115.96 63.25 20.18 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 118.47 57.23 15.57 119.32 58.77 16.73 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 10 hits 1js4_c01 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG B 74 ARG^? 1000.00 A 351 HIS E 96 HIS.? 1000.00 A 386 LEU B 32 LEU^? 1000.00 coo 57.36 53.34 128.83 58.45 50.56 128.34 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 60.60 50.64 133.59 60.63 48.82 132.56 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 63.28 54.23 126.45 63.53 52.07 126.70 -15.99 -30.98 -49.58 -14.58 -29.86 -48.38 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG B 74 ARG^? 1000.00 A 351 HIS E 97 HIS.? 1000.00 A 386 LEU B 32 LEU^? 1000.00 coo 57.36 53.34 128.83 58.45 50.56 128.34 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 60.60 50.64 133.59 60.63 48.82 132.56 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 63.28 54.23 126.45 63.53 52.07 126.70 -15.99 -30.98 -49.58 -14.58 -29.86 -48.38 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 3 3 # 3 A 290 ARG D 74 ARG^? 1000.00 A 351 HIS C 96 HIS.? 1000.00 A 386 LEU D 32 LEU^? 1000.00 coo 57.36 53.34 128.83 58.45 50.56 128.34 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 60.60 50.64 133.59 60.63 48.82 132.56 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 63.28 54.23 126.45 63.53 52.07 126.70 -33.10 -49.89 -17.38 -34.15 -51.52 -18.36 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 4 3 # 4 A 290 ARG G 74 ARG^? 1000.00 A 351 HIS E 94 HIS.? 1000.00 A 386 LEU G 32 LEU^? 1000.00 coo 57.36 53.34 128.83 58.45 50.56 128.34 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 60.60 50.64 133.59 60.63 48.82 132.56 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 63.28 54.23 126.45 63.53 52.07 126.70 -1.43 -40.60 -48.11 -1.40 -39.04 -46.63 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 5 3 # 5 A 290 ARG H 74 ARG^? 1000.00 A 351 HIS C 94 HIS.? 1000.00 A 386 LEU H 32 LEU^? 1000.00 coo 57.36 53.34 128.83 58.45 50.56 128.34 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 60.60 50.64 133.59 60.63 48.82 132.56 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 63.28 54.23 126.45 63.53 52.07 126.70 -22.41 -63.70 -16.92 -23.69 -64.17 -18.56 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 5 hits 1knp_c00 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP D 43 ASP.? 1000.00 262 LYS D 38 LYS.? 1000.00 336 ARG B 37 ARG^? 1000.00 coo 61.88 50.78 12.96 63.84 50.60 13.71 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 63.59 44.40 18.32 63.20 49.74 17.95 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 coo 72.60 57.42 15.86 71.61 56.68 18.70 -25.67 -45.26 -38.37 -22.78 -45.37 -37.35 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 1 hits 1lam_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG B 74 ARG^? 1000.00 245 HIS E 94 HIS.? 1000.00 343 THR B 46 THR^? 1000.00 coo 18.11 85.25 41.19 18.04 83.33 43.59 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 5.34 86.23 43.48 6.16 87.26 45.12 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 9.06 92.76 42.80 7.04 92.63 42.14 -15.59 -35.86 -44.93 -16.46 -33.88 -45.17 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG D 74 ARG^? 1000.00 245 HIS C 94 HIS.? 1000.00 343 THR D 46 THR^? 1000.00 coo 18.11 85.25 41.19 18.04 83.33 43.59 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 5.34 86.23 43.48 6.16 87.26 45.12 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 9.06 92.76 42.80 7.04 92.63 42.14 -27.50 -50.23 -21.22 -29.54 -49.49 -21.28 ULMN 3 1lci_c00 LUCIFERASE user 3 3 # 3 218 ARG G 37 ARG^? 1000.00 245 HIS E 98 HIS.? 1000.00 343 THR G 34 THR^? 1000.00 coo 18.11 85.25 41.19 18.04 83.33 43.59 2.57 -36.22 -67.13 1.93 -33.23 -67.01 coo 5.34 86.23 43.48 6.16 87.26 45.12 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 9.06 92.76 42.80 7.04 92.63 42.14 -0.50 -39.88 -54.46 1.25 -38.89 -53.69 ULMN 3 1lci_c00 LUCIFERASE user 4 3 # 4 218 ARG G 70 ARG^? 1000.00 245 HIS E 98 HIS.? 1000.00 343 THR G 46 THR^? 1000.00 coo 18.11 85.25 41.19 18.04 83.33 43.59 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo 5.34 86.23 43.48 6.16 87.26 45.12 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 9.06 92.76 42.80 7.04 92.63 42.14 -1.95 -36.32 -52.94 -0.35 -36.61 -51.51 ULMN 3 1lci_c00 LUCIFERASE user 5 3 # 5 218 ARG G 74 ARG^? 1000.00 245 HIS E 97 HIS.? 1000.00 343 THR G 46 THR^? 1000.00 coo 18.11 85.25 41.19 18.04 83.33 43.59 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 5.34 86.23 43.48 6.16 87.26 45.12 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 9.06 92.76 42.80 7.04 92.63 42.14 -1.95 -36.32 -52.94 -0.35 -36.61 -51.51 ULMN 3 1lci_c00 LUCIFERASE user 6 3 # 6 218 ARG H 70 ARG^? 1000.00 245 HIS C 98 HIS.? 1000.00 343 THR H 45 THR^? 1000.00 coo 18.11 85.25 41.19 18.04 83.33 43.59 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo 5.34 86.23 43.48 6.16 87.26 45.12 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 9.06 92.76 42.80 7.04 92.63 42.14 -28.98 -64.21 -9.31 -29.95 -62.48 -8.44 ULMN 3 1lci_c00 LUCIFERASE user 7 3 # 7 218 ARG H 70 ARG^? 1000.00 245 HIS C 98 HIS.? 1000.00 343 THR H 46 THR^? 1000.00 coo 18.11 85.25 41.19 18.04 83.33 43.59 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo 5.34 86.23 43.48 6.16 87.26 45.12 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 9.06 92.76 42.80 7.04 92.63 42.14 -27.27 -63.43 -12.62 -26.65 -64.97 -14.02 ULMN 3 1lci_c00 LUCIFERASE user 8 3 # 8 218 ARG H 74 ARG^? 1000.00 245 HIS C 97 HIS.? 1000.00 343 THR H 46 THR^? 1000.00 coo 18.11 85.25 41.19 18.04 83.33 43.59 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 5.34 86.23 43.48 6.16 87.26 45.12 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 9.06 92.76 42.80 7.04 92.63 42.14 -27.27 -63.43 -12.62 -26.65 -64.97 -14.02 ULMN 3 1lci_c00 LUCIFERASE user 9 3 # 9 218 ARG H 74 ARG^? 1000.00 245 HIS C 98 HIS.? 1000.00 343 THR H 34 THR^? 1000.00 coo 18.11 85.25 41.19 18.04 83.33 43.59 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 5.34 86.23 43.48 6.16 87.26 45.12 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 9.06 92.76 42.80 7.04 92.63 42.14 -23.65 -64.63 -10.64 -24.28 -66.51 -11.50 ULMN 3 1lci_c00 LUCIFERASE user 10 3 # 10 218 ARG H 74 ARG^? 1000.00 245 HIS C 98 HIS.? 1000.00 343 THR H 46 THR^? 1000.00 coo 18.11 85.25 41.19 18.04 83.33 43.59 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 5.34 86.23 43.48 6.16 87.26 45.12 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 9.06 92.76 42.80 7.04 92.63 42.14 -27.27 -63.43 -12.62 -26.65 -64.97 -14.02 1lci_c00 source 1lci LUCIFERASE : 10 hits 1lci_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP B 48 ASP^? 1000.00 169 ARG B 74 ARG^? 1000.00 193 HIS E 97 HIS.? 1000.00 coo 20.88 15.91 3.60 20.25 17.72 4.50 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 18.81 19.85 7.63 17.55 19.89 5.97 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP D 48 ASP^? 1000.00 169 ARG D 74 ARG^? 1000.00 193 HIS C 97 HIS.? 1000.00 coo 20.88 15.91 3.60 20.25 17.72 4.50 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 18.81 19.85 7.63 17.55 19.89 5.97 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 3 3 # 3 166 ASP G 48 ASP^? 1000.00 169 ARG G 74 ARG^? 1000.00 193 HIS E 94 HIS.? 1000.00 coo 20.88 15.91 3.60 20.25 17.72 4.50 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 18.81 19.85 7.63 17.55 19.89 5.97 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 4 3 # 4 166 ASP G 48 ASP^? 1000.00 169 ARG G 74 ARG^? 1000.00 193 HIS E 95 HIS.? 1000.00 coo 20.88 15.91 3.60 20.25 17.72 4.50 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 18.81 19.85 7.63 17.55 19.89 5.97 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 5 3 # 5 166 ASP H 48 ASP^? 1000.00 169 ARG H 74 ARG^? 1000.00 193 HIS C 94 HIS.? 1000.00 coo 20.88 15.91 3.60 20.25 17.72 4.50 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 18.81 19.85 7.63 17.55 19.89 5.97 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 6 3 # 6 166 ASP H 48 ASP^? 1000.00 169 ARG H 74 ARG^? 1000.00 193 HIS C 95 HIS.? 1000.00 coo 20.88 15.91 3.60 20.25 17.72 4.50 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 18.81 19.85 7.63 17.55 19.89 5.97 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 6 hits 1ldm_c01 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS C 98 HIS.? 1000.00 A 45 HIS C 97 HIS.? 1000.00 A 261 PHE H 35 PHE^? 1000.00 coo 49.89 1.93 30.83 50.54 1.43 32.81 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -24.93 -61.82 -6.79 -26.97 -60.00 -7.45 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 1 hits 1luc_c00 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 43 ASP.? 1000.00 A 265 GLU G 29 GLU.? 1000.00 A 369 ASP D 40 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 -5.31 -41.94 -36.91 -3.79 -40.93 -35.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 43 ASP.? 1000.00 A 265 GLU G 29 GLU.? 1000.00 A 369 ASP D 43 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 -5.31 -41.94 -36.91 -3.79 -40.93 -35.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP D 40 ASP.? 1000.00 A 265 GLU G 29 GLU.? 1000.00 A 369 ASP B 43 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 17.36 23.57 72.04 18.68 21.92 71.98 -5.31 -41.94 -36.91 -3.79 -40.93 -35.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP D 43 ASP.? 1000.00 A 265 GLU G 29 GLU.? 1000.00 A 369 ASP B 43 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 17.36 23.57 72.04 18.68 21.92 71.98 -5.31 -41.94 -36.91 -3.79 -40.93 -35.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c05 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG B 70 ARG^? 1000.00 229 SER B 84 SER^? 1000.00 325 GLU B 68 GLU^? 1000.00 coo 2.54 15.84 18.57 3.24 17.85 16.30 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 10.17 13.48 15.92 9.61 15.76 15.27 -27.31 -34.98 -51.96 -28.03 -35.42 -49.66 coo 5.42 13.04 19.75 5.74 13.81 17.79 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG E 70 ARG^? 1000.00 229 SER E 84 SER^? 1000.00 325 GLU E 68 GLU^? 1000.00 coo 2.54 15.84 18.57 3.24 17.85 16.30 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 coo 10.17 13.48 15.92 9.61 15.76 15.27 -30.80 -14.58 -31.79 -29.28 -13.30 -30.42 coo 5.42 13.04 19.75 5.74 13.81 17.79 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 2 hits 1mbb_c00 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP B 43 ASP.? 1000.00 35 SER B 42 SER.? 1000.00 215 ASP D 43 ASP.? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 16.04 14.72 33.82 17.27 13.71 31.95 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 20.65 22.00 33.80 20.06 20.56 32.39 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP D 40 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 40 ASP.? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 16.04 14.72 33.82 17.27 13.71 31.95 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 20.65 22.00 33.80 20.06 20.56 32.39 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 3 # 3 32 ASP D 40 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 43 ASP.? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 16.04 14.72 33.82 17.27 13.71 31.95 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 20.65 22.00 33.80 20.06 20.56 32.39 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 3 # 4 32 ASP D 43 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 43 ASP.? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 16.04 14.72 33.82 17.27 13.71 31.95 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 20.65 22.00 33.80 20.06 20.56 32.39 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 4 hits 1mpp_c04 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY C 30 GLY^? 1000.00 A 501 ASP C 43 ASP.? 1000.00 B 367 TYR A 67 TYR^? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -55.71 -25.17 -28.07 -55.65 -25.05 -28.84 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY C 36 GLY^? 1000.00 A 501 ASP D 48 ASP^? 1000.00 B 367 TYR F 79 TYR.? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -49.78 -44.46 -28.07 -49.37 -44.25 -28.79 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -56.52 -31.25 -6.27 -58.44 -31.38 -8.30 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY C 76 GLY.? 1000.00 A 501 ASP F 43 ASP.? 1000.00 B 367 TYR C 67 TYR^? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -63.59 -23.21 -30.61 -63.01 -23.90 -30.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY E 30 GLY^? 1000.00 A 501 ASP E 43 ASP.? 1000.00 B 367 TYR F 67 TYR^? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -42.85 -9.05 -41.99 -42.98 -9.00 -41.23 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY E 36 GLY^? 1000.00 A 501 ASP B 48 ASP^? 1000.00 B 367 TYR A 79 TYR^? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -34.77 -7.49 -62.99 -34.80 -5.56 -60.96 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY F 76 GLY.? 1000.00 A 501 ASP C 43 ASP.? 1000.00 B 367 TYR F 67 TYR^? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -59.76 -37.51 -9.11 -59.30 -36.97 -8.71 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY G 30 GLY^? 1000.00 A 501 ASP G 43 ASP.? 1000.00 B 367 TYR E 67 TYR^? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY H 30 GLY^? 1000.00 A 501 ASP H 43 ASP.? 1000.00 B 367 TYR C 67 TYR^? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -30.59 -68.33 -3.12 -29.92 -66.39 -2.72 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY H 76 GLY.? 1000.00 A 501 ASP D 43 ASP.? 1000.00 B 367 TYR H 67 TYR^? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 9 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY C 30 GLY^? 1000.00 D 501 ASP C 43 ASP.? 1000.00 E 367 TYR A 67 TYR^? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -55.71 -25.17 -28.07 -55.65 -25.05 -28.84 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY C 36 GLY^? 1000.00 D 501 ASP D 48 ASP^? 1000.00 E 367 TYR F 79 TYR.? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -49.78 -44.46 -28.07 -49.37 -44.25 -28.79 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -56.52 -31.25 -6.27 -58.44 -31.38 -8.30 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY C 76 GLY.? 1000.00 D 501 ASP F 43 ASP.? 1000.00 E 367 TYR C 67 TYR^? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -63.59 -23.21 -30.61 -63.01 -23.90 -30.77 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY E 30 GLY^? 1000.00 D 501 ASP E 43 ASP.? 1000.00 E 367 TYR F 67 TYR^? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -42.85 -9.05 -41.99 -42.98 -9.00 -41.23 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY E 36 GLY^? 1000.00 D 501 ASP B 48 ASP^? 1000.00 E 367 TYR A 79 TYR^? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -34.77 -7.49 -62.99 -34.80 -5.56 -60.96 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY F 76 GLY.? 1000.00 D 501 ASP C 43 ASP.? 1000.00 E 367 TYR F 67 TYR^? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -59.76 -37.51 -9.11 -59.30 -36.97 -8.71 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY G 30 GLY^? 1000.00 D 501 ASP G 43 ASP.? 1000.00 E 367 TYR E 67 TYR^? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -5.93 -42.24 -42.88 -5.40 -42.82 -42.72 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY H 30 GLY^? 1000.00 D 501 ASP H 43 ASP.? 1000.00 E 367 TYR C 67 TYR^? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -20.31 -59.01 -21.96 -19.73 -59.55 -22.07 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -30.59 -68.33 -3.12 -29.92 -66.39 -2.72 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY H 76 GLY.? 1000.00 D 501 ASP D 43 ASP.? 1000.00 E 367 TYR H 67 TYR^? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 9 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 43 ASP.? 1000.00 A 55 TYR A 67 TYR^? 1000.00 A 84 LYS A 38 LYS.? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 -52.49 -15.23 -55.19 -52.13 -15.99 -53.25 coo 4.60 40.33 20.42 7.25 39.50 20.05 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo 9.71 44.83 15.47 10.13 41.43 19.93 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 43 ASP.? 1000.00 A 55 TYR B 67 TYR^? 1000.00 A 84 LYS B 38 LYS.? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 4.60 40.33 20.42 7.25 39.50 20.05 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 coo 9.71 44.83 15.47 10.13 41.43 19.93 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP C 43 ASP.? 1000.00 A 55 TYR C 67 TYR^? 1000.00 A 84 LYS C 38 LYS.? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 4.60 40.33 20.42 7.25 39.50 20.05 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 9.71 44.83 15.47 10.13 41.43 19.93 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP D 43 ASP.? 1000.00 A 55 TYR D 67 TYR^? 1000.00 A 84 LYS D 38 LYS.? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 4.60 40.33 20.42 7.25 39.50 20.05 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo 9.71 44.83 15.47 10.13 41.43 19.93 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP E 43 ASP.? 1000.00 A 55 TYR E 67 TYR^? 1000.00 A 84 LYS E 38 LYS.? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 coo 4.60 40.33 20.42 7.25 39.50 20.05 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo 9.71 44.83 15.47 10.13 41.43 19.93 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP F 43 ASP.? 1000.00 A 55 TYR F 67 TYR^? 1000.00 A 84 LYS F 38 LYS.? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 -51.97 -13.19 -16.04 -50.63 -14.35 -17.22 coo 4.60 40.33 20.42 7.25 39.50 20.05 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 9.71 44.83 15.47 10.13 41.43 19.93 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 7 3 # 7 A 50 ASP G 43 ASP.? 1000.00 A 55 TYR G 67 TYR^? 1000.00 A 84 LYS G 38 LYS.? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 4.60 40.33 20.42 7.25 39.50 20.05 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo 9.71 44.83 15.47 10.13 41.43 19.93 6.01 -41.17 -63.42 7.43 -47.25 -63.10 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 7 hits 1mrq_c02 naa= 3 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 205 ASP B 48 ASP^? 1000.00 A 208 HIS E 96 HIS.? 1000.00 C 104 HIS E 95 HIS.? 1000.00 coo 20.72 31.33 73.27 20.15 33.36 73.56 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 17.00 33.82 71.84 16.59 31.98 70.88 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 20.06 38.06 74.21 21.19 36.81 72.96 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 205 ASP B 48 ASP^? 1000.00 A 208 HIS E 96 HIS.? 1000.00 C 104 HIS E 97 HIS.? 1000.00 coo 20.72 31.33 73.27 20.15 33.36 73.56 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 17.00 33.82 71.84 16.59 31.98 70.88 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 20.06 38.06 74.21 21.19 36.81 72.96 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 A 205 ASP D 48 ASP^? 1000.00 A 208 HIS C 96 HIS.? 1000.00 C 104 HIS C 95 HIS.? 1000.00 coo 20.72 31.33 73.27 20.15 33.36 73.56 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 17.00 33.82 71.84 16.59 31.98 70.88 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 20.06 38.06 74.21 21.19 36.81 72.96 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 A 205 ASP D 48 ASP^? 1000.00 A 208 HIS C 96 HIS.? 1000.00 C 104 HIS C 97 HIS.? 1000.00 coo 20.72 31.33 73.27 20.15 33.36 73.56 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 17.00 33.82 71.84 16.59 31.98 70.88 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 20.06 38.06 74.21 21.19 36.81 72.96 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 A 205 ASP D 48 ASP^? 1000.00 A 208 HIS C 97 HIS.? 1000.00 C 104 HIS C 96 HIS.? 1000.00 coo 20.72 31.33 73.27 20.15 33.36 73.56 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 17.00 33.82 71.84 16.59 31.98 70.88 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 20.06 38.06 74.21 21.19 36.81 72.96 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 A 205 ASP H 48 ASP^? 1000.00 A 208 HIS C 95 HIS.? 1000.00 C 104 HIS C 96 HIS.? 1000.00 coo 20.72 31.33 73.27 20.15 33.36 73.56 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 17.00 33.82 71.84 16.59 31.98 70.88 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 20.06 38.06 74.21 21.19 36.81 72.96 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 1ndo_c00 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 6 hits 1ndo_c00 naa= 3 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 104 HIS C 95 HIS.? 1000.00 E 205 ASP D 48 ASP^? 1000.00 E 208 HIS C 96 HIS.? 1000.00 coo 36.32 11.24 30.83 37.00 13.22 30.81 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 38.79 15.70 26.44 37.66 14.35 27.62 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 34.24 14.63 26.81 34.14 16.25 25.49 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 104 HIS C 96 HIS.? 1000.00 E 205 ASP D 48 ASP^? 1000.00 E 208 HIS C 97 HIS.? 1000.00 coo 36.32 11.24 30.83 37.00 13.22 30.81 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 38.79 15.70 26.44 37.66 14.35 27.62 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 34.24 14.63 26.81 34.14 16.25 25.49 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 A 104 HIS C 96 HIS.? 1000.00 E 205 ASP H 48 ASP^? 1000.00 E 208 HIS C 95 HIS.? 1000.00 coo 36.32 11.24 30.83 37.00 13.22 30.81 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 38.79 15.70 26.44 37.66 14.35 27.62 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 34.24 14.63 26.81 34.14 16.25 25.49 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 A 104 HIS C 97 HIS.? 1000.00 E 205 ASP D 48 ASP^? 1000.00 E 208 HIS C 96 HIS.? 1000.00 coo 36.32 11.24 30.83 37.00 13.22 30.81 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 38.79 15.70 26.44 37.66 14.35 27.62 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 34.24 14.63 26.81 34.14 16.25 25.49 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 A 104 HIS E 95 HIS.? 1000.00 E 205 ASP B 48 ASP^? 1000.00 E 208 HIS E 96 HIS.? 1000.00 coo 36.32 11.24 30.83 37.00 13.22 30.81 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 38.79 15.70 26.44 37.66 14.35 27.62 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 34.24 14.63 26.81 34.14 16.25 25.49 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 A 104 HIS E 97 HIS.? 1000.00 E 205 ASP B 48 ASP^? 1000.00 E 208 HIS E 96 HIS.? 1000.00 coo 36.32 11.24 30.83 37.00 13.22 30.81 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 38.79 15.70 26.44 37.66 14.35 27.62 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 34.24 14.63 26.81 34.14 16.25 25.49 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 1ndo_c01 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 6 hits 1ndo_c01 naa= 3 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 C 205 ASP B 48 ASP^? 1000.00 C 208 HIS E 96 HIS.? 1000.00 E 104 HIS E 95 HIS.? 1000.00 coo 36.50 67.03 37.59 36.77 66.38 35.61 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 33.45 66.12 34.16 32.13 66.40 35.76 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 38.29 64.94 31.33 38.08 64.16 33.27 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 C 205 ASP B 48 ASP^? 1000.00 C 208 HIS E 96 HIS.? 1000.00 E 104 HIS E 97 HIS.? 1000.00 coo 36.50 67.03 37.59 36.77 66.38 35.61 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 33.45 66.12 34.16 32.13 66.40 35.76 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 38.29 64.94 31.33 38.08 64.16 33.27 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 3 3 # 3 C 205 ASP D 48 ASP^? 1000.00 C 208 HIS C 96 HIS.? 1000.00 E 104 HIS C 95 HIS.? 1000.00 coo 36.50 67.03 37.59 36.77 66.38 35.61 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 33.45 66.12 34.16 32.13 66.40 35.76 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 38.29 64.94 31.33 38.08 64.16 33.27 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 4 3 # 4 C 205 ASP D 48 ASP^? 1000.00 C 208 HIS C 96 HIS.? 1000.00 E 104 HIS C 97 HIS.? 1000.00 coo 36.50 67.03 37.59 36.77 66.38 35.61 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 33.45 66.12 34.16 32.13 66.40 35.76 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 38.29 64.94 31.33 38.08 64.16 33.27 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 5 3 # 5 C 205 ASP D 48 ASP^? 1000.00 C 208 HIS C 97 HIS.? 1000.00 E 104 HIS C 96 HIS.? 1000.00 coo 36.50 67.03 37.59 36.77 66.38 35.61 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 33.45 66.12 34.16 32.13 66.40 35.76 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 38.29 64.94 31.33 38.08 64.16 33.27 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 6 3 # 6 C 205 ASP H 48 ASP^? 1000.00 C 208 HIS C 95 HIS.? 1000.00 E 104 HIS C 96 HIS.? 1000.00 coo 36.50 67.03 37.59 36.77 66.38 35.61 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 33.45 66.12 34.16 32.13 66.40 35.76 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 38.29 64.94 31.33 38.08 64.16 33.27 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 1ndo_c02 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 6 hits 1ndo_c02 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU B 29 GLU.? 1000.00 B 128 HIS E 98 HIS.? 1000.00 C 263 HIS E 95 HIS.? 1000.00 coo 6.12 5.94 82.00 7.16 6.32 83.81 -9.38 -24.09 -58.12 -8.97 -22.30 -57.06 coo 12.51 16.35 80.99 13.16 14.90 82.37 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 11.58 14.94 93.26 12.25 14.03 91.50 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 1 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS E 95 HIS.? 1000.00 D 59 GLU B 29 GLU.? 1000.00 D 128 HIS E 98 HIS.? 1000.00 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -9.38 -24.09 -58.12 -8.97 -22.30 -57.06 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 1 hits 1ni4_c01 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN B 75 ASN^? 1000.00 A 192 ASP B 48 ASP^? 1000.00 A 195 HIS E 96 HIS.? 1000.00 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -13.12 -21.77 -56.53 -13.64 -22.77 -58.34 coo 2.03 47.14 19.75 1.72 46.26 21.64 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN B 75 ASN^? 1000.00 A 192 ASP B 48 ASP^? 1000.00 A 195 HIS E 97 HIS.? 1000.00 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -13.12 -21.77 -56.53 -13.64 -22.77 -58.34 coo 2.03 47.14 19.75 1.72 46.26 21.64 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 A 74 ASN C 64 ASN.? 1000.00 A 192 ASP D 48 ASP^? 1000.00 A 195 HIS C 96 HIS.? 1000.00 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 coo 2.03 47.14 19.75 1.72 46.26 21.64 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 A 74 ASN D 75 ASN^? 1000.00 A 192 ASP D 48 ASP^? 1000.00 A 195 HIS C 96 HIS.? 1000.00 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 coo 2.03 47.14 19.75 1.72 46.26 21.64 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 A 74 ASN D 75 ASN^? 1000.00 A 192 ASP D 48 ASP^? 1000.00 A 195 HIS C 97 HIS.? 1000.00 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 coo 2.03 47.14 19.75 1.72 46.26 21.64 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 A 74 ASN E 64 ASN.? 1000.00 A 192 ASP B 48 ASP^? 1000.00 A 195 HIS E 96 HIS.? 1000.00 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 coo 2.03 47.14 19.75 1.72 46.26 21.64 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 7 3 # 7 A 74 ASN G 75 ASN^? 1000.00 A 192 ASP G 48 ASP^? 1000.00 A 195 HIS E 94 HIS.? 1000.00 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -1.10 -45.07 -37.41 -2.90 -46.10 -36.91 coo 2.03 47.14 19.75 1.72 46.26 21.64 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 8 3 # 8 A 74 ASN H 75 ASN.? 1000.00 A 192 ASP H 48 ASP^? 1000.00 A 195 HIS C 94 HIS.? 1000.00 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -16.78 -63.47 -26.75 -16.16 -62.12 -28.26 coo 2.03 47.14 19.75 1.72 46.26 21.64 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 8 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN B 75 ASN^? 1000.00 B 192 ASP B 48 ASP^? 1000.00 B 195 HIS E 96 HIS.? 1000.00 coo -1.08 51.41 10.34 0.65 52.62 10.17 -13.12 -21.77 -56.53 -13.64 -22.77 -58.34 coo 11.36 52.33 5.59 10.18 53.87 6.47 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 7.99 56.74 7.55 6.88 55.39 8.70 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN B 75 ASN^? 1000.00 B 192 ASP B 48 ASP^? 1000.00 B 195 HIS E 97 HIS.? 1000.00 coo -1.08 51.41 10.34 0.65 52.62 10.17 -13.12 -21.77 -56.53 -13.64 -22.77 -58.34 coo 11.36 52.33 5.59 10.18 53.87 6.47 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 7.99 56.74 7.55 6.88 55.39 8.70 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN C 64 ASN.? 1000.00 B 192 ASP D 48 ASP^? 1000.00 B 195 HIS C 95 HIS.? 1000.00 coo -1.08 51.41 10.34 0.65 52.62 10.17 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 coo 11.36 52.33 5.59 10.18 53.87 6.47 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 7.99 56.74 7.55 6.88 55.39 8.70 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 B 74 ASN C 64 ASN.? 1000.00 B 192 ASP D 48 ASP^? 1000.00 B 195 HIS C 96 HIS.? 1000.00 coo -1.08 51.41 10.34 0.65 52.62 10.17 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 coo 11.36 52.33 5.59 10.18 53.87 6.47 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 7.99 56.74 7.55 6.88 55.39 8.70 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 B 74 ASN D 75 ASN^? 1000.00 B 192 ASP D 48 ASP^? 1000.00 B 195 HIS C 96 HIS.? 1000.00 coo -1.08 51.41 10.34 0.65 52.62 10.17 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 coo 11.36 52.33 5.59 10.18 53.87 6.47 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 7.99 56.74 7.55 6.88 55.39 8.70 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 B 74 ASN D 75 ASN^? 1000.00 B 192 ASP D 48 ASP^? 1000.00 B 195 HIS C 97 HIS.? 1000.00 coo -1.08 51.41 10.34 0.65 52.62 10.17 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 coo 11.36 52.33 5.59 10.18 53.87 6.47 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 7.99 56.74 7.55 6.88 55.39 8.70 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 7 3 # 7 B 74 ASN E 64 ASN.? 1000.00 B 192 ASP B 48 ASP^? 1000.00 B 195 HIS E 95 HIS.? 1000.00 coo -1.08 51.41 10.34 0.65 52.62 10.17 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 coo 11.36 52.33 5.59 10.18 53.87 6.47 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 7.99 56.74 7.55 6.88 55.39 8.70 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 8 3 # 8 B 74 ASN E 64 ASN.? 1000.00 B 192 ASP B 48 ASP^? 1000.00 B 195 HIS E 96 HIS.? 1000.00 coo -1.08 51.41 10.34 0.65 52.62 10.17 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 coo 11.36 52.33 5.59 10.18 53.87 6.47 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 7.99 56.74 7.55 6.88 55.39 8.70 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 9 3 # 9 B 74 ASN G 75 ASN^? 1000.00 B 192 ASP G 48 ASP^? 1000.00 B 195 HIS E 94 HIS.? 1000.00 coo -1.08 51.41 10.34 0.65 52.62 10.17 -1.10 -45.07 -37.41 -2.90 -46.10 -36.91 coo 11.36 52.33 5.59 10.18 53.87 6.47 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 7.99 56.74 7.55 6.88 55.39 8.70 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 10 3 # 10 B 74 ASN H 75 ASN.? 1000.00 B 192 ASP H 48 ASP^? 1000.00 B 195 HIS C 94 HIS.? 1000.00 coo -1.08 51.41 10.34 0.65 52.62 10.17 -16.78 -63.47 -26.75 -16.16 -62.12 -28.26 coo 11.36 52.33 5.59 10.18 53.87 6.47 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 7.99 56.74 7.55 6.88 55.39 8.70 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 10 hits 1pp4_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU B 29 GLU.? 1000.00 A 67 ARG B 74 ARG^? 1000.00 A 86 HIS E 97 HIS.? 1000.00 coo 18.15 3.28 18.56 20.10 2.92 19.20 -9.38 -24.09 -58.12 -8.97 -22.30 -57.06 coo 21.52 6.83 26.64 21.22 5.53 23.85 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1pyl_c00 source 1pyl RIBONUCLEASE : 1 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU B 29 GLU.? 1000.00 B 67 ARG B 74 ARG^? 1000.00 B 86 HIS E 97 HIS.? 1000.00 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -9.38 -24.09 -58.12 -8.97 -22.30 -57.06 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1pyl_c01 source 1pyl RIBONUCLEASE : 1 hits 1pyl_c01 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 75 ASN^? 1000.00 A 239 ARG A 74 ARG^? 1000.00 A 246 TYR A 79 TYR^? 1000.00 coo 2.50 7.27 18.06 0.76 7.28 16.81 -26.84 -8.14 -61.63 -24.82 -7.63 -61.10 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -32.79 -7.25 -57.44 -31.11 -6.28 -55.07 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -34.77 -7.49 -62.99 -34.80 -5.56 -60.96 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 2 3 # 2 A 191 ASN B 75 ASN^? 1000.00 A 239 ARG B 74 ARG^? 1000.00 A 246 TYR B 79 TYR^? 1000.00 coo 2.50 7.27 18.06 0.76 7.28 16.81 -13.12 -21.77 -56.53 -13.64 -22.77 -58.34 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 3 3 # 3 A 191 ASN D 75 ASN^? 1000.00 A 239 ARG D 74 ARG^? 1000.00 A 246 TYR D 79 TYR^? 1000.00 coo 2.50 7.27 18.06 0.76 7.28 16.81 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 4 3 # 4 A 191 ASN H 75 ASN.? 1000.00 A 239 ARG H 74 ARG^? 1000.00 A 246 TYR H 79 TYR.? 1000.00 coo 2.50 7.27 18.06 0.76 7.28 16.81 -16.78 -63.47 -26.75 -16.16 -62.12 -28.26 coo -1.16 0.95 13.41 -2.50 3.71 13.61 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 1.59 5.18 12.30 -0.74 6.52 11.61 -20.92 -68.65 -21.95 -23.38 -67.79 -22.98 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 4 hits 1qaz_c00 naa= 3 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 1 3 # 1 A 554 SER B 51 SER.? 1000.00 A 641 ASP B 48 ASP^? 1000.00 A 680 HIS E 97 HIS.? 1000.00 coo 34.48 40.33 79.08 36.40 39.98 80.55 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 40.64 47.22 77.43 39.90 45.49 78.43 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 38.53 44.50 81.45 37.60 42.73 80.84 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1qfm_c00 source 1qfm PROLYL OLIGOPEPTIDASE : 1 hits 1qfm_c00 naa= 3 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER B 51 SER.? 1000.00 A 207 ASP B 48 ASP^? 1000.00 A 235 HIS E 97 HIS.? 1000.00 coo 15.54 46.73 17.13 17.06 48.44 16.17 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 23.60 50.31 20.82 21.66 50.51 20.06 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 20.17 51.16 17.08 18.31 50.28 17.44 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1qj4_c00 source 1qj4 HYDROXYNITRILE LYASE : 1 hits 1qj4_c00 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 86 THR^? 1000.00 A 182 TYR A 67 TYR^? 1000.00 A 186 LYS A 38 LYS.? 1000.00 coo 69.38 87.38 24.64 71.11 88.47 25.40 -45.50 -25.51 -60.06 -46.77 -25.59 -61.84 coo 73.61 90.42 31.12 71.36 89.66 29.64 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 coo 73.54 84.00 28.64 69.01 86.68 29.71 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 86 THR^? 1000.00 A 182 TYR B 67 TYR^? 1000.00 A 186 LYS B 38 LYS.? 1000.00 coo 69.38 87.38 24.64 71.11 88.47 25.40 -29.28 -41.29 -49.77 -31.08 -40.36 -48.98 coo 73.61 90.42 31.12 71.36 89.66 29.64 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 coo 73.54 84.00 28.64 69.01 86.68 29.71 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR C 86 THR^? 1000.00 A 182 TYR C 67 TYR^? 1000.00 A 186 LYS C 38 LYS.? 1000.00 coo 69.38 87.38 24.64 71.11 88.47 25.40 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 73.61 90.42 31.12 71.36 89.66 29.64 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 coo 73.54 84.00 28.64 69.01 86.68 29.71 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 3 # 4 A 145 THR D 86 THR^? 1000.00 A 182 TYR D 67 TYR^? 1000.00 A 186 LYS D 38 LYS.? 1000.00 coo 69.38 87.38 24.64 71.11 88.47 25.40 -24.01 -35.70 -16.08 -25.04 -34.15 -17.17 coo 73.61 90.42 31.12 71.36 89.66 29.64 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 coo 73.54 84.00 28.64 69.01 86.68 29.71 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 5 3 # 5 A 145 THR E 86 THR^? 1000.00 A 182 TYR E 67 TYR^? 1000.00 A 186 LYS E 38 LYS.? 1000.00 coo 69.38 87.38 24.64 71.11 88.47 25.40 -24.93 -18.44 -32.83 -23.81 -17.47 -31.27 coo 73.61 90.42 31.12 71.36 89.66 29.64 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo 73.54 84.00 28.64 69.01 86.68 29.71 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 6 3 # 6 A 145 THR F 86 THR^? 1000.00 A 182 TYR F 67 TYR^? 1000.00 A 186 LYS F 38 LYS.? 1000.00 coo 69.38 87.38 24.64 71.11 88.47 25.40 -40.71 -18.28 -10.10 -40.84 -17.16 -8.25 coo 73.61 90.42 31.12 71.36 89.66 29.64 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 73.54 84.00 28.64 69.01 86.68 29.71 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 7 3 # 7 A 145 THR G 86 THR^? 1000.00 A 182 TYR G 67 TYR^? 1000.00 A 186 LYS G 38 LYS.? 1000.00 coo 69.38 87.38 24.64 71.11 88.47 25.40 2.42 -48.12 -62.78 4.54 -47.79 -63.09 coo 73.61 90.42 31.12 71.36 89.66 29.64 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo 73.54 84.00 28.64 69.01 86.68 29.71 6.01 -41.17 -63.42 7.43 -47.25 -63.10 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 8 3 # 8 A 145 THR H 86 THR^? 1000.00 A 182 TYR H 67 TYR^? 1000.00 A 186 LYS H 38 LYS.? 1000.00 coo 69.38 87.38 24.64 71.11 88.47 25.40 -16.49 -66.84 -1.43 -17.05 -68.81 -0.71 coo 73.61 90.42 31.12 71.36 89.66 29.64 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo 73.54 84.00 28.64 69.01 86.68 29.71 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 8 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS C 94 HIS.? 1000.00 A 646 ASP D 48 ASP^? 1000.00 A 739 GLY D 36 GLY^? 1000.00 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS C 94 HIS.? 1000.00 A 646 ASP D 48 ASP^? 1000.00 A 739 GLY H 76 GLY.? 1000.00 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS C 95 HIS.? 1000.00 A 646 ASP D 48 ASP^? 1000.00 A 739 GLY H 76 GLY.? 1000.00 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -21.02 -64.87 -28.80 -20.85 -65.18 -28.06 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS C 96 HIS.? 1000.00 A 646 ASP H 48 ASP^? 1000.00 A 739 GLY C 90 GLY.? 1000.00 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1qrz_c20 PLASMINOGEN user 5 3 # 5 A 603 HIS C 97 HIS.? 1000.00 A 646 ASP H 48 ASP^? 1000.00 A 739 GLY H 36 GLY^? 1000.00 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 ULMN 3 1qrz_c20 PLASMINOGEN user 6 3 # 6 A 603 HIS C 98 HIS.? 1000.00 A 646 ASP H 48 ASP^? 1000.00 A 739 GLY H 36 GLY^? 1000.00 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 ULMN 3 1qrz_c20 PLASMINOGEN user 7 3 # 7 A 603 HIS E 94 HIS.? 1000.00 A 646 ASP B 48 ASP^? 1000.00 A 739 GLY B 36 GLY^? 1000.00 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 ULMN 3 1qrz_c20 PLASMINOGEN user 8 3 # 8 A 603 HIS E 96 HIS.? 1000.00 A 646 ASP G 48 ASP^? 1000.00 A 739 GLY E 90 GLY.? 1000.00 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1qrz_c20 PLASMINOGEN user 9 3 # 9 A 603 HIS E 97 HIS.? 1000.00 A 646 ASP G 48 ASP^? 1000.00 A 739 GLY G 36 GLY^? 1000.00 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 0.93 -38.28 -61.29 1.11 -39.11 -61.33 ULMN 3 1qrz_c20 PLASMINOGEN user 10 3 # 10 A 603 HIS E 98 HIS.? 1000.00 A 646 ASP G 48 ASP^? 1000.00 A 739 GLY B 76 GLY.? 1000.00 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -10.66 -22.05 -52.24 -11.47 -21.98 -52.32 1qrz_c20 source 1qrz PLASMINOGEN : 10 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS C 94 HIS.? 1000.00 B 646 ASP D 48 ASP^? 1000.00 B 739 GLY D 36 GLY^? 1000.00 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS C 96 HIS.? 1000.00 B 646 ASP H 48 ASP^? 1000.00 B 739 GLY C 90 GLY.? 1000.00 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS C 97 HIS.? 1000.00 B 646 ASP H 48 ASP^? 1000.00 B 739 GLY H 36 GLY^? 1000.00 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS C 98 HIS.? 1000.00 B 646 ASP H 48 ASP^? 1000.00 B 739 GLY H 36 GLY^? 1000.00 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS E 94 HIS.? 1000.00 B 646 ASP B 48 ASP^? 1000.00 B 739 GLY B 36 GLY^? 1000.00 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 ULMN 3 1qrz_c21 PLASMINOGEN user 6 3 # 6 B 603 HIS E 95 HIS.? 1000.00 B 646 ASP G 48 ASP^? 1000.00 B 739 GLY B 76 GLY.? 1000.00 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -10.66 -22.05 -52.24 -11.47 -21.98 -52.32 ULMN 3 1qrz_c21 PLASMINOGEN user 7 3 # 7 B 603 HIS E 95 HIS.? 1000.00 B 646 ASP G 48 ASP^? 1000.00 B 739 GLY E 90 GLY.? 1000.00 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1qrz_c21 PLASMINOGEN user 8 3 # 8 B 603 HIS E 96 HIS.? 1000.00 B 646 ASP G 48 ASP^? 1000.00 B 739 GLY E 90 GLY.? 1000.00 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1qrz_c21 PLASMINOGEN user 9 3 # 9 B 603 HIS E 97 HIS.? 1000.00 B 646 ASP G 48 ASP^? 1000.00 B 739 GLY G 36 GLY^? 1000.00 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 0.93 -38.28 -61.29 1.11 -39.11 -61.33 1qrz_c21 source 1qrz PLASMINOGEN : 9 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS C 94 HIS.? 1000.00 C 646 ASP D 48 ASP^? 1000.00 C 739 GLY D 36 GLY^? 1000.00 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 7.82 1.25 3.03 7.30 1.31 3.65 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS C 96 HIS.? 1000.00 C 646 ASP H 48 ASP^? 1000.00 C 739 GLY C 90 GLY.? 1000.00 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 7.82 1.25 3.03 7.30 1.31 3.65 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS C 97 HIS.? 1000.00 C 646 ASP H 48 ASP^? 1000.00 C 739 GLY H 36 GLY^? 1000.00 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 7.82 1.25 3.03 7.30 1.31 3.65 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS C 98 HIS.? 1000.00 C 646 ASP H 48 ASP^? 1000.00 C 739 GLY H 36 GLY^? 1000.00 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 7.82 1.25 3.03 7.30 1.31 3.65 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 ULMN 3 1qrz_c22 PLASMINOGEN user 5 3 # 5 C 603 HIS E 94 HIS.? 1000.00 C 646 ASP B 48 ASP^? 1000.00 C 739 GLY B 36 GLY^? 1000.00 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 7.82 1.25 3.03 7.30 1.31 3.65 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 ULMN 3 1qrz_c22 PLASMINOGEN user 6 3 # 6 C 603 HIS E 96 HIS.? 1000.00 C 646 ASP G 48 ASP^? 1000.00 C 739 GLY E 90 GLY.? 1000.00 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 7.82 1.25 3.03 7.30 1.31 3.65 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1qrz_c22 PLASMINOGEN user 7 3 # 7 C 603 HIS E 97 HIS.? 1000.00 C 646 ASP G 48 ASP^? 1000.00 C 739 GLY G 36 GLY^? 1000.00 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 7.82 1.25 3.03 7.30 1.31 3.65 0.93 -38.28 -61.29 1.11 -39.11 -61.33 1qrz_c22 source 1qrz PLASMINOGEN : 7 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS C 94 HIS.? 1000.00 D 646 ASP D 48 ASP^? 1000.00 D 739 GLY D 36 GLY^? 1000.00 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS C 96 HIS.? 1000.00 D 646 ASP H 48 ASP^? 1000.00 D 739 GLY C 90 GLY.? 1000.00 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS C 97 HIS.? 1000.00 D 646 ASP H 48 ASP^? 1000.00 D 739 GLY H 36 GLY^? 1000.00 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS C 98 HIS.? 1000.00 D 646 ASP H 48 ASP^? 1000.00 D 739 GLY H 36 GLY^? 1000.00 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 ULMN 3 1qrz_c23 PLASMINOGEN user 5 3 # 5 D 603 HIS E 94 HIS.? 1000.00 D 646 ASP B 48 ASP^? 1000.00 D 739 GLY B 36 GLY^? 1000.00 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 ULMN 3 1qrz_c23 PLASMINOGEN user 6 3 # 6 D 603 HIS E 96 HIS.? 1000.00 D 646 ASP G 48 ASP^? 1000.00 D 739 GLY E 90 GLY.? 1000.00 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 ULMN 3 1qrz_c23 PLASMINOGEN user 7 3 # 7 D 603 HIS E 97 HIS.? 1000.00 D 646 ASP G 48 ASP^? 1000.00 D 739 GLY G 36 GLY^? 1000.00 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -45.82 1.31 41.67 -46.38 1.39 42.31 0.93 -38.28 -61.29 1.11 -39.11 -61.33 1qrz_c23 source 1qrz PLASMINOGEN : 7 hits 1qrz_c23 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP D 48 ASP^? 1000.00 A 610 HIS C 94 HIS.? 1000.00 A 661 HIS C 98 HIS.? 1000.00 coo 75.99 81.56 1.86 73.91 81.34 2.28 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 71.04 78.84 0.46 71.54 76.90 1.02 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 75.40 81.38 12.06 74.88 79.42 12.63 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP G 48 ASP^? 1000.00 A 610 HIS E 94 HIS.? 1000.00 A 661 HIS E 97 HIS.? 1000.00 coo 75.99 81.56 1.86 73.91 81.34 2.28 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 71.04 78.84 0.46 71.54 76.90 1.02 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 75.40 81.38 12.06 74.88 79.42 12.63 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 3 3 # 3 A 608 ASP G 48 ASP^? 1000.00 A 610 HIS E 95 HIS.? 1000.00 A 661 HIS E 98 HIS.? 1000.00 coo 75.99 81.56 1.86 73.91 81.34 2.28 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 71.04 78.84 0.46 71.54 76.90 1.02 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 75.40 81.38 12.06 74.88 79.42 12.63 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 4 3 # 4 A 608 ASP H 48 ASP^? 1000.00 A 610 HIS C 94 HIS.? 1000.00 A 661 HIS C 97 HIS.? 1000.00 coo 75.99 81.56 1.86 73.91 81.34 2.28 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 71.04 78.84 0.46 71.54 76.90 1.02 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 75.40 81.38 12.06 74.88 79.42 12.63 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 5 3 # 5 A 608 ASP H 48 ASP^? 1000.00 A 610 HIS C 94 HIS.? 1000.00 A 661 HIS C 98 HIS.? 1000.00 coo 75.99 81.56 1.86 73.91 81.34 2.28 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 71.04 78.84 0.46 71.54 76.90 1.02 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 75.40 81.38 12.06 74.88 79.42 12.63 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 5 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP G 48 ASP^? 1000.00 C 610 HIS E 94 HIS.? 1000.00 C 661 HIS E 97 HIS.? 1000.00 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP G 48 ASP^? 1000.00 C 610 HIS E 95 HIS.? 1000.00 C 661 HIS E 98 HIS.? 1000.00 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 3 3 # 3 C 608 ASP H 48 ASP^? 1000.00 C 610 HIS C 94 HIS.? 1000.00 C 661 HIS C 97 HIS.? 1000.00 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 4 3 # 4 C 608 ASP H 48 ASP^? 1000.00 C 610 HIS C 94 HIS.? 1000.00 C 661 HIS C 98 HIS.? 1000.00 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c11 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP D 40 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 40 ASP.? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 12.20 12.71 75.45 13.69 13.84 74.03 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 5.22 15.03 71.43 7.19 14.88 70.83 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP D 40 ASP.? 1000.00 35 SER D 42 SER.? 1000.00 215 ASP B 43 ASP.? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 12.20 12.71 75.45 13.69 13.84 74.03 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 5.22 15.03 71.43 7.19 14.88 70.83 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 2 hits 1rne_c04 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS C 97 HIS.? 1000.00 B 102 ASP D 48 ASP^? 1000.00 B 195 SER D 51 SER.? 1000.00 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -33.08 -53.53 -7.15 -34.77 -54.71 -5.86 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS E 97 HIS.? 1000.00 B 102 ASP B 48 ASP^? 1000.00 B 195 SER B 51 SER.? 1000.00 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 2 hits 1rtf_c03 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS C 96 HIS.? 1000.00 B 102 ASP D 48 ASP^? 1000.00 B 193 GLY D 76 GLY.? 1000.00 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS C 97 HIS.? 1000.00 B 102 ASP D 48 ASP^? 1000.00 B 193 GLY D 76 GLY.? 1000.00 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 2 hits 1rtf_c06 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS E 94 HIS.? 1000.00 62 GLU E 93 GLU.? 1000.00 101 HIS E 96 HIS.? 1000.00 coo 13.91 26.31 13.70 14.98 27.08 12.06 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 9.15 26.32 13.85 8.75 28.20 13.02 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 7.90 34.31 7.89 9.24 33.73 9.42 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 1 hits 1rtu_c00 naa= 3 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 3 # 1 A 104 ILE B 31 ILE^? 1000.00 A 106 HIS E 97 HIS.? 1000.00 A 142 ASP B 48 ASP^? 1000.00 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -15.11 -32.19 -55.18 -16.26 -32.83 -55.86 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 3 # 2 A 104 ILE D 31 ILE^? 1000.00 A 106 HIS C 97 HIS.? 1000.00 A 142 ASP D 48 ASP^? 1000.00 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -32.72 -50.86 -11.69 -32.57 -49.80 -10.70 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 3 3 # 3 A 104 ILE G 31 ILE^? 1000.00 A 106 HIS E 94 HIS.? 1000.00 A 142 ASP G 48 ASP^? 1000.00 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -5.73 -44.40 -47.03 -5.95 -45.70 -47.68 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 1s3i_c00 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 3 hits 1s3i_c00 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP B 48 ASP^? 1000.00 64 HIS E 97 HIS.? 1000.00 221 SER B 51 SER.? 1000.00 coo 80.16 73.25 62.48 80.01 71.25 61.82 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 78.27 67.69 61.83 79.58 67.76 60.19 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 83.63 66.07 58.16 81.31 66.75 57.98 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP D 48 ASP^? 1000.00 64 HIS C 97 HIS.? 1000.00 221 SER D 51 SER.? 1000.00 coo 80.16 73.25 62.48 80.01 71.25 61.82 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 78.27 67.69 61.83 79.58 67.76 60.19 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 83.63 66.07 58.16 81.31 66.75 57.98 -33.08 -53.53 -7.15 -34.77 -54.71 -5.86 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 2 hits 1sca_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP B 48 ASP^? 1000.00 64 HIS E 95 HIS.? 1000.00 155 ASN E 64 ASN.? 1000.00 coo 80.16 73.25 62.48 80.01 71.25 61.82 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 78.27 67.69 61.83 79.58 67.76 60.19 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 80.34 61.88 52.75 81.25 63.19 54.35 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP B 48 ASP^? 1000.00 64 HIS E 96 HIS.? 1000.00 155 ASN E 64 ASN.? 1000.00 coo 80.16 73.25 62.48 80.01 71.25 61.82 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 78.27 67.69 61.83 79.58 67.76 60.19 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 80.34 61.88 52.75 81.25 63.19 54.35 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP B 48 ASP^? 1000.00 64 HIS E 97 HIS.? 1000.00 155 ASN G 60 ASN.? 1000.00 coo 80.16 73.25 62.48 80.01 71.25 61.82 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 78.27 67.69 61.83 79.58 67.76 60.19 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 80.34 61.88 52.75 81.25 63.19 54.35 -7.92 -34.66 -65.50 -6.82 -32.91 -66.09 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP D 48 ASP^? 1000.00 64 HIS C 95 HIS.? 1000.00 155 ASN C 64 ASN.? 1000.00 coo 80.16 73.25 62.48 80.01 71.25 61.82 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 78.27 67.69 61.83 79.58 67.76 60.19 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 80.34 61.88 52.75 81.25 63.19 54.35 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP D 48 ASP^? 1000.00 64 HIS C 96 HIS.? 1000.00 155 ASN C 64 ASN.? 1000.00 coo 80.16 73.25 62.48 80.01 71.25 61.82 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 78.27 67.69 61.83 79.58 67.76 60.19 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 80.34 61.88 52.75 81.25 63.19 54.35 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP G 48 ASP^? 1000.00 64 HIS E 94 HIS.? 1000.00 155 ASN G 75 ASN^? 1000.00 coo 80.16 73.25 62.48 80.01 71.25 61.82 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 78.27 67.69 61.83 79.58 67.76 60.19 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 80.34 61.88 52.75 81.25 63.19 54.35 -1.10 -45.07 -37.41 -2.90 -46.10 -36.91 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP G 48 ASP^? 1000.00 64 HIS E 95 HIS.? 1000.00 155 ASN E 64 ASN.? 1000.00 coo 80.16 73.25 62.48 80.01 71.25 61.82 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 78.27 67.69 61.83 79.58 67.76 60.19 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 80.34 61.88 52.75 81.25 63.19 54.35 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 8 3 # 8 32 ASP H 48 ASP^? 1000.00 64 HIS C 95 HIS.? 1000.00 155 ASN C 64 ASN.? 1000.00 coo 80.16 73.25 62.48 80.01 71.25 61.82 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 78.27 67.69 61.83 79.58 67.76 60.19 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 80.34 61.88 52.75 81.25 63.19 54.35 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 8 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 40 ASP.? 1000.00 595 GLU A 62 GLU.? 1000.00 713 TYR A 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -55.02 -16.32 -57.84 -55.96 -14.51 -57.37 coo 4.35 13.73 37.63 3.39 12.18 36.55 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 coo 3.76 10.25 31.38 3.16 9.87 34.10 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP A 40 ASP.? 1000.00 595 GLU A 68 GLU^? 1000.00 713 TYR A 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -55.02 -16.32 -57.84 -55.96 -14.51 -57.37 coo 4.35 13.73 37.63 3.39 12.18 36.55 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 coo 3.76 10.25 31.38 3.16 9.87 34.10 -49.35 -22.86 -54.08 -51.27 -22.55 -52.07 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP B 40 ASP.? 1000.00 595 GLU B 62 GLU.? 1000.00 713 TYR B 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 4.35 13.73 37.63 3.39 12.18 36.55 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 coo 3.76 10.25 31.38 3.16 9.87 34.10 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP B 40 ASP.? 1000.00 595 GLU B 68 GLU^? 1000.00 713 TYR B 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 4.35 13.73 37.63 3.39 12.18 36.55 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 3.76 10.25 31.38 3.16 9.87 34.10 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 ULMN 3 1sll_c00 SIALIDASE L user 5 3 # 5 318 ASP B 43 ASP.? 1000.00 595 GLU B 68 GLU^? 1000.00 713 TYR B 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 4.35 13.73 37.63 3.39 12.18 36.55 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 coo 3.76 10.25 31.38 3.16 9.87 34.10 -24.70 -45.02 -44.95 -23.53 -46.73 -43.10 ULMN 3 1sll_c00 SIALIDASE L user 6 3 # 6 318 ASP C 40 ASP.? 1000.00 595 GLU C 62 GLU.? 1000.00 713 TYR C 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 4.35 13.73 37.63 3.39 12.18 36.55 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 3.76 10.25 31.38 3.16 9.87 34.10 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1sll_c00 SIALIDASE L user 7 3 # 7 318 ASP C 40 ASP.? 1000.00 595 GLU C 68 GLU^? 1000.00 713 TYR C 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 4.35 13.73 37.63 3.39 12.18 36.55 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 coo 3.76 10.25 31.38 3.16 9.87 34.10 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1sll_c00 SIALIDASE L user 8 3 # 8 318 ASP C 43 ASP.? 1000.00 595 GLU C 62 GLU.? 1000.00 713 TYR C 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 4.35 13.73 37.63 3.39 12.18 36.55 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 3.76 10.25 31.38 3.16 9.87 34.10 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1sll_c00 SIALIDASE L user 9 3 # 9 318 ASP C 43 ASP.? 1000.00 595 GLU C 68 GLU^? 1000.00 713 TYR C 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 4.35 13.73 37.63 3.39 12.18 36.55 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 coo 3.76 10.25 31.38 3.16 9.87 34.10 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 1sll_c00 SIALIDASE L user 10 3 # 10 318 ASP D 40 ASP.? 1000.00 595 GLU D 62 GLU.? 1000.00 713 TYR D 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 4.35 13.73 37.63 3.39 12.18 36.55 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 coo 3.76 10.25 31.38 3.16 9.87 34.10 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 ULMN 3 1sll_c00 SIALIDASE L user 11 3 # 11 318 ASP D 40 ASP.? 1000.00 595 GLU D 68 GLU^? 1000.00 713 TYR D 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 4.35 13.73 37.63 3.39 12.18 36.55 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 coo 3.76 10.25 31.38 3.16 9.87 34.10 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 ULMN 3 1sll_c00 SIALIDASE L user 12 3 # 12 318 ASP D 43 ASP.? 1000.00 595 GLU D 62 GLU.? 1000.00 713 TYR D 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 4.35 13.73 37.63 3.39 12.18 36.55 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 coo 3.76 10.25 31.38 3.16 9.87 34.10 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 ULMN 3 1sll_c00 SIALIDASE L user 13 3 # 13 318 ASP D 43 ASP.? 1000.00 595 GLU D 68 GLU^? 1000.00 713 TYR D 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 4.35 13.73 37.63 3.39 12.18 36.55 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 coo 3.76 10.25 31.38 3.16 9.87 34.10 -19.69 -40.31 -20.58 -17.59 -41.38 -22.07 ULMN 3 1sll_c00 SIALIDASE L user 14 3 # 14 318 ASP E 40 ASP.? 1000.00 595 GLU E 62 GLU.? 1000.00 713 TYR E 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -17.17 -9.50 -39.47 -16.76 -7.92 -40.81 coo 4.35 13.73 37.63 3.39 12.18 36.55 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 3.76 10.25 31.38 3.16 9.87 34.10 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 ULMN 3 1sll_c00 SIALIDASE L user 15 3 # 15 318 ASP E 40 ASP.? 1000.00 595 GLU E 68 GLU^? 1000.00 713 TYR E 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -17.17 -9.50 -39.47 -16.76 -7.92 -40.81 coo 4.35 13.73 37.63 3.39 12.18 36.55 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 coo 3.76 10.25 31.38 3.16 9.87 34.10 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 ULMN 3 1sll_c00 SIALIDASE L user 16 3 # 16 318 ASP E 43 ASP.? 1000.00 595 GLU E 62 GLU.? 1000.00 713 TYR E 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 coo 4.35 13.73 37.63 3.39 12.18 36.55 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 coo 3.76 10.25 31.38 3.16 9.87 34.10 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 ULMN 3 1sll_c00 SIALIDASE L user 17 3 # 17 318 ASP E 43 ASP.? 1000.00 595 GLU E 68 GLU^? 1000.00 713 TYR E 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 coo 4.35 13.73 37.63 3.39 12.18 36.55 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 coo 3.76 10.25 31.38 3.16 9.87 34.10 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 ULMN 3 1sll_c00 SIALIDASE L user 18 3 # 18 318 ASP F 40 ASP.? 1000.00 595 GLU F 62 GLU.? 1000.00 713 TYR F 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 4.35 13.73 37.63 3.39 12.18 36.55 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 coo 3.76 10.25 31.38 3.16 9.87 34.10 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 ULMN 3 1sll_c00 SIALIDASE L user 19 3 # 19 318 ASP F 40 ASP.? 1000.00 595 GLU F 68 GLU^? 1000.00 713 TYR F 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 4.35 13.73 37.63 3.39 12.18 36.55 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 coo 3.76 10.25 31.38 3.16 9.87 34.10 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 ULMN 3 1sll_c00 SIALIDASE L user 20 3 # 20 318 ASP G 40 ASP.? 1000.00 595 GLU G 62 GLU.? 1000.00 713 TYR G 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 4.35 13.73 37.63 3.39 12.18 36.55 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 3.76 10.25 31.38 3.16 9.87 34.10 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 ULMN 3 1sll_c00 SIALIDASE L user 21 3 # 21 318 ASP G 40 ASP.? 1000.00 595 GLU G 68 GLU^? 1000.00 713 TYR G 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 4.35 13.73 37.63 3.39 12.18 36.55 4.41 -43.97 -59.17 6.44 -44.61 -59.08 coo 3.76 10.25 31.38 3.16 9.87 34.10 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 ULMN 3 1sll_c00 SIALIDASE L user 22 3 # 22 318 ASP G 43 ASP.? 1000.00 595 GLU G 62 GLU.? 1000.00 713 TYR G 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 4.35 13.73 37.63 3.39 12.18 36.55 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 coo 3.76 10.25 31.38 3.16 9.87 34.10 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 ULMN 3 1sll_c00 SIALIDASE L user 23 3 # 23 318 ASP G 43 ASP.? 1000.00 595 GLU G 68 GLU^? 1000.00 713 TYR G 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo 4.35 13.73 37.63 3.39 12.18 36.55 4.41 -43.97 -59.17 6.44 -44.61 -59.08 coo 3.76 10.25 31.38 3.16 9.87 34.10 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 ULMN 3 1sll_c00 SIALIDASE L user 24 3 # 24 318 ASP H 40 ASP.? 1000.00 595 GLU H 62 GLU.? 1000.00 713 TYR H 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -28.41 -71.72 -1.86 -30.52 -71.82 -1.58 coo 4.35 13.73 37.63 3.39 12.18 36.55 -29.93 -63.04 6.06 -30.63 -65.03 6.10 coo 3.76 10.25 31.38 3.16 9.87 34.10 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 ULMN 3 1sll_c00 SIALIDASE L user 25 3 # 25 318 ASP H 40 ASP.? 1000.00 595 GLU H 68 GLU^? 1000.00 713 TYR H 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -28.41 -71.72 -1.86 -30.52 -71.82 -1.58 coo 4.35 13.73 37.63 3.39 12.18 36.55 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 coo 3.76 10.25 31.38 3.16 9.87 34.10 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 ULMN 3 1sll_c00 SIALIDASE L user 26 3 # 26 318 ASP H 43 ASP.? 1000.00 595 GLU H 62 GLU.? 1000.00 713 TYR H 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -30.59 -68.33 -3.12 -29.92 -66.39 -2.72 coo 4.35 13.73 37.63 3.39 12.18 36.55 -29.93 -63.04 6.06 -30.63 -65.03 6.10 coo 3.76 10.25 31.38 3.16 9.87 34.10 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 ULMN 3 1sll_c00 SIALIDASE L user 27 3 # 27 318 ASP H 43 ASP.? 1000.00 595 GLU H 68 GLU^? 1000.00 713 TYR H 67 TYR^? 1000.00 coo 5.64 2.82 38.49 4.59 4.19 37.25 -30.59 -68.33 -3.12 -29.92 -66.39 -2.72 coo 4.35 13.73 37.63 3.39 12.18 36.55 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 coo 3.76 10.25 31.38 3.16 9.87 34.10 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 1sll_c00 source 1sll SIALIDASE L : 27 hits 1sll_c00 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP B 43 ASP.? 1000.00 A 37 SER B 42 SER.? 1000.00 A 214 ASP D 43 ASP.? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 51.10 65.11 20.73 52.62 63.74 19.42 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 48.59 58.89 25.78 50.13 59.74 24.61 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP D 40 ASP.? 1000.00 A 37 SER D 42 SER.? 1000.00 A 214 ASP B 40 ASP.? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 51.10 65.11 20.73 52.62 63.74 19.42 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 48.59 58.89 25.78 50.13 59.74 24.61 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1sme_c04 PLASMEPSIN II user 3 3 # 3 A 34 ASP D 40 ASP.? 1000.00 A 37 SER D 42 SER.? 1000.00 A 214 ASP B 43 ASP.? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 51.10 65.11 20.73 52.62 63.74 19.42 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 48.59 58.89 25.78 50.13 59.74 24.61 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1sme_c04 PLASMEPSIN II user 4 3 # 4 A 34 ASP D 43 ASP.? 1000.00 A 37 SER D 42 SER.? 1000.00 A 214 ASP B 43 ASP.? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 51.10 65.11 20.73 52.62 63.74 19.42 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 48.59 58.89 25.78 50.13 59.74 24.61 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1sme_c04 source 1sme PLASMEPSIN II : 4 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP B 40 ASP.? 1000.00 B 37 SER B 42 SER.? 1000.00 B 214 ASP D 43 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 20.67 100.44 55.84 20.21 98.51 54.45 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 12.41 98.71 58.47 14.37 98.17 58.05 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP B 43 ASP.? 1000.00 B 37 SER B 42 SER.? 1000.00 B 214 ASP D 43 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 20.67 100.44 55.84 20.21 98.51 54.45 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 12.41 98.71 58.47 14.37 98.17 58.05 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1sme_c05 PLASMEPSIN II user 3 3 # 3 B 34 ASP D 40 ASP.? 1000.00 B 37 SER D 42 SER.? 1000.00 B 214 ASP B 40 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 20.67 100.44 55.84 20.21 98.51 54.45 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 12.41 98.71 58.47 14.37 98.17 58.05 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1sme_c05 PLASMEPSIN II user 4 3 # 4 B 34 ASP D 40 ASP.? 1000.00 B 37 SER D 42 SER.? 1000.00 B 214 ASP B 43 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 20.67 100.44 55.84 20.21 98.51 54.45 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 12.41 98.71 58.47 14.37 98.17 58.05 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 1sme_c05 PLASMEPSIN II user 5 3 # 5 B 34 ASP D 43 ASP.? 1000.00 B 37 SER D 42 SER.? 1000.00 B 214 ASP B 40 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 20.67 100.44 55.84 20.21 98.51 54.45 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 12.41 98.71 58.47 14.37 98.17 58.05 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1sme_c05 PLASMEPSIN II user 6 3 # 6 B 34 ASP D 43 ASP.? 1000.00 B 37 SER D 42 SER.? 1000.00 B 214 ASP B 43 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 20.67 100.44 55.84 20.21 98.51 54.45 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 12.41 98.71 58.47 14.37 98.17 58.05 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1sme_c05 source 1sme PLASMEPSIN II : 6 hits 1sme_c05 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS C 96 HIS.? 1000.00 A 102 ASP D 48 ASP^? 1000.00 A 193 GLY D 76 GLY.? 1000.00 coo 15.02 29.17 19.44 15.63 29.96 17.60 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 19.67 30.58 22.61 18.30 29.87 21.17 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 14.52 29.10 10.01 15.08 29.66 10.19 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 1 hits 1ssx_c02 naa= 3 ULMN 3 1stc_c02 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP G 40 ASP.? 1000.00 E 168 LYS G 38 LYS.? 1000.00 E 201 THR G 66 THR^? 1000.00 coo 5.36 16.20 22.10 3.88 17.00 23.31 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 5.06 22.32 18.11 1.02 22.08 22.74 6.01 -41.17 -63.42 7.43 -47.25 -63.10 coo -1.79 18.29 19.05 -1.19 20.28 19.71 2.66 -43.43 -68.00 4.28 -44.88 -68.13 1stc_c02 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 1 hits 1stc_c02 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 40 ASP.? 1000.00 E 168 LYS A 38 LYS.? 1000.00 E 171 ASN A 39 ASN.? 1000.00 coo 5.36 16.20 22.10 3.88 17.00 23.31 -55.02 -16.32 -57.84 -55.96 -14.51 -57.37 coo 5.06 22.32 18.11 1.02 22.08 22.74 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 coo 6.68 21.78 22.39 5.28 20.74 23.60 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP B 40 ASP.? 1000.00 E 168 LYS B 38 LYS.? 1000.00 E 171 ASN B 39 ASN.? 1000.00 coo 5.36 16.20 22.10 3.88 17.00 23.31 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 5.06 22.32 18.11 1.02 22.08 22.74 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 coo 6.68 21.78 22.39 5.28 20.74 23.60 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP C 40 ASP.? 1000.00 E 168 LYS C 38 LYS.? 1000.00 E 171 ASN C 39 ASN.? 1000.00 coo 5.36 16.20 22.10 3.88 17.00 23.31 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 5.06 22.32 18.11 1.02 22.08 22.74 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 coo 6.68 21.78 22.39 5.28 20.74 23.60 -49.60 -52.13 -34.79 -48.70 -51.69 -36.70 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP D 40 ASP.? 1000.00 E 168 LYS D 38 LYS.? 1000.00 E 171 ASN D 39 ASN.? 1000.00 coo 5.36 16.20 22.10 3.88 17.00 23.31 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 5.06 22.32 18.11 1.02 22.08 22.74 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 coo 6.68 21.78 22.39 5.28 20.74 23.60 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP E 40 ASP.? 1000.00 E 168 LYS E 38 LYS.? 1000.00 E 171 ASN E 39 ASN.? 1000.00 coo 5.36 16.20 22.10 3.88 17.00 23.31 -17.17 -9.50 -39.47 -16.76 -7.92 -40.81 coo 5.06 22.32 18.11 1.02 22.08 22.74 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 coo 6.68 21.78 22.39 5.28 20.74 23.60 -15.68 -13.10 -36.31 -13.95 -13.09 -35.06 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 6 3 # 6 E 166 ASP F 40 ASP.? 1000.00 E 168 LYS F 38 LYS.? 1000.00 E 171 ASN F 39 ASN.? 1000.00 coo 5.36 16.20 22.10 3.88 17.00 23.31 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 5.06 22.32 18.11 1.02 22.08 22.74 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 coo 6.68 21.78 22.39 5.28 20.74 23.60 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 7 3 # 7 E 166 ASP G 40 ASP.? 1000.00 E 168 LYS G 38 LYS.? 1000.00 E 171 ASN G 39 ASN.? 1000.00 coo 5.36 16.20 22.10 3.88 17.00 23.31 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 5.06 22.32 18.11 1.02 22.08 22.74 6.01 -41.17 -63.42 7.43 -47.25 -63.10 coo 6.68 21.78 22.39 5.28 20.74 23.60 8.96 -39.36 -66.77 9.19 -41.39 -67.43 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 8 3 # 8 E 166 ASP H 40 ASP.? 1000.00 E 168 LYS H 38 LYS.? 1000.00 E 171 ASN H 39 ASN.? 1000.00 coo 5.36 16.20 22.10 3.88 17.00 23.31 -28.41 -71.72 -1.86 -30.52 -71.82 -1.58 coo 5.06 22.32 18.11 1.02 22.08 22.74 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 coo 6.68 21.78 22.39 5.28 20.74 23.60 -23.52 -74.80 -1.64 -21.44 -75.05 -2.04 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 8 hits 1stc_c03 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 94 HIS.? 1000.00 B 80 GLU A 93 GLU.? 1000.00 B 223 ARG F 74 ARG.? 1000.00 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -61.56 -37.44 -41.77 -61.34 -38.91 -40.29 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -56.59 -34.51 -11.73 -58.13 -35.73 -14.10 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 1 hits 1t0u_c01 naa= 3 ULMN 3 1tah_c00 LIPASE user 1 3 # 1 B 87 SER B 51 SER.? 1000.00 B 263 ASP B 48 ASP^? 1000.00 B 285 HIS E 97 HIS.? 1000.00 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1tah_c00 source 1tah LIPASE : 1 hits 1tah_c00 naa= 3 ULMN 3 1tah_c01 LIPASE user 1 3 # 1 A 87 SER B 51 SER.? 1000.00 A 263 ASP B 48 ASP^? 1000.00 A 285 HIS E 97 HIS.? 1000.00 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1tah_c01 source 1tah LIPASE : 1 hits 1tah_c01 naa= 3 ULMN 3 1tah_c02 LIPASE user 1 3 # 1 C 87 SER B 51 SER.? 1000.00 C 263 ASP B 48 ASP^? 1000.00 C 285 HIS E 97 HIS.? 1000.00 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1tah_c02 source 1tah LIPASE : 1 hits 1tah_c02 naa= 3 ULMN 3 1tah_c03 LIPASE user 1 3 # 1 D 87 SER B 51 SER.? 1000.00 D 263 ASP B 48 ASP^? 1000.00 D 285 HIS E 97 HIS.? 1000.00 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1tah_c03 source 1tah LIPASE : 1 hits 1tah_c03 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 94 HIS.? 1000.00 89 GLU A 93 GLU.? 1000.00 243 ASN C 75 ASN^? 1000.00 coo 5.83 15.74 17.38 6.41 17.70 17.86 -61.56 -37.44 -41.77 -61.34 -38.91 -40.29 coo 3.11 16.19 13.44 4.96 17.09 13.42 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 coo 0.53 21.81 31.33 1.05 20.47 29.70 -59.90 -22.40 -33.64 -59.93 -20.29 -33.32 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 1 hits 1ula_c00 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 40 ASP.? 1000.00 218 GLU D 29 GLU.? 1000.00 329 ASP D 43 ASP.? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 70.09 11.71 8.46 70.56 12.89 6.77 -40.72 -57.02 -11.50 -41.62 -58.18 -13.02 coo 59.16 37.82 13.95 57.63 37.03 15.12 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP D 43 ASP.? 1000.00 218 GLU C 44 GLU.? 1000.00 329 ASP B 40 ASP.? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 70.09 11.71 8.46 70.56 12.89 6.77 -54.59 -42.81 -28.85 -55.68 -43.01 -30.66 coo 59.16 37.82 13.95 57.63 37.03 15.12 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP D 43 ASP.? 1000.00 218 GLU E 68 GLU^? 1000.00 329 ASP B 40 ASP.? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 70.09 11.71 8.46 70.56 12.89 6.77 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP D 43 ASP.? 1000.00 218 GLU E 68 GLU^? 1000.00 329 ASP B 43 ASP.? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 70.09 11.71 8.46 70.56 12.89 6.77 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 4 hits 1uok_c04 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 39 ASN.? 1000.00 457 GLY A 36 GLY^? 1000.00 459 GLU A 44 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -48.92 -17.78 -55.02 -48.59 -18.42 -55.51 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -47.53 -13.80 -58.12 -49.26 -14.21 -59.28 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 39 ASN.? 1000.00 457 GLY A 36 GLY^? 1000.00 459 GLU A 68 GLU^? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -48.92 -17.78 -55.02 -48.59 -18.42 -55.51 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -45.71 -20.94 -61.21 -46.13 -19.90 -63.00 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 39 ASN.? 1000.00 457 GLY B 36 GLY^? 1000.00 459 GLU B 68 GLU^? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -27.35 -37.50 -46.86 -28.72 -36.11 -46.05 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN C 39 ASN.? 1000.00 457 GLY C 36 GLY^? 1000.00 459 GLU C 68 GLU^? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -49.60 -52.13 -34.79 -48.70 -51.69 -36.70 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -49.78 -44.46 -28.07 -49.37 -44.25 -28.79 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -49.02 -42.63 -35.11 -50.05 -43.74 -36.58 ULMN 3 1vom_c00 MYOSIN user 5 3 # 5 233 ASN D 39 ASN.? 1000.00 457 GLY D 36 GLY^? 1000.00 459 GLU D 44 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 ULMN 3 1vom_c00 MYOSIN user 6 3 # 6 233 ASN D 39 ASN.? 1000.00 457 GLY D 36 GLY^? 1000.00 459 GLU D 68 GLU^? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -27.43 -37.88 -19.20 -28.83 -36.58 -20.08 ULMN 3 1vom_c00 MYOSIN user 7 3 # 7 233 ASN E 39 ASN.? 1000.00 457 GLY E 36 GLY^? 1000.00 459 GLU E 44 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -15.68 -13.10 -36.31 -13.95 -13.09 -35.06 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -24.48 -8.54 -40.01 -24.93 -7.20 -38.47 ULMN 3 1vom_c00 MYOSIN user 8 3 # 8 233 ASN E 39 ASN.? 1000.00 457 GLY E 36 GLY^? 1000.00 459 GLU E 68 GLU^? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -15.68 -13.10 -36.31 -13.95 -13.09 -35.06 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -25.52 -13.77 -33.74 -25.11 -11.95 -32.73 ULMN 3 1vom_c00 MYOSIN user 9 3 # 9 233 ASN F 39 ASN.? 1000.00 457 GLY F 36 GLY^? 1000.00 459 GLU F 44 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -48.82 -16.54 -15.32 -48.14 -16.69 -14.82 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -53.53 -17.09 -12.40 -51.47 -16.99 -11.89 ULMN 3 1vom_c00 MYOSIN user 10 3 # 10 233 ASN F 39 ASN.? 1000.00 457 GLY F 36 GLY^? 1000.00 459 GLU F 68 GLU^? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -48.82 -16.54 -15.32 -48.14 -16.69 -14.82 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -45.92 -18.46 -9.00 -46.90 -17.53 -7.35 ULMN 3 1vom_c00 MYOSIN user 11 3 # 11 233 ASN G 39 ASN.? 1000.00 457 GLY G 36 GLY^? 1000.00 459 GLU G 68 GLU^? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 8.96 -39.36 -66.77 9.19 -41.39 -67.43 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 0.93 -38.28 -61.29 1.11 -39.11 -61.33 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 4.41 -43.97 -59.17 6.44 -44.61 -59.08 ULMN 3 1vom_c00 MYOSIN user 12 3 # 12 233 ASN H 39 ASN.? 1000.00 457 GLY H 36 GLY^? 1000.00 459 GLU H 44 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -23.52 -74.80 -1.64 -21.44 -75.05 -2.04 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 ULMN 3 1vom_c00 MYOSIN user 13 3 # 13 233 ASN H 39 ASN.? 1000.00 457 GLY H 36 GLY^? 1000.00 459 GLU H 68 GLU^? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -23.52 -74.80 -1.64 -21.44 -75.05 -2.04 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -19.34 -69.05 -5.09 -19.26 -71.11 -5.56 1vom_c00 source 1vom MYOSIN : 13 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR D 79 TYR^? 1000.00 A 317 GLU C 62 GLU.? 1000.00 A 365 ARG D 70 ARG^? 1000.00 coo 1.77 6.56 57.05 3.05 7.44 59.37 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 3.06 2.85 52.79 4.83 3.89 53.24 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 3.82 17.09 49.56 4.09 14.32 50.84 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 1vzx_c02 source 1vzx 2.04.01.0087 : 1 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR D 79 TYR^? 1000.00 B1317 GLU C 62 GLU.? 1000.00 B1365 ARG D 70 ARG^? 1000.00 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 1vzx_c03 source 1vzx 2.04.01.0087 : 1 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR B 79 TYR^? 1000.00 A 40 ASP B 48 ASP^? 1000.00 A 103 LEU E 14 LEU.? 1000.00 coo 12.09 16.13 10.57 11.28 18.80 10.73 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 coo 7.55 25.51 14.34 9.65 25.73 14.24 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 11.83 18.73 16.99 10.99 19.71 15.26 -18.09 -28.20 -44.42 -17.13 -29.65 -43.15 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR D 79 TYR^? 1000.00 A 40 ASP D 48 ASP^? 1000.00 A 103 LEU C 14 LEU.? 1000.00 coo 12.09 16.13 10.57 11.28 18.80 10.73 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 7.55 25.51 14.34 9.65 25.73 14.24 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 11.83 18.73 16.99 10.99 19.71 15.26 -34.65 -47.50 -22.93 -33.38 -48.86 -24.05 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR B 79 TYR^? 1000.00 B 40 ASP B 48 ASP^? 1000.00 B 103 LEU E 14 LEU.? 1000.00 coo 14.25 20.09 37.35 13.48 17.40 37.38 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 coo 9.39 10.77 34.53 11.50 10.63 34.41 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 12.89 17.60 31.13 12.34 16.51 32.90 -18.09 -28.20 -44.42 -17.13 -29.65 -43.15 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR D 79 TYR^? 1000.00 B 40 ASP D 48 ASP^? 1000.00 B 103 LEU C 14 LEU.? 1000.00 coo 14.25 20.09 37.35 13.48 17.40 37.38 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 9.39 10.77 34.53 11.50 10.63 34.41 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 12.89 17.60 31.13 12.34 16.51 32.90 -34.65 -47.50 -22.93 -33.38 -48.86 -24.05 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 2 hits 1vzz_c01 naa= 3 ULMN 3 1zoi_c00 ESTERASE user 1 3 # 1 A 97 SER B 51 SER.? 1000.00 A 227 ASP B 48 ASP^? 1000.00 A 256 HIS E 97 HIS.? 1000.00 coo 64.84 24.93 59.62 66.28 24.42 57.72 -12.20 -32.38 -59.02 -11.51 -30.61 -60.51 coo 73.80 27.56 60.96 72.24 26.45 60.08 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 70.86 23.63 59.28 68.91 24.23 58.80 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 1zoi_c00 source 1zoi ESTERASE : 1 hits 1zoi_c00 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 40 ASP.? 1000.00 A 371 LYS A 38 LYS.? 1000.00 A 374 ASN A 39 ASN.? 1000.00 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -55.02 -16.32 -57.84 -55.96 -14.51 -57.37 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 43 ASP.? 1000.00 A 371 LYS A 38 LYS.? 1000.00 A 374 ASN A 39 ASN.? 1000.00 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -52.49 -15.23 -55.19 -52.13 -15.99 -53.25 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP B 40 ASP.? 1000.00 A 371 LYS B 38 LYS.? 1000.00 A 374 ASN B 39 ASN.? 1000.00 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP C 40 ASP.? 1000.00 A 371 LYS C 38 LYS.? 1000.00 A 374 ASN C 39 ASN.? 1000.00 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -49.60 -52.13 -34.79 -48.70 -51.69 -36.70 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP D 40 ASP.? 1000.00 A 371 LYS D 38 LYS.? 1000.00 A 374 ASN D 39 ASN.? 1000.00 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 6 3 # 6 A 369 ASP E 40 ASP.? 1000.00 A 371 LYS E 38 LYS.? 1000.00 A 374 ASN E 39 ASN.? 1000.00 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -17.17 -9.50 -39.47 -16.76 -7.92 -40.81 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -15.68 -13.10 -36.31 -13.95 -13.09 -35.06 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 7 3 # 7 A 369 ASP E 43 ASP.? 1000.00 A 371 LYS E 38 LYS.? 1000.00 A 374 ASN E 39 ASN.? 1000.00 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -15.68 -13.10 -36.31 -13.95 -13.09 -35.06 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 8 3 # 8 A 369 ASP F 40 ASP.? 1000.00 A 371 LYS F 38 LYS.? 1000.00 A 374 ASN F 39 ASN.? 1000.00 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 9 3 # 9 A 369 ASP G 40 ASP.? 1000.00 A 371 LYS G 38 LYS.? 1000.00 A 374 ASN G 39 ASN.? 1000.00 coo -5.17 31.09 15.73 -7.07 31.12 16.73 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo -4.43 30.92 22.89 -6.61 31.91 19.71 6.01 -41.17 -63.42 7.43 -47.25 -63.10 coo -4.84 27.04 20.49 -6.40 27.76 19.26 8.96 -39.36 -66.77 9.19 -41.39 -67.43 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 10 3 # 10 A 369 ASP H 40 ASP.? 1000.00 A 371 LYS H 38 LYS.? 1000.00 A 374 ASN H 39 ASN.? 1000.00 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -28.41 -71.72 -1.86 -30.52 -71.82 -1.58 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 coo -4.84 27.04 20.49 -6.40 27.76 19.26 -23.52 -74.80 -1.64 -21.44 -75.05 -2.04 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 10 hits 1zrz_c03 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 40 ASP.? 1000.00 231 ASP B 48 ASP^? 1000.00 294 ASP D 40 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 33.16 106.80 7.72 33.34 104.87 6.92 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP B 40 ASP.? 1000.00 231 ASP G 48 ASP^? 1000.00 294 ASP D 40 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 40 ASP.? 1000.00 231 ASP G 48 ASP^? 1000.00 294 ASP D 43 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP D 40 ASP.? 1000.00 231 ASP D 48 ASP^? 1000.00 294 ASP B 40 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 33.16 106.80 7.72 33.34 104.87 6.92 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP D 40 ASP.? 1000.00 231 ASP D 48 ASP^? 1000.00 294 ASP B 43 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 33.16 106.80 7.72 33.34 104.87 6.92 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP D 40 ASP.? 1000.00 231 ASP G 48 ASP^? 1000.00 294 ASP B 40 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP D 40 ASP.? 1000.00 231 ASP H 48 ASP^? 1000.00 294 ASP B 40 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP D 40 ASP.? 1000.00 231 ASP H 48 ASP^? 1000.00 294 ASP B 43 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 33.16 106.80 7.72 33.34 104.87 6.92 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 8 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP B 43 ASP.? 1000.00 38 SER B 42 SER.? 1000.00 218 ASP D 43 ASP.? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo 46.04 57.35 103.96 44.97 58.52 105.78 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo 41.33 60.20 97.63 42.00 60.96 99.49 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP D 40 ASP.? 1000.00 38 SER D 42 SER.? 1000.00 218 ASP B 40 ASP.? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 46.04 57.35 103.96 44.97 58.52 105.78 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 41.33 60.20 97.63 42.00 60.96 99.49 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 3 3 # 3 35 ASP D 40 ASP.? 1000.00 38 SER D 42 SER.? 1000.00 218 ASP B 43 ASP.? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 46.04 57.35 103.96 44.97 58.52 105.78 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 41.33 60.20 97.63 42.00 60.96 99.49 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 4 3 # 4 35 ASP D 43 ASP.? 1000.00 38 SER D 42 SER.? 1000.00 218 ASP B 43 ASP.? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo 46.04 57.35 103.96 44.97 58.52 105.78 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo 41.33 60.20 97.63 42.00 60.96 99.49 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 4 hits 2apr_c04 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG C 70 ARG^? 1000.00 A 161 ASP C 40 ASP.? 1000.00 A 174 TYR C 67 TYR^? 1000.00 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG C 70 ARG^? 1000.00 B 161 ASP C 40 ASP.? 1000.00 B 174 TYR C 67 TYR^? 1000.00 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG C 70 ARG^? 1000.00 C 161 ASP C 43 ASP.? 1000.00 C 174 TYR C 67 TYR^? 1000.00 coo 2.84 19.43 40.34 1.59 20.35 37.65 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo 5.94 13.28 27.17 3.53 13.05 28.58 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG C 70 ARG^? 1000.00 D 161 ASP C 40 ASP.? 1000.00 D 174 TYR C 67 TYR^? 1000.00 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG C 70 ARG^? 1000.00 D 161 ASP C 43 ASP.? 1000.00 D 174 TYR C 67 TYR^? 1000.00 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -44.80 -45.20 -28.73 -44.64 -46.75 -26.40 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c11 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP D 40 ASP.? 1000.00 A 233 GLU D 44 GLU.? 1000.00 A 300 ASN C 11 ASN.? 1000.00 coo 12.51 17.07 49.46 12.44 16.89 47.35 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 6.52 19.14 48.16 7.77 18.42 46.61 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 coo 9.30 22.40 41.76 10.10 20.96 40.36 -33.93 -36.54 -26.69 -32.43 -35.02 -26.74 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP H 43 ASP.? 1000.00 A 233 GLU H 44 GLU.? 1000.00 A 300 ASN H 39 ASN.? 1000.00 coo 12.51 17.07 49.46 12.44 16.89 47.35 -30.59 -68.33 -3.12 -29.92 -66.39 -2.72 coo 6.52 19.14 48.16 7.77 18.42 46.61 -26.81 -69.31 -7.75 -25.96 -70.91 -8.83 coo 9.30 22.40 41.76 10.10 20.96 40.36 -23.52 -74.80 -1.64 -21.44 -75.05 -2.04 2cpu_c01 source 2cpu ALPHA-AMYLASE : 2 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU B 44 GLU.? 1000.00 A 156 GLU E 93 GLU.? 1000.00 A 194 ASN D 39 ASN.? 1000.00 coo 74.14 15.91 8.55 72.08 15.36 8.63 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 67.47 20.07 1.34 65.99 20.06 2.88 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 67.44 25.26 13.91 67.54 23.65 15.28 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 2dbt_c00 source 2dbt CHITINASE C : 1 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU B 44 GLU.? 1000.00 C 156 GLU E 93 GLU.? 1000.00 C 194 ASN D 39 ASN.? 1000.00 coo 41.23 29.31 13.28 43.03 29.85 12.29 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 coo 44.75 23.09 5.51 46.77 22.91 6.12 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 49.75 21.00 18.12 50.45 23.02 18.26 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 2dbt_c02 source 2dbt CHITINASE C : 1 hits 2dbt_c02 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS C 94 HIS.? 1000.00 A 341 GLU C 93 GLU.? 1000.00 A 356 HIS C 95 HIS.? 1000.00 coo 121.00 36.37 19.26 121.57 38.37 19.56 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 125.72 32.70 19.75 124.44 34.16 18.84 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 124.34 41.73 25.55 123.79 42.60 23.72 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS C 94 HIS.? 1000.00 A 341 GLU C 93 GLU.? 1000.00 A 356 HIS C 96 HIS.? 1000.00 coo 121.00 36.37 19.26 121.57 38.37 19.56 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 125.72 32.70 19.75 124.44 34.16 18.84 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 124.34 41.73 25.55 123.79 42.60 23.72 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 A 311 HIS E 94 HIS.? 1000.00 A 341 GLU E 93 GLU.? 1000.00 A 356 HIS E 95 HIS.? 1000.00 coo 121.00 36.37 19.26 121.57 38.37 19.56 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 125.72 32.70 19.75 124.44 34.16 18.84 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 124.34 41.73 25.55 123.79 42.60 23.72 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 A 311 HIS E 94 HIS.? 1000.00 A 341 GLU E 93 GLU.? 1000.00 A 356 HIS E 96 HIS.? 1000.00 coo 121.00 36.37 19.26 121.57 38.37 19.56 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 125.72 32.70 19.75 124.44 34.16 18.84 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 124.34 41.73 25.55 123.79 42.60 23.72 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 A 311 HIS G 94 HIS.? 1000.00 A 341 GLU G 93 GLU.? 1000.00 A 356 HIS G 96 HIS.? 1000.00 coo 121.00 36.37 19.26 121.57 38.37 19.56 -8.64 -42.01 -86.48 -9.37 -43.48 -87.79 coo 125.72 32.70 19.75 124.44 34.16 18.84 -5.22 -46.46 -82.88 -6.14 -48.32 -83.21 coo 124.34 41.73 25.55 123.79 42.60 23.72 -4.23 -34.33 -81.91 -3.90 -35.35 -80.10 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 5 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS C 94 HIS.? 1000.00 B 341 GLU C 93 GLU.? 1000.00 B 356 HIS C 95 HIS.? 1000.00 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS C 94 HIS.? 1000.00 B 341 GLU C 93 GLU.? 1000.00 B 356 HIS C 96 HIS.? 1000.00 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 B 311 HIS E 94 HIS.? 1000.00 B 341 GLU E 93 GLU.? 1000.00 B 356 HIS E 95 HIS.? 1000.00 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 B 311 HIS E 94 HIS.? 1000.00 B 341 GLU E 93 GLU.? 1000.00 B 356 HIS E 96 HIS.? 1000.00 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 B 311 HIS G 94 HIS.? 1000.00 B 341 GLU G 93 GLU.? 1000.00 B 356 HIS G 96 HIS.? 1000.00 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -8.64 -42.01 -86.48 -9.37 -43.48 -87.79 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -5.22 -46.46 -82.88 -6.14 -48.32 -83.21 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -4.23 -34.33 -81.91 -3.90 -35.35 -80.10 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 5 hits 2isd_c01 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP B 43 ASP.? 1000.00 A 35 SER B 42 SER.? 1000.00 A 215 ASP D 43 ASP.? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -21.88 -37.46 -34.64 -22.77 -39.44 -33.60 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP D 40 ASP.? 1000.00 A 35 SER D 42 SER.? 1000.00 A 215 ASP B 40 ASP.? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 ULMN 3 2jxr_c04 LIGAND CP-081282 user 3 3 # 3 A 32 ASP D 40 ASP.? 1000.00 A 35 SER D 42 SER.? 1000.00 A 215 ASP B 43 ASP.? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 ULMN 3 2jxr_c04 LIGAND CP-081282 user 4 3 # 4 A 32 ASP D 43 ASP.? 1000.00 A 35 SER D 42 SER.? 1000.00 A 215 ASP B 43 ASP.? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -22.53 -43.18 -28.06 -21.23 -43.39 -26.40 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -26.05 -44.20 -31.02 -24.47 -43.29 -32.64 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 2jxr_c04 source 2jxr LIGAND CP-081282 : 4 hits 2jxr_c04 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS C 96 HIS.? 1000.00 A 102 ASP D 48 ASP^? 1000.00 A 193 GLY D 76 GLY.? 1000.00 coo 14.96 29.22 19.55 15.62 29.93 17.67 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 19.64 30.69 22.61 18.18 29.94 21.25 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 14.54 28.99 9.76 15.06 29.59 10.02 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS C 97 HIS.? 1000.00 A 102 ASP D 48 ASP^? 1000.00 A 193 GLY D 76 GLY.? 1000.00 coo 14.96 29.22 19.55 15.62 29.93 17.67 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 19.64 30.69 22.61 18.18 29.94 21.25 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 14.54 28.99 9.76 15.06 29.59 10.02 -44.06 -55.37 -15.75 -43.43 -54.72 -15.82 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 2 hits 2lpr_c02 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 40 ASP.? 1000.00 A 151 LYS A 38 LYS.? 1000.00 A 154 ASN A 39 ASN.? 1000.00 coo 41.42 17.90 44.98 43.39 18.36 45.61 -55.02 -16.32 -57.84 -55.96 -14.51 -57.37 coo 45.75 16.58 39.61 47.43 18.26 45.54 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 coo 44.77 13.10 43.25 45.01 14.21 45.03 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 43 ASP.? 1000.00 A 151 LYS A 38 LYS.? 1000.00 A 154 ASN A 39 ASN.? 1000.00 coo 41.42 17.90 44.98 43.39 18.36 45.61 -52.49 -15.23 -55.19 -52.13 -15.99 -53.25 coo 45.75 16.58 39.61 47.43 18.26 45.54 -51.21 -20.57 -60.12 -48.60 -24.25 -64.45 coo 44.77 13.10 43.25 45.01 14.21 45.03 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 ULMN 3 2phk_c03 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 40 ASP.? 1000.00 A 151 LYS B 38 LYS.? 1000.00 A 154 ASN B 39 ASN.? 1000.00 coo 41.42 17.90 44.98 43.39 18.36 45.61 -26.07 -40.58 -36.83 -24.74 -40.71 -35.19 coo 45.75 16.58 39.61 47.43 18.26 45.54 -28.55 -40.34 -42.27 -33.10 -38.98 -46.38 coo 44.77 13.10 43.25 45.01 14.21 45.03 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 ULMN 3 2phk_c03 MC-PEPTIDE user 4 3 # 4 A 149 ASP C 40 ASP.? 1000.00 A 151 LYS C 38 LYS.? 1000.00 A 154 ASN C 39 ASN.? 1000.00 coo 41.42 17.90 44.98 43.39 18.36 45.61 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo 45.75 16.58 39.61 47.43 18.26 45.54 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 coo 44.77 13.10 43.25 45.01 14.21 45.03 -49.60 -52.13 -34.79 -48.70 -51.69 -36.70 ULMN 3 2phk_c03 MC-PEPTIDE user 5 3 # 5 A 149 ASP D 40 ASP.? 1000.00 A 151 LYS D 38 LYS.? 1000.00 A 154 ASN D 39 ASN.? 1000.00 coo 41.42 17.90 44.98 43.39 18.36 45.61 -23.12 -39.68 -29.43 -22.77 -41.22 -30.83 coo 45.75 16.58 39.61 47.43 18.26 45.54 -24.48 -36.70 -24.17 -26.63 -33.27 -20.23 coo 44.77 13.10 43.25 45.01 14.21 45.03 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 ULMN 3 2phk_c03 MC-PEPTIDE user 6 3 # 6 A 149 ASP E 40 ASP.? 1000.00 A 151 LYS E 38 LYS.? 1000.00 A 154 ASN E 39 ASN.? 1000.00 coo 41.42 17.90 44.98 43.39 18.36 45.61 -17.17 -9.50 -39.47 -16.76 -7.92 -40.81 coo 45.75 16.58 39.61 47.43 18.26 45.54 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 coo 44.77 13.10 43.25 45.01 14.21 45.03 -15.68 -13.10 -36.31 -13.95 -13.09 -35.06 ULMN 3 2phk_c03 MC-PEPTIDE user 7 3 # 7 A 149 ASP E 43 ASP.? 1000.00 A 151 LYS E 38 LYS.? 1000.00 A 154 ASN E 39 ASN.? 1000.00 coo 41.42 17.90 44.98 43.39 18.36 45.61 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 coo 45.75 16.58 39.61 47.43 18.26 45.54 -20.31 -13.14 -35.38 -21.71 -15.41 -29.66 coo 44.77 13.10 43.25 45.01 14.21 45.03 -15.68 -13.10 -36.31 -13.95 -13.09 -35.06 ULMN 3 2phk_c03 MC-PEPTIDE user 8 3 # 8 A 149 ASP F 40 ASP.? 1000.00 A 151 LYS F 38 LYS.? 1000.00 A 154 ASN F 39 ASN.? 1000.00 coo 41.42 17.90 44.98 43.39 18.36 45.61 -50.84 -10.11 -12.96 -52.76 -9.84 -13.77 coo 45.75 16.58 39.61 47.43 18.26 45.54 -46.44 -13.40 -10.67 -42.01 -14.76 -6.37 coo 44.77 13.10 43.25 45.01 14.21 45.03 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 3 2phk_c03 MC-PEPTIDE user 9 3 # 9 A 149 ASP G 40 ASP.? 1000.00 A 151 LYS G 38 LYS.? 1000.00 A 154 ASN G 39 ASN.? 1000.00 coo 41.42 17.90 44.98 43.39 18.36 45.61 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo 45.75 16.58 39.61 47.43 18.26 45.54 6.01 -41.17 -63.42 7.43 -47.25 -63.10 coo 44.77 13.10 43.25 45.01 14.21 45.03 8.96 -39.36 -66.77 9.19 -41.39 -67.43 ULMN 3 2phk_c03 MC-PEPTIDE user 10 3 # 10 A 149 ASP H 40 ASP.? 1000.00 A 151 LYS H 38 LYS.? 1000.00 A 154 ASN H 39 ASN.? 1000.00 coo 41.42 17.90 44.98 43.39 18.36 45.61 -28.41 -71.72 -1.86 -30.52 -71.82 -1.58 coo 45.75 16.58 39.61 47.43 18.26 45.54 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 coo 44.77 13.10 43.25 45.01 14.21 45.03 -23.52 -74.80 -1.64 -21.44 -75.05 -2.04 2phk_c03 source 2phk MC-PEPTIDE : 10 hits 2phk_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 40 ASP.? 1000.00 166 GLY A 90 GLY.? 1000.00 169 GLU A 93 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -55.02 -16.32 -57.84 -55.96 -14.51 -57.37 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -51.65 -32.58 -50.51 -51.99 -31.85 -50.50 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -58.23 -39.46 -44.71 -56.91 -40.86 -43.86 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 48 ASP^? 1000.00 166 GLY A 36 GLY^? 1000.00 169 GLU A 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -48.92 -17.78 -55.02 -48.59 -18.42 -55.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -55.52 -22.04 -48.78 -55.83 -22.12 -46.66 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 48 ASP^? 1000.00 166 GLY E 36 GLY^? 1000.00 169 GLU E 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -35.45 -8.95 -52.36 -33.56 -8.55 -53.24 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 43 ASP.? 1000.00 166 GLY C 90 GLY.? 1000.00 169 GLU C 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -21.90 -41.55 -37.18 -21.29 -42.77 -38.79 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 48 ASP^? 1000.00 166 GLY B 36 GLY^? 1000.00 169 GLU B 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -22.50 -41.19 -42.75 -23.11 -41.11 -43.34 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -22.88 -49.80 -39.31 -21.34 -51.14 -38.73 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 48 ASP^? 1000.00 166 GLY G 36 GLY^? 1000.00 169 GLU G 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.93 -38.28 -61.29 1.11 -39.11 -61.33 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -1.79 -35.47 -70.29 0.16 -34.68 -70.26 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP C 40 ASP.? 1000.00 166 GLY C 90 GLY.? 1000.00 169 GLU C 93 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP C 40 ASP.? 1000.00 166 GLY C 90 GLY.? 1000.00 169 GLU D 44 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -51.77 -50.90 -29.92 -52.85 -51.30 -28.13 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP C 43 ASP.? 1000.00 166 GLY C 90 GLY.? 1000.00 169 GLU C 93 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -27.89 -54.02 -28.07 -26.15 -53.25 -29.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP C 43 ASP.? 1000.00 166 GLY C 90 GLY.? 1000.00 169 GLU D 44 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -52.26 -48.35 -26.01 -50.70 -47.15 -25.23 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -34.47 -47.85 -28.16 -35.19 -48.09 -27.80 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -27.41 -43.48 -25.41 -29.39 -42.96 -24.87 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP C 48 ASP^? 1000.00 166 GLY C 36 GLY^? 1000.00 169 GLU C 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -49.78 -44.46 -28.07 -49.37 -44.25 -28.79 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP C 48 ASP^? 1000.00 166 GLY F 36 GLY^? 1000.00 169 GLU F 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -56.38 -30.36 -23.59 -57.81 -31.22 -24.82 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -48.82 -16.54 -15.32 -48.14 -16.69 -14.82 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP D 48 ASP^? 1000.00 166 GLY D 36 GLY^? 1000.00 169 GLU D 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP D 48 ASP^? 1000.00 166 GLY H 36 GLY^? 1000.00 169 GLU H 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -26.14 -65.80 -4.11 -25.33 -65.96 -3.96 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -29.93 -63.04 6.06 -30.63 -65.03 6.10 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP E 40 ASP.? 1000.00 166 GLY E 90 GLY.? 1000.00 169 GLU E 93 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -17.17 -9.50 -39.47 -16.76 -7.92 -40.81 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP E 43 ASP.? 1000.00 166 GLY E 90 GLY.? 1000.00 169 GLU B 44 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -21.11 -36.33 -41.49 -22.32 -34.63 -41.36 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP E 43 ASP.? 1000.00 166 GLY E 90 GLY.? 1000.00 169 GLU E 93 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -19.36 -10.06 -42.72 -20.13 -11.84 -43.56 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.30 -28.07 -39.25 -18.01 -27.35 -39.56 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.66 -34.68 -38.92 -11.75 -35.64 -37.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 18 3 # 18 141 ASP E 48 ASP^? 1000.00 166 GLY E 36 GLY^? 1000.00 169 GLU E 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -37.64 -7.84 -46.04 -39.54 -7.13 -45.44 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -23.09 -13.07 -40.89 -23.29 -13.51 -40.18 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -14.64 -19.91 -44.28 -13.47 -18.20 -43.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 19 3 # 19 141 ASP F 48 ASP^? 1000.00 166 GLY C 36 GLY^? 1000.00 169 GLU C 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -49.78 -44.46 -28.07 -49.37 -44.25 -28.79 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -42.64 -51.67 -23.57 -44.07 -53.00 -24.35 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 20 3 # 20 141 ASP F 48 ASP^? 1000.00 166 GLY F 36 GLY^? 1000.00 169 GLU F 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -55.44 -31.25 -16.95 -55.78 -33.00 -15.82 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -48.82 -16.54 -15.32 -48.14 -16.69 -14.82 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -45.56 -10.12 -21.90 -46.60 -8.36 -21.37 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 21 3 # 21 141 ASP G 40 ASP.? 1000.00 166 GLY G 90 GLY.? 1000.00 169 GLU G 93 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 6.57 -35.54 -64.10 6.50 -33.43 -64.08 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -4.70 -45.99 -73.87 -4.44 -45.21 -73.62 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -5.22 -46.46 -82.88 -6.14 -48.32 -83.21 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 22 3 # 22 141 ASP G 43 ASP.? 1000.00 166 GLY G 90 GLY.? 1000.00 169 GLU G 93 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 2.83 -33.73 -62.69 0.93 -34.64 -62.87 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -4.70 -45.99 -73.87 -4.44 -45.21 -73.62 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -5.22 -46.46 -82.88 -6.14 -48.32 -83.21 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 23 3 # 23 141 ASP H 48 ASP^? 1000.00 166 GLY D 36 GLY^? 1000.00 169 GLU D 62 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -22.79 -42.64 -22.94 -23.03 -42.04 -22.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 23 hits 2tdt_c00 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG B 74 ARG^? 1000.00 195 HIS E 97 HIS.? 1000.00 199 ASP B 48 ASP^? 1000.00 coo 21.96 2.03 15.24 19.33 1.86 13.55 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 2 3 # 2 18 ARG D 74 ARG^? 1000.00 195 HIS C 95 HIS.? 1000.00 199 ASP D 48 ASP^? 1000.00 coo 21.96 2.03 15.24 19.33 1.86 13.55 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 3 3 # 3 18 ARG D 74 ARG^? 1000.00 195 HIS C 97 HIS.? 1000.00 199 ASP D 48 ASP^? 1000.00 coo 21.96 2.03 15.24 19.33 1.86 13.55 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 4 3 # 4 18 ARG G 74 ARG^? 1000.00 195 HIS E 94 HIS.? 1000.00 199 ASP G 48 ASP^? 1000.00 coo 21.96 2.03 15.24 19.33 1.86 13.55 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 5 3 # 5 18 ARG G 74 ARG^? 1000.00 195 HIS E 95 HIS.? 1000.00 199 ASP G 48 ASP^? 1000.00 coo 21.96 2.03 15.24 19.33 1.86 13.55 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 6 3 # 6 18 ARG H 74 ARG^? 1000.00 195 HIS C 94 HIS.? 1000.00 199 ASP H 48 ASP^? 1000.00 coo 21.96 2.03 15.24 19.33 1.86 13.55 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 7 3 # 7 18 ARG H 74 ARG^? 1000.00 195 HIS C 95 HIS.? 1000.00 199 ASP H 48 ASP^? 1000.00 coo 21.96 2.03 15.24 19.33 1.86 13.55 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 7 hits 3cla_c00 naa= 3 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 1 3 # 1 A 202 HIS C 94 HIS.? 1000.00 A 295 HIS C 97 HIS.? 1000.00 A 296 HIS C 96 HIS.? 1000.00 coo 65.34 65.04 50.22 63.95 63.70 51.06 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 63.46 53.34 50.98 63.08 55.39 51.17 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 64.71 54.80 47.28 63.92 56.57 48.06 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 2 3 # 2 A 202 HIS C 98 HIS.? 1000.00 A 295 HIS C 96 HIS.? 1000.00 A 296 HIS C 95 HIS.? 1000.00 coo 65.34 65.04 50.22 63.95 63.70 51.06 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 63.46 53.34 50.98 63.08 55.39 51.17 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 64.71 54.80 47.28 63.92 56.57 48.06 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 3 3 # 3 A 202 HIS E 95 HIS.? 1000.00 A 295 HIS E 98 HIS.? 1000.00 A 296 HIS E 97 HIS.? 1000.00 coo 65.34 65.04 50.22 63.95 63.70 51.06 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 63.46 53.34 50.98 63.08 55.39 51.17 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 64.71 54.80 47.28 63.92 56.57 48.06 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 4 3 # 4 A 202 HIS E 98 HIS.? 1000.00 A 295 HIS E 95 HIS.? 1000.00 A 296 HIS E 96 HIS.? 1000.00 coo 65.34 65.04 50.22 63.95 63.70 51.06 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 63.46 53.34 50.98 63.08 55.39 51.17 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 64.71 54.80 47.28 63.92 56.57 48.06 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 5 3 # 5 A 202 HIS E 98 HIS.? 1000.00 A 295 HIS E 96 HIS.? 1000.00 A 296 HIS E 95 HIS.? 1000.00 coo 65.34 65.04 50.22 63.95 63.70 51.06 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 63.46 53.34 50.98 63.08 55.39 51.17 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 64.71 54.80 47.28 63.92 56.57 48.06 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 4kbp_c00 source 4kbp PURPLE ACID PHOSPHATASE : 5 hits 4kbp_c00 naa= 3 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 1 3 # 1 B 202 HIS C 94 HIS.? 1000.00 B 295 HIS C 96 HIS.? 1000.00 B 296 HIS C 97 HIS.? 1000.00 coo 20.09 23.80 58.44 19.07 25.34 59.44 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 19.00 35.58 58.05 18.83 33.61 58.74 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 22.88 34.01 57.66 22.04 32.37 58.63 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 2 3 # 2 B 202 HIS C 94 HIS.? 1000.00 B 295 HIS C 97 HIS.? 1000.00 B 296 HIS C 96 HIS.? 1000.00 coo 20.09 23.80 58.44 19.07 25.34 59.44 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 19.00 35.58 58.05 18.83 33.61 58.74 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 22.88 34.01 57.66 22.04 32.37 58.63 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 3 3 # 3 B 202 HIS C 98 HIS.? 1000.00 B 295 HIS C 96 HIS.? 1000.00 B 296 HIS C 95 HIS.? 1000.00 coo 20.09 23.80 58.44 19.07 25.34 59.44 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 19.00 35.58 58.05 18.83 33.61 58.74 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 22.88 34.01 57.66 22.04 32.37 58.63 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 4 3 # 4 B 202 HIS E 95 HIS.? 1000.00 B 295 HIS E 98 HIS.? 1000.00 B 296 HIS E 97 HIS.? 1000.00 coo 20.09 23.80 58.44 19.07 25.34 59.44 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 19.00 35.58 58.05 18.83 33.61 58.74 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 22.88 34.01 57.66 22.04 32.37 58.63 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 5 3 # 5 B 202 HIS E 98 HIS.? 1000.00 B 295 HIS E 95 HIS.? 1000.00 B 296 HIS E 96 HIS.? 1000.00 coo 20.09 23.80 58.44 19.07 25.34 59.44 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 19.00 35.58 58.05 18.83 33.61 58.74 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 22.88 34.01 57.66 22.04 32.37 58.63 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 6 3 # 6 B 202 HIS E 98 HIS.? 1000.00 B 295 HIS E 96 HIS.? 1000.00 B 296 HIS E 95 HIS.? 1000.00 coo 20.09 23.80 58.44 19.07 25.34 59.44 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 19.00 35.58 58.05 18.83 33.61 58.74 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 22.88 34.01 57.66 22.04 32.37 58.63 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 4kbp_c01 source 4kbp PURPLE ACID PHOSPHATASE : 6 hits 4kbp_c01 naa= 3 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 1 3 # 1 C 202 HIS C 94 HIS.? 1000.00 C 295 HIS C 97 HIS.? 1000.00 C 296 HIS C 96 HIS.? 1000.00 coo 56.07 24.38 61.64 57.15 25.46 60.21 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 57.19 35.56 57.82 57.34 33.47 57.88 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 53.24 34.19 58.78 54.08 32.31 58.44 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 2 3 # 2 C 202 HIS C 98 HIS.? 1000.00 C 295 HIS C 96 HIS.? 1000.00 C 296 HIS C 95 HIS.? 1000.00 coo 56.07 24.38 61.64 57.15 25.46 60.21 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 57.19 35.56 57.82 57.34 33.47 57.88 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 53.24 34.19 58.78 54.08 32.31 58.44 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 3 3 # 3 C 202 HIS E 94 HIS.? 1000.00 C 295 HIS E 97 HIS.? 1000.00 C 296 HIS E 96 HIS.? 1000.00 coo 56.07 24.38 61.64 57.15 25.46 60.21 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 coo 57.19 35.56 57.82 57.34 33.47 57.88 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 coo 53.24 34.19 58.78 54.08 32.31 58.44 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 4 3 # 4 C 202 HIS E 95 HIS.? 1000.00 C 295 HIS E 98 HIS.? 1000.00 C 296 HIS E 97 HIS.? 1000.00 coo 56.07 24.38 61.64 57.15 25.46 60.21 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 57.19 35.56 57.82 57.34 33.47 57.88 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 53.24 34.19 58.78 54.08 32.31 58.44 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 5 3 # 5 C 202 HIS E 98 HIS.? 1000.00 C 295 HIS E 95 HIS.? 1000.00 C 296 HIS E 96 HIS.? 1000.00 coo 56.07 24.38 61.64 57.15 25.46 60.21 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 57.19 35.56 57.82 57.34 33.47 57.88 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 53.24 34.19 58.78 54.08 32.31 58.44 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 6 3 # 6 C 202 HIS E 98 HIS.? 1000.00 C 295 HIS E 96 HIS.? 1000.00 C 296 HIS E 95 HIS.? 1000.00 coo 56.07 24.38 61.64 57.15 25.46 60.21 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 57.19 35.56 57.82 57.34 33.47 57.88 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 53.24 34.19 58.78 54.08 32.31 58.44 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 4kbp_c02 source 4kbp PURPLE ACID PHOSPHATASE : 6 hits 4kbp_c02 naa= 3 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 1 3 # 1 D 202 HIS C 94 HIS.? 1000.00 D 295 HIS C 96 HIS.? 1000.00 D 296 HIS C 97 HIS.? 1000.00 coo 61.78 113.98 49.61 62.80 115.33 50.85 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 63.27 125.61 50.94 63.59 123.54 51.16 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 63.24 124.12 46.99 63.79 122.40 48.02 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 2 3 # 2 D 202 HIS C 94 HIS.? 1000.00 D 295 HIS C 97 HIS.? 1000.00 D 296 HIS C 96 HIS.? 1000.00 coo 61.78 113.98 49.61 62.80 115.33 50.85 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 coo 63.27 125.61 50.94 63.59 123.54 51.16 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 coo 63.24 124.12 46.99 63.79 122.40 48.02 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 3 3 # 3 D 202 HIS C 98 HIS.? 1000.00 D 295 HIS C 96 HIS.? 1000.00 D 296 HIS C 95 HIS.? 1000.00 coo 61.78 113.98 49.61 62.80 115.33 50.85 -31.43 -66.72 -14.53 -31.88 -68.71 -15.03 coo 63.27 125.61 50.94 63.59 123.54 51.16 -34.70 -58.43 -18.95 -35.56 -57.28 -20.49 coo 63.24 124.12 46.99 63.79 122.40 48.02 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 4 3 # 4 D 202 HIS E 95 HIS.? 1000.00 D 295 HIS E 98 HIS.? 1000.00 D 296 HIS E 97 HIS.? 1000.00 coo 61.78 113.98 49.61 62.80 115.33 50.85 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 63.27 125.61 50.94 63.59 123.54 51.16 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 63.24 124.12 46.99 63.79 122.40 48.02 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 5 3 # 5 D 202 HIS E 98 HIS.? 1000.00 D 295 HIS E 95 HIS.? 1000.00 D 296 HIS E 96 HIS.? 1000.00 coo 61.78 113.98 49.61 62.80 115.33 50.85 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 63.27 125.61 50.94 63.59 123.54 51.16 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 coo 63.24 124.12 46.99 63.79 122.40 48.02 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 6 3 # 6 D 202 HIS E 98 HIS.? 1000.00 D 295 HIS E 96 HIS.? 1000.00 D 296 HIS E 95 HIS.? 1000.00 coo 61.78 113.98 49.61 62.80 115.33 50.85 -1.03 -30.91 -54.82 -1.57 -30.66 -56.84 coo 63.27 125.61 50.94 63.59 123.54 51.16 -7.73 -28.69 -47.80 -9.36 -27.74 -46.87 coo 63.24 124.12 46.99 63.79 122.40 48.02 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 4kbp_c03 source 4kbp PURPLE ACID PHOSPHATASE : 6 hits 4kbp_c03 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP B 48 ASP^? 1000.00 A 161 ARG B 74 ARG^? 1000.00 A 186 HIS E 97 HIS.? 1000.00 coo 18.62 26.83 58.17 18.48 28.64 57.08 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 23.76 27.69 57.88 24.05 29.81 55.69 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 16.67 31.22 54.64 18.74 31.15 54.14 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP D 48 ASP^? 1000.00 A 161 ARG D 74 ARG^? 1000.00 A 186 HIS C 97 HIS.? 1000.00 coo 18.62 26.83 58.17 18.48 28.64 57.08 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 23.76 27.69 57.88 24.05 29.81 55.69 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 16.67 31.22 54.64 18.74 31.15 54.14 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 A 158 ASP G 48 ASP^? 1000.00 A 161 ARG G 74 ARG^? 1000.00 A 186 HIS E 94 HIS.? 1000.00 coo 18.62 26.83 58.17 18.48 28.64 57.08 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 23.76 27.69 57.88 24.05 29.81 55.69 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 16.67 31.22 54.64 18.74 31.15 54.14 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 A 158 ASP G 48 ASP^? 1000.00 A 161 ARG G 74 ARG^? 1000.00 A 186 HIS E 95 HIS.? 1000.00 coo 18.62 26.83 58.17 18.48 28.64 57.08 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 23.76 27.69 57.88 24.05 29.81 55.69 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 16.67 31.22 54.64 18.74 31.15 54.14 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 3 # 5 A 158 ASP H 48 ASP^? 1000.00 A 161 ARG H 74 ARG^? 1000.00 A 186 HIS C 94 HIS.? 1000.00 coo 18.62 26.83 58.17 18.48 28.64 57.08 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 23.76 27.69 57.88 24.05 29.81 55.69 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 16.67 31.22 54.64 18.74 31.15 54.14 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 3 # 6 A 158 ASP H 48 ASP^? 1000.00 A 161 ARG H 74 ARG^? 1000.00 A 186 HIS C 95 HIS.? 1000.00 coo 18.62 26.83 58.17 18.48 28.64 57.08 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 23.76 27.69 57.88 24.05 29.81 55.69 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 16.67 31.22 54.64 18.74 31.15 54.14 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 6 hits 4mdh_c02 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP B 48 ASP^? 1000.00 B 161 ARG B 74 ARG^? 1000.00 B 186 HIS E 97 HIS.? 1000.00 coo 44.53 16.44 28.54 44.89 18.45 28.77 -10.68 -32.03 -49.16 -10.22 -30.55 -50.65 coo 39.64 19.27 28.15 40.19 21.74 29.94 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 48.32 20.00 31.44 46.45 20.91 31.50 -6.41 -30.59 -53.57 -8.33 -30.41 -54.39 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 B 158 ASP D 48 ASP^? 1000.00 B 161 ARG D 74 ARG^? 1000.00 B 186 HIS C 95 HIS.? 1000.00 coo 44.53 16.44 28.54 44.89 18.45 28.77 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 39.64 19.27 28.15 40.19 21.74 29.94 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 48.32 20.00 31.44 46.45 20.91 31.50 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 B 158 ASP D 48 ASP^? 1000.00 B 161 ARG D 74 ARG^? 1000.00 B 186 HIS C 97 HIS.? 1000.00 coo 44.53 16.44 28.54 44.89 18.45 28.77 -31.42 -55.35 -17.21 -33.11 -55.77 -15.99 coo 39.64 19.27 28.15 40.19 21.74 29.94 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 48.32 20.00 31.44 46.45 20.91 31.50 -33.61 -59.44 -13.15 -33.92 -57.44 -12.61 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 B 158 ASP G 48 ASP^? 1000.00 B 161 ARG G 74 ARG^? 1000.00 B 186 HIS E 94 HIS.? 1000.00 coo 44.53 16.44 28.54 44.89 18.45 28.77 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 39.64 19.27 28.15 40.19 21.74 29.94 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 48.32 20.00 31.44 46.45 20.91 31.50 -9.29 -37.28 -43.26 -9.82 -39.10 -42.36 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 3 # 5 B 158 ASP G 48 ASP^? 1000.00 B 161 ARG G 74 ARG^? 1000.00 B 186 HIS E 95 HIS.? 1000.00 coo 44.53 16.44 28.54 44.89 18.45 28.77 -5.76 -36.87 -46.82 -5.55 -37.68 -44.86 coo 39.64 19.27 28.15 40.19 21.74 29.94 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 48.32 20.00 31.44 46.45 20.91 31.50 -4.55 -30.61 -44.52 -3.95 -28.61 -44.33 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 3 # 6 B 158 ASP H 48 ASP^? 1000.00 B 161 ARG H 74 ARG^? 1000.00 B 186 HIS C 94 HIS.? 1000.00 coo 44.53 16.44 28.54 44.89 18.45 28.77 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 39.64 19.27 28.15 40.19 21.74 29.94 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 48.32 20.00 31.44 46.45 20.91 31.50 -25.71 -56.15 -22.34 -23.80 -55.62 -23.02 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 7 3 # 7 B 158 ASP H 48 ASP^? 1000.00 B 161 ARG H 74 ARG^? 1000.00 B 186 HIS C 95 HIS.? 1000.00 coo 44.53 16.44 28.54 44.89 18.45 28.77 -26.39 -59.83 -19.00 -25.38 -59.86 -20.86 coo 39.64 19.27 28.15 40.19 21.74 29.94 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 48.32 20.00 31.44 46.45 20.91 31.50 -32.15 -61.42 -21.92 -34.17 -61.85 -22.26 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 7 hits 4mdh_c03 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 6 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.69 -27.01 -60.63 -31.82 -29.10 -60.16 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 11 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -40.60 -31.75 -47.42 -38.71 -32.73 -47.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 39 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -56.04 -20.54 -60.13 -56.74 -22.38 -60.98 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 60 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -49.81 -20.16 -43.76 -51.67 -19.27 -43.26 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 64 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -56.38 -30.36 -52.57 -56.99 -30.84 -54.55 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 75 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -26.84 -8.14 -61.63 -24.82 -7.63 -61.10 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 6 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -25.96 -37.29 -62.56 -27.50 -37.05 -64.03 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 11 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -21.79 -51.90 -56.91 -21.57 -52.35 -58.98 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 39 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.13 -41.21 -38.31 -32.89 -41.03 -39.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 60 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -15.86 -50.56 -42.98 -15.94 -50.96 -40.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 64 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -30.23 -53.68 -43.07 -32.28 -53.15 -43.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 75 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.12 -21.77 -56.53 -13.64 -22.77 -58.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN C 6 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -42.10 -28.46 -38.73 -40.02 -28.94 -38.77 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN C 11 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -33.93 -36.54 -26.69 -32.43 -35.02 -26.74 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN C 39 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -49.60 -52.13 -34.79 -48.70 -51.69 -36.70 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN C 60 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -44.35 -44.07 -18.35 -45.01 -45.72 -17.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN C 64 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN C 75 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -59.90 -22.40 -33.64 -59.93 -20.29 -33.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN D 6 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -29.84 -39.89 -4.27 -29.61 -38.33 -2.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN D 11 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.39 -42.03 -7.81 -13.24 -42.08 -5.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN D 39 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN D 60 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.49 -48.64 -21.67 -12.21 -50.31 -21.41 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN D 64 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.34 -34.22 -21.55 -12.11 -32.24 -21.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN D 75 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN E 6 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -38.98 -21.76 -31.06 -40.11 -22.17 -29.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN E 11 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -29.20 -29.79 -41.39 -30.70 -31.31 -41.23 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN E 39 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -15.68 -13.10 -36.31 -13.95 -13.09 -35.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN E 60 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -22.11 -19.81 -50.15 -20.36 -18.78 -50.75 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN E 64 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN E 75 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.28 -5.16 -37.03 -48.34 -5.12 -37.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN F 6 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -36.26 -31.68 -8.47 -34.18 -31.58 -8.89 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN F 11 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -33.67 -23.03 -22.79 -32.30 -24.62 -23.11 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 33 1 # 33 A 461 ASN F 39 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.62 -8.58 -10.47 -44.56 -8.84 -9.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 34 1 # 34 A 461 ASN F 60 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -46.99 -16.58 -26.18 -47.19 -16.72 -28.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 35 1 # 35 A 461 ASN F 64 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -37.43 -7.55 -18.77 -36.26 -6.95 -17.07 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 36 1 # 36 A 461 ASN F 75 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -55.55 -38.95 -7.02 -53.42 -39.19 -7.13 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 37 1 # 37 A 461 ASN G 6 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -4.06 -56.28 -52.83 -4.67 -57.86 -54.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 38 1 # 38 A 461 ASN G 11 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.72 -49.35 -65.84 -13.49 -50.35 -66.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 39 1 # 39 A 461 ASN G 39 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 8.96 -39.36 -66.77 9.19 -41.39 -67.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 40 1 # 40 A 461 ASN G 60 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.92 -34.66 -65.50 -6.82 -32.91 -66.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 41 1 # 41 A 461 ASN G 64 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -0.17 -42.42 -75.48 1.47 -43.70 -76.00 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 42 1 # 42 A 461 ASN G 75 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -1.10 -45.07 -37.41 -2.90 -46.10 -36.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 43 1 # 43 A 461 ASN H 6 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.41 -59.81 -10.36 -6.89 -58.60 -8.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 44 1 # 44 A 461 ASN H 11 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.58 -51.98 1.51 -14.95 -50.69 1.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 45 1 # 45 A 461 ASN H 39 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -23.52 -74.80 -1.64 -21.44 -75.05 -2.04 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 46 1 # 46 A 461 ASN H 60 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -31.01 -56.42 0.05 -32.76 -57.44 0.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 47 1 # 47 A 461 ASN H 64 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -24.09 -64.10 10.32 -22.76 -65.61 11.03 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 48 1 # 48 A 461 ASN H 75 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.78 -63.47 -26.75 -16.16 -62.12 -28.26 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 48 hits 1kbk_p00 naa= 1 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 1 4 # 1 A 25 ILE E 7 ILE^? 1000.00 A 52 ASN B 11 ASN.? 1000.00 A 53 VAL B 18 VAL^? 1000.00 A 78 ASN E 6 ASN^? 1000.00 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -34.01 -18.77 -33.22 -32.68 -18.20 -33.33 coo 81.20 29.47 37.49 79.47 28.44 38.24 -21.79 -51.90 -56.91 -21.57 -52.35 -58.98 coo 82.17 24.86 36.27 81.03 23.67 37.80 -19.95 -47.28 -55.06 -19.02 -48.23 -56.81 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -38.98 -21.76 -31.06 -40.11 -22.17 -29.30 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 2 4 # 2 A 25 ILE G 28 ILE.? 1000.00 A 52 ASN H 11 ASN.? 1000.00 A 53 VAL H 18 VAL^? 1000.00 A 78 ASN G 75 ASN^? 1000.00 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -4.63 -46.69 -40.37 -4.24 -47.46 -41.55 coo 81.20 29.47 37.49 79.47 28.44 38.24 -16.58 -51.98 1.51 -14.95 -50.69 1.02 coo 82.17 24.86 36.27 81.03 23.67 37.80 -18.30 -54.54 -3.01 -17.48 -52.52 -3.20 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -1.10 -45.07 -37.41 -2.90 -46.10 -36.91 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 3 4 # 3 A 25 ILE H 28 ILE.? 1000.00 A 52 ASN G 11 ASN.? 1000.00 A 53 VAL G 18 VAL^? 1000.00 A 78 ASN H 75 ASN.? 1000.00 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 -15.57 -60.00 -23.89 -14.92 -60.30 -22.63 coo 81.20 29.47 37.49 79.47 28.44 38.24 -11.72 -49.35 -65.84 -13.49 -50.35 -66.39 coo 82.17 24.86 36.27 81.03 23.67 37.80 -9.77 -46.99 -61.69 -11.73 -47.89 -61.44 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 -16.78 -63.47 -26.75 -16.16 -62.12 -28.26 1qfw_p00 source 1qfw GONADOTROPIN ALPHA SUBUNIT : 3 hits 1qfw_p00 naa= 4 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN B 64 ASN.? 1000.00 A 384 ASN H 75 ASN.? 1000.00 A 385 GLU H 29 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 -30.23 -53.68 -43.07 -32.28 -53.15 -43.30 coo 7.06 50.07 96.17 8.50 48.54 96.31 -16.78 -63.47 -26.75 -16.16 -62.12 -28.26 coo 11.59 49.83 99.41 10.92 47.97 100.16 -19.75 -60.10 -27.61 -21.15 -61.23 -28.71 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN C 11 ASN.? 1000.00 A 384 ASN D 64 ASN.? 1000.00 A 385 GLU D 62 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 -33.93 -36.54 -26.69 -32.43 -35.02 -26.74 coo 7.06 50.07 96.17 8.50 48.54 96.31 -11.34 -34.22 -21.55 -12.11 -32.24 -21.32 coo 11.59 49.83 99.41 10.92 47.97 100.16 -12.74 -40.32 -25.63 -13.68 -39.77 -27.45 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN C 64 ASN.? 1000.00 A 384 ASN H 75 ASN.? 1000.00 A 385 GLU H 29 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 coo 7.06 50.07 96.17 8.50 48.54 96.31 -16.78 -63.47 -26.75 -16.16 -62.12 -28.26 coo 11.59 49.83 99.41 10.92 47.97 100.16 -19.75 -60.10 -27.61 -21.15 -61.23 -28.71 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN D 39 ASN.? 1000.00 A 384 ASN G 75 ASN^? 1000.00 A 385 GLU G 29 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 -23.85 -34.50 -28.36 -24.19 -32.78 -27.13 coo 7.06 50.07 96.17 8.50 48.54 96.31 -1.10 -45.07 -37.41 -2.90 -46.10 -36.91 coo 11.59 49.83 99.41 10.92 47.97 100.16 -5.31 -41.94 -36.91 -3.79 -40.93 -35.87 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN E 64 ASN.? 1000.00 A 384 ASN G 75 ASN^? 1000.00 A 385 GLU G 29 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 coo 7.06 50.07 96.17 8.50 48.54 96.31 -1.10 -45.07 -37.41 -2.90 -46.10 -36.91 coo 11.59 49.83 99.41 10.92 47.97 100.16 -5.31 -41.94 -36.91 -3.79 -40.93 -35.87 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 5 hits 2v3r_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 37 ARG^? 1000.00 B 6 THR A 66 THR^? 1000.00 B 8 THR A 86 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -55.09 -19.97 -54.34 -55.19 -17.28 -52.85 coo 36.11 13.64 95.03 34.54 14.86 95.91 -51.73 -25.65 -57.14 -51.84 -26.51 -59.11 coo 32.72 8.05 92.39 31.25 9.11 91.35 -45.50 -25.51 -60.06 -46.77 -25.59 -61.84 ULMN 3 1b01_d00 GENE REGULATION/DNA user 2 3 # 2 B 4 ARG A 74 ARG^? 1000.00 B 6 THR A 50 THR.? 1000.00 B 8 THR A 54 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -32.79 -7.25 -57.44 -31.11 -6.28 -55.07 coo 36.11 13.64 95.03 34.54 14.86 95.91 -29.16 -13.23 -51.85 -28.30 -12.69 -49.95 coo 32.72 8.05 92.39 31.25 9.11 91.35 -30.80 -21.49 -51.59 -28.90 -22.44 -51.89 ULMN 3 1b01_d00 GENE REGULATION/DNA user 3 3 # 3 B 4 ARG A 74 ARG^? 1000.00 B 6 THR A 50 THR.? 1000.00 B 8 THR E 45 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -32.79 -7.25 -57.44 -31.11 -6.28 -55.07 coo 36.11 13.64 95.03 34.54 14.86 95.91 -29.16 -13.23 -51.85 -28.30 -12.69 -49.95 coo 32.72 8.05 92.39 31.25 9.11 91.35 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 ULMN 3 1b01_d00 GENE REGULATION/DNA user 4 3 # 4 B 4 ARG B 37 ARG^? 1000.00 B 6 THR B 66 THR^? 1000.00 B 8 THR B 86 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -25.67 -45.26 -38.37 -22.78 -45.37 -37.35 coo 36.11 13.64 95.03 34.54 14.86 95.91 -29.43 -45.79 -44.56 -31.38 -45.09 -45.08 coo 32.72 8.05 92.39 31.25 9.11 91.35 -29.28 -41.29 -49.77 -31.08 -40.36 -48.98 ULMN 3 1b01_d00 GENE REGULATION/DNA user 5 3 # 5 B 4 ARG B 70 ARG^? 1000.00 B 6 THR E 13 THR.? 1000.00 B 8 THR E 89 THR.? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 36.11 13.64 95.03 34.54 14.86 95.91 -22.32 -28.98 -42.19 -23.52 -29.23 -44.03 coo 32.72 8.05 92.39 31.25 9.11 91.35 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 ULMN 3 1b01_d00 GENE REGULATION/DNA user 6 3 # 6 B 4 ARG B 70 ARG^? 1000.00 B 6 THR E 15 THR.? 1000.00 B 8 THR E 89 THR.? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 36.11 13.64 95.03 34.54 14.86 95.91 -20.74 -24.83 -45.55 -19.80 -25.51 -47.38 coo 32.72 8.05 92.39 31.25 9.11 91.35 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 ULMN 3 1b01_d00 GENE REGULATION/DNA user 7 3 # 7 B 4 ARG B 70 ARG^? 1000.00 B 6 THR E 16 THR.? 1000.00 B 8 THR E 57 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 36.11 13.64 95.03 34.54 14.86 95.91 -24.49 -24.91 -44.90 -24.95 -26.52 -46.29 coo 32.72 8.05 92.39 31.25 9.11 91.35 -31.19 -22.88 -45.65 -31.34 -24.89 -46.32 ULMN 3 1b01_d00 GENE REGULATION/DNA user 8 3 # 8 B 4 ARG B 70 ARG^? 1000.00 B 6 THR E 16 THR.? 1000.00 B 8 THR E 89 THR.? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 36.11 13.64 95.03 34.54 14.86 95.91 -24.49 -24.91 -44.90 -24.95 -26.52 -46.29 coo 32.72 8.05 92.39 31.25 9.11 91.35 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 ULMN 3 1b01_d00 GENE REGULATION/DNA user 9 3 # 9 B 4 ARG B 74 ARG^? 1000.00 B 6 THR B 50 THR.? 1000.00 B 8 THR B 54 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 36.11 13.64 95.03 34.54 14.86 95.91 -9.35 -33.01 -56.60 -7.44 -33.01 -57.62 coo 32.72 8.05 92.39 31.25 9.11 91.35 -15.28 -38.81 -60.02 -15.02 -38.82 -62.16 ULMN 3 1b01_d00 GENE REGULATION/DNA user 10 3 # 10 B 4 ARG B 74 ARG^? 1000.00 B 6 THR B 50 THR.? 1000.00 B 8 THR G 45 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 36.11 13.64 95.03 34.54 14.86 95.91 -9.35 -33.01 -56.60 -7.44 -33.01 -57.62 coo 32.72 8.05 92.39 31.25 9.11 91.35 -1.50 -34.99 -56.46 -3.32 -34.36 -57.43 ULMN 3 1b01_d00 GENE REGULATION/DNA user 11 3 # 11 B 4 ARG B 74 ARG^? 1000.00 B 6 THR B 50 THR.? 1000.00 B 8 THR G 46 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 36.11 13.64 95.03 34.54 14.86 95.91 -9.35 -33.01 -56.60 -7.44 -33.01 -57.62 coo 32.72 8.05 92.39 31.25 9.11 91.35 -1.95 -36.32 -52.94 -0.35 -36.61 -51.51 ULMN 3 1b01_d00 GENE REGULATION/DNA user 12 3 # 12 B 4 ARG C 37 ARG^? 1000.00 B 6 THR C 66 THR^? 1000.00 B 8 THR C 86 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -47.98 -50.77 -27.47 -48.61 -50.31 -24.50 coo 36.11 13.64 95.03 34.54 14.86 95.91 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 coo 32.72 8.05 92.39 31.25 9.11 91.35 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 ULMN 3 1b01_d00 GENE REGULATION/DNA user 13 3 # 13 B 4 ARG C 74 ARG^? 1000.00 B 6 THR C 50 THR.? 1000.00 B 8 THR F 45 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -60.49 -27.62 -28.92 -60.33 -25.05 -27.20 coo 36.11 13.64 95.03 34.54 14.86 95.91 -52.69 -23.89 -24.82 -52.37 -22.60 -23.10 coo 32.72 8.05 92.39 31.25 9.11 91.35 -53.13 -20.55 -17.44 -52.54 -20.20 -19.48 ULMN 3 1b01_d00 GENE REGULATION/DNA user 14 3 # 14 B 4 ARG C 74 ARG^? 1000.00 B 6 THR C 50 THR.? 1000.00 B 8 THR F 46 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -60.49 -27.62 -28.92 -60.33 -25.05 -27.20 coo 36.11 13.64 95.03 34.54 14.86 95.91 -52.69 -23.89 -24.82 -52.37 -22.60 -23.10 coo 32.72 8.05 92.39 31.25 9.11 91.35 -53.66 -24.14 -16.36 -54.70 -24.62 -14.51 ULMN 3 1b01_d00 GENE REGULATION/DNA user 15 3 # 15 B 4 ARG D 37 ARG^? 1000.00 B 6 THR D 66 THR^? 1000.00 B 8 THR D 86 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -18.79 -39.36 -27.13 -18.50 -42.28 -28.04 coo 36.11 13.64 95.03 34.54 14.86 95.91 -19.29 -35.44 -21.10 -20.09 -33.46 -20.75 coo 32.72 8.05 92.39 31.25 9.11 91.35 -24.01 -35.70 -16.08 -25.04 -34.15 -17.17 ULMN 3 1b01_d00 GENE REGULATION/DNA user 16 3 # 16 B 4 ARG D 70 ARG^? 1000.00 B 6 THR C 16 THR.? 1000.00 B 8 THR C 57 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo 36.11 13.64 95.03 34.54 14.86 95.91 -38.73 -41.54 -23.23 -37.24 -40.73 -21.87 coo 32.72 8.05 92.39 31.25 9.11 91.35 -41.24 -34.76 -22.98 -39.22 -34.48 -22.21 ULMN 3 1b01_d00 GENE REGULATION/DNA user 17 3 # 17 B 4 ARG D 74 ARG^? 1000.00 B 6 THR D 50 THR.? 1000.00 B 8 THR D 54 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 36.11 13.64 95.03 34.54 14.86 95.91 -31.64 -55.98 -9.68 -30.59 -57.74 -8.93 coo 32.72 8.05 92.39 31.25 9.11 91.35 -26.58 -49.74 -5.75 -26.83 -49.90 -3.63 ULMN 3 1b01_d00 GENE REGULATION/DNA user 18 3 # 18 B 4 ARG D 74 ARG^? 1000.00 B 6 THR D 50 THR.? 1000.00 B 8 THR H 45 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 36.11 13.64 95.03 34.54 14.86 95.91 -31.64 -55.98 -9.68 -30.59 -57.74 -8.93 coo 32.72 8.05 92.39 31.25 9.11 91.35 -28.98 -64.21 -9.31 -29.95 -62.48 -8.44 ULMN 3 1b01_d00 GENE REGULATION/DNA user 19 3 # 19 B 4 ARG E 37 ARG^? 1000.00 B 6 THR E 66 THR^? 1000.00 B 8 THR E 86 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -16.50 -14.01 -41.09 -16.70 -12.05 -43.45 coo 36.11 13.64 95.03 34.54 14.86 95.91 -18.84 -18.95 -36.17 -18.49 -18.94 -34.03 coo 32.72 8.05 92.39 31.25 9.11 91.35 -24.93 -18.44 -32.83 -23.81 -17.47 -31.27 ULMN 3 1b01_d00 GENE REGULATION/DNA user 20 3 # 20 B 4 ARG E 74 ARG^? 1000.00 B 6 THR E 50 THR.? 1000.00 B 8 THR A 45 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -40.74 -4.80 -41.62 -42.54 -4.95 -44.12 coo 36.11 13.64 95.03 34.54 14.86 95.91 -43.37 -12.85 -45.31 -44.88 -13.46 -46.71 coo 32.72 8.05 92.39 31.25 9.11 91.35 -45.89 -12.76 -52.82 -46.50 -13.35 -50.80 ULMN 3 1b01_d00 GENE REGULATION/DNA user 21 3 # 21 B 4 ARG E 74 ARG^? 1000.00 B 6 THR E 50 THR.? 1000.00 B 8 THR A 46 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -40.74 -4.80 -41.62 -42.54 -4.95 -44.12 coo 36.11 13.64 95.03 34.54 14.86 95.91 -43.37 -12.85 -45.31 -44.88 -13.46 -46.71 coo 32.72 8.05 92.39 31.25 9.11 91.35 -42.27 -11.77 -53.40 -41.71 -11.05 -55.38 ULMN 3 1b01_d00 GENE REGULATION/DNA user 22 3 # 22 B 4 ARG E 74 ARG^? 1000.00 B 6 THR E 50 THR.? 1000.00 B 8 THR E 54 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -40.74 -4.80 -41.62 -42.54 -4.95 -44.12 coo 36.11 13.64 95.03 34.54 14.86 95.91 -43.37 -12.85 -45.31 -44.88 -13.46 -46.71 coo 32.72 8.05 92.39 31.25 9.11 91.35 -40.50 -20.24 -41.39 -42.17 -21.46 -40.79 ULMN 3 1b01_d00 GENE REGULATION/DNA user 23 3 # 23 B 4 ARG F 37 ARG^? 1000.00 B 6 THR F 66 THR^? 1000.00 B 8 THR F 86 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -48.09 -10.25 -16.84 -50.78 -9.38 -18.06 coo 36.11 13.64 95.03 34.54 14.86 95.91 -41.46 -12.42 -13.58 -40.70 -12.09 -11.59 coo 32.72 8.05 92.39 31.25 9.11 91.35 -40.71 -18.28 -10.10 -40.84 -17.16 -8.25 ULMN 3 1b01_d00 GENE REGULATION/DNA user 24 3 # 24 B 4 ARG F 74 ARG.? 1000.00 B 6 THR F 50 THR.? 1000.00 B 8 THR C 45 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -56.59 -34.51 -11.73 -58.13 -35.73 -14.10 coo 36.11 13.64 95.03 34.54 14.86 95.91 -50.93 -37.33 -17.07 -51.41 -38.42 -18.85 coo 32.72 8.05 92.39 31.25 9.11 91.35 -53.59 -40.92 -24.31 -52.41 -41.01 -22.49 ULMN 3 1b01_d00 GENE REGULATION/DNA user 25 3 # 25 B 4 ARG F 74 ARG.? 1000.00 B 6 THR F 50 THR.? 1000.00 B 8 THR C 46 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -56.59 -34.51 -11.73 -58.13 -35.73 -14.10 coo 36.11 13.64 95.03 34.54 14.86 95.91 -50.93 -37.33 -17.07 -51.41 -38.42 -18.85 coo 32.72 8.05 92.39 31.25 9.11 91.35 -54.65 -37.38 -25.18 -56.17 -36.99 -26.65 ULMN 3 1b01_d00 GENE REGULATION/DNA user 26 3 # 26 B 4 ARG G 37 ARG^? 1000.00 B 6 THR G 66 THR^? 1000.00 B 8 THR G 86 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 2.57 -36.22 -67.13 1.93 -33.23 -67.01 coo 36.11 13.64 95.03 34.54 14.86 95.91 2.66 -43.43 -68.00 4.28 -44.88 -68.13 coo 32.72 8.05 92.39 31.25 9.11 91.35 2.42 -48.12 -62.78 4.54 -47.79 -63.09 ULMN 3 1b01_d00 GENE REGULATION/DNA user 27 3 # 27 B 4 ARG G 74 ARG^? 1000.00 B 6 THR G 50 THR.? 1000.00 B 8 THR B 45 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 36.11 13.64 95.03 34.54 14.86 95.91 -10.38 -42.50 -44.42 -12.53 -42.19 -44.48 coo 32.72 8.05 92.39 31.25 9.11 91.35 -16.90 -38.16 -42.20 -16.20 -40.16 -42.73 ULMN 3 1b01_d00 GENE REGULATION/DNA user 28 3 # 28 B 4 ARG G 74 ARG^? 1000.00 B 6 THR G 50 THR.? 1000.00 B 8 THR B 46 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 coo 36.11 13.64 95.03 34.54 14.86 95.91 -10.38 -42.50 -44.42 -12.53 -42.19 -44.48 coo 32.72 8.05 92.39 31.25 9.11 91.35 -15.59 -35.86 -44.93 -16.46 -33.88 -45.17 ULMN 3 1b01_d00 GENE REGULATION/DNA user 29 3 # 29 B 4 ARG H 37 ARG^? 1000.00 B 6 THR H 66 THR^? 1000.00 B 8 THR H 86 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -28.82 -68.15 1.75 -31.05 -66.20 1.05 coo 36.11 13.64 95.03 34.54 14.86 95.91 -21.74 -67.10 3.11 -20.33 -68.69 3.44 coo 32.72 8.05 92.39 31.25 9.11 91.35 -16.49 -66.84 -1.43 -17.05 -68.81 -0.71 ULMN 3 1b01_d00 GENE REGULATION/DNA user 30 3 # 30 B 4 ARG H 70 ARG^? 1000.00 B 6 THR H 86 THR^? 1000.00 B 8 THR H 66 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo 36.11 13.64 95.03 34.54 14.86 95.91 -16.49 -66.84 -1.43 -17.05 -68.81 -0.71 coo 32.72 8.05 92.39 31.25 9.11 91.35 -21.74 -67.10 3.11 -20.33 -68.69 3.44 ULMN 3 1b01_d00 GENE REGULATION/DNA user 31 3 # 31 B 4 ARG H 70 ARG^? 1000.00 B 6 THR H 86 THR^? 1000.00 B 8 THR H 88 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo 36.11 13.64 95.03 34.54 14.86 95.91 -16.49 -66.84 -1.43 -17.05 -68.81 -0.71 coo 32.72 8.05 92.39 31.25 9.11 91.35 -19.24 -64.03 4.54 -19.35 -65.74 5.89 ULMN 3 1b01_d00 GENE REGULATION/DNA user 32 3 # 32 B 4 ARG H 74 ARG^? 1000.00 B 6 THR H 50 THR.? 1000.00 B 8 THR D 45 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 36.11 13.64 95.03 34.54 14.86 95.91 -20.90 -54.68 -20.55 -21.09 -52.53 -20.50 coo 32.72 8.05 92.39 31.25 9.11 91.35 -24.99 -48.61 -23.54 -22.98 -49.39 -23.53 ULMN 3 1b01_d00 GENE REGULATION/DNA user 33 3 # 33 B 4 ARG H 74 ARG^? 1000.00 B 6 THR H 50 THR.? 1000.00 B 8 THR D 46 THR^? 1000.00 coo 40.52 16.08 100.90 37.97 16.41 102.60 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 coo 36.11 13.64 95.03 34.54 14.86 95.91 -20.90 -54.68 -20.55 -21.09 -52.53 -20.50 coo 32.72 8.05 92.39 31.25 9.11 91.35 -27.50 -50.23 -21.22 -29.54 -49.49 -21.28 1b01_d00 source 1b01 GENE REGULATION/DNA : 33 hits 1b01_d00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 2 GLN.? 1000.00 A 11 ASN A 75 ASN^? 1000.00 A 13 ARG A 74 ARG^? 1000.00 coo 33.45 2.10 7.21 34.51 1.09 5.67 -25.90 -14.03 -63.96 -24.99 -12.36 -64.97 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -26.84 -8.14 -61.63 -24.82 -7.63 -61.10 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -32.79 -7.25 -57.44 -31.11 -6.28 -55.07 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN D 2 GLN.? 1000.00 A 11 ASN D 75 ASN^? 1000.00 A 13 ARG D 74 ARG^? 1000.00 coo 33.45 2.10 7.21 34.51 1.09 5.67 -41.44 -45.58 -6.76 -41.93 -43.56 -6.27 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 -42.84 -52.74 -11.90 -43.58 -54.13 -10.49 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 1bdv_d00 source 1bdv GENE REGULATION/DNA : 2 hits 1bdv_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 79 TYR^? 1000.00 I 306 VAL A 72 VAL^? 1000.00 I 308 VAL A 33 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -34.77 -7.49 -62.99 -34.80 -5.56 -60.96 coo 23.55 29.53 9.81 23.15 27.39 10.24 -35.63 -13.87 -61.02 -36.75 -12.37 -62.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 -38.62 -15.44 -55.32 -37.81 -17.18 -54.27 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 79 TYR^? 1000.00 I 306 VAL A 72 VAL^? 1000.00 I 308 VAL A 83 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -34.77 -7.49 -62.99 -34.80 -5.56 -60.96 coo 23.55 29.53 9.81 23.15 27.39 10.24 -35.63 -13.87 -61.02 -36.75 -12.37 -62.12 coo 16.43 30.18 9.35 15.05 30.67 11.01 -37.68 -19.50 -64.15 -35.86 -20.66 -63.99 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR B 79 TYR^? 1000.00 I 306 VAL B 72 VAL^? 1000.00 I 308 VAL B 33 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 coo 23.55 29.53 9.81 23.15 27.39 10.24 -19.80 -29.62 -52.47 -20.40 -28.25 -50.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 -17.53 -35.39 -50.03 -17.45 -36.96 -51.55 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR B 79 TYR^? 1000.00 I 306 VAL B 72 VAL^? 1000.00 I 308 VAL B 83 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 coo 23.55 29.53 9.81 23.15 27.39 10.24 -19.80 -29.62 -52.47 -20.40 -28.25 -50.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 -25.84 -32.10 -53.89 -25.34 -32.22 -55.98 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR C 79 TYR^? 1000.00 I 306 VAL C 72 VAL^? 1000.00 I 308 VAL C 33 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -61.03 -30.52 -33.37 -62.03 -30.38 -30.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 -54.22 -31.17 -33.71 -56.13 -32.11 -34.23 coo 16.43 30.18 9.35 15.05 30.67 11.01 -51.46 -34.18 -28.59 -49.42 -33.59 -28.15 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR C 79 TYR^? 1000.00 I 306 VAL C 72 VAL^? 1000.00 I 308 VAL C 83 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -61.03 -30.52 -33.37 -62.03 -30.38 -30.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 -54.22 -31.17 -33.71 -56.13 -32.11 -34.23 coo 16.43 30.18 9.35 15.05 30.67 11.01 -49.93 -33.71 -38.31 -48.42 -32.27 -37.71 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR D 79 TYR^? 1000.00 I 306 VAL D 72 VAL^? 1000.00 I 308 VAL D 33 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -35.06 -46.21 -14.84 -36.20 -45.67 -16.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 -28.90 -48.04 -16.23 -27.67 -48.06 -14.42 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR D 79 TYR^? 1000.00 I 306 VAL D 72 VAL^? 1000.00 I 308 VAL D 83 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 23.55 29.53 9.81 23.15 27.39 10.24 -35.06 -46.21 -14.84 -36.20 -45.67 -16.65 coo 16.43 30.18 9.35 15.05 30.67 11.01 -33.38 -39.99 -13.06 -33.42 -40.28 -10.91 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR E 79 TYR^? 1000.00 I 306 VAL E 72 VAL^? 1000.00 I 308 VAL E 33 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -37.58 -3.32 -36.78 -36.84 -2.73 -39.43 coo 23.55 29.53 9.81 23.15 27.39 10.24 -36.89 -9.68 -35.81 -36.05 -7.69 -35.36 coo 16.43 30.18 9.35 15.05 30.67 11.01 -33.52 -12.27 -40.75 -33.78 -14.42 -41.08 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR E 79 TYR^? 1000.00 I 306 VAL E 72 VAL^? 1000.00 I 308 VAL E 83 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -37.58 -3.32 -36.78 -36.84 -2.73 -39.43 coo 23.55 29.53 9.81 23.15 27.39 10.24 -36.89 -9.68 -35.81 -36.05 -7.69 -35.36 coo 16.43 30.18 9.35 15.05 30.67 11.01 -34.31 -13.44 -31.00 -35.73 -15.05 -30.63 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR F 79 TYR.? 1000.00 I 306 VAL F 72 VAL^? 1000.00 I 308 VAL F 33 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -56.52 -31.25 -6.27 -58.44 -31.38 -8.30 coo 23.55 29.53 9.81 23.15 27.39 10.24 -50.22 -29.81 -8.29 -51.94 -28.96 -7.21 coo 16.43 30.18 9.35 15.05 30.67 11.01 -49.38 -26.94 -14.25 -47.53 -27.47 -15.26 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR F 79 TYR.? 1000.00 I 306 VAL F 72 VAL^? 1000.00 I 308 VAL F 83 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -56.52 -31.25 -6.27 -58.44 -31.38 -8.30 coo 23.55 29.53 9.81 23.15 27.39 10.24 -50.22 -29.81 -8.29 -51.94 -28.96 -7.21 coo 16.43 30.18 9.35 15.05 30.67 11.01 -44.96 -26.92 -5.54 -43.57 -28.55 -5.80 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR G 79 TYR^? 1000.00 I 306 VAL G 72 VAL^? 1000.00 I 308 VAL G 33 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.85 -41.15 -42.84 3.12 -38.52 -42.24 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.50 -44.88 -47.73 2.30 -43.72 -47.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 -3.03 -41.79 -52.35 -4.64 -42.86 -53.31 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR G 79 TYR^? 1000.00 I 306 VAL G 72 VAL^? 1000.00 I 308 VAL G 83 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 3.85 -41.15 -42.84 3.12 -38.52 -42.24 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.50 -44.88 -47.73 2.30 -43.72 -47.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 2.82 -49.63 -52.11 1.77 -51.41 -51.51 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR H 79 TYR.? 1000.00 I 306 VAL H 72 VAL^? 1000.00 I 308 VAL H 33 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -20.92 -68.65 -21.95 -23.38 -67.79 -22.98 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.88 -65.33 -16.69 -18.85 -67.21 -17.26 coo 16.43 30.18 9.35 15.05 30.67 11.01 -21.88 -61.93 -12.67 -20.98 -60.17 -11.76 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR H 79 TYR.? 1000.00 I 306 VAL H 72 VAL^? 1000.00 I 308 VAL H 83 VAL^? 1000.00 coo 26.18 35.24 6.87 24.33 35.18 8.97 -20.92 -68.65 -21.95 -23.38 -67.79 -22.98 coo 23.55 29.53 9.81 23.15 27.39 10.24 -17.88 -65.33 -16.69 -18.85 -67.21 -17.26 coo 16.43 30.18 9.35 15.05 30.67 11.01 -13.38 -67.17 -11.75 -11.64 -65.86 -11.95 1cqt_d00 source 1cqt GENE REGULATION/DNA : 16 hits 1cqt_d00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 24 PRO.? 1000.00 A 272 LEU A 1 LEU.? 1000.00 A 276 ARG A 74 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -28.23 -16.61 -60.77 -26.99 -18.46 -60.63 coo 10.97 0.43 16.73 11.31 2.11 18.06 -29.32 -10.68 -66.11 -28.49 -10.21 -64.16 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -32.79 -7.25 -57.44 -31.11 -6.28 -55.07 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO A 63 PRO.? 1000.00 A 272 LEU A 61 LEU.? 1000.00 A 276 ARG A 37 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -55.80 -27.75 -46.91 -54.86 -27.26 -48.86 coo 10.97 0.43 16.73 11.31 2.11 18.06 -49.83 -23.71 -48.61 -48.05 -23.01 -49.62 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -55.09 -19.97 -54.34 -55.19 -17.28 -52.85 ULMN 3 1emh_d00 HYDROLASE/DNA user 3 3 # 3 A 271 PRO A 81 PRO.? 1000.00 A 272 LEU A 1 LEU.? 1000.00 A 276 ARG A 74 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -34.08 -15.18 -68.99 -35.07 -13.96 -67.40 coo 10.97 0.43 16.73 11.31 2.11 18.06 -29.32 -10.68 -66.11 -28.49 -10.21 -64.16 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -32.79 -7.25 -57.44 -31.11 -6.28 -55.07 ULMN 3 1emh_d00 HYDROLASE/DNA user 4 3 # 4 A 271 PRO B 63 PRO.? 1000.00 A 272 LEU B 61 LEU.? 1000.00 A 276 ARG B 37 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -24.34 -55.27 -41.87 -25.24 -53.37 -42.56 coo 10.97 0.43 16.73 11.31 2.11 18.06 -21.40 -49.49 -45.06 -21.14 -47.70 -46.24 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -25.67 -45.26 -38.37 -22.78 -45.37 -37.35 ULMN 3 1emh_d00 HYDROLASE/DNA user 5 3 # 5 A 271 PRO C 24 PRO.? 1000.00 A 272 LEU C 1 LEU.? 1000.00 A 276 ARG C 74 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -51.97 -24.01 -36.24 -50.07 -22.85 -36.36 coo 10.97 0.43 16.73 11.31 2.11 18.06 -58.75 -25.15 -38.19 -58.15 -23.97 -36.48 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -60.49 -27.62 -28.92 -60.33 -25.05 -27.20 ULMN 3 1emh_d00 HYDROLASE/DNA user 6 3 # 6 A 271 PRO C 63 PRO.? 1000.00 A 272 LEU C 14 LEU.? 1000.00 A 276 ARG D 70 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -37.97 -50.55 -22.62 -39.16 -50.13 -24.45 coo 10.97 0.43 16.73 11.31 2.11 18.06 -34.65 -47.50 -22.93 -33.38 -48.86 -24.05 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 ULMN 3 1emh_d00 HYDROLASE/DNA user 7 3 # 7 A 271 PRO C 63 PRO.? 1000.00 A 272 LEU C 61 LEU.? 1000.00 A 276 ARG C 37 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -37.97 -50.55 -22.62 -39.16 -50.13 -24.45 coo 10.97 0.43 16.73 11.31 2.11 18.06 -42.16 -44.73 -23.87 -43.04 -43.08 -24.96 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -47.98 -50.77 -27.47 -48.61 -50.31 -24.50 ULMN 3 1emh_d00 HYDROLASE/DNA user 8 3 # 8 A 271 PRO C 63 PRO.? 1000.00 A 272 LEU D 32 LEU^? 1000.00 A 276 ARG D 70 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -37.97 -50.55 -22.62 -39.16 -50.13 -24.45 coo 10.97 0.43 16.73 11.31 2.11 18.06 -33.10 -49.89 -17.38 -34.15 -51.52 -18.36 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 ULMN 3 1emh_d00 HYDROLASE/DNA user 9 3 # 9 A 271 PRO C 81 PRO.? 1000.00 A 272 LEU C 1 LEU.? 1000.00 A 276 ARG C 74 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -55.62 -30.57 -41.49 -56.55 -31.39 -39.65 coo 10.97 0.43 16.73 11.31 2.11 18.06 -58.75 -25.15 -38.19 -58.15 -23.97 -36.48 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -60.49 -27.62 -28.92 -60.33 -25.05 -27.20 ULMN 3 1emh_d00 HYDROLASE/DNA user 10 3 # 10 A 271 PRO D 3 PRO.? 1000.00 A 272 LEU D 1 LEU.? 1000.00 A 276 ARG D 74 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -38.97 -42.03 -10.08 -38.84 -44.23 -9.89 coo 10.97 0.43 16.73 11.31 2.11 18.06 -43.48 -47.31 -12.39 -42.58 -48.99 -11.33 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 ULMN 3 1emh_d00 HYDROLASE/DNA user 11 3 # 11 A 271 PRO D 24 PRO.? 1000.00 A 272 LEU D 1 LEU.? 1000.00 A 276 ARG D 74 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -36.92 -47.80 -7.54 -36.58 -47.25 -5.40 coo 10.97 0.43 16.73 11.31 2.11 18.06 -43.48 -47.31 -12.39 -42.58 -48.99 -11.33 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 ULMN 3 1emh_d00 HYDROLASE/DNA user 12 3 # 12 A 271 PRO D 63 PRO.? 1000.00 A 272 LEU D 61 LEU.? 1000.00 A 276 ARG D 37 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -9.06 -40.12 -22.43 -11.11 -39.32 -22.13 coo 10.97 0.43 16.73 11.31 2.11 18.06 -15.18 -43.21 -19.83 -16.93 -43.67 -18.65 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -18.79 -39.36 -27.13 -18.50 -42.28 -28.04 ULMN 3 1emh_d00 HYDROLASE/DNA user 13 3 # 13 A 271 PRO D 81 PRO.? 1000.00 A 272 LEU D 1 LEU.? 1000.00 A 276 ARG D 74 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -40.42 -40.67 -13.51 -39.79 -42.11 -15.08 coo 10.97 0.43 16.73 11.31 2.11 18.06 -43.48 -47.31 -12.39 -42.58 -48.99 -11.33 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 ULMN 3 1emh_d00 HYDROLASE/DNA user 14 3 # 14 A 271 PRO E 4 PRO.? 1000.00 A 272 LEU E 32 LEU^? 1000.00 A 276 ARG E 70 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -39.39 -12.76 -34.88 -40.26 -13.58 -32.99 coo 10.97 0.43 16.73 11.31 2.11 18.06 -36.02 -8.28 -40.44 -36.81 -6.59 -41.55 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 ULMN 3 1emh_d00 HYDROLASE/DNA user 15 3 # 15 A 271 PRO E 63 PRO.? 1000.00 A 272 LEU B 32 LEU^? 1000.00 A 276 ARG B 70 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -15.10 -24.61 -44.99 -15.96 -23.42 -43.32 coo 10.97 0.43 16.73 11.31 2.11 18.06 -15.99 -30.98 -49.58 -14.58 -29.86 -48.38 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 ULMN 3 1emh_d00 HYDROLASE/DNA user 16 3 # 16 A 271 PRO E 63 PRO.? 1000.00 A 272 LEU E 14 LEU.? 1000.00 A 276 ARG B 70 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -15.10 -24.61 -44.99 -15.96 -23.42 -43.32 coo 10.97 0.43 16.73 11.31 2.11 18.06 -18.09 -28.20 -44.42 -17.13 -29.65 -43.15 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 ULMN 3 1emh_d00 HYDROLASE/DNA user 17 3 # 17 A 271 PRO E 63 PRO.? 1000.00 A 272 LEU E 61 LEU.? 1000.00 A 276 ARG E 37 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -15.10 -24.61 -44.99 -15.96 -23.42 -43.32 coo 10.97 0.43 16.73 11.31 2.11 18.06 -21.51 -21.08 -44.31 -23.39 -20.36 -43.52 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -16.50 -14.01 -41.09 -16.70 -12.05 -43.45 ULMN 3 1emh_d00 HYDROLASE/DNA user 18 3 # 18 A 271 PRO F 63 PRO.? 1000.00 A 272 LEU F 61 LEU.? 1000.00 A 276 ARG F 37 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -39.94 -9.38 -24.24 -40.31 -10.05 -22.15 coo 10.97 0.43 16.73 11.31 2.11 18.06 -43.28 -15.58 -21.60 -43.79 -17.39 -20.54 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -48.09 -10.25 -16.84 -50.78 -9.38 -18.06 ULMN 3 1emh_d00 HYDROLASE/DNA user 19 3 # 19 A 271 PRO G 4 PRO.? 1000.00 A 272 LEU G 32 LEU^? 1000.00 A 276 ARG G 70 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -2.06 -48.51 -47.38 -1.40 -50.62 -47.29 coo 10.97 0.43 16.73 11.31 2.11 18.06 -1.43 -40.60 -48.11 -1.40 -39.04 -46.63 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 5.12 -43.35 -54.49 4.64 -40.53 -53.35 ULMN 3 1emh_d00 HYDROLASE/DNA user 20 3 # 20 A 271 PRO G 63 PRO.? 1000.00 A 272 LEU G 61 LEU.? 1000.00 A 276 ARG G 37 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -5.11 -38.76 -74.30 -3.51 -39.59 -72.99 coo 10.97 0.43 16.73 11.31 2.11 18.06 -5.26 -39.72 -67.18 -5.08 -40.64 -65.25 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 2.57 -36.22 -67.13 1.93 -33.23 -67.01 ULMN 3 1emh_d00 HYDROLASE/DNA user 21 3 # 21 A 271 PRO H 63 PRO.? 1000.00 A 272 LEU H 61 LEU.? 1000.00 A 276 ARG H 37 ARG^? 1000.00 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -27.77 -59.30 8.59 -26.77 -60.93 7.45 coo 10.97 0.43 16.73 11.31 2.11 18.06 -25.94 -59.30 1.67 -24.80 -59.65 -0.12 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -28.82 -68.15 1.75 -31.05 -66.20 1.05 1emh_d00 source 1emh HYDROLASE/DNA : 21 hits 1emh_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG B 74 ARG^? 1000.00 E 41 TYR B 79 TYR^? 1000.00 E 83 ARG C 74 ARG^? 1000.00 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -60.49 -27.62 -28.92 -60.33 -25.05 -27.20 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 2 3 # 2 E 40 ARG B 74 ARG^? 1000.00 E 41 TYR B 79 TYR^? 1000.00 E 83 ARG D 74 ARG^? 1000.00 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -17.36 -23.74 -50.14 -15.01 -23.83 -48.64 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 3 3 # 3 E 40 ARG D 74 ARG^? 1000.00 E 41 TYR D 79 TYR^? 1000.00 E 83 ARG B 74 ARG^? 1000.00 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 4 3 # 4 E 40 ARG D 74 ARG^? 1000.00 E 41 TYR D 79 TYR^? 1000.00 E 83 ARG E 37 ARG^? 1000.00 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -37.44 -53.81 -16.49 -37.27 -56.70 -15.47 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -40.28 -49.19 -18.44 -40.04 -51.71 -19.61 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -16.50 -14.01 -41.09 -16.70 -12.05 -43.45 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 5 3 # 5 E 40 ARG E 37 ARG^? 1000.00 E 41 TYR E 67 TYR^? 1000.00 E 83 ARG H 74 ARG^? 1000.00 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -16.50 -14.01 -41.09 -16.70 -12.05 -43.45 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -21.78 -17.97 -39.77 -20.04 -18.25 -41.94 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -22.72 -62.96 -22.57 -23.62 -60.53 -24.20 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 6 3 # 6 E 40 ARG E 74 ARG^? 1000.00 E 41 TYR E 79 TYR^? 1000.00 E 83 ARG G 74 ARG^? 1000.00 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -40.74 -4.80 -41.62 -42.54 -4.95 -44.12 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -37.58 -3.32 -36.78 -36.84 -2.73 -39.43 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -2.13 -39.52 -42.51 -4.38 -37.99 -41.06 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 7 3 # 7 E 40 ARG F 37 ARG^? 1000.00 E 41 TYR F 67 TYR^? 1000.00 E 83 ARG B 74 ARG^? 1000.00 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -48.09 -10.25 -16.84 -50.78 -9.38 -18.06 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -43.92 -15.50 -16.38 -44.69 -13.85 -18.53 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -12.51 -26.29 -51.32 -9.62 -26.77 -52.26 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 8 3 # 8 E 40 ARG G 37 ARG^? 1000.00 E 41 TYR G 67 TYR^? 1000.00 E 83 ARG A 70 ARG^? 1000.00 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 2.57 -36.22 -67.13 1.93 -33.23 -67.01 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -0.57 -41.43 -65.05 -1.28 -39.10 -66.39 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 9 3 # 9 E 40 ARG H 37 ARG^? 1000.00 E 41 TYR H 67 TYR^? 1000.00 E 83 ARG F 70 ARG^? 1000.00 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 -28.82 -68.15 1.75 -31.05 -66.20 1.05 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 -23.66 -64.07 -0.07 -26.11 -63.42 1.10 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 9 hits 1id3_d00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS C 38 LYS.? 1000.00 D 25 THR C 86 THR^? 1000.00 D 27 SER C 84 SER^? 1000.00 coo 86.60 33.38 44.00 87.05 39.52 42.71 -48.91 -47.57 -33.37 -46.51 -47.64 -39.26 coo 81.20 31.58 48.03 79.23 32.24 47.54 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 coo 79.09 29.82 54.20 77.17 28.90 53.05 -48.21 -36.91 -37.27 -49.64 -38.47 -38.48 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS H 38 LYS.? 1000.00 D 25 THR H 86 THR^? 1000.00 D 27 SER H 84 SER^? 1000.00 coo 86.60 33.38 44.00 87.05 39.52 42.71 -23.13 -70.35 -1.09 -17.90 -72.37 -2.16 coo 81.20 31.58 48.03 79.23 32.24 47.54 -16.49 -66.84 -1.43 -17.05 -68.81 -0.71 coo 79.09 29.82 54.20 77.17 28.90 53.05 -15.03 -67.12 -8.36 -15.25 -69.39 -7.72 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 2 hits 1mjo_d00 naa= 3 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 19 ARG A 70 ARG^? 1000.00 A 30 THR A 54 THR^? 1000.00 A 34 VAL A 19 VAL^? 1000.00 A 38 LYS A 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -30.80 -21.49 -51.59 -28.90 -22.44 -51.89 coo 18.16 36.88 2.14 19.60 35.97 0.73 -38.42 -24.85 -52.20 -39.57 -23.33 -53.18 coo 16.75 32.35 6.21 21.42 30.93 2.22 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 19 ARG A 70 ARG^? 1000.00 A 30 THR A 57 THR^? 1000.00 A 34 VAL A 19 VAL^? 1000.00 A 38 LYS A 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -39.95 -23.49 -46.38 -39.66 -25.04 -44.91 coo 18.16 36.88 2.14 19.60 35.97 0.73 -38.42 -24.85 -52.20 -39.57 -23.33 -53.18 coo 16.75 32.35 6.21 21.42 30.93 2.22 -37.22 -28.25 -56.85 -32.28 -32.18 -57.60 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 3 4 # 3 A 19 ARG B 70 ARG^? 1000.00 A 30 THR B 54 THR^? 1000.00 A 34 VAL B 19 VAL^? 1000.00 A 38 LYS B 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -15.28 -38.81 -60.02 -15.02 -38.82 -62.16 coo 18.16 36.88 2.14 19.60 35.97 0.73 -20.41 -43.49 -55.28 -20.65 -42.35 -53.46 coo 16.75 32.35 6.21 21.42 30.93 2.22 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 4 4 # 4 A 19 ARG B 70 ARG^? 1000.00 A 30 THR B 57 THR^? 1000.00 A 34 VAL B 19 VAL^? 1000.00 A 38 LYS B 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -24.70 -33.13 -46.38 -27.63 -32.17 -46.15 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -15.96 -46.87 -53.11 -15.82 -48.81 -54.08 coo 18.16 36.88 2.14 19.60 35.97 0.73 -20.41 -43.49 -55.28 -20.65 -42.35 -53.46 coo 16.75 32.35 6.21 21.42 30.93 2.22 -25.38 -42.11 -58.10 -26.47 -42.83 -64.39 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 5 4 # 5 A 19 ARG C 70 ARG^? 1000.00 A 30 THR C 54 THR^? 1000.00 A 34 VAL C 19 VAL^? 1000.00 A 38 LYS C 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -44.51 -26.06 -28.26 -43.42 -24.24 -28.77 coo 18.16 36.88 2.14 19.60 35.97 0.73 -41.92 -34.10 -29.06 -43.72 -35.29 -29.37 coo 16.75 32.35 6.21 21.42 30.93 2.22 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 6 4 # 6 A 19 ARG C 70 ARG^? 1000.00 A 30 THR C 57 THR^? 1000.00 A 34 VAL C 19 VAL^? 1000.00 A 38 LYS C 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -54.17 -38.57 -34.81 -56.52 -38.85 -32.83 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -41.24 -34.76 -22.98 -39.22 -34.48 -22.21 coo 18.16 36.88 2.14 19.60 35.97 0.73 -41.92 -34.10 -29.06 -43.72 -35.29 -29.37 coo 16.75 32.35 6.21 21.42 30.93 2.22 -40.26 -33.71 -34.54 -36.67 -32.01 -38.81 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 7 4 # 7 A 19 ARG D 70 ARG^? 1000.00 A 30 THR D 54 THR^? 1000.00 A 34 VAL D 19 VAL^? 1000.00 A 38 LYS D 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -26.58 -49.74 -5.75 -26.83 -49.90 -3.63 coo 18.16 36.88 2.14 19.60 35.97 0.73 -21.95 -44.31 -10.15 -22.96 -44.14 -12.06 coo 16.75 32.35 6.21 21.42 30.93 2.22 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 8 4 # 8 A 19 ARG D 70 ARG^? 1000.00 A 30 THR D 57 THR^? 1000.00 A 34 VAL D 19 VAL^? 1000.00 A 38 LYS D 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -31.42 -41.54 -20.39 -29.35 -40.19 -22.21 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -17.76 -48.52 -11.62 -16.05 -48.76 -10.33 coo 18.16 36.88 2.14 19.60 35.97 0.73 -21.95 -44.31 -10.15 -22.96 -44.14 -12.06 coo 16.75 32.35 6.21 21.42 30.93 2.22 -24.12 -39.44 -7.74 -25.62 -37.12 -1.98 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 9 4 # 9 A 19 ARG E 70 ARG^? 1000.00 A 30 THR E 57 THR^? 1000.00 A 34 VAL E 19 VAL^? 1000.00 A 38 LYS E 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -28.66 -9.13 -35.52 -27.38 -8.32 -32.86 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -31.19 -22.88 -45.65 -31.34 -24.89 -46.32 coo 18.16 36.88 2.14 19.60 35.97 0.73 -32.44 -21.90 -39.82 -31.44 -20.01 -39.55 coo 16.75 32.35 6.21 21.42 30.93 2.22 -33.26 -23.22 -34.19 -36.22 -27.63 -31.10 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 10 4 # 10 A 19 ARG F 70 ARG^? 1000.00 A 30 THR F 54 THR^? 1000.00 A 34 VAL F 19 VAL^? 1000.00 A 38 LYS F 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -42.11 -34.37 -17.32 -40.78 -36.07 -17.42 coo 18.16 36.88 2.14 19.60 35.97 0.73 -40.01 -26.27 -17.45 -41.67 -25.25 -16.50 coo 16.75 32.35 6.21 21.42 30.93 2.22 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 11 4 # 11 A 19 ARG F 70 ARG^? 1000.00 A 30 THR F 57 THR^? 1000.00 A 34 VAL F 19 VAL^? 1000.00 A 38 LYS F 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -41.73 -25.54 -23.37 -40.24 -25.50 -24.95 coo 18.16 36.88 2.14 19.60 35.97 0.73 -40.01 -26.27 -17.45 -41.67 -25.25 -16.50 coo 16.75 32.35 6.21 21.42 30.93 2.22 -36.18 -26.50 -12.89 -30.68 -29.80 -12.62 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 12 4 # 12 A 19 ARG G 70 ARG^? 1000.00 A 30 THR G 57 THR^? 1000.00 A 34 VAL G 19 VAL^? 1000.00 A 38 LYS G 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 5.12 -43.35 -54.49 4.64 -40.53 -53.35 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -11.73 -43.22 -60.42 -13.41 -43.82 -61.59 coo 18.16 36.88 2.14 19.60 35.97 0.73 -7.56 -47.60 -58.66 -5.80 -46.38 -58.39 coo 16.75 32.35 6.21 21.42 30.93 2.22 -4.85 -52.61 -58.68 -5.53 -58.63 -59.63 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 13 4 # 13 A 19 ARG H 70 ARG^? 1000.00 A 30 THR H 57 THR^? 1000.00 A 34 VAL H 19 VAL^? 1000.00 A 38 LYS H 8 LYS^? 1000.00 coo 30.09 31.19 5.41 30.53 28.24 4.72 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 -22.01 -53.02 -4.72 -21.58 -51.28 -3.54 coo 18.16 36.88 2.14 19.60 35.97 0.73 -17.16 -56.78 -5.85 -18.24 -58.59 -6.29 coo 16.75 32.35 6.21 21.42 30.93 2.22 -11.90 -59.13 -5.02 -6.18 -56.50 -4.31 1mnm_d00 source 1mnm TRANSCRIPTION/DNA : 13 hits 1mnm_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 80 SER.? 1000.00 E 5 VAL A 83 VAL^? 1000.00 E 7 ARG A 70 ARG^? 1000.00 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -32.87 -12.53 -65.75 -33.07 -14.16 -63.94 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -37.68 -19.50 -64.15 -35.86 -20.66 -63.99 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -43.51 -16.24 -62.58 -44.66 -13.63 -61.47 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER F 80 SER.? 1000.00 E 5 VAL F 83 VAL^? 1000.00 E 7 ARG F 70 ARG^? 1000.00 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -51.56 -32.47 -3.21 -49.55 -32.33 -4.58 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -44.96 -26.92 -5.54 -43.57 -28.55 -5.80 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -49.51 -21.56 -7.04 -51.52 -19.98 -8.76 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER G 80 SER.? 1000.00 E 5 VAL G 83 VAL^? 1000.00 E 7 ARG G 70 ARG^? 1000.00 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 4.05 -47.12 -43.72 2.13 -47.59 -45.11 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 2.82 -49.63 -52.11 1.77 -51.41 -51.51 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 5.12 -43.35 -54.49 4.64 -40.53 -53.35 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER H 80 SER.? 1000.00 E 5 VAL H 83 VAL^? 1000.00 E 7 ARG H 70 ARG^? 1000.00 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -15.09 -68.56 -20.48 -14.89 -66.67 -19.01 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -13.38 -67.17 -11.75 -11.64 -65.86 -11.95 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -19.76 -70.15 -9.86 -22.49 -69.62 -11.16 2bsq_d00 source 2bsq TRANSCRIPTION : 4 hits 2bsq_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 52 SER.? 1000.00 B 37 ASN E 60 ASN.? 1000.00 B 45 THR E 65 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -26.12 -17.23 -50.15 -24.23 -15.85 -49.52 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -22.11 -19.81 -50.15 -20.36 -18.78 -50.75 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -16.52 -20.30 -38.89 -16.35 -18.81 -40.45 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 52 SER.? 1000.00 B 37 ASN E 60 ASN.? 1000.00 B 45 THR E 66 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -26.12 -17.23 -50.15 -24.23 -15.85 -49.52 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -22.11 -19.81 -50.15 -20.36 -18.78 -50.75 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -18.84 -18.95 -36.17 -18.49 -18.94 -34.03 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER A 52 SER.? 1000.00 B 37 ASN E 60 ASN.? 1000.00 B 45 THR E 88 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -26.12 -17.23 -50.15 -24.23 -15.85 -49.52 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -22.11 -19.81 -50.15 -20.36 -18.78 -50.75 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER A 52 SER.? 1000.00 B 37 ASN E 60 ASN.? 1000.00 B 45 THR E 89 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -26.12 -17.23 -50.15 -24.23 -15.85 -49.52 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -22.11 -19.81 -50.15 -20.36 -18.78 -50.75 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER A 91 SER.? 1000.00 B 37 ASN A 64 ASN.? 1000.00 B 45 THR A 59 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -55.38 -33.21 -50.09 -55.69 -35.22 -51.40 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -56.38 -30.36 -52.57 -56.99 -30.84 -54.55 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -46.25 -22.51 -44.71 -45.19 -22.08 -42.90 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER A 91 SER.? 1000.00 B 37 ASN A 64 ASN.? 1000.00 B 45 THR A 86 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -55.38 -33.21 -50.09 -55.69 -35.22 -51.40 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -56.38 -30.36 -52.57 -56.99 -30.84 -54.55 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -45.50 -25.51 -60.06 -46.77 -25.59 -61.84 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 B 34 SER B 52 SER.? 1000.00 B 37 ASN G 60 ASN.? 1000.00 B 45 THR G 13 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -10.50 -34.89 -61.35 -8.18 -35.21 -60.61 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -7.92 -34.66 -65.50 -6.82 -32.91 -66.09 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -8.92 -45.57 -71.07 -10.80 -44.92 -70.18 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 B 34 SER B 52 SER.? 1000.00 B 37 ASN G 60 ASN.? 1000.00 B 45 THR G 65 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -10.50 -34.89 -61.35 -8.18 -35.21 -60.61 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -7.92 -34.66 -65.50 -6.82 -32.91 -66.09 coo -30.87 34.84 80.57 -28.94 34.51 81.49 1.07 -41.53 -70.84 1.01 -39.41 -70.46 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 B 34 SER B 52 SER.? 1000.00 B 37 ASN G 60 ASN.? 1000.00 B 45 THR G 66 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -10.50 -34.89 -61.35 -8.18 -35.21 -60.61 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -7.92 -34.66 -65.50 -6.82 -32.91 -66.09 coo -30.87 34.84 80.57 -28.94 34.51 81.49 2.66 -43.43 -68.00 4.28 -44.88 -68.13 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 B 34 SER B 52 SER.? 1000.00 B 37 ASN G 60 ASN.? 1000.00 B 45 THR G 88 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -10.50 -34.89 -61.35 -8.18 -35.21 -60.61 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -7.92 -34.66 -65.50 -6.82 -32.91 -66.09 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -0.28 -46.35 -69.13 1.51 -46.38 -70.37 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 B 34 SER B 80 SER.? 1000.00 B 37 ASN E 60 ASN.? 1000.00 B 45 THR E 45 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -21.51 -24.30 -54.11 -21.06 -26.53 -54.83 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -22.11 -19.81 -50.15 -20.36 -18.78 -50.75 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -27.09 -9.60 -44.64 -26.73 -10.81 -46.40 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 B 34 SER B 80 SER.? 1000.00 B 37 ASN E 60 ASN.? 1000.00 B 45 THR E 65 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -21.51 -24.30 -54.11 -21.06 -26.53 -54.83 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -22.11 -19.81 -50.15 -20.36 -18.78 -50.75 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -16.52 -20.30 -38.89 -16.35 -18.81 -40.45 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 B 34 SER B 80 SER.? 1000.00 B 37 ASN E 60 ASN.? 1000.00 B 45 THR E 88 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -21.51 -24.30 -54.11 -21.06 -26.53 -54.83 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -22.11 -19.81 -50.15 -20.36 -18.78 -50.75 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -20.19 -22.76 -35.85 -18.31 -22.41 -34.78 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 14 3 # 14 B 34 SER B 80 SER.? 1000.00 B 37 ASN E 60 ASN.? 1000.00 B 45 THR E 89 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -21.51 -24.30 -54.11 -21.06 -26.53 -54.83 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -22.11 -19.81 -50.15 -20.36 -18.78 -50.75 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -19.86 -24.63 -39.11 -19.59 -23.22 -40.69 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 15 3 # 15 B 34 SER B 91 SER.? 1000.00 B 37 ASN B 64 ASN.? 1000.00 B 45 THR B 59 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -29.69 -56.83 -45.14 -32.02 -56.93 -45.79 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -30.23 -53.68 -43.07 -32.28 -53.15 -43.30 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -16.35 -50.05 -47.32 -14.72 -51.46 -47.70 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 16 3 # 16 B 34 SER B 91 SER.? 1000.00 B 37 ASN B 64 ASN.? 1000.00 B 45 THR B 86 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -29.69 -56.83 -45.14 -32.02 -56.93 -45.79 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -30.23 -53.68 -43.07 -32.28 -53.15 -43.30 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -29.28 -41.29 -49.77 -31.08 -40.36 -48.98 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 17 3 # 17 B 34 SER C 52 SER.? 1000.00 B 37 ASN F 60 ASN.? 1000.00 B 45 THR F 13 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -48.44 -21.43 -26.31 -49.43 -20.95 -24.16 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -46.99 -16.58 -26.18 -47.19 -16.72 -28.31 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -35.07 -16.47 -23.41 -35.86 -17.71 -24.98 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 18 3 # 18 B 34 SER C 52 SER.? 1000.00 B 37 ASN F 60 ASN.? 1000.00 B 45 THR F 65 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -48.44 -21.43 -26.31 -49.43 -20.95 -24.16 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -46.99 -16.58 -26.18 -47.19 -16.72 -28.31 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -41.00 -10.22 -16.65 -42.99 -9.90 -17.42 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 19 3 # 19 B 34 SER C 52 SER.? 1000.00 B 37 ASN F 60 ASN.? 1000.00 B 45 THR F 66 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -48.44 -21.43 -26.31 -49.43 -20.95 -24.16 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -46.99 -16.58 -26.18 -47.19 -16.72 -28.31 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -41.46 -12.42 -13.58 -40.70 -12.09 -11.59 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 20 3 # 20 B 34 SER C 52 SER.? 1000.00 B 37 ASN F 60 ASN.? 1000.00 B 45 THR F 88 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -48.44 -21.43 -26.31 -49.43 -20.95 -24.16 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -46.99 -16.58 -26.18 -47.19 -16.72 -28.31 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -37.77 -14.05 -15.00 -37.42 -12.10 -14.15 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 21 3 # 21 B 34 SER C 52 SER.? 1000.00 B 37 ASN F 60 ASN.? 1000.00 B 45 THR F 89 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -48.44 -21.43 -26.31 -49.43 -20.95 -24.16 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -46.99 -16.58 -26.18 -47.19 -16.72 -28.31 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -37.46 -13.84 -18.76 -39.46 -13.48 -19.54 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 22 3 # 22 B 34 SER C 91 SER.? 1000.00 B 37 ASN C 64 ASN.? 1000.00 B 45 THR C 59 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -33.93 -51.43 -27.03 -33.28 -52.39 -29.17 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -41.85 -40.94 -20.16 -41.56 -39.78 -18.35 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 23 3 # 23 B 34 SER C 91 SER.? 1000.00 B 37 ASN C 64 ASN.? 1000.00 B 45 THR C 86 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -33.93 -51.43 -27.03 -33.28 -52.39 -29.17 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -37.37 -52.62 -28.56 -37.15 -53.44 -30.52 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -44.12 -42.56 -35.90 -45.06 -43.90 -37.35 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 24 3 # 24 B 34 SER D 52 SER.? 1000.00 B 37 ASN H 60 ASN.? 1000.00 B 45 THR H 65 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -30.43 -54.65 -4.66 -29.82 -56.98 -5.11 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -31.01 -56.42 0.05 -32.76 -57.44 0.72 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -24.12 -65.51 5.61 -26.16 -65.65 4.84 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 25 3 # 25 B 34 SER D 52 SER.? 1000.00 B 37 ASN H 60 ASN.? 1000.00 B 45 THR H 66 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -30.43 -54.65 -4.66 -29.82 -56.98 -5.11 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -31.01 -56.42 0.05 -32.76 -57.44 0.72 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -21.74 -67.10 3.11 -20.33 -68.69 3.44 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 26 3 # 26 B 34 SER D 52 SER.? 1000.00 B 37 ASN H 60 ASN.? 1000.00 B 45 THR H 88 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -30.43 -54.65 -4.66 -29.82 -56.98 -5.11 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -31.01 -56.42 0.05 -32.76 -57.44 0.72 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -19.24 -64.03 4.54 -19.35 -65.74 5.89 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 27 3 # 27 B 34 SER D 52 SER.? 1000.00 B 37 ASN H 60 ASN.? 1000.00 B 45 THR H 89 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -30.43 -54.65 -4.66 -29.82 -56.98 -5.11 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -31.01 -56.42 0.05 -32.76 -57.44 0.72 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -21.17 -60.97 5.70 -23.15 -61.14 4.87 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 28 3 # 28 B 34 SER D 80 SER.? 1000.00 B 37 ASN C 60 ASN.? 1000.00 B 45 THR C 65 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -40.65 -44.96 -14.21 -38.59 -44.99 -12.95 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -44.35 -44.07 -18.35 -45.01 -45.72 -17.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -41.67 -50.27 -29.26 -43.16 -50.66 -27.74 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 29 3 # 29 B 34 SER D 80 SER.? 1000.00 B 37 ASN C 60 ASN.? 1000.00 B 45 THR C 66 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -40.65 -44.96 -14.21 -38.59 -44.99 -12.95 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -44.35 -44.07 -18.35 -45.01 -45.72 -17.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 30 3 # 30 B 34 SER D 80 SER.? 1000.00 B 37 ASN C 60 ASN.? 1000.00 B 45 THR C 88 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -40.65 -44.96 -14.21 -38.59 -44.99 -12.95 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -44.35 -44.07 -18.35 -45.01 -45.72 -17.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 31 3 # 31 B 34 SER D 80 SER.? 1000.00 B 37 ASN C 60 ASN.? 1000.00 B 45 THR C 89 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -40.65 -44.96 -14.21 -38.59 -44.99 -12.95 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -44.35 -44.07 -18.35 -45.01 -45.72 -17.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 32 3 # 32 B 34 SER D 80 SER.? 1000.00 B 37 ASN C 60 ASN.? 1000.00 B 45 THR F 20 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -40.65 -44.96 -14.21 -38.59 -44.99 -12.95 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -44.35 -44.07 -18.35 -45.01 -45.72 -17.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -38.97 -29.60 -16.00 -37.34 -30.58 -17.02 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 33 3 # 33 B 34 SER D 91 SER.? 1000.00 B 37 ASN D 64 ASN.? 1000.00 B 45 THR D 59 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -8.43 -33.97 -19.43 -7.90 -31.74 -18.64 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -11.34 -34.22 -21.55 -12.11 -32.24 -21.32 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -14.09 -48.01 -17.36 -13.52 -49.95 -16.61 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 34 3 # 34 B 34 SER D 91 SER.? 1000.00 B 37 ASN D 64 ASN.? 1000.00 B 45 THR D 86 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -8.43 -33.97 -19.43 -7.90 -31.74 -18.64 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -11.34 -34.22 -21.55 -12.11 -32.24 -21.32 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -24.01 -35.70 -16.08 -25.04 -34.15 -17.17 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 35 3 # 35 B 34 SER E 52 SER.? 1000.00 B 37 ASN A 60 ASN.? 1000.00 B 45 THR A 65 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -45.50 -17.46 -43.82 -46.19 -17.10 -46.12 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -49.81 -20.16 -43.76 -51.67 -19.27 -43.26 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -54.07 -26.33 -54.24 -54.69 -24.40 -53.55 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 36 3 # 36 B 34 SER E 52 SER.? 1000.00 B 37 ASN A 60 ASN.? 1000.00 B 45 THR A 66 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -45.50 -17.46 -43.82 -46.19 -17.10 -46.12 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -49.81 -20.16 -43.76 -51.67 -19.27 -43.26 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -51.73 -25.65 -57.14 -51.84 -26.51 -59.11 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 37 3 # 37 B 34 SER E 52 SER.? 1000.00 B 37 ASN A 60 ASN.? 1000.00 B 45 THR A 88 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -45.50 -17.46 -43.82 -46.19 -17.10 -46.12 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -49.81 -20.16 -43.76 -51.67 -19.27 -43.26 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -49.69 -29.03 -55.58 -51.35 -29.56 -56.84 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 38 3 # 38 B 34 SER E 52 SER.? 1000.00 B 37 ASN A 60 ASN.? 1000.00 B 45 THR A 89 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -45.50 -17.46 -43.82 -46.19 -17.10 -46.12 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -49.81 -20.16 -43.76 -51.67 -19.27 -43.26 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -50.23 -29.32 -51.83 -50.84 -27.38 -51.08 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 39 3 # 39 B 34 SER E 91 SER.? 1000.00 B 37 ASN E 64 ASN.? 1000.00 B 45 THR E 59 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -14.63 -28.61 -39.94 -13.90 -29.30 -37.73 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -25.29 -22.15 -48.17 -26.48 -22.83 -49.84 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 40 3 # 40 B 34 SER E 91 SER.? 1000.00 B 37 ASN E 64 ASN.? 1000.00 B 45 THR E 86 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -14.63 -28.61 -39.94 -13.90 -29.30 -37.73 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -13.58 -24.21 -39.04 -13.01 -24.92 -37.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -24.93 -18.44 -32.83 -23.81 -17.47 -31.27 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 41 3 # 41 B 34 SER F 52 SER.? 1000.00 B 37 ASN C 60 ASN.? 1000.00 B 45 THR C 65 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -46.01 -39.55 -17.99 -47.86 -39.76 -19.53 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -44.35 -44.07 -18.35 -45.01 -45.72 -17.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -41.67 -50.27 -29.26 -43.16 -50.66 -27.74 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 42 3 # 42 B 34 SER F 52 SER.? 1000.00 B 37 ASN C 60 ASN.? 1000.00 B 45 THR C 66 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -46.01 -39.55 -17.99 -47.86 -39.76 -19.53 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -44.35 -44.07 -18.35 -45.01 -45.72 -17.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -43.18 -48.26 -32.10 -43.09 -48.60 -34.21 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 43 3 # 43 B 34 SER F 52 SER.? 1000.00 B 37 ASN C 60 ASN.? 1000.00 B 45 THR C 88 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -46.01 -39.55 -17.99 -47.86 -39.76 -19.53 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -44.35 -44.07 -18.35 -45.01 -45.72 -17.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -39.54 -46.44 -32.09 -39.38 -48.35 -33.07 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 44 3 # 44 B 34 SER F 52 SER.? 1000.00 B 37 ASN C 60 ASN.? 1000.00 B 45 THR C 89 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -46.01 -39.55 -17.99 -47.86 -39.76 -19.53 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -44.35 -44.07 -18.35 -45.01 -45.72 -17.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -37.95 -46.45 -28.66 -39.53 -46.70 -27.23 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 45 3 # 45 B 34 SER F 91 SER.? 1000.00 B 37 ASN F 64 ASN.? 1000.00 B 45 THR F 59 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -34.13 -8.62 -20.75 -32.18 -7.69 -19.64 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -37.43 -7.55 -18.77 -36.26 -6.95 -17.07 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -43.89 -19.57 -25.18 -44.09 -20.84 -26.90 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 46 3 # 46 B 34 SER F 91 SER.? 1000.00 B 37 ASN F 64 ASN.? 1000.00 B 45 THR F 86 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -34.13 -8.62 -20.75 -32.18 -7.69 -19.64 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -37.43 -7.55 -18.77 -36.26 -6.95 -17.07 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -40.71 -18.28 -10.10 -40.84 -17.16 -8.25 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 47 3 # 47 B 34 SER G 52 SER.? 1000.00 B 37 ASN B 60 ASN.? 1000.00 B 45 THR B 65 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -13.13 -46.81 -45.25 -14.55 -45.95 -43.43 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -15.86 -50.56 -42.98 -15.94 -50.96 -40.87 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -28.51 -49.05 -42.85 -27.19 -48.57 -41.20 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 48 3 # 48 B 34 SER G 52 SER.? 1000.00 B 37 ASN B 60 ASN.? 1000.00 B 45 THR B 66 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -13.13 -46.81 -45.25 -14.55 -45.95 -43.43 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -15.86 -50.56 -42.98 -15.94 -50.96 -40.87 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -29.43 -45.79 -44.56 -31.38 -45.09 -45.08 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 49 3 # 49 B 34 SER G 52 SER.? 1000.00 B 37 ASN B 60 ASN.? 1000.00 B 45 THR B 88 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -13.13 -46.81 -45.25 -14.55 -45.95 -43.43 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -15.86 -50.56 -42.98 -15.94 -50.96 -40.87 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -29.52 -48.22 -47.90 -31.42 -48.56 -46.89 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 50 3 # 50 B 34 SER G 52 SER.? 1000.00 B 37 ASN B 60 ASN.? 1000.00 B 45 THR B 89 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -13.13 -46.81 -45.25 -14.55 -45.95 -43.43 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -15.86 -50.56 -42.98 -15.94 -50.96 -40.87 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -27.18 -51.21 -47.58 -25.70 -50.66 -46.11 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 51 3 # 51 B 34 SER G 91 SER.? 1000.00 B 37 ASN G 64 ASN.? 1000.00 B 45 THR G 59 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -3.55 -44.09 -76.94 -2.03 -45.54 -78.17 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -0.17 -42.42 -75.48 1.47 -43.70 -76.00 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -9.93 -38.54 -64.86 -11.89 -37.80 -64.34 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 52 3 # 52 B 34 SER G 91 SER.? 1000.00 B 37 ASN G 64 ASN.? 1000.00 B 45 THR G 86 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -3.55 -44.09 -76.94 -2.03 -45.54 -78.17 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -0.17 -42.42 -75.48 1.47 -43.70 -76.00 coo -30.87 34.84 80.57 -28.94 34.51 81.49 2.42 -48.12 -62.78 4.54 -47.79 -63.09 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 53 3 # 53 B 34 SER H 52 SER.? 1000.00 B 37 ASN D 60 ASN.? 1000.00 B 45 THR D 65 THR.? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -16.59 -51.82 -19.50 -18.37 -50.36 -20.32 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -13.49 -48.64 -21.67 -12.21 -50.31 -21.41 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -15.80 -36.12 -22.45 -15.92 -37.62 -24.01 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 54 3 # 54 B 34 SER H 52 SER.? 1000.00 B 37 ASN D 60 ASN.? 1000.00 B 45 THR D 66 THR^? 1000.00 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -16.59 -51.82 -19.50 -18.37 -50.36 -20.32 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -13.49 -48.64 -21.67 -12.21 -50.31 -21.41 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -19.29 -35.44 -21.10 -20.09 -33.46 -20.75 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 55 3 # 55 B 34 SER H 52 SER.? 1000.00 B 37 ASN D 60 ASN.? 1000.00 B 45 THR D 88 THR^? 1000.00